data_5x3y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x3y _Structure_validation_residue.Date_analyzed 2017-12-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -139.61 160.62 39.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.224 1.41 . . . . 0.0 112.196 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.07 151.71 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.907 1.283 . . . . 0.0 112.675 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.57 149.78 25.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.044 1.738 . . . . 0.0 112.519 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.24 138.22 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.417 1.487 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.56 15.0 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.033 0.773 . . . . 0.0 115.033 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.02 14.13 25.45 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.749 1.642 . . . . 0.0 114.397 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.6 139.25 57.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.37 1.468 . . . . 0.0 112.325 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.87 151.67 44.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.72 0.808 . . . . 0.0 111.165 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 t -68.37 -20.67 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.553 -0.717 . . . . 0.0 111.346 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -68.07 -28.94 67.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.528 1.131 . . . . 0.0 113.214 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 60.1 m -79.36 132.77 36.52 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.542 1.537 . . . . 0.0 112.827 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.69 165.9 13.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.17 -31.59 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -74.21 -33.47 63.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.38 0.672 . . . . 0.0 111.735 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.55 -47.98 83.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.099 0.56 . . . . 0.0 112.14 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.94 -45.47 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.106 0.562 . . . . 0.0 110.725 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -42.54 91.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.094 0.558 . . . . 0.0 111.813 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.71 -53.58 32.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.526 1.131 . . . . 0.0 112.774 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -59.2 -34.57 72.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 117.633 2.456 . . . . 0.0 117.633 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.32 38.0 m-85 -70.75 -15.8 62.71 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 173.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.42 -10.97 58.86 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -62.52 -25.6 68.11 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.159 -0.963 . . . . 0.0 113.59 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.77 -30.51 18.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.399 1.08 . . . . 0.0 113.284 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 177.83 36.74 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.97 2.224 . . . . 0.0 110.765 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -61.89 124.96 22.21 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.996 . . . . 0.0 112.375 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.3 t -95.87 125.24 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.753 1.621 . . . . 0.0 107.019 168.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.64 -41.03 19.95 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.835 -0.541 . . . . 0.0 109.688 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -162.69 165.72 25.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.317 2.247 . . . . 0.0 114.987 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.66 154.25 45.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.169 1.388 . . . . 0.0 110.748 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.1 mtp -148.95 152.96 37.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.655 1.582 . . . . 0.0 111.462 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -125.85 150.97 47.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.321 1.448 . . . . 0.0 111.742 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.601 0.76 . . . . 0.0 111.386 179.519 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.7 p80 . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.242 0.544 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -80.64 8.81 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.17 11.59 69.37 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.631 1.11 . . . . 0.0 114.503 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.273 12.3 p90 -144.56 158.75 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.93 -158.22 18.38 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.187 0.899 . . . . 0.0 114.739 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -139.78 151.36 45.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.953 2.101 . . . . 0.0 114.18 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.6 129.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.125 1.37 . . . . 0.0 111.804 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.0 m -94.44 128.89 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.28 1.832 . . . . 0.0 113.045 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -104.98 150.31 25.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.14 -35.7 81.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 113.048 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.1 t -147.45 141.22 25.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.667 1.187 . . . . 0.0 112.652 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.35 -26.25 68.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.292 1.437 . . . . 0.0 113.474 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.9 -27.43 66.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.6 mm -77.74 -50.1 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.777 0.831 . . . . 0.0 109.89 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 66.9 t -54.84 -35.12 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.155 1.382 . . . . 0.0 111.576 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -48.91 -51.05 32.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -70.36 -44.18 68.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.555 0.616 . . . . 0.0 111.606 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.25 -47.18 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 18.9 t -74.51 -29.58 61.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.558 1.143 . . . . 0.0 112.53 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.52 -41.4 93.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.947 -1.096 . . . . 0.0 112.047 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.75 119.85 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -68.39 -59.14 3.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.993 -1.067 . . . . 0.0 111.36 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.302 61.3 m-85 -101.81 139.18 37.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -135.79 135.53 39.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.554 1.942 . . . . 0.0 110.819 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -80.85 135.84 36.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.309 0.644 . . . . 0.0 111.904 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.7 mt -144.89 122.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.732 2.013 . . . . 0.0 108.383 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 50.48 38.65 18.94 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.3 t30 62.78 -12.5 0.07 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 128.112 2.565 . . . . 0.0 115.942 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -73.36 141.81 47.04 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.307 -1.495 . . . . 0.0 108.594 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 51.8 mtm -94.32 142.45 27.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.078 0.854 . . . . 0.0 112.346 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.67 153.35 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.325 2.25 . . . . 0.0 111.311 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.44 157.06 16.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 112.106 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.7 p -133.93 157.27 46.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.537 0.735 . . . . 0.0 112.063 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -145.9 171.59 14.59 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.981 1.712 . . . . 0.0 111.327 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -61.07 149.51 36.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.124 0.97 . . . . 0.0 113.217 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 125.137 1.375 . . . . 0.0 111.275 172.571 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -133.22 159.31 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.547 1.139 . . . . 0.0 112.865 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.94 152.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 112.861 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -86.44 148.71 25.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 112.317 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.5 135.88 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.428 1.491 . . . . 0.0 109.421 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.41 146.71 15.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.97 10.29 32.66 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.828 1.68 . . . . 0.0 114.287 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.06 141.09 58.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.342 1.457 . . . . 0.0 112.321 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -68.81 156.77 37.77 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.791 0.836 . . . . 0.0 112.588 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.38 -27.72 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.649 0.78 . . . . 0.0 110.067 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -64.91 -31.84 73.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.972 0.909 . . . . 0.0 112.696 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 135.53 50.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.015 1.326 . . . . 0.0 113.426 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.88 166.64 13.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.177 1.391 . . . . 0.0 114.635 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.74 -32.75 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -34.84 78.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.85 0.86 . . . . 0.0 112.744 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -67.18 -45.37 77.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.698 0.799 . . . . 0.0 109.853 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.85 -48.08 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.702 1.201 . . . . 0.0 110.428 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -62.53 -47.33 84.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 111.93 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.13 -40.98 87.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.747 0.819 . . . . 0.0 112.419 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -65.89 -51.55 57.72 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 46.9 m-85 -64.17 -25.85 68.26 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -60.74 -17.51 49.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.21 -29.47 70.28 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.369 -0.832 . . . . 0.0 113.058 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.53 -36.19 38.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.5 33.43 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.219 2.342 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.81 124.64 21.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.349 1.074 . . . . 0.0 112.723 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.46 118.45 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.251 1.42 . . . . 0.0 108.637 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.19 -31.6 43.89 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -162.05 160.4 27.46 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.938 1.295 . . . . 0.0 109.516 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.87 152.29 31.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.15 1.38 . . . . 0.0 111.093 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -156.77 156.05 32.64 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.377 1.071 . . . . 0.0 112.323 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.03 149.54 44.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.619 1.568 . . . . 0.0 110.391 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 70.3 mtp . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 112.201 -176.689 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 p80 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.364 0.602 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.06 8.76 2.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.49 13.9 66.93 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.855 1.217 . . . . 0.0 114.329 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.269 8.9 p90 -146.49 160.09 42.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.16 -162.15 21.94 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.221 0.915 . . . . 0.0 114.797 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -138.24 147.3 43.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.88 2.072 . . . . 0.0 114.447 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.71 125.47 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 111.159 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 m -96.42 123.3 40.03 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 111.739 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.29 152.59 18.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -67.67 -34.16 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.541 -0.724 . . . . 0.0 112.399 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.5 t -142.87 137.73 29.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.464 1.126 . . . . 0.0 113.845 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -56.3 -27.36 55.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.117 2.167 . . . . 0.0 112.972 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.92 -28.38 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.72 -48.62 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.893 0.877 . . . . 0.0 109.786 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.02 -38.98 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.075 1.35 . . . . 0.0 110.998 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.62 -34.34 67.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.93 -48.36 14.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.02 0.827 . . . . 0.0 111.713 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.89 -44.73 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.964 0.802 . . . . 0.0 112.558 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.12 -21.45 58.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.011 1.324 . . . . 0.0 112.907 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -78.02 -34.68 50.52 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.946 -1.096 . . . . 0.0 112.396 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.56 139.94 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.691 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -127.08 156.69 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 0.0 113.108 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.466 24.9 m-85 60.31 49.27 7.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -58.86 133.47 56.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.858 2.063 . . . . 0.0 110.993 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -98.66 126.51 44.29 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.287 0.948 . . . . 0.0 113.155 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 mt -142.57 123.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.951 1.7 . . . . 0.0 109.392 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 50.36 41.54 24.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.39 1.076 . . . . 0.0 113.55 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 64.89 -13.41 0.11 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 127.822 2.449 . . . . 0.0 116.002 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -73.9 155.43 38.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.069 1.748 . . . . 0.0 109.283 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.4 ptm -120.77 136.06 54.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.874 0.87 . . . . 0.0 111.188 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.77 143.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.808 1.643 . . . . 0.0 113.602 -169.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -87.02 159.24 19.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.268 0.556 . . . . 0.0 111.353 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.5 p -138.13 155.96 48.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.122 0.969 . . . . 0.0 111.583 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -146.15 167.73 22.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.682 1.593 . . . . 0.0 110.865 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -58.9 151.47 21.62 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.591 -0.693 . . . . 0.0 112.248 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 125.283 1.433 . . . . 0.0 110.138 173.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.591 0.71 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -149.29 154.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.612 1.165 . . . . 0.0 110.641 -171.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.51 150.77 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.361 1.064 . . . . 0.0 112.884 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.44 145.51 25.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.367 1.867 . . . . 0.0 111.912 166.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.21 137.83 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.614 1.566 . . . . 0.0 110.117 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.28 147.18 17.07 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 114.688 0.635 . . . . 0.0 114.688 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.96 13.21 29.9 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.693 1.616 . . . . 0.0 114.649 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.54 137.95 58.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.729 1.264 . . . . 0.0 112.205 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -64.72 156.43 30.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.714 1.206 . . . . 0.0 112.821 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 m -71.86 -16.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.252 0.621 . . . . 0.0 111.349 168.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.02 -38.12 85.37 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 111.739 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.15 146.97 54.28 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 t -133.2 166.45 22.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.388 1.875 . . . . 0.0 112.76 169.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.73 -33.33 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.0 -39.89 87.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.436 0.694 . . . . 0.0 112.149 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.9 -43.52 95.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.77 -47.2 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.204 0.602 . . . . 0.0 110.467 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.77 -48.19 82.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.591 0.632 . . . . 0.0 111.803 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -60.8 -39.03 87.38 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -68.3 -40.74 81.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.323 52.8 m-85 -71.32 -29.82 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.44 -18.1 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -65.71 -24.9 67.09 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.295 -0.878 . . . . 0.0 112.884 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.27 -29.32 26.54 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.94 178.87 36.21 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.57 2.033 . . . . 0.0 110.921 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.86 116.3 6.21 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.654 -0.91 . . . . 0.0 112.549 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.65 130.68 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.844 1.658 . . . . 0.0 107.146 169.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.38 -54.07 7.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.673 0.789 . . . . 0.0 112.918 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.84 165.94 29.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.528 1.131 . . . . 0.0 110.003 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.93 149.8 37.38 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.588 1.555 . . . . 0.0 111.647 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.9 mtp -148.41 152.17 36.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.555 1.542 . . . . 0.0 111.713 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.8 mt -125.88 154.11 43.2 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.04 1.336 . . . . 0.0 111.92 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 123.642 0.777 . . . . 0.0 110.664 178.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 p80 . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.508 0.67 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -73.73 0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.691 1.996 . . . . 0.0 115.603 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.19 9.01 65.91 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.714 1.15 . . . . 0.0 113.88 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 17.6 p90 -144.99 158.82 43.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.74 -158.66 19.36 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.228 0.918 . . . . 0.0 114.693 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.69 148.95 47.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.605 1.962 . . . . 0.0 114.02 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 t -133.81 132.0 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.132 1.373 . . . . 0.0 111.38 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.8 m -98.52 139.83 33.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.353 1.861 . . . . 0.0 113.954 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.56 154.96 34.66 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.49 -32.58 70.15 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -150.02 146.55 27.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.44 1.096 . . . . 0.0 113.14 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.15 -28.43 69.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.809 1.244 . . . . 0.0 112.613 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.57 -31.79 71.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.9 mm -76.86 -46.12 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.711 0.804 . . . . 0.0 110.152 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.38 -41.13 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.688 1.195 . . . . 0.0 110.252 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -57.72 -49.93 74.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.038 0.836 . . . . 0.0 113.137 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.53 -44.78 81.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.764 0.711 . . . . 0.0 111.779 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.15 -45.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.534 0.607 . . . . 0.0 110.138 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.5 t -67.83 -36.19 79.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.391 1.077 . . . . 0.0 112.745 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -66.68 -41.03 88.77 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.13 -0.981 . . . . 0.0 112.657 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mt -67.01 134.42 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.682 0.793 . . . . 0.0 110.496 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -112.12 148.64 33.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.128 1.371 . . . . 0.0 111.586 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.49 29.3 m-85 57.16 57.02 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -63.59 128.92 38.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.471 1.508 . . . . 0.0 111.405 173.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.06 133.46 36.12 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.84 0.745 . . . . 0.0 112.264 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.4 mt -146.34 124.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.974 2.11 . . . . 0.0 108.235 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.6 m120 50.98 43.23 28.94 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.175 0.99 . . . . 0.0 113.167 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.78 -13.99 0.08 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.262 2.625 . . . . 0.0 116.485 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.08 169.97 17.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.819 2.047 . . . . 0.0 109.28 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.2 ptp -127.33 146.11 50.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.852 0.861 . . . . 0.0 113.193 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.38 164.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.935 2.494 . . . . 0.0 112.894 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -128.25 158.38 38.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.504 0.722 . . . . 0.0 111.893 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.53 157.42 44.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 113.37 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -142.27 159.07 42.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.167 1.787 . . . . 0.0 111.256 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.15 144.5 45.62 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.577 0.626 . . . . 0.0 112.542 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 C-N-CA 125.346 1.458 . . . . 0.0 111.07 178.496 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 pttp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 122.121 0.962 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -136.4 155.99 49.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.755 1.622 . . . . 0.0 112.485 -168.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.26 157.52 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.571 1.549 . . . . 0.0 113.379 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -94.09 147.34 23.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.173 2.189 . . . . 0.0 113.29 167.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.4 t -137.31 138.93 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.727 1.611 . . . . 0.0 110.061 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.77 154.16 25.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.704 0.669 . . . . 0.0 114.414 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.12 15.02 31.83 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.379 1.466 . . . . 0.0 114.596 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.66 143.03 58.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.004 1.322 . . . . 0.0 112.493 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 p -76.51 175.5 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.453 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 m -81.61 -24.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 0.0 112.684 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -77.32 -33.3 55.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.194 0.998 . . . . 0.0 111.663 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.8 m -65.44 143.97 57.35 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.246 1.418 . . . . 0.0 113.356 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 t -142.72 173.42 11.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.26 1.824 . . . . 0.0 112.715 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.52 -34.15 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.58 -38.67 84.39 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.879 0.872 . . . . 0.0 112.165 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.64 -43.24 85.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.1 t -58.66 -46.88 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.388 0.675 . . . . 0.0 109.867 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -60.57 -46.94 88.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.427 0.558 . . . . 0.0 111.887 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -61.43 -45.09 95.76 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -66.61 -38.75 87.63 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.333 46.7 m-85 -71.62 -29.84 65.12 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.91 -18.93 48.64 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -66.17 -24.96 66.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.494 0.718 . . . . 0.0 112.746 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.67 -34.86 30.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.43 169.54 28.13 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.059 2.266 . . . . 0.0 110.466 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -57.49 130.42 46.23 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.953 0.901 . . . . 0.0 112.768 -170.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.81 122.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.465 1.506 . . . . 0.0 108.249 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.08 -40.02 63.05 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -156.52 154.84 30.97 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.062 2.145 . . . . 0.0 114.646 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.38 142.72 30.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.359 1.064 . . . . 0.0 110.7 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.2 mtm -150.38 151.83 33.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.499 1.52 . . . . 0.0 111.649 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.98 156.86 31.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.173 1.389 . . . . 0.0 111.694 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.4 tpp . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.752 0.821 . . . . 0.0 110.205 170.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.1 p80 . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -86.37 8.23 22.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.85 6.37 67.41 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.136 1.35 . . . . 0.0 115.035 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -146.38 162.77 37.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.03 -158.14 20.24 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.186 0.898 . . . . 0.0 114.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -135.97 151.06 49.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.28 1.832 . . . . 0.0 114.547 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -135.42 123.74 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.151 1.38 . . . . 0.0 111.468 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 m -87.79 129.04 35.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.163 1.385 . . . . 0.0 113.125 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.86 160.26 14.44 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -62.24 -39.69 93.7 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.418 -0.801 . . . . 0.0 112.038 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.2 t -149.21 148.57 29.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.728 1.211 . . . . 0.0 113.592 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -57.83 -27.5 63.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 112.674 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.82 -21.86 66.22 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.46 -50.38 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.739 0.816 . . . . 0.0 109.819 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.94 -38.67 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.281 1.433 . . . . 0.0 111.275 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -60.33 -43.17 96.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -68.29 -37.76 80.98 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.666 0.667 . . . . 0.0 111.552 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.67 -37.74 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.482 0.583 . . . . 0.0 110.996 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 85.6 m -77.65 -28.85 51.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.243 1.417 . . . . 0.0 114.585 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -69.06 -38.41 79.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.048 0.84 . . . . 0.0 112.939 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.8 mt -74.61 140.86 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.796 0.838 . . . . 0.0 109.94 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -130.44 164.04 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.478 1.111 . . . . 0.0 112.666 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.331 57.5 m-85 60.87 40.67 15.43 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -175.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -57.39 131.87 51.4 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 111.584 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.22 128.97 34.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.368 -0.833 . . . . 0.0 112.27 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.26 120.86 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.358 1.863 . . . . 0.0 108.812 172.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 50.58 40.6 24.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.844 0.858 . . . . 0.0 113.04 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 63.25 -12.97 0.08 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 128.203 2.601 . . . . 0.0 116.421 -171.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -74.02 142.91 45.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.829 1.652 . . . . 0.0 109.052 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 34.3 mtt -89.06 141.0 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.244 -0.91 . . . . 0.0 112.487 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.3 159.49 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.297 2.239 . . . . 0.0 111.916 173.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.83 154.64 44.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 110.166 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.4 p -140.31 159.62 41.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.027 0.931 . . . . 0.0 113.292 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -141.48 158.94 43.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.735 1.614 . . . . 0.0 110.653 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -62.4 140.19 58.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.707 1.603 . . . . 0.0 110.71 170.153 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 49.7 pttt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.829 1.299 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -137.18 151.95 49.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.407 1.883 . . . . 0.0 111.325 -167.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -134.01 153.76 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.658 1.183 . . . . 0.0 113.285 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -88.93 146.47 24.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.613 1.965 . . . . 0.0 112.747 166.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.48 132.87 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.694 1.598 . . . . 0.0 109.769 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.04 145.91 14.52 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 114.623 0.609 . . . . 0.0 114.623 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.09 11.37 32.19 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.633 1.587 . . . . 0.0 114.436 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.75 138.44 58.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.196 1.398 . . . . 0.0 111.947 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -69.4 156.93 38.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.507 1.123 . . . . 0.0 112.447 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.36 -16.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.618 -0.676 . . . . 0.0 111.62 168.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -73.47 -7.57 52.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.604 1.562 . . . . 0.0 114.238 169.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER -92.02 151.67 20.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -139.64 161.31 37.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.887 1.275 . . . . 0.0 113.953 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.39 -33.23 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -68.37 -38.85 81.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.541 0.736 . . . . 0.0 112.318 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -67.44 -38.86 85.18 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.55 -51.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.398 1.079 . . . . 0.0 109.322 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.78 -43.56 98.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.008 0.822 . . . . 0.0 112.352 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -59.89 -39.29 84.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.752 0.821 . . . . 0.0 112.665 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -66.79 -48.37 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.313 55.6 m-85 -64.16 -29.97 71.06 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -57.37 -22.64 44.04 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.476 1.51 . . . . 0.0 114.65 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.66 -24.85 62.77 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.192 -0.943 . . . . 0.0 112.761 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -79.25 -37.91 36.83 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.58 172.04 35.03 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.593 2.044 . . . . 0.0 110.895 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.07 130.76 48.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.766 0.783 . . . . 0.0 112.579 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.4 t -99.12 131.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.138 1.775 . . . . 0.0 108.493 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -79.12 -54.14 6.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.82 0.848 . . . . 0.0 112.952 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -152.86 157.27 40.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.019 1.327 . . . . 0.0 110.57 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.4 141.08 23.52 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.022 1.329 . . . . 0.0 110.915 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 54.5 mmm -149.85 153.21 36.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.666 1.586 . . . . 0.0 112.341 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.38 152.98 39.63 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.423 1.489 . . . . 0.0 110.648 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.47 0.542 0 O-C-N 121.894 -0.503 . . . . 0.0 110.36 176.242 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 121.529 0.681 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -79.26 5.52 12.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.294 1.838 . . . . 0.0 114.643 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.34 6.11 63.08 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.468 1.509 . . . . 0.0 114.334 -170.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.255 10.9 p90 -147.69 157.0 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.67 -162.3 22.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.507 1.051 . . . . 0.0 114.63 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -138.54 148.62 44.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.338 1.855 . . . . 0.0 114.112 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.34 124.3 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.138 1.375 . . . . 0.0 111.64 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 135.7 33.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.504 1.522 . . . . 0.0 113.741 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.19 156.0 20.39 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.14 -28.87 65.71 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.2 t -150.39 141.52 23.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.57 1.148 . . . . 0.0 112.89 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -59.63 -26.56 65.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 113.234 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.59 -29.33 69.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.3 mm -78.24 -46.36 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.771 0.828 . . . . 0.0 110.074 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.23 -43.09 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.965 1.306 . . . . 0.0 110.522 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.9 -46.36 65.6 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.64 -0.662 . . . . 0.0 112.076 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.65 -37.24 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.042 0.837 . . . . 0.0 111.638 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.83 -35.1 67.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.887 1.275 . . . . 0.0 112.765 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -68.8 -37.95 79.61 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.208 -0.932 . . . . 0.0 112.661 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.19 139.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 110.636 174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -129.88 161.97 29.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.399 1.48 . . . . 0.0 111.426 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.44 8.1 m-30 64.46 46.07 3.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -68.13 122.42 18.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.974 2.11 . . . . 0.0 111.056 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -86.93 121.34 29.27 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.545 1.066 . . . . 0.0 113.467 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.5 mt -143.21 124.74 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.277 1.431 . . . . 0.0 109.6 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 48.04 49.84 16.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.33 1.452 . . . . 0.0 113.02 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 64.92 -12.32 0.13 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.905 2.882 . . . . 0.0 116.575 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -86.08 165.37 16.68 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.361 2.264 . . . . 0.0 110.304 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 44.5 mtm -122.09 143.13 49.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.639 0.775 . . . . 0.0 112.485 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.72 163.58 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.912 2.085 . . . . 0.0 113.642 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -115.18 148.75 38.67 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.138 1.375 . . . . 0.0 111.896 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 81.2 m -120.57 152.35 38.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.857 1.263 . . . . 0.0 112.508 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.92 158.24 43.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.579 1.552 . . . . 0.0 111.2 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.662 -0.649 . . . . 0.0 111.002 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.68 . . . . 0.0 110.571 174.458 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.68 0.752 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -152.82 146.36 24.98 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.442 1.497 . . . . 0.0 111.031 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.2 pt -138.21 149.66 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -83.32 147.89 27.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.411 1.885 . . . . 0.0 111.724 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.35 136.5 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.266 1.426 . . . . 0.0 109.584 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.37 147.76 18.25 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.52 39.27 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.706 1.622 . . . . 0.0 114.552 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.4 mt -65.01 139.88 58.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 112.494 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 t -64.76 156.8 29.36 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.575 1.15 . . . . 0.0 112.4 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.91 -25.28 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.899 0.88 . . . . 0.0 109.504 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.741 0.816 . . . . 0.0 112.592 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -75.23 125.51 29.1 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.52 1.528 . . . . 0.0 115.095 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -91.91 167.82 11.85 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.95 -29.71 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.23 -38.3 63.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.313 0.645 . . . . 0.0 111.537 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.28 -44.93 92.44 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.31 -50.81 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.37 1.068 . . . . 0.0 109.115 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -62.01 -45.86 91.74 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.842 0.746 . . . . 0.0 111.88 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.62 -42.38 98.81 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.97 0.908 . . . . 0.0 112.592 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -63.55 -48.63 76.67 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.305 52.0 m-85 -65.29 -30.54 71.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -61.6 -19.12 61.87 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 172.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -68.59 -24.64 64.61 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.143 0.883 . . . . 0.0 112.712 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -80.86 -38.22 28.52 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.98 0.912 . . . . 0.0 113.012 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 170.37 30.82 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.904 2.192 . . . . 0.0 110.981 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -169.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.32 120.36 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 109.109 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.92 -42.44 69.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.829 1.252 . . . . 0.0 114.24 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -155.94 155.25 32.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.074 2.15 . . . . 0.0 114.874 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.65 141.7 27.14 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.426 1.09 . . . . 0.0 110.692 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.1 mtm -151.0 146.12 26.01 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.343 1.457 . . . . 0.0 111.713 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.9 mt -125.15 156.15 38.81 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.268 1.427 . . . . 0.0 111.49 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.471 0.586 0 C-N-CA 124.155 0.982 . . . . 0.0 113.01 -175.839 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.784 0.802 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -75.7 3.96 8.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.973 1.709 . . . . 0.0 115.138 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.16 12.06 59.21 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.243 1.401 . . . . 0.0 114.804 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -147.58 159.88 43.26 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.85 -156.16 15.78 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 114.957 0.743 . . . . 0.0 114.957 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -134.47 147.12 50.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.612 1.965 . . . . 0.0 115.202 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.48 126.47 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.63 1.572 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.1 m -99.69 130.39 45.91 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.307 1.443 . . . . 0.0 112.693 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.6 152.72 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -67.17 -33.49 75.52 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.4 t -148.06 143.88 27.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.608 1.163 . . . . 0.0 113.035 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -58.51 -26.67 63.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 113.143 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -58.7 -27.94 65.32 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.33 -50.51 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.47 0.708 . . . . 0.0 110.163 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.12 -37.3 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.855 1.262 . . . . 0.0 112.492 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -55.07 -38.17 67.71 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.79 -48.05 27.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.765 0.711 . . . . 0.0 111.721 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.45 -44.52 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 118.739 0.7 . . . . 0.0 112.651 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 25.1 t -73.26 -29.84 63.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.659 1.184 . . . . 0.0 112.427 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -70.34 -38.03 74.76 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.077 -1.014 . . . . 0.0 112.677 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.3 mt -66.06 139.57 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.752 0.821 . . . . 0.0 110.577 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -125.54 149.9 47.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.353 1.461 . . . . 0.0 111.104 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.458 24.6 m-85 58.31 53.3 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -59.0 124.72 20.85 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.803 2.041 . . . . 0.0 111.423 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -93.6 124.22 37.45 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.3 mt -143.53 125.65 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.548 1.539 . . . . 0.0 109.324 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 49.73 42.7 23.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.398 1.079 . . . . 0.0 113.443 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 63.06 -11.05 0.09 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 128.212 2.605 . . . . 0.0 116.236 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -77.9 161.52 27.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.149 1.78 . . . . 0.0 109.336 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.1 ptp -122.32 144.33 49.07 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.8 164.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.678 2.391 . . . . 0.0 112.949 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -133.66 160.79 36.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.664 0.786 . . . . 0.0 112.278 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.46 157.6 45.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 0.0 113.679 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -144.07 162.82 35.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.666 1.986 . . . . 0.0 110.646 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -63.46 152.15 39.18 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.402 1.001 . . . . 0.0 111.621 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.765 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -142.07 154.4 44.91 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.901 -1.125 . . . . 0.0 112.464 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.42 154.32 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 113.425 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -91.61 146.2 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.361 2.264 . . . . 0.0 112.768 167.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.29 135.98 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.354 1.462 . . . . 0.0 109.595 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.74 154.64 25.84 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.785 0.707 . . . . 0.0 114.256 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.59 16.05 41.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.675 1.131 . . . . 0.0 114.0 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -67.2 159.47 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.228 . . . . 0.0 111.314 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.6 p -128.92 -168.8 1.98 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.332 1.053 . . . . 0.0 111.847 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.7 m -75.82 -15.44 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.127 0.971 . . . . 0.0 112.622 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -75.55 -32.34 60.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.261 0.2 OUTLIER -77.32 145.04 37.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.7 t -140.58 158.21 44.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.123 1.369 . . . . 0.0 113.73 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.37 -34.56 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -67.54 -39.37 85.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.445 0.698 . . . . 0.0 111.836 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.65 -34.99 67.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.18 -50.15 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.776 0.83 . . . . 0.0 109.318 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.86 -49.37 77.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.592 0.633 . . . . 0.0 111.501 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -59.07 -40.83 86.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.854 0.862 . . . . 0.0 112.803 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -65.71 -49.0 70.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 50.7 m-85 -64.58 -29.14 70.15 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -59.44 -22.76 61.96 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.23 -26.04 64.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.21 0.913 . . . . 0.0 112.953 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.68 -35.8 57.69 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.34 168.33 30.27 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.506 2.479 . . . . 0.0 109.992 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -65.58 125.12 24.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.363 1.082 . . . . 0.0 113.003 -168.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.37 133.86 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.629 1.972 . . . . 0.0 107.629 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -70.2 -52.12 25.73 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -163.99 161.28 22.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.389 2.276 . . . . 0.0 114.101 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -131.81 150.81 52.04 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.96 1.304 . . . . 0.0 110.18 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 91.3 mtp -148.36 152.42 37.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.964 1.305 . . . . 0.0 111.907 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.3 mt -122.41 133.2 54.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.753 1.621 . . . . 0.0 109.286 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 122.097 0.951 . . . . 0.0 112.077 -176.176 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.1 p80 . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -97.43 21.96 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.308 1.443 . . . . 0.0 114.56 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.12 14.47 62.37 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.914 1.245 . . . . 0.0 114.45 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.293 4.8 p90 -146.82 158.18 43.85 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.38 -160.27 17.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.108 1.337 . . . . 0.0 114.009 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -138.88 152.22 47.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.433 1.893 . . . . 0.0 114.914 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -135.94 126.36 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.352 1.461 . . . . 0.0 112.048 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.2 m -94.18 127.73 40.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 112.022 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -106.73 151.46 25.1 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -71.55 -36.33 70.94 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 t -135.47 137.98 42.7 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.449 1.1 . . . . 0.0 113.438 -171.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -65.32 -30.64 71.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.828 1.251 . . . . 0.0 112.597 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -60.41 -30.26 69.49 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.28 -47.9 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.817 0.847 . . . . 0.0 110.256 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 24.7 t -56.28 -42.47 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.636 1.174 . . . . 0.0 110.327 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.28 -50.8 72.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.743 0.701 . . . . 0.0 112.458 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -66.59 -45.03 80.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.273 0.942 . . . . 0.0 112.145 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.84 -40.62 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.221 0.919 . . . . 0.0 110.66 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.7 t -74.41 -31.32 62.28 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.148 0.979 . . . . 0.0 113.253 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -66.29 -37.41 85.35 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.777 -1.202 . . . . 0.0 113.246 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.1 mt -72.45 136.32 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.859 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.88 158.66 37.19 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.45 1.1 . . . . 0.0 112.701 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.525 22.3 m-85 60.43 45.27 11.11 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -56.36 153.94 8.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.949 1.7 . . . . 0.0 110.825 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -132.62 133.95 44.27 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.971 -1.081 . . . . 0.0 113.294 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . 0.272 4.5 mt -121.52 -127.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.483 1.113 . . . . 0.0 109.144 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -69.14 73.67 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.208 1.803 . . . . 0.0 112.126 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 61.41 -30.28 0.07 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 129.215 3.006 . . . . 0.0 115.389 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -75.56 140.53 42.76 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.295 2.238 . . . . 0.0 111.398 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 13.2 ptm -97.6 150.27 21.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.619 1.168 . . . . 0.0 111.925 171.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.07 162.14 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.402 2.281 . . . . 0.0 112.759 -169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -125.91 163.33 23.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.007 1.323 . . . . 0.0 111.687 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.5 p -143.14 161.35 38.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -144.77 164.55 30.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.632 1.973 . . . . 0.0 110.859 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -61.33 150.18 35.84 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.487 -0.758 . . . . 0.0 111.277 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 124.158 0.983 . . . . 0.0 112.484 177.189 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 122.98 1.372 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -159.74 142.37 13.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.268 2.627 . . . . 0.0 107.855 -168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.19 154.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.241 1.016 . . . . 0.0 112.496 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.36 148.71 25.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.992 1.717 . . . . 0.0 113.025 166.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.3 t -135.91 137.53 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.627 1.571 . . . . 0.0 109.576 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.01 149.3 20.98 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.89 11.83 36.31 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.714 1.626 . . . . 0.0 114.296 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.8 mt -64.38 135.38 56.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.36 1.464 . . . . 0.0 112.103 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.5 t -64.98 156.53 30.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.487 1.115 . . . . 0.0 112.402 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.44 -16.37 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.279 0.632 . . . . 0.0 111.188 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -68.71 -33.98 74.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.025 0.93 . . . . 0.0 111.895 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -71.84 144.46 49.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.327 1.851 . . . . 0.0 115.41 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 t -135.69 171.1 14.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.204 1.802 . . . . 0.0 112.469 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.57 -33.0 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.59 -39.41 88.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.189 0.996 . . . . 0.0 112.337 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -64.15 -41.37 97.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.35 -50.46 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.852 0.861 . . . . 0.0 110.367 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.64 -44.16 96.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.485 0.584 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.62 -42.37 92.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.783 0.833 . . . . 0.0 112.586 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.28 -53.41 44.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 47.3 m-85 -63.79 -21.1 66.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -64.05 -12.25 36.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.32 -28.6 69.42 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.431 1.014 . . . . 0.0 112.766 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.74 -32.98 21.58 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.235 1.014 . . . . 0.0 112.051 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.93 -178.83 40.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.903 2.192 . . . . 0.0 110.874 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 120.56 12.28 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.585 -0.95 . . . . 0.0 112.571 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.32 121.53 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.381 1.473 . . . . 0.0 108.023 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -76.06 -36.93 58.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -165.36 165.78 19.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 109.28 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.81 43.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.317 1.447 . . . . 0.0 111.284 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.6 ptm -156.56 157.03 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.882 1.273 . . . . 0.0 112.2 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.79 151.99 48.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.267 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 53.6 mtp . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 123.696 0.798 . . . . 0.0 110.745 174.266 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.6 p80 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.482 0.658 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.97 -0.52 24.66 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.823 1.649 . . . . 0.0 115.385 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.64 10.47 81.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.301 0.953 . . . . 0.0 113.417 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.285 15.6 p90 -143.6 157.7 44.22 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.28 -161.73 20.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.684 1.135 . . . . 0.0 114.153 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -138.64 152.56 48.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.938 1.695 . . . . 0.0 113.883 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.91 129.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.293 1.437 . . . . 0.0 111.499 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -91.38 138.59 31.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.15 1.78 . . . . 0.0 114.541 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -120.22 152.44 37.72 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -70.04 -30.17 67.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.1 t -155.7 149.69 25.46 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.609 1.163 . . . . 0.0 112.728 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.46 -29.68 66.37 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.029 0.932 . . . . 0.0 112.096 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -56.91 -26.41 59.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 24.1 mm -80.87 -52.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.815 0.846 . . . . 0.0 110.129 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.4 t -53.87 -36.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.617 1.567 . . . . 0.0 112.271 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -53.4 -47.16 69.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.886 0.874 . . . . 0.0 112.937 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -68.08 -44.84 75.37 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.074 0.852 . . . . 0.0 111.392 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.2 t -54.46 -41.93 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 96.7 m -72.21 -37.44 69.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.278 1.431 . . . . 0.0 114.453 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -66.31 -33.66 76.24 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.4 mt -73.0 112.05 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -70.64 -61.12 1.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.179 -0.951 . . . . 0.0 111.648 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 52.8 m-85 -94.66 133.41 38.36 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -127.23 124.2 38.36 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.499 1.92 . . . . 0.0 110.382 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.23 107.7 19.38 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.339 -0.851 . . . . 0.0 112.718 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.14 122.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.377 1.071 . . . . 0.0 110.832 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.37 45.02 23.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.472 1.109 . . . . 0.0 112.818 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 63.31 -9.75 0.12 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 128.502 2.721 . . . . 0.0 116.158 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -87.89 142.47 27.77 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 126.322 1.849 . . . . 0.0 109.83 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 58.5 mtt -86.09 129.96 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.416 -0.803 . . . . 0.0 112.512 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.9 163.14 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.046 2.138 . . . . 0.0 111.718 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -128.26 162.94 25.85 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.519 0.727 . . . . 0.0 110.899 169.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.5 158.19 43.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.374 1.07 . . . . 0.0 113.196 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -144.25 165.53 27.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.631 1.573 . . . . 0.0 111.242 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.48 152.13 18.69 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 169.713 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -148.57 149.32 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.15 1.78 . . . . 0.0 111.232 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.55 149.3 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 111.316 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.88 134.58 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.781 1.233 . . . . 0.0 109.58 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.43 145.95 14.95 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 114.518 0.567 . . . . 0.0 114.518 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.6 7.16 32.34 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.689 1.614 . . . . 0.0 114.609 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.5 139.48 58.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.164 1.385 . . . . 0.0 112.183 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -62.66 155.02 27.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.235 1.014 . . . . 0.0 112.506 171.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.57 -20.1 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.479 0.712 . . . . 0.0 112.214 169.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -71.76 -26.9 62.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.065 0.946 . . . . 0.0 113.151 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.0 m -73.59 143.49 46.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.735 1.614 . . . . 0.0 113.812 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 t -123.94 163.71 20.78 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 0.0 114.207 169.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.6 p -57.9 -30.61 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.78 -34.51 78.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.832 0.853 . . . . 0.0 112.458 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -68.27 -47.19 68.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.85 -45.25 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.662 0.785 . . . . 0.0 111.025 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -61.01 -46.29 91.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 118.952 -0.547 . . . . 0.0 112.151 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -59.7 -42.8 93.8 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -65.03 -38.8 92.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -75.97 -29.19 58.17 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -58.71 -18.9 35.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.334 1.454 . . . . 0.0 114.572 171.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -66.19 -23.88 66.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.388 -0.82 . . . . 0.0 112.777 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -89.28 -37.76 14.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.04 176.47 39.69 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.175 1.845 . . . . 0.0 111.45 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.44 127.82 34.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.6 t -100.39 118.27 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.184 1.794 . . . . 0.0 108.397 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -78.27 -37.33 45.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -152.15 153.26 33.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.958 2.103 . . . . 0.0 114.684 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.18 29.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.4 ptp -157.85 147.59 20.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.248 1.019 . . . . 0.0 112.3 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.6 mt -127.83 153.87 46.1 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.521 1.529 . . . . 0.0 111.673 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 124.358 1.063 . . . . 0.0 112.52 -178.126 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 p80 . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -70.5 -0.21 8.0 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.57 63.44 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.769 1.176 . . . . 0.0 114.376 -172.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -144.8 159.82 42.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -176.17 -160.15 23.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.0 0.81 . . . . 0.0 114.909 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -132.8 149.29 52.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.608 1.963 . . . . 0.0 115.357 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 t -135.09 128.11 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.254 1.421 . . . . 0.0 111.749 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 61.6 m -96.55 127.34 42.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.668 1.587 . . . . 0.0 111.418 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.43 157.95 15.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -61.81 -37.96 86.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.745 0.818 . . . . 0.0 112.84 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -151.79 143.52 23.65 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -57.14 -26.78 61.1 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.573 1.549 . . . . 0.0 113.051 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.91 -26.92 68.46 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.72 -50.28 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.628 0.771 . . . . 0.0 109.458 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.96 -33.11 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.664 1.186 . . . . 0.0 111.201 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -48.16 -43.1 31.17 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -76.41 -45.51 31.29 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.639 -0.663 . . . . 0.0 111.764 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.35 -36.95 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.1 t -84.07 -24.27 30.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.583 1.153 . . . . 0.0 112.567 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -72.7 -35.61 67.66 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.02 -1.05 . . . . 0.0 112.155 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.14 138.41 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.022 0.929 . . . . 0.0 110.465 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -127.37 156.14 42.49 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.863 1.265 . . . . 0.0 111.951 169.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.443 18.2 m-85 61.04 47.15 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 -171.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -56.96 129.47 41.77 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.83 1.652 . . . . 0.0 111.201 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.29 125.0 28.62 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.446 0.566 . . . . 0.0 111.803 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.68 117.06 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.245 1.818 . . . . 0.0 108.781 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 50.03 43.79 25.61 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.287 1.035 . . . . 0.0 112.95 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.74 -13.88 0.08 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 128.173 2.589 . . . . 0.0 116.4 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.48 157.16 36.06 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.81 1.644 . . . . 0.0 109.265 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 26.7 mtt -109.6 141.06 42.65 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.73 151.24 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.122 1.769 . . . . 0.0 114.031 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.72 144.98 26.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.842 0.857 . . . . 0.0 112.14 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 4.9 t -108.77 143.67 37.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.627 1.571 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -140.8 157.7 45.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.728 1.611 . . . . 0.0 111.123 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.74 129.81 41.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.549 0.739 . . . . 0.0 111.894 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 123.906 0.882 . . . . 0.0 112.364 -179.097 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.74 147.76 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.785 1.634 . . . . 0.0 111.672 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.29 152.85 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.27 148.25 22.28 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.375 2.27 . . . . 0.0 111.86 167.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.0 t -137.79 135.1 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.015 1.326 . . . . 0.0 109.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.23 155.84 26.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.977 0.798 . . . . 0.0 114.288 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.94 10.01 41.16 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.558 1.551 . . . . 0.0 114.725 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -67.13 137.67 56.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.866 1.266 . . . . 0.0 112.532 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 t -65.93 152.46 44.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.256 1.023 . . . . 0.0 111.76 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -70.53 -15.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.574 -0.704 . . . . 0.0 111.796 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -70.38 -29.85 66.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.303 1.041 . . . . 0.0 112.689 170.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.3 m -78.85 139.12 38.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.992 1.717 . . . . 0.0 113.605 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 t -118.82 165.14 14.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.44 1.496 . . . . 0.0 114.726 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.93 -33.98 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -72.63 -27.01 61.87 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.72 -46.88 64.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.977 0.808 . . . . 0.0 109.169 171.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.44 -46.61 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.686 0.794 . . . . 0.0 110.493 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -57.18 -50.77 71.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.005 0.922 . . . . 0.0 111.855 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -60.21 -44.29 95.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 112.973 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.07 -38.8 92.37 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.306 48.6 m-85 -73.07 -31.2 64.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -60.42 -18.07 48.49 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.45 -24.88 67.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.55 0.74 . . . . 0.0 112.718 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -85.55 -35.64 20.97 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.85 175.3 36.19 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.668 2.08 . . . . 0.0 111.139 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -58.81 125.03 21.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.761 -0.847 . . . . 0.0 112.98 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.1 t -94.01 124.01 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.835 1.654 . . . . 0.0 107.234 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.85 -31.5 20.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.987 0.515 . . . . 0.0 110.356 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -161.51 155.56 22.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.884 1.274 . . . . 0.0 109.767 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.83 149.51 34.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.048 1.339 . . . . 0.0 111.268 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.4 ptp -156.07 154.9 31.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.634 1.174 . . . . 0.0 112.166 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.41 152.3 46.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.302 1.441 . . . . 0.0 111.419 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.764 0.826 . . . . 0.0 111.788 -176.293 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.3 p80 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.602 0.715 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -80.87 7.47 10.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.193 1.797 . . . . 0.0 115.096 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.46 11.84 63.74 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.992 1.282 . . . . 0.0 114.414 -172.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -145.98 160.78 41.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.66 -162.16 23.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.54 1.066 . . . . 0.0 114.77 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.07 148.12 44.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.653 1.981 . . . . 0.0 113.84 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.56 123.59 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.422 1.489 . . . . 0.0 111.606 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 90.4 m -93.25 128.47 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.026 1.33 . . . . 0.0 110.501 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.91 153.15 19.39 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.2 -33.29 75.47 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -152.94 143.65 22.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 112.815 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -55.83 -27.16 50.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 113.185 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.38 -27.12 69.09 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.3 mm -77.54 -48.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.254 0.621 . . . . 0.0 109.686 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.08 -34.07 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.292 1.037 . . . . 0.0 111.244 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -50.23 -42.85 52.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.476 1.51 . . . . 0.0 113.54 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -77.35 -47.61 19.47 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.497 0.719 . . . . 0.0 111.595 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.3 -43.3 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.9 t -76.01 -24.47 55.29 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 112.19 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -78.27 -33.27 49.7 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.041 -1.037 . . . . 0.0 112.539 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 30.2 mt -67.97 148.47 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.429 1.091 . . . . 0.0 110.748 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -134.84 152.03 51.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.368 26.6 m-85 58.42 50.6 9.17 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -171.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -60.13 133.55 56.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.334 . . . . 0.0 111.971 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -82.93 133.47 35.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.805 -0.56 . . . . 0.0 111.896 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.1 mt -145.24 125.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 126.695 1.998 . . . . 0.0 108.842 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 50.08 36.28 11.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.56 1.144 . . . . 0.0 113.495 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.07 -7.73 0.14 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 128.242 2.617 . . . . 0.0 116.058 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.17 173.62 11.65 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 109.33 167.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.3 mtt -120.85 145.78 47.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.42 161.75 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.366 2.266 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.27 152.25 50.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.403 1.081 . . . . 0.0 110.017 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.06 157.97 44.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -147.44 160.93 42.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.88 2.072 . . . . 0.0 111.14 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 146.95 42.59 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.988 0.813 . . . . 0.0 111.844 172.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.887 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 122.768 1.27 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -147.27 142.17 26.91 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.745 2.018 . . . . 0.0 109.393 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 pt -139.52 151.87 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.948 0.899 . . . . 0.0 113.236 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -92.67 145.71 24.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.17 2.188 . . . . 0.0 112.404 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.27 134.97 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 109.952 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.98 148.22 19.77 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.784 0.72 . . . . 0.0 114.256 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.77 9.57 59.72 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.936 1.255 . . . . 0.0 114.261 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.45 144.01 54.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.976 1.31 . . . . 0.0 111.575 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -67.15 158.03 32.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.155 0.582 . . . . 0.0 110.993 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.21 -26.3 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -71.31 -25.92 62.63 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.56 1.144 . . . . 0.0 113.712 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -70.2 119.15 13.96 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.299 1.3 t -98.5 164.18 12.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.45 -33.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -174.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.19 -32.49 72.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.1 0.96 . . . . 0.0 113.052 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.59 -46.06 73.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.849 0.75 . . . . 0.0 110.364 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.43 -48.97 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.303 1.041 . . . . 0.0 110.567 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.87 -49.07 79.15 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.869 0.867 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -60.0 -39.55 86.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 112.773 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -68.87 -49.07 61.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.324 49.4 m-85 -63.23 -29.22 70.6 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.44 -21.48 60.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -70.36 -25.73 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.019 0.827 . . . . 0.0 112.846 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -76.32 -38.81 55.46 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.63 167.65 29.57 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.328 2.394 . . . . 0.0 110.276 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.02 131.86 51.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.135 0.968 . . . . 0.0 113.294 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -93.69 138.26 20.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 126.565 1.946 . . . . 0.0 108.335 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.99 -45.11 10.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.932 1.293 . . . . 0.0 112.946 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -158.9 161.53 36.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.295 1.438 . . . . 0.0 109.881 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.11 156.86 42.82 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.148 1.379 . . . . 0.0 111.767 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -157.09 159.34 37.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.54 1.136 . . . . 0.0 113.163 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 73.3 mt -124.05 146.64 48.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.889 2.076 . . . . 0.0 111.136 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.474 0.71 . . . . 0.0 111.884 176.038 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.53 -8.49 15.0 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.11 76.45 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.384 0.993 . . . . 0.0 114.767 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.292 15.3 p90 -142.48 161.2 38.67 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 174.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.25 -168.41 25.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.689 1.138 . . . . 0.0 113.761 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -141.27 153.66 45.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.125 1.37 . . . . 0.0 112.965 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.0 130.98 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.356 1.462 . . . . 0.0 112.094 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.3 m -93.48 138.04 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.77 1.628 . . . . 0.0 113.85 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.51 148.8 32.4 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -69.76 -28.95 66.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.107 0.963 . . . . 0.0 112.738 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.2 t -143.45 130.36 20.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.937 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.6 pm0 -57.85 -28.55 64.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.741 2.016 . . . . 0.0 113.378 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.32 -28.25 69.18 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -74.7 -45.01 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 110.094 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.8 t -58.63 -37.59 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.435 1.094 . . . . 0.0 110.516 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -56.14 -45.51 79.57 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.987 0.812 . . . . 0.0 113.128 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -69.33 -45.95 68.24 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.923 0.783 . . . . 0.0 111.836 173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.88 -44.11 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 118.851 0.75 . . . . 0.0 110.834 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.67 -36.61 76.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.331 1.452 . . . . 0.0 113.033 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -37.32 86.25 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.116 -0.99 . . . . 0.0 112.816 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.01 117.38 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.54 0.736 . . . . 0.0 109.232 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -70.28 -61.44 1.77 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.486 -0.759 . . . . 0.0 111.777 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.335 53.5 m-85 -95.71 139.55 31.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.423 ' CD2' ' HG ' ' A' ' 181' ' ' CYS . 87.2 m-70 -137.28 153.08 50.39 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.716 2.406 . . . . 0.0 109.606 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -124.2 115.93 21.89 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.129 -0.982 . . . . 0.0 112.82 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.4 126.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.108 0.963 . . . . 0.0 111.049 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 51.0 38.23 19.89 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 112.826 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.12 -7.1 0.12 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.914 2.486 . . . . 0.0 115.86 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -78.52 140.52 38.55 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.128 1.771 . . . . 0.0 109.178 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 96.5 mtp -88.64 143.26 27.06 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.546 -0.721 . . . . 0.0 111.879 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.0 164.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.566 2.346 . . . . 0.0 111.628 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -124.9 158.29 33.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.818 0.847 . . . . 0.0 110.867 168.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.423 ' HG ' ' CD2' ' A' ' 172' ' ' HIS . 24.1 p -141.41 158.27 44.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.637 0.732 . . . . 0.0 112.58 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -155.78 163.07 40.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.62 1.568 . . . . 0.0 111.702 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -57.69 147.14 28.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.494 1.118 . . . . 0.0 112.416 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 125.704 1.601 . . . . 0.0 110.965 178.216 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -140.56 151.78 44.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.21 1.404 . . . . 0.0 111.921 -172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -139.8 151.57 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.608 1.163 . . . . 0.0 113.648 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -90.12 146.95 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.252 2.221 . . . . 0.0 112.973 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.28 138.06 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.099 1.76 . . . . 0.0 110.348 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.52 142.41 9.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.887 0.767 . . . . 0.0 114.85 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.54 4.92 30.16 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.089 1.804 . . . . 0.0 114.649 -175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.22 140.05 58.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.368 1.467 . . . . 0.0 112.277 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -66.23 152.47 44.81 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.802 0.841 . . . . 0.0 111.741 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.15 -14.81 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.43 -0.793 . . . . 0.0 111.552 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -71.03 -28.81 64.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.133 0.973 . . . . 0.0 112.68 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.0 m -74.08 140.54 45.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.658 1.583 . . . . 0.0 112.78 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.53 164.48 15.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.404 1.482 . . . . 0.0 114.572 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.81 -32.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -67.24 -32.1 72.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.893 0.877 . . . . 0.0 112.739 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -67.25 -50.06 61.98 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.5 -45.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 111.207 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.16 -47.76 84.58 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 111.747 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.16 -43.79 98.04 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -64.13 -38.6 91.64 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 48.1 m-85 -73.51 -29.68 62.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -60.76 -17.09 46.76 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -65.52 -24.14 67.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.61 0.764 . . . . 0.0 112.794 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -83.49 -34.4 25.36 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.06 174.64 34.98 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.849 2.166 . . . . 0.0 110.798 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -59.23 126.5 27.93 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.951 0.876 . . . . 0.0 113.162 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.92 126.83 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.707 1.603 . . . . 0.0 108.628 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -76.69 -46.3 26.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.071 0.948 . . . . 0.0 112.631 175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -158.72 161.11 37.03 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.22 1.008 . . . . 0.0 110.894 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.83 156.27 41.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.508 1.523 . . . . 0.0 111.818 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -154.47 158.88 40.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.81 1.244 . . . . 0.0 112.629 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.1 mt -126.8 147.79 49.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.874 1.67 . . . . 0.0 111.445 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.997 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.2 p80 . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.577 0.703 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -78.23 7.26 6.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.853 1.661 . . . . 0.0 115.314 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.24 14.89 67.9 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.554 1.073 . . . . 0.0 114.41 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.311 14.6 p90 -139.52 158.26 44.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.07 -171.75 30.71 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.224 0.916 . . . . 0.0 114.845 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -134.23 149.4 50.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.923 2.089 . . . . 0.0 114.246 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.81 129.37 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.246 1.418 . . . . 0.0 111.209 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 76.8 m -100.53 124.1 45.63 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.409 1.484 . . . . 0.0 111.434 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -97.16 155.9 16.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -68.91 -30.86 69.43 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.2 t -153.02 143.59 22.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.343 1.057 . . . . 0.0 113.309 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -57.82 -26.2 61.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.571 1.548 . . . . 0.0 113.673 170.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -59.02 -35.68 73.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.202 1.001 . . . . 0.0 111.809 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.75 -47.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.052 0.941 . . . . 0.0 110.418 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.7 t -58.4 -37.56 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.635 1.174 . . . . 0.0 111.146 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.69 -48.71 74.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.036 0.835 . . . . 0.0 113.218 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.63 -42.1 82.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.082 0.855 . . . . 0.0 111.676 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.79 -39.16 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.512 0.596 . . . . 0.0 111.241 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 88.9 m -73.62 -38.48 65.04 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.29 -35.61 80.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.21 116.36 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -68.94 -56.2 8.58 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.278 -0.889 . . . . 0.0 111.77 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.315 50.9 m-85 -104.12 136.82 43.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -130.81 137.42 49.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.787 2.035 . . . . 0.0 110.629 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -84.31 131.19 34.74 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.76 -0.588 . . . . 0.0 111.731 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.98 122.29 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.546 1.939 . . . . 0.0 109.546 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 49.62 40.01 18.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.555 1.142 . . . . 0.0 112.855 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 62.43 -8.01 0.12 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 128.688 2.795 . . . . 0.0 116.259 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -77.17 154.62 32.98 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.276 -1.515 . . . . 0.0 108.532 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 22.6 ptm -100.29 139.74 35.53 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.238 -0.914 . . . . 0.0 111.769 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.45 162.0 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.709 2.004 . . . . 0.0 111.719 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.82 162.55 17.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.5 p -144.06 154.27 43.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.695 1.198 . . . . 0.0 113.675 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -144.06 165.43 27.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.681 1.993 . . . . 0.0 111.758 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.54 134.67 57.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.024 0.93 . . . . 0.0 111.655 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.17 0.988 . . . . 0.0 112.988 -176.874 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -141.13 149.65 41.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.724 1.61 . . . . 0.0 111.431 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.84 151.3 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.344 1.058 . . . . 0.0 113.763 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -88.72 145.64 25.51 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.526 1.931 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.3 138.05 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.471 1.509 . . . . 0.0 110.627 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.77 153.52 25.16 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.861 0.743 . . . . 0.0 114.33 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.81 34.88 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.034 1.302 . . . . 0.0 114.602 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.0 mt -64.21 136.24 57.02 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.106 1.363 . . . . 0.0 112.18 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -62.62 152.66 34.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.348 1.059 . . . . 0.0 112.37 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.6 -23.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.81 0.844 . . . . 0.0 111.725 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -67.62 -26.68 66.36 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.65 1.18 . . . . 0.0 113.282 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.2 m -76.97 147.64 36.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.074 1.749 . . . . 0.0 115.495 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 t -129.3 162.66 27.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.07 1.748 . . . . 0.0 113.094 168.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -57.72 -30.86 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.14 -33.99 77.33 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.911 0.884 . . . . 0.0 112.42 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.07 -47.24 68.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.23 -45.35 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.58 0.752 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -60.91 -47.44 86.38 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.141 0.577 . . . . 0.0 111.65 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -58.9 -45.76 89.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.971 0.908 . . . . 0.0 113.415 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -65.62 -38.68 90.1 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 49.4 m-85 -73.75 -29.18 62.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 171.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -61.19 -17.39 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -64.93 -23.04 67.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.659 0.784 . . . . 0.0 112.8 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -86.1 -29.29 23.46 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.73 174.95 30.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.98 2.228 . . . . 0.0 110.729 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -59.3 126.88 29.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.249 1.025 . . . . 0.0 112.882 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.53 123.25 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.799 1.64 . . . . 0.0 107.502 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.16 -33.73 24.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.325 0.65 . . . . 0.0 110.398 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -160.54 158.08 28.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.683 1.193 . . . . 0.0 110.168 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.01 149.11 30.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.205 1.402 . . . . 0.0 111.165 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.14 159.09 42.67 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.432 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.0 mt -125.98 155.8 40.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.913 1.685 . . . . 0.0 111.028 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.3 mmm . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.381 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 p80 . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.259 0.552 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -84.48 1.55 45.08 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.52 66.8 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.267 1.413 . . . . 0.0 114.597 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -145.22 159.74 42.55 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.94 -164.43 27.49 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.271 0.939 . . . . 0.0 115.129 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -136.59 147.67 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.75 2.02 . . . . 0.0 114.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.26 127.6 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.704 1.202 . . . . 0.0 111.3 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.9 m -96.81 122.67 40.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.343 1.457 . . . . 0.0 111.278 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.29 158.99 16.26 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.617 -0.677 . . . . 0.0 112.597 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -149.73 147.23 27.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.562 1.145 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -62.17 -24.5 67.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.687 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.76 -30.31 71.35 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.22 -47.46 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.549 0.739 . . . . 0.0 109.874 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.65 -34.28 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.383 1.073 . . . . 0.0 110.526 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.24 -40.09 61.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.8 1.24 . . . . 0.0 113.163 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -80.54 -45.24 17.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.615 0.643 . . . . 0.0 112.09 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.8 -44.66 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.845 0.748 . . . . 0.0 112.006 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 22.3 t -73.21 -33.0 65.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.085 1.354 . . . . 0.0 112.145 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -67.42 -38.74 85.03 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.292 -0.88 . . . . 0.0 112.484 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.7 mt -71.66 114.81 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -68.75 -49.63 57.19 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.897 -1.127 . . . . 0.0 112.149 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 62.4 m-85 -108.43 138.85 44.04 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.97 129.45 34.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.919 1.687 . . . . 0.0 111.123 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -77.94 134.15 37.93 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.53 -0.731 . . . . 0.0 112.39 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.9 mt -145.83 118.71 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 127.493 2.317 . . . . 0.0 108.199 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 50.69 45.94 26.38 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.05 0.94 . . . . 0.0 113.359 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 65.86 -18.22 0.1 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 128.045 2.538 . . . . 0.0 116.259 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -75.26 155.33 36.84 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.403 1.881 . . . . 0.0 109.844 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.7 mtm -108.17 125.09 51.23 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.472 -0.768 . . . . 0.0 111.397 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.16 163.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.345 1.858 . . . . 0.0 111.868 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -122.44 155.71 35.56 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.349 0.66 . . . . 0.0 111.112 168.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 30.1 p -139.14 155.84 47.57 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -145.06 173.46 11.88 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.491 1.917 . . . . 0.0 111.775 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -60.34 135.39 57.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.113 0.965 . . . . 0.0 111.315 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 123.208 0.603 . . . . 0.0 110.793 174.76 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.35 0.595 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -151.92 154.2 35.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.033 1.333 . . . . 0.0 110.286 -169.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.66 154.81 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.076 . . . . 0.0 112.896 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -91.01 145.57 24.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.399 1.879 . . . . 0.0 112.054 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.03 131.4 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.55 1.54 . . . . 0.0 109.908 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.13 12.66 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.607 0.622 . . . . 0.0 114.5 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.58 10.79 26.42 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.759 1.647 . . . . 0.0 114.717 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 37.7 mt -61.61 136.38 57.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.219 1.408 . . . . 0.0 111.929 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 p -79.92 179.18 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -79.5 -20.17 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.306 1.043 . . . . 0.0 112.56 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.38 -37.75 56.72 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.897 0.879 . . . . 0.0 110.527 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 m -68.96 140.5 55.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.72 1.608 . . . . 0.0 115.295 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 t -144.44 173.71 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.678 1.991 . . . . 0.0 112.218 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.1 -32.28 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -68.44 -39.98 81.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.906 0.882 . . . . 0.0 112.433 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -65.06 -41.89 94.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.97 -53.02 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.374 1.07 . . . . 0.0 109.137 174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -58.86 -48.17 82.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.67 0.668 . . . . 0.0 111.962 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -60.5 -42.01 95.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.737 0.815 . . . . 0.0 112.832 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.14 -46.02 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.329 54.6 m-85 -66.57 -28.0 68.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -59.57 -21.01 59.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -71.51 -25.89 62.44 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.417 -0.802 . . . . 0.0 112.767 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -75.49 -36.26 60.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 177.08 37.86 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.877 2.179 . . . . 0.0 110.963 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -60.01 131.27 50.34 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.12 0.96 . . . . 0.0 112.968 -172.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 36.9 t -108.06 133.46 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.757 2.023 . . . . 0.0 107.446 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -101.32 -23.12 14.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.01 150.9 17.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.892 2.077 . . . . 0.0 113.379 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.0 31.65 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.289 1.036 . . . . 0.0 110.997 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.7 ptm -157.43 158.77 36.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.742 1.217 . . . . 0.0 112.331 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.14 150.13 49.64 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.805 1.642 . . . . 0.0 111.808 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 110.564 169.518 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 p80 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 121.222 0.534 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -82.34 2.53 31.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -172.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.7 9.92 82.23 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.56 1.076 . . . . 0.0 113.771 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.27 19.6 p90 -143.47 156.65 44.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.08 -164.69 22.09 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.441 1.019 . . . . 0.0 114.174 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.09 151.72 46.93 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.994 1.718 . . . . 0.0 114.144 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 t -137.26 128.27 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.944 1.298 . . . . 0.0 112.101 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -90.36 139.62 30.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.866 1.666 . . . . 0.0 113.287 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.34 150.5 43.57 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -174.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -67.15 -33.02 74.53 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.4 t -147.4 148.59 31.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.74 1.216 . . . . 0.0 113.192 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -57.44 -29.38 64.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.543 1.137 . . . . 0.0 112.836 171.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -61.64 -30.8 70.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -78.94 -48.67 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 110.249 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.95 -43.06 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.04 1.336 . . . . 0.0 110.434 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -56.4 -47.98 77.87 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.975 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -64.99 -45.13 86.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.019 0.827 . . . . 0.0 111.688 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.48 -36.13 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.629 0.65 . . . . 0.0 111.705 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.6 m -73.24 -39.87 65.11 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -66.4 -35.3 79.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.037 0.935 . . . . 0.0 113.22 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.18 115.0 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -68.29 -58.74 3.93 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.716 -0.615 . . . . 0.0 111.279 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.327 53.4 m-85 -104.71 137.94 41.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.05 125.48 33.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.981 2.112 . . . . 0.0 109.865 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.51 121.57 32.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.416 -0.803 . . . . 0.0 112.535 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.4 mt -139.15 126.44 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.891 1.277 . . . . 0.0 109.91 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.41 40.0 21.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.622 1.169 . . . . 0.0 113.687 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 62.97 -7.91 0.14 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 128.1 2.56 . . . . 0.0 115.876 -171.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -81.58 170.13 16.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.807 2.043 . . . . 0.0 110.37 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.6 mtp -121.21 134.89 55.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.207 1.003 . . . . 0.0 112.105 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.02 159.04 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.849 2.06 . . . . 0.0 112.399 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -124.79 152.3 44.05 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.81 0.844 . . . . 0.0 112.506 172.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.7 m -124.5 144.95 49.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.547 1.139 . . . . 0.0 113.015 -169.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -141.79 169.89 16.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.276 1.43 . . . . 0.0 112.78 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -63.1 150.32 42.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.512 1.125 . . . . 0.0 112.789 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.291 1.436 . . . . 0.0 110.681 171.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.85 149.5 37.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.345 1.458 . . . . 0.0 111.859 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -139.38 151.03 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.406 1.083 . . . . 0.0 113.919 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.13 148.39 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.97 2.108 . . . . 0.0 112.782 167.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.0 t -134.89 134.99 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 109.645 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.48 155.85 26.72 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.016 0.817 . . . . 0.0 114.327 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.79 7.56 66.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.798 1.19 . . . . 0.0 113.784 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.76 143.56 57.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 111.656 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -69.47 154.08 42.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.174 0.589 . . . . 0.0 110.041 167.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.59 -15.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.771 -0.581 . . . . 0.0 111.708 168.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -73.75 -28.85 61.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.074 1.35 . . . . 0.0 113.126 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 m -67.06 123.89 21.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.265 0.8 OUTLIER -80.86 160.58 24.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.52 -29.85 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -75.23 -36.78 61.3 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.02 -43.37 98.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.78 -50.44 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.85 0.86 . . . . 0.0 109.681 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.49 -46.8 88.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.686 0.675 . . . . 0.0 112.313 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -59.15 -40.15 84.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.534 1.134 . . . . 0.0 112.237 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.41 -54.56 34.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 171.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 48.6 m-85 -63.41 -23.7 67.52 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -60.93 -13.85 18.6 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.31 -29.13 69.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.886 1.221 . . . . 0.0 112.726 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -85.1 -34.43 22.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.214 1.005 . . . . 0.0 112.248 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.21 -179.8 41.63 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 127.077 2.275 . . . . 0.0 110.788 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.71 122.72 16.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.19 0.995 . . . . 0.0 112.315 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.7 t -95.65 123.81 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -82.08 -39.94 22.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.753 -0.592 . . . . 0.0 109.547 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -157.91 159.89 37.03 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.63 1.172 . . . . 0.0 110.152 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.62 34.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.383 1.473 . . . . 0.0 110.955 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 mmt -148.65 159.37 44.17 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.654 1.582 . . . . 0.0 113.003 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.0 mt -126.84 143.57 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.983 2.113 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 43.0 mtm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.38 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.56 -11.31 49.1 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.22 14.35 66.7 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.175 0.893 . . . . 0.0 113.99 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.38 4.7 p90 -141.09 162.45 35.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.89 -169.88 28.02 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.089 1.328 . . . . 0.0 114.604 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.05 150.26 52.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.262 2.225 . . . . 0.0 114.394 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -136.32 125.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.209 1.404 . . . . 0.0 111.82 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 94.4 m -98.31 128.92 44.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.353 1.461 . . . . 0.0 110.767 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -104.85 150.69 24.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -67.0 -38.13 85.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.575 0.75 . . . . 0.0 112.673 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 t -143.11 134.69 26.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 122.201 1.0 . . . . 0.0 112.904 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -58.34 -27.25 63.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.53 1.932 . . . . 0.0 113.256 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.55 -26.26 68.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -76.75 -50.81 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.904 0.882 . . . . 0.0 109.489 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.08 -36.62 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 111.987 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.19 -30.88 60.82 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -84.0 -49.08 9.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.552 0.741 . . . . 0.0 111.668 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.66 -43.58 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.315 0.961 . . . . 0.0 113.433 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.9 t -77.59 -19.17 56.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.446 1.098 . . . . 0.0 112.514 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -81.54 -31.19 32.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.254 1.021 . . . . 0.0 112.215 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.15 142.06 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.19 0.996 . . . . 0.0 109.519 168.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -131.23 161.43 32.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.743 1.217 . . . . 0.0 111.728 171.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.581 2.1 p90 58.31 45.17 17.46 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -57.41 142.65 43.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 110.688 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.53 106.92 16.38 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.596 1.089 . . . . 0.0 112.978 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.53 122.93 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.765 1.226 . . . . 0.0 110.528 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 50.97 41.36 27.09 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.461 1.104 . . . . 0.0 112.634 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 62.97 -10.59 0.1 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.379 2.672 . . . . 0.0 116.191 -171.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.51 139.92 38.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.166 1.787 . . . . 0.0 109.723 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 20.4 ptm -91.96 140.54 29.57 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.59 -0.694 . . . . 0.0 111.716 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.19 149.5 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.249 1.82 . . . . 0.0 113.289 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -119.83 151.58 38.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.785 1.234 . . . . 0.0 111.093 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 p -129.34 156.11 44.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -143.59 170.37 15.96 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.449 1.899 . . . . 0.0 110.954 -175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.66 153.68 19.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.732 0.813 . . . . 0.0 112.174 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 124.555 1.142 . . . . 0.0 113.979 176.48 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.212 0.53 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -153.36 138.71 17.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.125 1.37 . . . . 0.0 110.324 -168.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.1 pt -140.61 149.16 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -87.88 147.93 24.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.039 1.736 . . . . 0.0 112.658 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.29 132.3 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.603 1.561 . . . . 0.0 109.777 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.96 11.64 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 115.026 0.771 . . . . 0.0 115.026 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.92 11.12 35.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.549 1.547 . . . . 0.0 114.453 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.44 140.82 58.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.031 1.333 . . . . 0.0 112.168 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 t -66.47 155.37 37.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.004 0.921 . . . . 0.0 111.625 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 m -72.26 -14.8 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.696 -0.628 . . . . 0.0 111.656 169.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.04 -39.88 93.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.05 0.94 . . . . 0.0 111.969 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.15 127.86 33.83 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.15 165.38 13.52 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -62.82 -30.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.34 -37.49 60.65 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.42 0.688 . . . . 0.0 111.509 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.73 -47.18 86.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 t -57.94 -49.22 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 109.039 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -61.52 -44.28 97.35 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.079 0.854 . . . . 0.0 112.355 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -60.71 -46.18 91.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.349 1.06 . . . . 0.0 112.507 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.13 -44.66 96.98 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 48.0 m-85 -66.48 -31.22 71.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -62.28 -12.98 23.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.78 -31.42 72.05 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.248 0.931 . . . . 0.0 113.216 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.81 -39.86 66.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.63 168.5 28.92 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.849 2.643 . . . . 0.0 109.539 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.81 135.59 57.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.483 1.141 . . . . 0.0 113.192 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.47 128.78 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.081 1.753 . . . . 0.0 109.025 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.85 -49.38 30.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.625 1.17 . . . . 0.0 113.891 172.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -154.7 157.29 37.86 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.003 2.121 . . . . 0.0 114.811 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.6 39.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.683 1.193 . . . . 0.0 110.959 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.4 ptm -155.43 148.15 24.22 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.774 1.229 . . . . 0.0 112.095 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.98 151.9 49.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.887 1.675 . . . . 0.0 111.297 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 124.226 1.01 . . . . 0.0 112.77 -177.591 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 p80 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 121.45 0.643 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.23 8.14 3.6 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.22 14.85 58.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.842 1.21 . . . . 0.0 115.099 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -145.56 158.49 43.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.86 -160.94 24.26 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -134.16 148.3 50.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.542 1.937 . . . . 0.0 114.751 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -136.28 133.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.267 1.427 . . . . 0.0 111.162 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.8 m -107.23 134.21 50.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 0.0 112.709 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.19 149.51 28.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 118.433 2.753 . . . . 0.0 118.433 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -67.91 -27.48 66.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.662 0.785 . . . . 0.0 112.932 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.4 t -147.76 138.74 23.41 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.876 1.27 . . . . 0.0 112.766 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -60.84 -27.63 68.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.697 1.599 . . . . 0.0 113.461 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -62.45 -26.53 68.56 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.2 mm -75.03 -50.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.962 0.905 . . . . 0.0 110.272 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 31.3 t -57.49 -34.51 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.348 1.459 . . . . 0.0 111.235 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -52.64 -42.68 64.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 113.165 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.58 -41.83 62.37 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.2 0.909 . . . . 0.0 112.127 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.42 -31.43 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 98.8 m -79.74 -40.28 29.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.171 1.388 . . . . 0.0 113.811 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.19 -43.27 95.59 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.407 0.683 . . . . 0.0 111.873 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.5 114.26 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.54 -51.71 26.8 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.087 -1.008 . . . . 0.0 111.81 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -94.8 139.28 31.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -133.49 132.64 41.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.654 1.582 . . . . 0.0 111.044 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -81.05 127.63 32.82 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.744 -0.598 . . . . 0.0 111.365 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 25.1 mt -140.46 125.0 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 109.136 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 50.47 40.24 22.76 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.219 1.008 . . . . 0.0 112.585 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.7 t30 63.22 -10.7 0.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 128.39 2.676 . . . . 0.0 115.912 -172.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -77.0 143.11 39.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.856 1.662 . . . . 0.0 109.426 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 23.1 ptm -97.15 138.35 34.78 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.424 -0.797 . . . . 0.0 111.458 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.89 146.69 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.731 2.012 . . . . 0.0 112.378 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -89.11 142.88 27.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.519 0.728 . . . . 0.0 111.324 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.87 148.63 52.56 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.626 1.17 . . . . 0.0 112.572 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -158.38 164.66 36.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.406 1.482 . . . . 0.0 112.179 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -61.79 143.28 56.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.019 0.927 . . . . 0.0 112.305 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.882 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.73 154.5 48.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.222 1.409 . . . . 0.0 112.063 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.98 154.54 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.996 1.318 . . . . 0.0 113.313 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.4 149.25 21.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.671 1.988 . . . . 0.0 112.979 167.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.85 131.91 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.858 1.663 . . . . 0.0 109.981 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.5 139.62 7.74 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.47 9.51 21.36 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.236 1.874 . . . . 0.0 114.771 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.75 136.3 57.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.369 1.468 . . . . 0.0 112.518 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -64.64 153.83 38.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.458 1.103 . . . . 0.0 112.05 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.19 -17.07 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.281 0.632 . . . . 0.0 112.332 169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -67.81 -37.5 82.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.938 0.895 . . . . 0.0 111.724 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -70.12 147.39 49.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.311 1.844 . . . . 0.0 114.484 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t -140.05 171.54 14.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.688 1.595 . . . . 0.0 112.846 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -57.21 -31.99 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.2 -40.92 86.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.169 0.988 . . . . 0.0 112.325 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -64.04 -42.46 97.06 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.1 -51.23 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.163 0.985 . . . . 0.0 109.653 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -61.86 -45.85 92.01 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.022 0.828 . . . . 0.0 112.105 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -59.03 -41.79 88.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.761 0.824 . . . . 0.0 112.851 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.46 -46.74 68.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.355 49.9 m-85 -66.43 -26.31 67.16 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.2 -24.95 66.7 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -65.96 -22.95 66.51 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.486 1.039 . . . . 0.0 112.765 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -71.94 -24.88 61.69 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.58 -98.62 0.13 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.617 1.103 . . . . 0.0 112.573 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -154.23 137.23 15.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.272 1.429 . . . . 0.0 112.031 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.33 130.5 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.194 1.798 . . . . 0.0 108.834 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 -46.97 19.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 112.869 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -158.55 161.21 37.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 110.452 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.05 155.17 41.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.433 1.493 . . . . 0.0 111.48 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.55 155.14 32.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.392 1.077 . . . . 0.0 112.741 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.23 152.58 47.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.399 0.68 . . . . 0.0 111.261 171.719 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.7 p80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.29 0.567 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -80.7 1.63 29.33 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.25 84.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.689 1.138 . . . . 0.0 114.115 -171.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.277 9.1 p90 -143.86 155.23 44.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.59 -160.93 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.978 0.799 . . . . 0.0 114.936 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -137.82 150.69 47.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.297 1.839 . . . . 0.0 114.14 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.41 129.57 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.081 1.352 . . . . 0.0 111.407 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.1 m -97.69 122.83 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.275 1.43 . . . . 0.0 112.055 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -95.05 154.83 16.99 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -70.08 -31.82 69.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.922 0.889 . . . . 0.0 113.387 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.2 t -152.07 140.26 20.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -53.21 -33.87 54.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.752 2.021 . . . . 0.0 113.615 170.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.73 -22.25 66.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.13 -54.31 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.099 0.96 . . . . 0.0 109.509 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.7 -39.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.766 1.626 . . . . 0.0 111.506 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.7 -40.81 66.34 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -75.48 -42.43 53.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.054 0.843 . . . . 0.0 112.361 173.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.58 -30.78 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.02 -40.53 24.12 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.018 1.727 . . . . 0.0 113.287 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.35 -39.77 94.2 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.028 -1.045 . . . . 0.0 111.712 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.6 mt -74.48 108.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 168.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.28 -45.86 44.92 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.999 -1.063 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.44 133.59 42.6 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -131.03 130.12 42.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.872 1.669 . . . . 0.0 110.624 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -91.39 130.56 37.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.829 0.852 . . . . 0.0 111.997 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.95 126.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.538 1.535 . . . . 0.0 109.253 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 49.91 42.18 23.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.39 1.076 . . . . 0.0 113.422 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.97 -13.62 0.15 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 127.313 2.245 . . . . 0.0 115.932 -172.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.74 168.3 20.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.168 1.787 . . . . 0.0 110.609 169.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 97.5 mtp -127.18 139.89 52.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.333 1.053 . . . . 0.0 112.151 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.67 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.614 1.966 . . . . 0.0 112.005 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -87.91 141.71 28.37 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.683 0.393 . . . . 0.0 110.876 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.85 146.69 50.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.966 1.306 . . . . 0.0 111.356 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -158.05 171.12 20.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.55 1.14 . . . . 0.0 111.847 174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -59.96 140.68 56.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.71 1.204 . . . . 0.0 111.992 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 124.718 1.207 . . . . 0.0 113.713 178.046 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 mptt . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.904 0.859 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -154.91 144.29 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.198 1.399 . . . . 0.0 111.374 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -140.41 155.01 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.586 1.155 . . . . 0.0 113.301 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -94.5 145.77 24.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.198 2.199 . . . . 0.0 112.789 167.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.1 138.77 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.051 1.74 . . . . 0.0 109.726 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.51 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.93 13.65 54.23 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.375 1.464 . . . . 0.0 114.215 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.5 mt -62.79 138.6 58.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.422 . . . . 0.0 112.215 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.44 155.15 33.56 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.112 0.965 . . . . 0.0 111.734 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 p -67.97 -21.07 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.868 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -69.95 -30.89 68.37 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.478 1.111 . . . . 0.0 112.911 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.4 m -79.7 128.69 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.393 1.477 . . . . 0.0 114.236 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.51 166.21 12.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.02 -30.12 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 169.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.76 -35.94 62.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.486 0.715 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.7 -46.87 87.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.632 0.651 . . . . 0.0 112.364 170.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.73 -50.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.595 1.158 . . . . 0.0 109.422 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.7 -48.59 81.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.82 0.736 . . . . 0.0 112.177 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -60.73 -39.45 88.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.789 0.836 . . . . 0.0 112.553 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.61 -48.66 66.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 50.4 m-85 -62.92 -29.5 70.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -59.91 -20.84 59.62 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -70.29 -25.66 63.43 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.14 0.882 . . . . 0.0 112.674 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.42 -38.28 59.91 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.17 37.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.518 2.008 . . . . 0.0 111.326 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -58.55 119.41 6.99 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.109 0.964 . . . . 0.0 112.995 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -93.93 131.4 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.0 107.987 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -86.44 -35.1 19.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -163.87 158.6 20.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.249 1.419 . . . . 0.0 109.398 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.21 139.52 22.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.067 1.347 . . . . 0.0 110.608 172.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.1 mmt -148.8 151.12 34.23 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.421 1.488 . . . . 0.0 112.254 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.62 151.73 41.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.487 1.515 . . . . 0.0 111.074 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtp . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 123.711 0.804 . . . . 0.0 112.35 -175.605 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.7 p80 . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 112.077 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -78.96 12.8 2.01 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.63 15.15 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.786 1.184 . . . . 0.0 114.674 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.266 8.5 p90 -146.91 159.09 43.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.28 -160.59 22.74 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.192 0.901 . . . . 0.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.35 150.65 44.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.029 1.731 . . . . 0.0 114.207 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.27 130.32 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.354 1.461 . . . . 0.0 111.938 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -93.75 144.73 25.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.401 1.88 . . . . 0.0 114.431 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -125.95 151.08 47.47 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 118.167 2.654 . . . . 0.0 118.167 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -61.57 -37.2 82.96 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.004 1.322 . . . . 0.0 113.636 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 t -153.94 148.19 25.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.321 1.049 . . . . 0.0 112.496 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -61.8 -24.73 67.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.184 0.994 . . . . 0.0 112.583 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.46 -35.92 68.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.545 1.138 . . . . 0.0 111.909 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.44 -51.42 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.954 0.902 . . . . 0.0 110.057 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.9 t -57.77 -38.41 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.351 1.06 . . . . 0.0 111.716 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -54.12 -45.75 72.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.021 0.928 . . . . 0.0 112.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -72.31 -43.36 64.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.828 0.74 . . . . 0.0 112.023 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.0 -43.33 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.057 0.844 . . . . 0.0 111.465 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.5 t -74.87 -33.64 62.12 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.083 1.353 . . . . 0.0 113.074 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -64.67 -42.05 95.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.44 107.62 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 169.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.69 -43.63 65.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.39 -1.444 . . . . 0.0 112.544 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -99.82 138.61 36.66 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.502 ' CD2' ' HG ' ' A' ' 181' ' ' CYS . 78.2 m-70 -138.88 136.51 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.993 1.717 . . . . 0.0 110.836 -173.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -103.15 130.6 50.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.089 0.956 . . . . 0.0 112.738 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.4 130.61 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.567 1.547 . . . . 0.0 109.285 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 52.33 37.14 21.56 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.33 1.052 . . . . 0.0 113.413 -175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 61.68 -5.47 0.14 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 127.946 2.498 . . . . 0.0 115.768 -170.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.43 167.33 20.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.697 2.399 . . . . 0.0 109.216 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 98.1 mtp -123.21 143.61 49.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.968 0.907 . . . . 0.0 112.909 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.78 164.54 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.226 2.61 . . . . 0.0 111.653 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -109.31 155.43 21.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.807 0.843 . . . . 0.0 110.826 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.502 ' HG ' ' CD2' ' A' ' 172' ' ' HIS . 14.4 p -141.85 154.67 45.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.285 0.634 . . . . 0.0 110.747 168.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -159.96 -175.36 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.749 1.22 . . . . 0.0 111.729 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -53.39 149.61 7.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.559 1.544 . . . . 0.0 114.637 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 126.698 1.999 . . . . 0.0 109.458 169.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.471 0.177 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -148.55 155.3 40.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.222 -0.924 . . . . 0.0 112.542 -167.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.31 153.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.908 1.283 . . . . 0.0 113.137 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -93.71 145.55 24.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.274 2.23 . . . . 0.0 112.237 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.43 139.93 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.759 1.624 . . . . 0.0 110.213 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.77 147.72 17.45 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 118.785 0.72 . . . . 0.0 114.652 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.55 12.04 34.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.667 1.603 . . . . 0.0 114.323 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.49 136.57 55.87 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.121 1.368 . . . . 0.0 112.117 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -65.89 154.98 37.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.169 0.988 . . . . 0.0 112.139 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.96 -17.0 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.655 -0.653 . . . . 0.0 111.327 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -69.73 -30.07 67.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.243 1.017 . . . . 0.0 112.54 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -74.96 131.39 40.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.814 1.645 . . . . 0.0 114.884 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -97.54 167.75 10.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 115.318 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.55 -28.75 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.01 -35.91 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.632 0.773 . . . . 0.0 111.795 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.49 -45.15 94.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 169.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -61.01 -51.25 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.206 1.002 . . . . 0.0 109.232 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.23 -49.49 75.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.436 0.694 . . . . 0.0 112.063 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -60.47 -41.72 94.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.065 0.946 . . . . 0.0 112.554 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -66.48 -48.21 70.58 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.316 54.5 m-85 -65.46 -29.47 70.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.37 -20.91 61.28 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -69.14 -26.47 64.9 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.184 0.902 . . . . 0.0 112.635 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -77.62 -38.52 47.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.65 179.9 41.16 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.406 1.955 . . . . 0.0 111.208 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -64.66 121.82 15.4 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.2 132.54 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.683 1.993 . . . . 0.0 107.827 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.85 -55.96 5.12 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 113.18 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.69 169.54 21.35 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.18 0.992 . . . . 0.0 109.872 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.4 152.95 47.51 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.557 1.543 . . . . 0.0 111.842 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 48.9 mmm -149.2 158.26 44.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.501 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.6 mt -124.19 152.33 43.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.58 1.552 . . . . 0.0 111.581 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 124.104 0.962 . . . . 0.0 110.317 173.759 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -81.96 7.32 13.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.19 10.54 71.21 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.773 1.177 . . . . 0.0 114.598 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.29 11.8 p90 -141.75 159.69 41.7 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.84 -162.43 23.17 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.99 0.805 . . . . 0.0 114.506 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.22 150.12 46.43 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.497 1.919 . . . . 0.0 113.891 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.4 t -133.72 128.14 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.921 1.288 . . . . 0.0 111.59 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.6 m -92.33 140.39 29.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.146 1.378 . . . . 0.0 113.067 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -122.53 152.65 40.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.056 2.142 . . . . 0.0 116.641 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -76.6 -29.13 56.42 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 t -135.83 129.95 33.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.187 0.995 . . . . 0.0 113.577 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 pm0 -62.88 -29.93 71.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.119 1.768 . . . . 0.0 112.791 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.57 -31.51 72.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.45 -46.41 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.766 0.826 . . . . 0.0 110.118 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.1 t -54.46 -43.5 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.265 1.026 . . . . 0.0 109.836 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.2 -53.13 61.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.0 0.92 . . . . 0.0 113.337 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -64.87 -43.0 94.39 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.22 0.918 . . . . 0.0 111.836 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.84 -42.12 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.777 0.717 . . . . 0.0 110.153 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.42 -31.38 68.56 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.87 -36.13 79.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.29 0.95 . . . . 0.0 112.892 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.9 136.13 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.985 0.914 . . . . 0.0 110.235 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.09 160.18 35.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.984 1.314 . . . . 0.0 111.67 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.477 5.3 m-85 63.34 46.79 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -62.29 134.92 57.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.374 1.869 . . . . 0.0 110.885 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -93.34 112.83 24.86 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.463 -0.773 . . . . 0.0 112.57 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.0 mt -132.62 120.34 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.556 0.742 . . . . 0.0 111.311 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 49.62 44.16 24.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.769 1.227 . . . . 0.0 113.109 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.4 m120 62.64 -8.04 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 128.076 2.55 . . . . 0.0 115.852 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -84.56 154.02 22.89 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.593 1.957 . . . . 0.0 109.471 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 57.5 mmm -99.64 139.91 34.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.175 0.59 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.37 160.44 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.815 1.646 . . . . 0.0 114.004 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -123.12 159.2 29.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.706 1.202 . . . . 0.0 111.482 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -144.99 159.18 43.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.245 1.018 . . . . 0.0 112.954 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -145.22 162.14 37.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.422 1.889 . . . . 0.0 111.037 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -58.64 145.82 38.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.673 0.789 . . . . 0.0 112.939 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.683 1.593 . . . . 0.0 110.012 174.529 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -133.73 167.51 20.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.457 1.903 . . . . 0.0 110.825 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 pt -140.88 148.74 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.709 1.204 . . . . 0.0 112.848 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -81.5 148.85 28.99 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.797 1.639 . . . . 0.0 111.189 164.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.35 135.2 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.533 1.533 . . . . 0.0 109.854 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.1 149.27 21.24 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.592 0.633 . . . . 0.0 114.674 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.86 9.03 55.06 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.535 1.54 . . . . 0.0 114.526 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.79 138.48 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.929 1.292 . . . . 0.0 112.018 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -65.23 152.09 44.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.508 0.723 . . . . 0.0 111.192 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 m -72.32 -14.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.579 -0.701 . . . . 0.0 111.696 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -70.43 -31.59 68.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.983 0.913 . . . . 0.0 112.199 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -73.83 141.0 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.794 1.638 . . . . 0.0 113.406 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -123.59 166.3 15.7 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.23 -31.21 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -65.84 -38.09 87.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.053 0.941 . . . . 0.0 112.334 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.8 -43.24 84.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.856 . . . . 0.0 109.547 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.47 -49.42 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.562 1.145 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -62.46 -46.4 88.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.575 0.625 . . . . 0.0 111.781 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -59.7 -42.25 92.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 112.368 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -66.03 -49.47 67.6 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.299 42.5 m-85 -62.93 -27.67 69.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.62 -16.44 48.4 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -65.41 -31.55 72.71 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.51 -35.71 58.18 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.9 175.51 36.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.117 2.294 . . . . 0.0 110.553 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -63.3 133.3 53.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.3 t -112.34 122.54 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.492 1.917 . . . . 0.0 109.492 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -77.31 -45.2 26.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.235 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.83 159.46 41.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.608 1.963 . . . . 0.0 115.18 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.68 152.33 40.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.084 1.354 . . . . 0.0 110.762 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.3 ptp -157.78 147.57 20.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.505 1.122 . . . . 0.0 112.19 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.6 mt -126.93 153.27 46.03 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.593 1.557 . . . . 0.0 111.593 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.5 mmm . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 112.641 -177.358 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.471 0.653 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -74.53 6.3 3.91 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.06 13.5 58.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.023 1.297 . . . . 0.0 114.862 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 16.0 p90 -145.69 161.1 40.67 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.32 -160.38 23.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.216 0.912 . . . . 0.0 114.72 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -136.9 151.97 49.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.245 1.818 . . . . 0.0 114.342 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.15 131.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.505 1.522 . . . . 0.0 111.042 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.8 m -99.06 126.42 44.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.037 1.735 . . . . 0.0 113.243 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -104.2 154.09 20.18 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -74.41 -18.46 60.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.5 t -153.04 141.14 20.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.327 1.051 . . . . 0.0 113.11 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -62.87 -27.4 69.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 112.817 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.34 -28.11 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.47 -48.7 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.765 0.826 . . . . 0.0 110.102 170.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.05 -40.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.065 1.346 . . . . 0.0 110.554 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -56.93 -43.7 81.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.041 0.837 . . . . 0.0 113.134 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -70.63 -43.18 69.76 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.109 0.868 . . . . 0.0 111.994 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.45 -37.54 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.717 0.69 . . . . 0.0 111.477 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 50.4 t -73.6 -41.56 62.69 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 113.092 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -62.43 -38.37 89.48 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.219 -0.925 . . . . 0.0 112.491 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.69 106.5 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -65.53 -55.63 16.74 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.158 -0.963 . . . . 0.0 111.671 -174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.361 63.9 m-85 -103.27 137.0 41.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -131.47 159.66 37.43 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.081 2.553 . . . . 0.0 109.655 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -126.66 125.24 41.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.629 1.104 . . . . 0.0 113.533 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.37 125.75 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.325 1.45 . . . . 0.0 109.757 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 50.17 40.19 21.37 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.237 1.015 . . . . 0.0 112.871 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.05 -8.61 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.308 2.643 . . . . 0.0 116.32 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -79.44 140.64 37.31 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.834 1.654 . . . . 0.0 109.232 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 39.5 mtm -92.33 147.78 22.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 m -138.24 153.49 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.769 2.428 . . . . 0.0 111.533 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.35 150.31 28.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.631 0.773 . . . . 0.0 111.293 170.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.26 142.91 31.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.827 0.851 . . . . 0.0 112.906 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -144.51 156.42 44.16 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.023 1.329 . . . . 0.0 111.626 -168.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -54.9 141.49 33.22 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.917 1.687 . . . . 0.0 111.59 -179.736 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.914 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 m 63.36 21.48 12.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.601 1.96 . . . . 0.0 116.037 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -81.17 178.05 8.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.368 1.067 . . . . 0.0 110.53 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 76.5 mtm -86.94 163.72 16.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.07 1.348 . . . . 0.0 112.412 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -97.64 2.68 50.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -139.61 160.62 39.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.224 1.41 . . . . 0.0 112.196 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.07 151.71 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.907 1.283 . . . . 0.0 112.675 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.57 149.78 25.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.044 1.738 . . . . 0.0 112.519 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.24 138.22 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.417 1.487 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.56 15.0 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.033 0.773 . . . . 0.0 115.033 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.02 14.13 25.45 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.749 1.642 . . . . 0.0 114.397 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.6 139.25 57.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.37 1.468 . . . . 0.0 112.325 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.87 151.67 44.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.72 0.808 . . . . 0.0 111.165 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 t -68.37 -20.67 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.553 -0.717 . . . . 0.0 111.346 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -68.07 -28.94 67.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.528 1.131 . . . . 0.0 113.214 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 60.1 m -79.36 132.77 36.52 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.542 1.537 . . . . 0.0 112.827 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.69 165.9 13.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.17 -31.59 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -74.21 -33.47 63.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.38 0.672 . . . . 0.0 111.735 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.55 -47.98 83.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.099 0.56 . . . . 0.0 112.14 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.94 -45.47 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.106 0.562 . . . . 0.0 110.725 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -42.54 91.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.094 0.558 . . . . 0.0 111.813 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.71 -53.58 32.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.526 1.131 . . . . 0.0 112.774 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -59.2 -34.57 72.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 117.633 2.456 . . . . 0.0 117.633 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.32 38.0 m-85 -70.75 -15.8 62.71 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 173.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.42 -10.97 58.86 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -62.52 -25.6 68.11 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.159 -0.963 . . . . 0.0 113.59 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.77 -30.51 18.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.399 1.08 . . . . 0.0 113.284 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 177.83 36.74 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.97 2.224 . . . . 0.0 110.765 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -61.89 124.96 22.21 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.996 . . . . 0.0 112.375 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.3 t -95.87 125.24 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.753 1.621 . . . . 0.0 107.019 168.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.64 -41.03 19.95 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.835 -0.541 . . . . 0.0 109.688 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -162.69 165.72 25.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.317 2.247 . . . . 0.0 114.987 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.66 154.25 45.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.169 1.388 . . . . 0.0 110.748 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.1 mtp -148.95 152.96 37.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.655 1.582 . . . . 0.0 111.462 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -125.85 150.97 47.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.321 1.448 . . . . 0.0 111.742 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.82 101.08 12.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.601 0.76 . . . . 0.0 111.386 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.263 61.2 m-85 -78.58 137.36 37.84 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -93.24 115.09 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.454 1.102 . . . . 0.0 108.764 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.31 -10.46 59.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.9 p -79.93 -17.12 53.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -128.61 -20.68 3.56 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.27 76.2 m-20 58.24 25.29 12.47 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.828 2.051 . . . . 0.0 114.337 -169.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -109.7 158.48 18.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.366 1.866 . . . . 0.0 110.055 169.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.33 152.61 32.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.62 -0.675 . . . . 0.0 111.871 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -80.64 8.81 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.17 11.59 69.37 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.631 1.11 . . . . 0.0 114.503 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.273 12.3 p90 -144.56 158.75 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.93 -158.22 18.38 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.187 0.899 . . . . 0.0 114.739 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -139.78 151.36 45.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.953 2.101 . . . . 0.0 114.18 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.6 129.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.125 1.37 . . . . 0.0 111.804 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.0 m -94.44 128.89 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.28 1.832 . . . . 0.0 113.045 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -104.98 150.31 25.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.14 -35.7 81.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 113.048 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.1 t -147.45 141.22 25.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.667 1.187 . . . . 0.0 112.652 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.35 -26.25 68.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.292 1.437 . . . . 0.0 113.474 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.9 -27.43 66.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.6 mm -77.74 -50.1 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.777 0.831 . . . . 0.0 109.89 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 66.9 t -54.84 -35.12 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.155 1.382 . . . . 0.0 111.576 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -48.91 -51.05 32.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -70.36 -44.18 68.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.555 0.616 . . . . 0.0 111.606 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.25 -47.18 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 18.9 t -74.51 -29.58 61.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.558 1.143 . . . . 0.0 112.53 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.52 -41.4 93.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.947 -1.096 . . . . 0.0 112.047 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.75 119.85 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -68.39 -59.14 3.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.993 -1.067 . . . . 0.0 111.36 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.302 61.3 m-85 -101.81 139.18 37.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -135.79 135.53 39.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.554 1.942 . . . . 0.0 110.819 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -80.85 135.84 36.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.309 0.644 . . . . 0.0 111.904 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.7 mt -144.89 122.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.732 2.013 . . . . 0.0 108.383 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 50.48 38.65 18.94 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.3 t30 62.78 -12.5 0.07 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 128.112 2.565 . . . . 0.0 115.942 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -73.36 141.81 47.04 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.307 -1.495 . . . . 0.0 108.594 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 51.8 mtm -94.32 142.45 27.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.078 0.854 . . . . 0.0 112.346 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.67 153.35 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.325 2.25 . . . . 0.0 111.311 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.44 157.06 16.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 112.106 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.7 p -133.93 157.27 46.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.537 0.735 . . . . 0.0 112.063 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -145.9 171.59 14.59 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.981 1.712 . . . . 0.0 111.327 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -61.07 149.51 36.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.124 0.97 . . . . 0.0 113.217 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -150.24 149.28 29.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.137 1.375 . . . . 0.0 111.275 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.63 145.17 96.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.57 169.15 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.853 3.035 . . . . 0.0 112.434 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -140.95 130.33 23.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.282 1.433 . . . . 0.0 110.69 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.06 123.47 25.84 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.96 0.904 . . . . 0.0 111.776 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 p -152.02 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 27.7 ptm -74.69 168.8 19.11 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.427 1.491 . . . . 0.0 112.746 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.4 t -145.91 122.49 5.91 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.692 1.197 . . . . 0.0 110.77 170.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -82.09 -10.07 11.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.445 2.764 . . . . 0.0 113.713 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.362 0.2 OUTLIER -71.24 35.97 0.05 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -169.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -73.55 175.17 47.02 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.562 1.077 . . . . 0.0 113.406 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 t -151.85 141.41 21.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.419 1.088 . . . . 0.0 112.152 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.93 55.9 1.84 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.899 1.68 . . . . 0.0 112.733 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -63.82 148.03 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.189 1.396 . . . . 0.0 112.909 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 175.46 -173.04 46.0 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.963 1.268 . . . . 0.0 113.334 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -151.69 169.11 22.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.763 1.625 . . . . 0.0 112.565 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.404 1.482 . . . . 0.0 113.122 168.272 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 143.57 51.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.31 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -80.51 157.76 26.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.966 1.306 . . . . 0.0 113.129 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 148.7 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.372 1.069 . . . . 0.0 112.748 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.21 7.82 44.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.465 1.506 . . . . 0.0 113.719 170.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -133.22 159.31 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.547 1.139 . . . . 0.0 112.865 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.94 152.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 112.861 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -86.44 148.71 25.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 112.317 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.5 135.88 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.428 1.491 . . . . 0.0 109.421 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.41 146.71 15.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.97 10.29 32.66 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.828 1.68 . . . . 0.0 114.287 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.06 141.09 58.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.342 1.457 . . . . 0.0 112.321 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -68.81 156.77 37.77 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.791 0.836 . . . . 0.0 112.588 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.38 -27.72 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.649 0.78 . . . . 0.0 110.067 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -64.91 -31.84 73.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.972 0.909 . . . . 0.0 112.696 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 135.53 50.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.015 1.326 . . . . 0.0 113.426 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.88 166.64 13.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.177 1.391 . . . . 0.0 114.635 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.74 -32.75 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -34.84 78.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.85 0.86 . . . . 0.0 112.744 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -67.18 -45.37 77.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.698 0.799 . . . . 0.0 109.853 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.85 -48.08 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.702 1.201 . . . . 0.0 110.428 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -62.53 -47.33 84.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 111.93 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.13 -40.98 87.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.747 0.819 . . . . 0.0 112.419 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -65.89 -51.55 57.72 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 46.9 m-85 -64.17 -25.85 68.26 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -60.74 -17.51 49.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.21 -29.47 70.28 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.369 -0.832 . . . . 0.0 113.058 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.53 -36.19 38.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.5 33.43 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.219 2.342 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.81 124.64 21.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.349 1.074 . . . . 0.0 112.723 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.46 118.45 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.251 1.42 . . . . 0.0 108.637 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.19 -31.6 43.89 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -162.05 160.4 27.46 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.938 1.295 . . . . 0.0 109.516 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.87 152.29 31.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.15 1.38 . . . . 0.0 111.093 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -156.77 156.05 32.64 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.377 1.071 . . . . 0.0 112.323 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.03 149.54 44.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.619 1.568 . . . . 0.0 110.391 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 70.3 mtp -79.33 72.45 5.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 112.201 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -59.78 141.85 54.46 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -132.35 116.97 17.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 113.051 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -64.08 -19.49 65.27 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.5 p -79.39 -13.47 59.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 172.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -125.23 -16.12 6.05 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 58.84 25.86 14.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.653 1.981 . . . . 0.0 114.648 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -149.27 172.1 15.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.553 1.941 . . . . 0.0 110.749 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -81.8 153.28 26.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.364 0.602 . . . . 0.0 111.839 170.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.06 8.76 2.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.49 13.9 66.93 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.855 1.217 . . . . 0.0 114.329 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.269 8.9 p90 -146.49 160.09 42.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.16 -162.15 21.94 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.221 0.915 . . . . 0.0 114.797 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -138.24 147.3 43.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.88 2.072 . . . . 0.0 114.447 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.71 125.47 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 111.159 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 m -96.42 123.3 40.03 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 111.739 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.29 152.59 18.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -67.67 -34.16 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.541 -0.724 . . . . 0.0 112.399 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.5 t -142.87 137.73 29.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.464 1.126 . . . . 0.0 113.845 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -56.3 -27.36 55.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.117 2.167 . . . . 0.0 112.972 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.92 -28.38 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.72 -48.62 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.893 0.877 . . . . 0.0 109.786 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.02 -38.98 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.075 1.35 . . . . 0.0 110.998 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.62 -34.34 67.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.93 -48.36 14.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.02 0.827 . . . . 0.0 111.713 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.89 -44.73 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.964 0.802 . . . . 0.0 112.558 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.12 -21.45 58.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.011 1.324 . . . . 0.0 112.907 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -78.02 -34.68 50.52 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.946 -1.096 . . . . 0.0 112.396 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.56 139.94 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.691 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -127.08 156.69 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 0.0 113.108 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.466 24.9 m-85 60.31 49.27 7.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -58.86 133.47 56.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.858 2.063 . . . . 0.0 110.993 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -98.66 126.51 44.29 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.287 0.948 . . . . 0.0 113.155 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 mt -142.57 123.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.951 1.7 . . . . 0.0 109.392 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 50.36 41.54 24.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.39 1.076 . . . . 0.0 113.55 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 64.89 -13.41 0.11 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 127.822 2.449 . . . . 0.0 116.002 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -73.9 155.43 38.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.069 1.748 . . . . 0.0 109.283 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.4 ptm -120.77 136.06 54.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.874 0.87 . . . . 0.0 111.188 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.77 143.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.808 1.643 . . . . 0.0 113.602 -169.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -87.02 159.24 19.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.268 0.556 . . . . 0.0 111.353 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.5 p -138.13 155.96 48.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.122 0.969 . . . . 0.0 111.583 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -146.15 167.73 22.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.682 1.593 . . . . 0.0 110.865 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -58.9 151.47 21.62 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.591 -0.693 . . . . 0.0 112.248 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.07 144.29 50.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.283 1.433 . . . . 0.0 110.138 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.71 142.84 97.78 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -68.54 164.75 31.67 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.729 2.953 . . . . 0.0 112.989 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -142.78 155.41 44.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.196 1.798 . . . . 0.0 110.729 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -74.03 61.56 0.83 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.631 1.572 . . . . 0.0 113.366 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.7 t -67.4 142.56 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.939 1.295 . . . . 0.0 111.768 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.45 167.36 8.82 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.437 1.095 . . . . 0.0 113.117 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.2 t -135.54 117.89 12.36 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.005 1.322 . . . . 0.0 109.358 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.44 145.22 26.48 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.97 2.446 . . . . 0.0 112.993 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.7 t -154.57 158.76 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.547 1.539 . . . . 0.0 114.075 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 174.03 155.92 12.78 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.508 1.051 . . . . 0.0 113.755 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.7 t -159.35 152.54 22.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.686 1.594 . . . . 0.0 110.838 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.988 1.315 . . . . 0.0 112.079 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 45.8 ttm105 -77.52 141.22 39.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 111.423 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 175.92 177.04 44.63 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.229 0.919 . . . . 0.0 114.025 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ttt-85 -68.2 147.14 52.66 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.675 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.255 1.357 0 C-N-CA 124.992 1.317 . . . . 0.0 112.361 168.571 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.176 -0.369 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 81.2 p -146.31 20.5 1.37 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.264 1.426 . . . . 0.0 113.483 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -77.7 48.85 0.71 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.389 2.275 . . . . 0.0 113.772 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 75.1 mtm -68.51 151.97 46.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.844 1.658 . . . . 0.0 113.078 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -130.49 35.57 4.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.644 1.577 . . . . 0.0 112.137 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -149.29 154.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.612 1.165 . . . . 0.0 110.641 -171.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.51 150.77 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.361 1.064 . . . . 0.0 112.884 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.44 145.51 25.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.367 1.867 . . . . 0.0 111.912 166.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.21 137.83 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.614 1.566 . . . . 0.0 110.117 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.28 147.18 17.07 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 114.688 0.635 . . . . 0.0 114.688 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.96 13.21 29.9 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.693 1.616 . . . . 0.0 114.649 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.54 137.95 58.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.729 1.264 . . . . 0.0 112.205 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -64.72 156.43 30.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.714 1.206 . . . . 0.0 112.821 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 m -71.86 -16.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.252 0.621 . . . . 0.0 111.349 168.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.02 -38.12 85.37 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 111.739 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.15 146.97 54.28 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 t -133.2 166.45 22.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.388 1.875 . . . . 0.0 112.76 169.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.73 -33.33 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.0 -39.89 87.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.436 0.694 . . . . 0.0 112.149 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.9 -43.52 95.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.77 -47.2 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.204 0.602 . . . . 0.0 110.467 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.77 -48.19 82.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.591 0.632 . . . . 0.0 111.803 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -60.8 -39.03 87.38 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -68.3 -40.74 81.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.323 52.8 m-85 -71.32 -29.82 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.44 -18.1 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -65.71 -24.9 67.09 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.295 -0.878 . . . . 0.0 112.884 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.27 -29.32 26.54 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.94 178.87 36.21 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.57 2.033 . . . . 0.0 110.921 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.86 116.3 6.21 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.654 -0.91 . . . . 0.0 112.549 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.65 130.68 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.844 1.658 . . . . 0.0 107.146 169.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.38 -54.07 7.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.673 0.789 . . . . 0.0 112.918 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.84 165.94 29.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.528 1.131 . . . . 0.0 110.003 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.93 149.8 37.38 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.588 1.555 . . . . 0.0 111.647 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.9 mtp -148.41 152.17 36.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.555 1.542 . . . . 0.0 111.713 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.8 mt -125.88 154.11 43.2 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.04 1.336 . . . . 0.0 111.92 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.1 mmm -84.12 103.98 13.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.642 0.777 . . . . 0.0 110.664 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.337 58.7 m-85 -77.18 145.65 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -111.49 114.2 27.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.202 1.801 . . . . 0.0 111.199 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -60.19 -23.29 63.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.609 1.164 . . . . 0.0 113.538 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -24.46 65.09 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 p -136.92 -15.94 1.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -171.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 60.55 14.91 5.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.62 1.968 . . . . 0.0 114.366 -169.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -101.12 174.08 6.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.199 1.8 . . . . 0.0 110.705 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -79.22 158.37 27.64 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.508 0.67 . . . . 0.0 112.346 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -73.73 0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.691 1.996 . . . . 0.0 115.603 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.19 9.01 65.91 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.714 1.15 . . . . 0.0 113.88 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 17.6 p90 -144.99 158.82 43.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.74 -158.66 19.36 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.228 0.918 . . . . 0.0 114.693 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.69 148.95 47.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.605 1.962 . . . . 0.0 114.02 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 t -133.81 132.0 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.132 1.373 . . . . 0.0 111.38 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.8 m -98.52 139.83 33.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.353 1.861 . . . . 0.0 113.954 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.56 154.96 34.66 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.49 -32.58 70.15 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -150.02 146.55 27.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.44 1.096 . . . . 0.0 113.14 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.15 -28.43 69.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.809 1.244 . . . . 0.0 112.613 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.57 -31.79 71.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.9 mm -76.86 -46.12 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.711 0.804 . . . . 0.0 110.152 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.38 -41.13 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.688 1.195 . . . . 0.0 110.252 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -57.72 -49.93 74.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.038 0.836 . . . . 0.0 113.137 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.53 -44.78 81.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.764 0.711 . . . . 0.0 111.779 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.15 -45.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.534 0.607 . . . . 0.0 110.138 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.5 t -67.83 -36.19 79.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.391 1.077 . . . . 0.0 112.745 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -66.68 -41.03 88.77 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.13 -0.981 . . . . 0.0 112.657 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mt -67.01 134.42 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.682 0.793 . . . . 0.0 110.496 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -112.12 148.64 33.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.128 1.371 . . . . 0.0 111.586 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.49 29.3 m-85 57.16 57.02 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -63.59 128.92 38.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.471 1.508 . . . . 0.0 111.405 173.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.06 133.46 36.12 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.84 0.745 . . . . 0.0 112.264 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.4 mt -146.34 124.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.974 2.11 . . . . 0.0 108.235 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.6 m120 50.98 43.23 28.94 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.175 0.99 . . . . 0.0 113.167 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.78 -13.99 0.08 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.262 2.625 . . . . 0.0 116.485 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.08 169.97 17.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.819 2.047 . . . . 0.0 109.28 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.2 ptp -127.33 146.11 50.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.852 0.861 . . . . 0.0 113.193 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.38 164.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.935 2.494 . . . . 0.0 112.894 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -128.25 158.38 38.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.504 0.722 . . . . 0.0 111.893 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.53 157.42 44.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 113.37 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -142.27 159.07 42.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.167 1.787 . . . . 0.0 111.256 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.15 144.5 45.62 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.577 0.626 . . . . 0.0 112.542 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.63 148.81 46.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.346 1.458 . . . . 0.0 111.07 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -71.31 138.09 84.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 121.728 -0.608 . . . . 0.0 111.74 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.51 148.44 83.73 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.207 2.605 . . . . 0.0 112.123 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -120.94 13.79 11.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.513 1.925 . . . . 0.0 112.265 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -156.45 161.99 40.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.297 2.639 . . . . 0.0 110.181 -171.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.47 145.45 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.7 ptm -71.76 163.68 27.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.519 1.128 . . . . 0.0 112.458 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.1 t -113.62 101.91 54.23 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.727 1.211 . . . . 0.0 109.922 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.15 -12.55 11.7 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.328 2.686 . . . . 0.0 114.006 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.273 1.0 OUTLIER -72.8 160.44 32.17 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 74.65 -162.8 54.16 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.339 0.971 . . . . 0.0 114.195 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 41.0 t -154.98 150.67 27.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.188 1.395 . . . . 0.0 112.031 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.15 -2.69 35.64 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.071 1.348 . . . . 0.0 114.117 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -60.58 156.67 15.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.3 1.44 . . . . 0.0 113.431 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -173.98 -168.68 35.25 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.87 1.224 . . . . 0.0 113.355 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 65.13 146.88 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 128.21 2.604 . . . . 0.0 114.438 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.206 1.802 . . . . 0.0 113.695 -178.829 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 64.1 m -74.87 -16.17 60.69 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -75.02 66.92 1.65 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.524 1.53 . . . . 0.0 112.176 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 24.9 ptp -82.55 -11.07 58.7 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -152.79 56.01 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.058 1.343 . . . . 0.0 111.538 -170.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -136.4 155.99 49.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.755 1.622 . . . . 0.0 112.485 -168.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.26 157.52 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.571 1.549 . . . . 0.0 113.379 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -94.09 147.34 23.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.173 2.189 . . . . 0.0 113.29 167.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.4 t -137.31 138.93 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.727 1.611 . . . . 0.0 110.061 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.77 154.16 25.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.704 0.669 . . . . 0.0 114.414 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.12 15.02 31.83 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.379 1.466 . . . . 0.0 114.596 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.66 143.03 58.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.004 1.322 . . . . 0.0 112.493 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 p -76.51 175.5 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.453 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 m -81.61 -24.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 0.0 112.684 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -77.32 -33.3 55.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.194 0.998 . . . . 0.0 111.663 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.8 m -65.44 143.97 57.35 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.246 1.418 . . . . 0.0 113.356 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 t -142.72 173.42 11.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.26 1.824 . . . . 0.0 112.715 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.52 -34.15 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.58 -38.67 84.39 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.879 0.872 . . . . 0.0 112.165 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.64 -43.24 85.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.1 t -58.66 -46.88 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.388 0.675 . . . . 0.0 109.867 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -60.57 -46.94 88.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.427 0.558 . . . . 0.0 111.887 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -61.43 -45.09 95.76 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -66.61 -38.75 87.63 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.333 46.7 m-85 -71.62 -29.84 65.12 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.91 -18.93 48.64 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -66.17 -24.96 66.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.494 0.718 . . . . 0.0 112.746 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.67 -34.86 30.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.43 169.54 28.13 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.059 2.266 . . . . 0.0 110.466 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -57.49 130.42 46.23 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.953 0.901 . . . . 0.0 112.768 -170.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.81 122.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.465 1.506 . . . . 0.0 108.249 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.08 -40.02 63.05 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -156.52 154.84 30.97 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.062 2.145 . . . . 0.0 114.646 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.38 142.72 30.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.359 1.064 . . . . 0.0 110.7 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.2 mtm -150.38 151.83 33.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.499 1.52 . . . . 0.0 111.649 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.98 156.86 31.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.173 1.389 . . . . 0.0 111.694 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.4 tpp -79.3 127.51 32.15 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.752 0.821 . . . . 0.0 110.205 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -111.75 155.61 23.23 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 117.603 2.446 . . . . 0.0 117.603 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -111.99 106.83 15.6 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.881 1.272 . . . . 0.0 112.053 168.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -61.74 -16.67 51.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 -22.51 66.05 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.9 p -139.01 -15.74 1.12 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.49 15.35 5.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.058 2.143 . . . . 0.0 114.95 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -83.29 150.31 26.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 110.609 169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -79.41 156.43 27.92 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -86.37 8.23 22.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.85 6.37 67.41 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.136 1.35 . . . . 0.0 115.035 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -146.38 162.77 37.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.03 -158.14 20.24 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.186 0.898 . . . . 0.0 114.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -135.97 151.06 49.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.28 1.832 . . . . 0.0 114.547 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -135.42 123.74 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.151 1.38 . . . . 0.0 111.468 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 m -87.79 129.04 35.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.163 1.385 . . . . 0.0 113.125 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.86 160.26 14.44 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -62.24 -39.69 93.7 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.418 -0.801 . . . . 0.0 112.038 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.2 t -149.21 148.57 29.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.728 1.211 . . . . 0.0 113.592 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -57.83 -27.5 63.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 112.674 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.82 -21.86 66.22 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.46 -50.38 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.739 0.816 . . . . 0.0 109.819 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.94 -38.67 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.281 1.433 . . . . 0.0 111.275 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -60.33 -43.17 96.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -68.29 -37.76 80.98 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.666 0.667 . . . . 0.0 111.552 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.67 -37.74 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.482 0.583 . . . . 0.0 110.996 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 85.6 m -77.65 -28.85 51.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.243 1.417 . . . . 0.0 114.585 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -69.06 -38.41 79.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.048 0.84 . . . . 0.0 112.939 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.8 mt -74.61 140.86 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.796 0.838 . . . . 0.0 109.94 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -130.44 164.04 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.478 1.111 . . . . 0.0 112.666 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.331 57.5 m-85 60.87 40.67 15.43 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -175.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -57.39 131.87 51.4 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 111.584 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.22 128.97 34.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.368 -0.833 . . . . 0.0 112.27 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.26 120.86 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.358 1.863 . . . . 0.0 108.812 172.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 50.58 40.6 24.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.844 0.858 . . . . 0.0 113.04 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 63.25 -12.97 0.08 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 128.203 2.601 . . . . 0.0 116.421 -171.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -74.02 142.91 45.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.829 1.652 . . . . 0.0 109.052 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 34.3 mtt -89.06 141.0 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.244 -0.91 . . . . 0.0 112.487 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.3 159.49 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.297 2.239 . . . . 0.0 111.916 173.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.83 154.64 44.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 110.166 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.4 p -140.31 159.62 41.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.027 0.931 . . . . 0.0 113.292 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -141.48 158.94 43.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.735 1.614 . . . . 0.0 110.653 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -62.4 140.19 58.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -122.43 24.57 9.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.707 1.603 . . . . 0.0 110.71 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.21 157.68 39.34 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 127.666 2.386 . . . . 0.0 110.791 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.4 133.14 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.791 2.994 . . . . 0.0 112.334 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -56.45 135.08 54.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.435 -0.79 . . . . 0.0 112.107 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -123.56 150.77 43.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.17 1.388 . . . . 0.0 110.935 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.87 127.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.469 1.508 . . . . 0.0 110.369 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 63.4 mtt -144.98 153.14 41.19 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.437 1.495 . . . . 0.0 111.492 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.8 m -134.55 60.34 41.99 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.808 1.243 . . . . 0.0 112.799 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.2 146.97 87.75 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.097 2.531 . . . . 0.0 111.992 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.1 t -152.87 159.39 43.02 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 176.67 148.3 7.01 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.707 1.622 . . . . 0.0 112.231 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.3 p -158.64 164.22 36.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.626 1.17 . . . . 0.0 112.935 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -149.65 156.25 41.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.61 153.87 42.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.034 0.934 . . . . 0.0 113.245 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -77.57 169.63 54.81 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.443 1.021 . . . . 0.0 113.308 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -65.93 148.34 51.95 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.506 1.122 . . . . 0.0 112.749 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.52 1.528 . . . . 0.0 113.407 -178.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.6 m -78.83 -8.35 58.72 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -67.8 151.76 46.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.2 1.4 . . . . 0.0 113.07 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -79.38 155.97 28.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.004 0.922 . . . . 0.0 111.341 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -148.61 63.35 1.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.819 1.648 . . . . 0.0 108.996 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -137.18 151.95 49.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.407 1.883 . . . . 0.0 111.325 -167.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -134.01 153.76 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.658 1.183 . . . . 0.0 113.285 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -88.93 146.47 24.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.613 1.965 . . . . 0.0 112.747 166.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.48 132.87 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.694 1.598 . . . . 0.0 109.769 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.04 145.91 14.52 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 114.623 0.609 . . . . 0.0 114.623 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.09 11.37 32.19 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.633 1.587 . . . . 0.0 114.436 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.75 138.44 58.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.196 1.398 . . . . 0.0 111.947 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -69.4 156.93 38.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.507 1.123 . . . . 0.0 112.447 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.36 -16.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.618 -0.676 . . . . 0.0 111.62 168.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -73.47 -7.57 52.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.604 1.562 . . . . 0.0 114.238 169.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER -92.02 151.67 20.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -139.64 161.31 37.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.887 1.275 . . . . 0.0 113.953 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.39 -33.23 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -68.37 -38.85 81.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.541 0.736 . . . . 0.0 112.318 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -67.44 -38.86 85.18 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.55 -51.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.398 1.079 . . . . 0.0 109.322 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.78 -43.56 98.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.008 0.822 . . . . 0.0 112.352 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -59.89 -39.29 84.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.752 0.821 . . . . 0.0 112.665 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -66.79 -48.37 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.313 55.6 m-85 -64.16 -29.97 71.06 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -57.37 -22.64 44.04 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.476 1.51 . . . . 0.0 114.65 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.66 -24.85 62.77 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.192 -0.943 . . . . 0.0 112.761 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -79.25 -37.91 36.83 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.58 172.04 35.03 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.593 2.044 . . . . 0.0 110.895 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.07 130.76 48.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.766 0.783 . . . . 0.0 112.579 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.4 t -99.12 131.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.138 1.775 . . . . 0.0 108.493 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -79.12 -54.14 6.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.82 0.848 . . . . 0.0 112.952 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -152.86 157.27 40.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.019 1.327 . . . . 0.0 110.57 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.4 141.08 23.52 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.022 1.329 . . . . 0.0 110.915 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 54.5 mmm -149.85 153.21 36.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.666 1.586 . . . . 0.0 112.341 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.38 152.98 39.63 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.423 1.489 . . . . 0.0 110.648 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.2 mtp -85.08 116.23 23.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.894 -0.503 . . . . 0.0 110.36 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.293 58.3 m-85 -90.57 148.33 22.76 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.417 2.747 . . . . 0.0 118.417 -173.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -102.6 112.94 25.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.518 1.527 . . . . 0.0 110.357 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.21 -32.64 71.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.686 1.195 . . . . 0.0 114.008 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.252 1.2 p -72.86 -20.06 61.18 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.5 p -118.63 -19.73 8.61 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.4 t30 57.2 26.25 11.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.928 1.691 . . . . 0.0 113.245 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -107.68 158.86 16.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.7 1.6 . . . . 0.0 110.506 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -75.04 159.04 32.21 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.529 0.681 . . . . 0.0 111.607 173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -79.26 5.52 12.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.294 1.838 . . . . 0.0 114.643 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.34 6.11 63.08 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.468 1.509 . . . . 0.0 114.334 -170.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.255 10.9 p90 -147.69 157.0 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.67 -162.3 22.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.507 1.051 . . . . 0.0 114.63 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -138.54 148.62 44.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.338 1.855 . . . . 0.0 114.112 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.34 124.3 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.138 1.375 . . . . 0.0 111.64 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 135.7 33.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.504 1.522 . . . . 0.0 113.741 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.19 156.0 20.39 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.14 -28.87 65.71 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.2 t -150.39 141.52 23.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.57 1.148 . . . . 0.0 112.89 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -59.63 -26.56 65.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 113.234 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.59 -29.33 69.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.3 mm -78.24 -46.36 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.771 0.828 . . . . 0.0 110.074 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.23 -43.09 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.965 1.306 . . . . 0.0 110.522 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.9 -46.36 65.6 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.64 -0.662 . . . . 0.0 112.076 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.65 -37.24 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.042 0.837 . . . . 0.0 111.638 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.83 -35.1 67.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.887 1.275 . . . . 0.0 112.765 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -68.8 -37.95 79.61 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.208 -0.932 . . . . 0.0 112.661 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.19 139.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 110.636 174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -129.88 161.97 29.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.399 1.48 . . . . 0.0 111.426 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.44 8.1 m-30 64.46 46.07 3.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -68.13 122.42 18.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.974 2.11 . . . . 0.0 111.056 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -86.93 121.34 29.27 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.545 1.066 . . . . 0.0 113.467 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.5 mt -143.21 124.74 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.277 1.431 . . . . 0.0 109.6 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 48.04 49.84 16.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.33 1.452 . . . . 0.0 113.02 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 64.92 -12.32 0.13 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.905 2.882 . . . . 0.0 116.575 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -86.08 165.37 16.68 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.361 2.264 . . . . 0.0 110.304 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 44.5 mtm -122.09 143.13 49.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.639 0.775 . . . . 0.0 112.485 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.72 163.58 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.912 2.085 . . . . 0.0 113.642 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -115.18 148.75 38.67 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.138 1.375 . . . . 0.0 111.896 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 81.2 m -120.57 152.35 38.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.857 1.263 . . . . 0.0 112.508 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.92 158.24 43.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.579 1.552 . . . . 0.0 111.2 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.662 -0.649 . . . . 0.0 111.002 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.22 32.2 5.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.68 . . . . 0.0 110.571 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.72 31.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 127.647 2.379 . . . . 0.0 110.764 -173.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -59.84 162.62 15.47 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.713 2.942 . . . . 0.0 116.257 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -79.6 56.9 2.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.283 1.433 . . . . 0.0 110.317 169.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.65 135.19 51.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.848 1.259 . . . . 0.0 112.474 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.7 136.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.816 1.246 . . . . 0.0 113.21 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.83 155.18 37.05 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.624 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.9 t -145.21 80.67 10.92 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.556 1.142 . . . . 0.0 110.486 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.98 152.71 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.453 2.769 . . . . 0.0 112.335 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 t -150.56 159.36 44.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.216 1.407 . . . . 0.0 114.655 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 172.97 -179.77 44.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.821 1.201 . . . . 0.0 113.784 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.1 t -154.37 162.37 41.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 110.815 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.15 135.29 56.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.038 0.935 . . . . 0.0 112.451 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -78.51 -5.84 53.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 63.74 -146.16 50.22 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.193 0.902 . . . . 0.0 113.458 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.09 154.01 51.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.923 1.689 . . . . 0.0 112.125 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.809 1.643 . . . . 0.0 114.1 176.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p -85.78 -165.89 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.488 1.115 . . . . 0.0 111.796 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -64.83 -7.82 12.7 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 25.4 ptm -142.09 145.89 34.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.723 1.209 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -151.67 31.68 0.57 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.625 1.57 . . . . 0.0 110.034 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -152.82 146.36 24.98 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.442 1.497 . . . . 0.0 111.031 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.2 pt -138.21 149.66 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -83.32 147.89 27.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.411 1.885 . . . . 0.0 111.724 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.35 136.5 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.266 1.426 . . . . 0.0 109.584 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.37 147.76 18.25 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.52 39.27 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.706 1.622 . . . . 0.0 114.552 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.4 mt -65.01 139.88 58.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 112.494 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 t -64.76 156.8 29.36 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.575 1.15 . . . . 0.0 112.4 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.91 -25.28 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.899 0.88 . . . . 0.0 109.504 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.741 0.816 . . . . 0.0 112.592 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -75.23 125.51 29.1 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.52 1.528 . . . . 0.0 115.095 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -91.91 167.82 11.85 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.95 -29.71 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.23 -38.3 63.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.313 0.645 . . . . 0.0 111.537 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.28 -44.93 92.44 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.31 -50.81 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.37 1.068 . . . . 0.0 109.115 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -62.01 -45.86 91.74 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.842 0.746 . . . . 0.0 111.88 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.62 -42.38 98.81 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.97 0.908 . . . . 0.0 112.592 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -63.55 -48.63 76.67 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.305 52.0 m-85 -65.29 -30.54 71.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -61.6 -19.12 61.87 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 172.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -68.59 -24.64 64.61 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.143 0.883 . . . . 0.0 112.712 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -80.86 -38.22 28.52 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.98 0.912 . . . . 0.0 113.012 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 170.37 30.82 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.904 2.192 . . . . 0.0 110.981 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -169.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.32 120.36 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 109.109 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.92 -42.44 69.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.829 1.252 . . . . 0.0 114.24 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -155.94 155.25 32.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.074 2.15 . . . . 0.0 114.874 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.65 141.7 27.14 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.426 1.09 . . . . 0.0 110.692 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.1 mtm -151.0 146.12 26.01 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.343 1.457 . . . . 0.0 111.713 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.9 mt -125.15 156.15 38.81 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.268 1.427 . . . . 0.0 111.49 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 mmt -78.53 67.76 4.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.155 0.982 . . . . 0.0 113.01 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -58.83 147.06 35.0 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -122.35 122.69 39.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.903 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -32.29 70.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.219 1.408 . . . . 0.0 113.751 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.259 1.1 p -75.33 -21.88 58.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.6 p -108.12 -19.14 13.59 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 58.17 25.65 12.79 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.233 1.813 . . . . 0.0 114.445 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -142.89 164.78 29.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.146 1.778 . . . . 0.0 111.241 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -89.33 161.03 16.57 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.876 0.87 . . . . 0.0 112.888 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -75.7 3.96 8.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.973 1.709 . . . . 0.0 115.138 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.16 12.06 59.21 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.243 1.401 . . . . 0.0 114.804 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -147.58 159.88 43.26 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.85 -156.16 15.78 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 114.957 0.743 . . . . 0.0 114.957 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -134.47 147.12 50.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.612 1.965 . . . . 0.0 115.202 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.48 126.47 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.63 1.572 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.1 m -99.69 130.39 45.91 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.307 1.443 . . . . 0.0 112.693 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.6 152.72 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -67.17 -33.49 75.52 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.4 t -148.06 143.88 27.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.608 1.163 . . . . 0.0 113.035 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -58.51 -26.67 63.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 113.143 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -58.7 -27.94 65.32 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.33 -50.51 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.47 0.708 . . . . 0.0 110.163 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.12 -37.3 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.855 1.262 . . . . 0.0 112.492 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -55.07 -38.17 67.71 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.79 -48.05 27.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.765 0.711 . . . . 0.0 111.721 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.45 -44.52 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 118.739 0.7 . . . . 0.0 112.651 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 25.1 t -73.26 -29.84 63.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.659 1.184 . . . . 0.0 112.427 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -70.34 -38.03 74.76 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.077 -1.014 . . . . 0.0 112.677 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.3 mt -66.06 139.57 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.752 0.821 . . . . 0.0 110.577 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -125.54 149.9 47.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.353 1.461 . . . . 0.0 111.104 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.458 24.6 m-85 58.31 53.3 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -59.0 124.72 20.85 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.803 2.041 . . . . 0.0 111.423 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -93.6 124.22 37.45 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.3 mt -143.53 125.65 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.548 1.539 . . . . 0.0 109.324 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 49.73 42.7 23.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.398 1.079 . . . . 0.0 113.443 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 63.06 -11.05 0.09 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 128.212 2.605 . . . . 0.0 116.236 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -77.9 161.52 27.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.149 1.78 . . . . 0.0 109.336 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.1 ptp -122.32 144.33 49.07 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.8 164.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.678 2.391 . . . . 0.0 112.949 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -133.66 160.79 36.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.664 0.786 . . . . 0.0 112.278 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.46 157.6 45.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 0.0 113.679 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -144.07 162.82 35.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.666 1.986 . . . . 0.0 110.646 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -63.46 152.15 39.18 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.402 1.001 . . . . 0.0 111.621 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -120.4 15.52 12.12 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -141.42 152.83 64.88 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.691 1.596 . . . . 0.0 112.001 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.35 139.5 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.239 2.626 . . . . 0.0 111.861 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -76.34 161.37 28.77 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -142.27 150.35 40.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.718 1.607 . . . . 0.0 110.629 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.7 42.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.836 2.055 . . . . 0.0 113.787 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 55.7 mtt -60.76 151.8 28.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.502 1.521 . . . . 0.0 113.162 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.2 p -134.87 68.84 71.41 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 111.868 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.02 -14.2 26.22 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.722 2.948 . . . . 0.0 114.431 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.267 1.2 p -65.15 152.28 43.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 173.37 -166.87 39.4 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.551 1.072 . . . . 0.0 113.333 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.7 t -151.75 158.19 43.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.26 1.424 . . . . 0.0 111.492 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -147.53 159.59 43.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.845 1.658 . . . . 0.0 111.521 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -120.46 158.71 26.64 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.493 1.917 . . . . 0.0 111.702 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -176.01 169.84 42.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.715 1.15 . . . . 0.0 113.342 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -69.5 156.18 39.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.716 1.206 . . . . 0.0 112.887 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.4 p . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.821 1.648 . . . . 0.0 114.406 174.663 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -66.54 151.42 47.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.552 1.141 . . . . 0.0 113.501 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -63.46 150.23 44.2 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.341 1.456 . . . . 0.0 111.553 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 70.4 mtp -135.94 134.36 38.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.396 1.078 . . . . 0.0 111.424 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -115.45 7.23 14.95 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -142.07 154.4 44.91 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.901 -1.125 . . . . 0.0 112.464 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.42 154.32 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 113.425 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -91.61 146.2 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.361 2.264 . . . . 0.0 112.768 167.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.29 135.98 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.354 1.462 . . . . 0.0 109.595 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.74 154.64 25.84 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.785 0.707 . . . . 0.0 114.256 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.59 16.05 41.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.675 1.131 . . . . 0.0 114.0 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -67.2 159.47 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.228 . . . . 0.0 111.314 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.6 p -128.92 -168.8 1.98 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.332 1.053 . . . . 0.0 111.847 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.7 m -75.82 -15.44 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.127 0.971 . . . . 0.0 112.622 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -75.55 -32.34 60.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.261 0.2 OUTLIER -77.32 145.04 37.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.7 t -140.58 158.21 44.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.123 1.369 . . . . 0.0 113.73 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.37 -34.56 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -67.54 -39.37 85.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.445 0.698 . . . . 0.0 111.836 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.65 -34.99 67.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.18 -50.15 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.776 0.83 . . . . 0.0 109.318 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.86 -49.37 77.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.592 0.633 . . . . 0.0 111.501 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -59.07 -40.83 86.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.854 0.862 . . . . 0.0 112.803 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -65.71 -49.0 70.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 50.7 m-85 -64.58 -29.14 70.15 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -59.44 -22.76 61.96 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.23 -26.04 64.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.21 0.913 . . . . 0.0 112.953 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.68 -35.8 57.69 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.34 168.33 30.27 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.506 2.479 . . . . 0.0 109.992 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -65.58 125.12 24.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.363 1.082 . . . . 0.0 113.003 -168.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.37 133.86 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.629 1.972 . . . . 0.0 107.629 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -70.2 -52.12 25.73 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -163.99 161.28 22.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.389 2.276 . . . . 0.0 114.101 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -131.81 150.81 52.04 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.96 1.304 . . . . 0.0 110.18 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 91.3 mtp -148.36 152.42 37.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.964 1.305 . . . . 0.0 111.907 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.3 mt -122.41 133.2 54.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.753 1.621 . . . . 0.0 109.286 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.9 ptm -82.27 81.34 8.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.097 0.951 . . . . 0.0 112.077 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.44 130.66 47.98 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -102.39 126.4 49.41 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.092 0.957 . . . . 0.0 112.893 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -59.09 -24.93 63.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -77.92 -13.88 59.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 p -122.78 -23.44 5.07 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 58.38 24.4 11.64 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.502 1.921 . . . . 0.0 114.528 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -146.27 170.11 17.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.671 1.589 . . . . 0.0 111.88 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -73.58 159.72 32.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.875 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -97.43 21.96 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.308 1.443 . . . . 0.0 114.56 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.12 14.47 62.37 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.914 1.245 . . . . 0.0 114.45 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.293 4.8 p90 -146.82 158.18 43.85 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.38 -160.27 17.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.108 1.337 . . . . 0.0 114.009 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -138.88 152.22 47.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.433 1.893 . . . . 0.0 114.914 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -135.94 126.36 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.352 1.461 . . . . 0.0 112.048 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.2 m -94.18 127.73 40.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 112.022 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -106.73 151.46 25.1 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -71.55 -36.33 70.94 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 t -135.47 137.98 42.7 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.449 1.1 . . . . 0.0 113.438 -171.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -65.32 -30.64 71.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.828 1.251 . . . . 0.0 112.597 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -60.41 -30.26 69.49 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.28 -47.9 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.817 0.847 . . . . 0.0 110.256 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 24.7 t -56.28 -42.47 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.636 1.174 . . . . 0.0 110.327 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.28 -50.8 72.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.743 0.701 . . . . 0.0 112.458 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -66.59 -45.03 80.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.273 0.942 . . . . 0.0 112.145 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.84 -40.62 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.221 0.919 . . . . 0.0 110.66 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.7 t -74.41 -31.32 62.28 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.148 0.979 . . . . 0.0 113.253 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -66.29 -37.41 85.35 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.777 -1.202 . . . . 0.0 113.246 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.1 mt -72.45 136.32 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.859 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.88 158.66 37.19 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.45 1.1 . . . . 0.0 112.701 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.525 22.3 m-85 60.43 45.27 11.11 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -56.36 153.94 8.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.949 1.7 . . . . 0.0 110.825 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -132.62 133.95 44.27 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.971 -1.081 . . . . 0.0 113.294 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . 0.272 4.5 mt -121.52 -127.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.483 1.113 . . . . 0.0 109.144 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -69.14 73.67 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.208 1.803 . . . . 0.0 112.126 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 61.41 -30.28 0.07 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 129.215 3.006 . . . . 0.0 115.389 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -75.56 140.53 42.76 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.295 2.238 . . . . 0.0 111.398 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 13.2 ptm -97.6 150.27 21.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.619 1.168 . . . . 0.0 111.925 171.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.07 162.14 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.402 2.281 . . . . 0.0 112.759 -169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -125.91 163.33 23.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.007 1.323 . . . . 0.0 111.687 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.5 p -143.14 161.35 38.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -144.77 164.55 30.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.632 1.973 . . . . 0.0 110.859 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -61.33 150.18 35.84 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.487 -0.758 . . . . 0.0 111.277 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.8 148.1 50.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.158 0.983 . . . . 0.0 112.484 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.31 136.64 78.55 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.411 1.084 . . . . 0.0 113.688 -168.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.02 124.94 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.634 2.222 . . . . 0.0 109.266 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -140.76 12.93 2.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.441 1.897 . . . . 0.0 113.188 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.6 160.39 43.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.772 2.029 . . . . 0.0 111.28 -173.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.0 p -147.69 143.15 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.04 1.336 . . . . 0.0 112.429 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 77.5 mtm -143.91 152.62 41.35 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.624 1.57 . . . . 0.0 111.656 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.5 t -159.48 129.09 3.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.363 1.465 . . . . 0.0 109.517 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.47 153.73 44.75 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.948 2.432 . . . . 0.0 112.844 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.27 1.1 p -131.82 154.23 49.34 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.766 1.626 . . . . 0.0 115.091 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.0 -178.26 37.22 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.324 0.964 . . . . 0.0 114.165 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.5 t -158.45 161.54 37.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.312 1.445 . . . . 0.0 111.239 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.47 153.94 41.56 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.385 1.074 . . . . 0.0 112.678 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -136.79 154.87 50.43 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.807 1.643 . . . . 0.0 112.156 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.15 -9.09 87.38 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.59 1.091 . . . . 0.0 115.257 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -68.52 150.84 47.58 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.223 1.409 . . . . 0.0 112.944 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.898 1.679 . . . . 0.0 113.547 178.381 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -140.45 25.39 2.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.706 2.002 . . . . 0.0 112.149 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.7 t60 60.31 22.47 11.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.382 1.873 . . . . 0.0 113.818 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.45 136.8 44.25 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.05 -1.031 . . . . 0.0 110.82 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -138.18 34.52 2.33 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.403 1.481 . . . . 0.0 109.875 -174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -159.74 142.37 13.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.268 2.627 . . . . 0.0 107.855 -168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.19 154.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.241 1.016 . . . . 0.0 112.496 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.36 148.71 25.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.992 1.717 . . . . 0.0 113.025 166.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.3 t -135.91 137.53 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.627 1.571 . . . . 0.0 109.576 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.01 149.3 20.98 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.89 11.83 36.31 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.714 1.626 . . . . 0.0 114.296 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.8 mt -64.38 135.38 56.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.36 1.464 . . . . 0.0 112.103 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.5 t -64.98 156.53 30.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.487 1.115 . . . . 0.0 112.402 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.44 -16.37 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.279 0.632 . . . . 0.0 111.188 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -68.71 -33.98 74.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.025 0.93 . . . . 0.0 111.895 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -71.84 144.46 49.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.327 1.851 . . . . 0.0 115.41 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 t -135.69 171.1 14.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.204 1.802 . . . . 0.0 112.469 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.57 -33.0 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.59 -39.41 88.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.189 0.996 . . . . 0.0 112.337 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -64.15 -41.37 97.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.35 -50.46 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.852 0.861 . . . . 0.0 110.367 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.64 -44.16 96.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.485 0.584 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.62 -42.37 92.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.783 0.833 . . . . 0.0 112.586 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.28 -53.41 44.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 47.3 m-85 -63.79 -21.1 66.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -64.05 -12.25 36.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.32 -28.6 69.42 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.431 1.014 . . . . 0.0 112.766 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.74 -32.98 21.58 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.235 1.014 . . . . 0.0 112.051 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.93 -178.83 40.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.903 2.192 . . . . 0.0 110.874 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 120.56 12.28 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.585 -0.95 . . . . 0.0 112.571 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.32 121.53 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.381 1.473 . . . . 0.0 108.023 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -76.06 -36.93 58.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -165.36 165.78 19.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 109.28 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.81 43.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.317 1.447 . . . . 0.0 111.284 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.6 ptm -156.56 157.03 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.882 1.273 . . . . 0.0 112.2 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.79 151.99 48.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.267 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 53.6 mtp -89.91 137.43 32.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.696 0.798 . . . . 0.0 110.745 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -121.56 158.51 28.37 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -132.04 135.83 46.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 169.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.7 -40.99 75.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.145 0.978 . . . . 0.0 112.674 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -69.81 -32.14 70.43 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 p -85.02 -22.47 29.04 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.95 28.58 12.87 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.394 2.278 . . . . 0.0 113.423 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -153.14 174.38 14.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.315 1.446 . . . . 0.0 111.843 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -74.45 156.99 36.38 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.482 0.658 . . . . 0.0 112.266 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.97 -0.52 24.66 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.823 1.649 . . . . 0.0 115.385 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.64 10.47 81.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.301 0.953 . . . . 0.0 113.417 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.285 15.6 p90 -143.6 157.7 44.22 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.28 -161.73 20.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.684 1.135 . . . . 0.0 114.153 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -138.64 152.56 48.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.938 1.695 . . . . 0.0 113.883 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.91 129.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.293 1.437 . . . . 0.0 111.499 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -91.38 138.59 31.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.15 1.78 . . . . 0.0 114.541 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -120.22 152.44 37.72 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -70.04 -30.17 67.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.1 t -155.7 149.69 25.46 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.609 1.163 . . . . 0.0 112.728 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.46 -29.68 66.37 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.029 0.932 . . . . 0.0 112.096 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -56.91 -26.41 59.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 24.1 mm -80.87 -52.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.815 0.846 . . . . 0.0 110.129 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.4 t -53.87 -36.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.617 1.567 . . . . 0.0 112.271 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -53.4 -47.16 69.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.886 0.874 . . . . 0.0 112.937 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -68.08 -44.84 75.37 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.074 0.852 . . . . 0.0 111.392 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.2 t -54.46 -41.93 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 96.7 m -72.21 -37.44 69.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.278 1.431 . . . . 0.0 114.453 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -66.31 -33.66 76.24 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.4 mt -73.0 112.05 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -70.64 -61.12 1.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.179 -0.951 . . . . 0.0 111.648 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 52.8 m-85 -94.66 133.41 38.36 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -127.23 124.2 38.36 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.499 1.92 . . . . 0.0 110.382 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.23 107.7 19.38 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.339 -0.851 . . . . 0.0 112.718 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.14 122.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.377 1.071 . . . . 0.0 110.832 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.37 45.02 23.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.472 1.109 . . . . 0.0 112.818 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 63.31 -9.75 0.12 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 128.502 2.721 . . . . 0.0 116.158 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -87.89 142.47 27.77 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 126.322 1.849 . . . . 0.0 109.83 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 58.5 mtt -86.09 129.96 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.416 -0.803 . . . . 0.0 112.512 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.9 163.14 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.046 2.138 . . . . 0.0 111.718 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -128.26 162.94 25.85 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.519 0.727 . . . . 0.0 110.899 169.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.5 158.19 43.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.374 1.07 . . . . 0.0 113.196 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -144.25 165.53 27.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.631 1.573 . . . . 0.0 111.242 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.48 152.13 18.69 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.16 155.22 45.3 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.91 144.93 99.0 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -168.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -67.65 168.53 18.11 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.279 3.32 . . . . 0.0 114.694 -171.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -136.59 163.02 31.52 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.415 2.286 . . . . 0.0 111.2 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -63.13 153.61 33.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.136 1.374 . . . . 0.0 113.155 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 p -82.65 152.71 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.221 1.408 . . . . 0.0 113.815 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.5 ptp -152.09 162.07 41.67 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.478 1.511 . . . . 0.0 111.709 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.6 t -155.69 131.56 5.63 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.997 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -83.39 -9.83 10.16 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.558 2.838 . . . . 0.0 114.014 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.285 1.1 p -70.11 159.32 34.12 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.05 175.39 40.95 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.058 1.313 . . . . 0.0 113.179 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.6 m -69.52 143.28 53.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.71 160.1 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.016 1.726 . . . . 0.0 111.366 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -151.29 154.25 36.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -83.15 172.7 51.49 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.616 1.103 . . . . 0.0 113.456 170.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -73.39 168.41 19.27 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.397 1.079 . . . . 0.0 112.924 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.5 p . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 112.768 168.053 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.784 -0.527 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -95.68 153.37 17.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.127 1.371 . . . . 0.0 113.32 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -128.2 25.35 5.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.385 1.874 . . . . 0.0 110.851 169.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 46.3 tpp -138.48 137.1 36.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.212 1.805 . . . . 0.0 111.394 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -89.78 31.54 0.95 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.617 1.567 . . . . 0.0 112.979 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -148.57 149.32 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.15 1.78 . . . . 0.0 111.232 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.55 149.3 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 111.316 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.88 134.58 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.781 1.233 . . . . 0.0 109.58 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.43 145.95 14.95 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 114.518 0.567 . . . . 0.0 114.518 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.6 7.16 32.34 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.689 1.614 . . . . 0.0 114.609 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.5 139.48 58.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.164 1.385 . . . . 0.0 112.183 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -62.66 155.02 27.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.235 1.014 . . . . 0.0 112.506 171.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.57 -20.1 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.479 0.712 . . . . 0.0 112.214 169.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -71.76 -26.9 62.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.065 0.946 . . . . 0.0 113.151 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.0 m -73.59 143.49 46.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.735 1.614 . . . . 0.0 113.812 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 t -123.94 163.71 20.78 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 0.0 114.207 169.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.6 p -57.9 -30.61 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.78 -34.51 78.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.832 0.853 . . . . 0.0 112.458 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -68.27 -47.19 68.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.85 -45.25 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.662 0.785 . . . . 0.0 111.025 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -61.01 -46.29 91.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 118.952 -0.547 . . . . 0.0 112.151 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -59.7 -42.8 93.8 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -65.03 -38.8 92.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -75.97 -29.19 58.17 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -58.71 -18.9 35.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.334 1.454 . . . . 0.0 114.572 171.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -66.19 -23.88 66.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.388 -0.82 . . . . 0.0 112.777 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -89.28 -37.76 14.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.04 176.47 39.69 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.175 1.845 . . . . 0.0 111.45 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.44 127.82 34.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.6 t -100.39 118.27 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.184 1.794 . . . . 0.0 108.397 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -78.27 -37.33 45.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -152.15 153.26 33.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.958 2.103 . . . . 0.0 114.684 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.18 29.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.4 ptp -157.85 147.59 20.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.248 1.019 . . . . 0.0 112.3 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.6 mt -127.83 153.87 46.1 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.521 1.529 . . . . 0.0 111.673 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 mmt -78.39 70.68 4.78 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.358 1.063 . . . . 0.0 112.52 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -60.33 140.98 56.83 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.48 119.51 29.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.899 1.279 . . . . 0.0 112.461 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -21.91 66.91 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.72 60.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -119.89 -19.31 7.96 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.17 26.19 13.46 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.571 1.948 . . . . 0.0 113.57 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -144.68 173.46 11.82 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.069 1.747 . . . . 0.0 110.93 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -92.12 158.82 15.99 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -70.5 -0.21 8.0 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.57 63.44 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.769 1.176 . . . . 0.0 114.376 -172.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -144.8 159.82 42.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -176.17 -160.15 23.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.0 0.81 . . . . 0.0 114.909 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -132.8 149.29 52.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.608 1.963 . . . . 0.0 115.357 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 t -135.09 128.11 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.254 1.421 . . . . 0.0 111.749 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 61.6 m -96.55 127.34 42.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.668 1.587 . . . . 0.0 111.418 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.43 157.95 15.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -61.81 -37.96 86.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.745 0.818 . . . . 0.0 112.84 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -151.79 143.52 23.65 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -57.14 -26.78 61.1 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.573 1.549 . . . . 0.0 113.051 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.91 -26.92 68.46 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.72 -50.28 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.628 0.771 . . . . 0.0 109.458 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.96 -33.11 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.664 1.186 . . . . 0.0 111.201 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -48.16 -43.1 31.17 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -76.41 -45.51 31.29 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.639 -0.663 . . . . 0.0 111.764 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.35 -36.95 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.1 t -84.07 -24.27 30.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.583 1.153 . . . . 0.0 112.567 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -72.7 -35.61 67.66 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.02 -1.05 . . . . 0.0 112.155 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.14 138.41 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.022 0.929 . . . . 0.0 110.465 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -127.37 156.14 42.49 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.863 1.265 . . . . 0.0 111.951 169.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.443 18.2 m-85 61.04 47.15 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 -171.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -56.96 129.47 41.77 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.83 1.652 . . . . 0.0 111.201 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.29 125.0 28.62 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.446 0.566 . . . . 0.0 111.803 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.68 117.06 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.245 1.818 . . . . 0.0 108.781 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 50.03 43.79 25.61 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.287 1.035 . . . . 0.0 112.95 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.74 -13.88 0.08 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 128.173 2.589 . . . . 0.0 116.4 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.48 157.16 36.06 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.81 1.644 . . . . 0.0 109.265 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 26.7 mtt -109.6 141.06 42.65 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.73 151.24 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.122 1.769 . . . . 0.0 114.031 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.72 144.98 26.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.842 0.857 . . . . 0.0 112.14 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 4.9 t -108.77 143.67 37.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.627 1.571 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -140.8 157.7 45.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.728 1.611 . . . . 0.0 111.123 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.74 129.81 41.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.549 0.739 . . . . 0.0 111.894 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.43 70.9 10.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.906 0.882 . . . . 0.0 112.364 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 49.87 71.76 1.47 Allowed Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 126.994 2.118 . . . . 0.0 114.721 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.71 161.7 20.57 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.603 2.869 . . . . 0.0 114.505 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -130.8 150.69 51.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.101 1.76 . . . . 0.0 110.938 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -78.88 46.05 0.65 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.294 1.438 . . . . 0.0 113.617 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.78 140.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.781 1.232 . . . . 0.0 114.116 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 66.2 mtt -84.3 160.24 20.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.553 1.141 . . . . 0.0 112.344 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -145.19 79.31 11.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 110.782 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.94 -13.57 17.44 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.664 2.91 . . . . 0.0 113.709 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 140.44 51.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 117.187 2.291 . . . . 0.0 117.187 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -176.33 -175.8 43.98 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.789 1.185 . . . . 0.0 113.123 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.7 t -152.09 158.69 43.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.174 1.389 . . . . 0.0 111.464 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.8 148.16 52.3 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.281 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -66.89 133.54 50.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 111.887 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.46 139.04 27.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.249 0.928 . . . . 0.0 112.883 173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.44 137.78 24.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.833 1.653 . . . . 0.0 111.412 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.253 1.276 0 C-N-CA 125.836 1.654 . . . . 0.0 114.484 -173.185 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.9 t -152.4 152.28 31.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.009 1.324 . . . . 0.0 111.482 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -145.95 38.26 1.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.165 1.786 . . . . 0.0 111.623 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -134.71 139.31 45.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.058 2.143 . . . . 0.0 109.444 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -108.42 10.72 27.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.74 147.76 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.785 1.634 . . . . 0.0 111.672 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.29 152.85 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.27 148.25 22.28 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.375 2.27 . . . . 0.0 111.86 167.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.0 t -137.79 135.1 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.015 1.326 . . . . 0.0 109.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.23 155.84 26.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.977 0.798 . . . . 0.0 114.288 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.94 10.01 41.16 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.558 1.551 . . . . 0.0 114.725 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -67.13 137.67 56.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.866 1.266 . . . . 0.0 112.532 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 t -65.93 152.46 44.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.256 1.023 . . . . 0.0 111.76 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -70.53 -15.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.574 -0.704 . . . . 0.0 111.796 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -70.38 -29.85 66.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.303 1.041 . . . . 0.0 112.689 170.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.3 m -78.85 139.12 38.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.992 1.717 . . . . 0.0 113.605 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 t -118.82 165.14 14.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.44 1.496 . . . . 0.0 114.726 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.93 -33.98 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -72.63 -27.01 61.87 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.72 -46.88 64.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.977 0.808 . . . . 0.0 109.169 171.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.44 -46.61 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.686 0.794 . . . . 0.0 110.493 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -57.18 -50.77 71.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.005 0.922 . . . . 0.0 111.855 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -60.21 -44.29 95.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 112.973 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.07 -38.8 92.37 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.306 48.6 m-85 -73.07 -31.2 64.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -60.42 -18.07 48.49 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.45 -24.88 67.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.55 0.74 . . . . 0.0 112.718 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -85.55 -35.64 20.97 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.85 175.3 36.19 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.668 2.08 . . . . 0.0 111.139 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -58.81 125.03 21.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.761 -0.847 . . . . 0.0 112.98 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.1 t -94.01 124.01 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.835 1.654 . . . . 0.0 107.234 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.85 -31.5 20.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.987 0.515 . . . . 0.0 110.356 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -161.51 155.56 22.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.884 1.274 . . . . 0.0 109.767 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.83 149.51 34.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.048 1.339 . . . . 0.0 111.268 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.4 ptp -156.07 154.9 31.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.634 1.174 . . . . 0.0 112.166 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.41 152.3 46.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.302 1.441 . . . . 0.0 111.419 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -83.31 84.13 7.61 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.764 0.826 . . . . 0.0 111.788 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.262 28.0 m-85 -67.18 119.27 11.81 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.1 115.46 21.9 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 111.811 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -66.44 -16.79 64.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.15 0.98 . . . . 0.0 112.821 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -22.75 60.4 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 171.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -130.29 -11.61 4.09 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.36 27.16 16.72 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.159 1.783 . . . . 0.0 114.515 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -134.13 167.33 20.86 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.905 1.682 . . . . 0.0 111.24 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -72.28 154.51 40.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.602 0.715 . . . . 0.0 112.32 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -80.87 7.47 10.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.193 1.797 . . . . 0.0 115.096 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.46 11.84 63.74 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.992 1.282 . . . . 0.0 114.414 -172.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -145.98 160.78 41.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.66 -162.16 23.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.54 1.066 . . . . 0.0 114.77 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.07 148.12 44.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.653 1.981 . . . . 0.0 113.84 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.56 123.59 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.422 1.489 . . . . 0.0 111.606 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 90.4 m -93.25 128.47 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.026 1.33 . . . . 0.0 110.501 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.91 153.15 19.39 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.2 -33.29 75.47 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -152.94 143.65 22.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 112.815 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -55.83 -27.16 50.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 113.185 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.38 -27.12 69.09 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.3 mm -77.54 -48.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.254 0.621 . . . . 0.0 109.686 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.08 -34.07 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.292 1.037 . . . . 0.0 111.244 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -50.23 -42.85 52.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.476 1.51 . . . . 0.0 113.54 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -77.35 -47.61 19.47 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.497 0.719 . . . . 0.0 111.595 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.3 -43.3 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.9 t -76.01 -24.47 55.29 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 112.19 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -78.27 -33.27 49.7 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.041 -1.037 . . . . 0.0 112.539 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 30.2 mt -67.97 148.47 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.429 1.091 . . . . 0.0 110.748 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -134.84 152.03 51.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.368 26.6 m-85 58.42 50.6 9.17 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -171.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -60.13 133.55 56.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.334 . . . . 0.0 111.971 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -82.93 133.47 35.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.805 -0.56 . . . . 0.0 111.896 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.1 mt -145.24 125.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 126.695 1.998 . . . . 0.0 108.842 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 50.08 36.28 11.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.56 1.144 . . . . 0.0 113.495 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.07 -7.73 0.14 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 128.242 2.617 . . . . 0.0 116.058 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.17 173.62 11.65 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 109.33 167.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.3 mtt -120.85 145.78 47.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.42 161.75 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.366 2.266 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.27 152.25 50.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.403 1.081 . . . . 0.0 110.017 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.06 157.97 44.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -147.44 160.93 42.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.88 2.072 . . . . 0.0 111.14 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 146.95 42.59 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.988 0.813 . . . . 0.0 111.844 172.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.73 23.83 5.03 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.51 164.19 21.32 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.397 1.079 . . . . 0.0 111.561 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.0 167.13 9.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.226 2.617 . . . . 0.0 113.49 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -56.46 142.98 36.73 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 0.0 112.458 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -147.66 156.21 42.55 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.286 1.435 . . . . 0.0 110.824 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -61.35 153.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.381 -0.824 . . . . 0.0 113.123 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 85.0 mmm -64.8 146.92 54.17 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.312 0.645 . . . . 0.0 111.661 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -63.88 -52.56 56.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.844 1.257 . . . . 0.0 113.16 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.6 138.83 35.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.204 1.936 . . . . 0.0 111.684 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 p -73.78 -19.7 60.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 175.72 163.88 29.21 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.884 1.707 . . . . 0.0 112.34 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.1 t -74.63 136.2 41.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.605 0.762 . . . . 0.0 111.882 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.13 39.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.194 0.997 . . . . 0.0 112.74 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -68.75 141.91 55.1 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.128 0.971 . . . . 0.0 111.063 174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -71.27 174.13 41.8 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.843 0.735 . . . . 0.0 113.631 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -64.7 139.18 58.74 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.94 0.896 . . . . 0.0 110.729 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.485 1.514 . . . . 0.0 113.731 -179.607 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.7 t -152.02 137.6 17.79 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.815 1.246 . . . . 0.0 111.447 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.19 -5.41 58.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.703 1.201 . . . . 0.0 113.788 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 56.3 mtt -69.08 141.63 54.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.774 0.829 . . . . 0.0 112.597 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -150.16 50.87 0.9 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.527 1.531 . . . . 0.0 110.768 -172.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -147.27 142.17 26.91 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.745 2.018 . . . . 0.0 109.393 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 pt -139.52 151.87 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.948 0.899 . . . . 0.0 113.236 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -92.67 145.71 24.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.17 2.188 . . . . 0.0 112.404 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.27 134.97 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 109.952 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.98 148.22 19.77 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.784 0.72 . . . . 0.0 114.256 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.77 9.57 59.72 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.936 1.255 . . . . 0.0 114.261 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.45 144.01 54.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.976 1.31 . . . . 0.0 111.575 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -67.15 158.03 32.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.155 0.582 . . . . 0.0 110.993 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.21 -26.3 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -71.31 -25.92 62.63 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.56 1.144 . . . . 0.0 113.712 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -70.2 119.15 13.96 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.299 1.3 t -98.5 164.18 12.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.45 -33.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -174.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.19 -32.49 72.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.1 0.96 . . . . 0.0 113.052 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.59 -46.06 73.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.849 0.75 . . . . 0.0 110.364 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.43 -48.97 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.303 1.041 . . . . 0.0 110.567 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.87 -49.07 79.15 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.869 0.867 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -60.0 -39.55 86.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 112.773 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -68.87 -49.07 61.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.324 49.4 m-85 -63.23 -29.22 70.6 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.44 -21.48 60.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -70.36 -25.73 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.019 0.827 . . . . 0.0 112.846 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -76.32 -38.81 55.46 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.63 167.65 29.57 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.328 2.394 . . . . 0.0 110.276 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.02 131.86 51.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.135 0.968 . . . . 0.0 113.294 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -93.69 138.26 20.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 126.565 1.946 . . . . 0.0 108.335 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.99 -45.11 10.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.932 1.293 . . . . 0.0 112.946 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -158.9 161.53 36.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.295 1.438 . . . . 0.0 109.881 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.11 156.86 42.82 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.148 1.379 . . . . 0.0 111.767 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -157.09 159.34 37.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.54 1.136 . . . . 0.0 113.163 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 73.3 mt -124.05 146.64 48.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.889 2.076 . . . . 0.0 111.136 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.9 mmm -85.56 128.76 34.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.474 0.71 . . . . 0.0 111.884 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.65 148.28 50.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.879 2.472 . . . . 0.0 114.064 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.61 116.77 30.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.081 0.952 . . . . 0.0 112.88 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -68.18 -22.47 64.83 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 p -76.04 -29.57 58.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 p -98.1 -16.45 19.55 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.622 1.569 . . . . 0.0 114.905 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 58.16 36.31 25.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.148 2.579 . . . . 0.0 113.812 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -152.52 169.34 22.87 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -56.11 154.63 7.47 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.362 3.065 . . . . 0.0 112.428 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.53 -8.49 15.0 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.11 76.45 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.384 0.993 . . . . 0.0 114.767 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.292 15.3 p90 -142.48 161.2 38.67 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 174.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.25 -168.41 25.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.689 1.138 . . . . 0.0 113.761 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -141.27 153.66 45.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.125 1.37 . . . . 0.0 112.965 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.0 130.98 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.356 1.462 . . . . 0.0 112.094 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.3 m -93.48 138.04 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.77 1.628 . . . . 0.0 113.85 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.51 148.8 32.4 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -69.76 -28.95 66.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.107 0.963 . . . . 0.0 112.738 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.2 t -143.45 130.36 20.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.937 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.6 pm0 -57.85 -28.55 64.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.741 2.016 . . . . 0.0 113.378 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.32 -28.25 69.18 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -74.7 -45.01 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 110.094 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.8 t -58.63 -37.59 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.435 1.094 . . . . 0.0 110.516 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -56.14 -45.51 79.57 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.987 0.812 . . . . 0.0 113.128 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -69.33 -45.95 68.24 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.923 0.783 . . . . 0.0 111.836 173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.88 -44.11 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 118.851 0.75 . . . . 0.0 110.834 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.67 -36.61 76.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.331 1.452 . . . . 0.0 113.033 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -37.32 86.25 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.116 -0.99 . . . . 0.0 112.816 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.01 117.38 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.54 0.736 . . . . 0.0 109.232 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -70.28 -61.44 1.77 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.486 -0.759 . . . . 0.0 111.777 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.335 53.5 m-85 -95.71 139.55 31.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.423 ' CD2' ' HG ' ' A' ' 181' ' ' CYS . 87.2 m-70 -137.28 153.08 50.39 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.716 2.406 . . . . 0.0 109.606 -174.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -124.2 115.93 21.89 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.129 -0.982 . . . . 0.0 112.82 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.4 126.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.108 0.963 . . . . 0.0 111.049 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 51.0 38.23 19.89 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 112.826 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.12 -7.1 0.12 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.914 2.486 . . . . 0.0 115.86 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -78.52 140.52 38.55 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.128 1.771 . . . . 0.0 109.178 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 96.5 mtp -88.64 143.26 27.06 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.546 -0.721 . . . . 0.0 111.879 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.0 164.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.566 2.346 . . . . 0.0 111.628 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -124.9 158.29 33.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.818 0.847 . . . . 0.0 110.867 168.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.423 ' HG ' ' CD2' ' A' ' 172' ' ' HIS . 24.1 p -141.41 158.27 44.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.637 0.732 . . . . 0.0 112.58 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -155.78 163.07 40.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.62 1.568 . . . . 0.0 111.702 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -57.69 147.14 28.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.494 1.118 . . . . 0.0 112.416 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.81 161.62 37.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.704 1.601 . . . . 0.0 110.965 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -98.89 115.84 65.58 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.64 0.776 . . . . 0.0 112.222 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.54 166.71 21.72 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.684 2.922 . . . . 0.0 112.287 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 151.58 30.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.006 0.923 . . . . 0.0 111.487 168.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.55 135.72 50.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.71 0.804 . . . . 0.0 112.229 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.7 p -155.13 157.17 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.899 1.68 . . . . 0.0 113.11 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 76.6 mtm -126.77 152.11 47.33 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.65 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.0 p -145.01 59.8 6.46 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.496 1.119 . . . . 0.0 113.852 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.69 -16.81 29.95 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.49 2.793 . . . . 0.0 114.129 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.4 0.1 OUTLIER 62.88 -48.69 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -177.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 64.56 18.33 63.43 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.695 1.14 . . . . 0.0 114.494 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 139.08 58.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.399 1.099 . . . . 0.0 113.151 -172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.15 29.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.06 1.344 . . . . 0.0 113.692 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -148.08 150.81 34.57 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.031 1.732 . . . . 0.0 111.019 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 79.63 -162.84 47.61 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.413 1.006 . . . . 0.0 113.814 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.9 ttm-85 -144.07 145.07 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.825 1.65 . . . . 0.0 111.498 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.093 1.757 . . . . 0.0 113.666 -179.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.5 p -150.4 153.41 35.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.979 1.311 . . . . 0.0 112.738 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -78.35 154.89 30.4 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.144 1.378 . . . . 0.0 113.208 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.09 151.16 26.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.697 1.199 . . . . 0.0 110.437 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.29 2.17 50.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.867 1.267 . . . . 0.0 113.528 173.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -140.56 151.78 44.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.21 1.404 . . . . 0.0 111.921 -172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -139.8 151.57 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.608 1.163 . . . . 0.0 113.648 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -90.12 146.95 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.252 2.221 . . . . 0.0 112.973 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.28 138.06 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.099 1.76 . . . . 0.0 110.348 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.52 142.41 9.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.887 0.767 . . . . 0.0 114.85 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.54 4.92 30.16 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.089 1.804 . . . . 0.0 114.649 -175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.22 140.05 58.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.368 1.467 . . . . 0.0 112.277 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -66.23 152.47 44.81 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.802 0.841 . . . . 0.0 111.741 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.15 -14.81 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.43 -0.793 . . . . 0.0 111.552 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -71.03 -28.81 64.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.133 0.973 . . . . 0.0 112.68 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.0 m -74.08 140.54 45.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.658 1.583 . . . . 0.0 112.78 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.53 164.48 15.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.404 1.482 . . . . 0.0 114.572 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.81 -32.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -67.24 -32.1 72.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.893 0.877 . . . . 0.0 112.739 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -67.25 -50.06 61.98 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.5 -45.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 111.207 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.16 -47.76 84.58 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 111.747 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.16 -43.79 98.04 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -64.13 -38.6 91.64 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 48.1 m-85 -73.51 -29.68 62.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -60.76 -17.09 46.76 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -65.52 -24.14 67.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.61 0.764 . . . . 0.0 112.794 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -83.49 -34.4 25.36 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.06 174.64 34.98 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.849 2.166 . . . . 0.0 110.798 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -59.23 126.5 27.93 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.951 0.876 . . . . 0.0 113.162 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.92 126.83 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.707 1.603 . . . . 0.0 108.628 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -76.69 -46.3 26.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.071 0.948 . . . . 0.0 112.631 175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -158.72 161.11 37.03 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.22 1.008 . . . . 0.0 110.894 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.83 156.27 41.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.508 1.523 . . . . 0.0 111.818 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -154.47 158.88 40.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.81 1.244 . . . . 0.0 112.629 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.1 mt -126.8 147.79 49.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.874 1.67 . . . . 0.0 111.445 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.64 85.45 6.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.997 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.283 42.3 m-85 -65.11 128.14 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 171.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.36 134.02 34.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.33 1.052 . . . . 0.0 111.293 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.13 -39.4 93.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.35 1.06 . . . . 0.0 113.641 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.33 -39.96 18.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.268 1.4 p -93.17 -12.75 29.57 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 58.1 27.91 15.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.785 2.034 . . . . 0.0 114.619 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -138.33 164.53 29.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.446 1.898 . . . . 0.0 110.521 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -73.92 148.87 41.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.577 0.703 . . . . 0.0 112.726 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -78.23 7.26 6.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.853 1.661 . . . . 0.0 115.314 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.24 14.89 67.9 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.554 1.073 . . . . 0.0 114.41 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.311 14.6 p90 -139.52 158.26 44.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.07 -171.75 30.71 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.224 0.916 . . . . 0.0 114.845 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -134.23 149.4 50.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.923 2.089 . . . . 0.0 114.246 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.81 129.37 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.246 1.418 . . . . 0.0 111.209 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 76.8 m -100.53 124.1 45.63 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.409 1.484 . . . . 0.0 111.434 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -97.16 155.9 16.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -68.91 -30.86 69.43 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.2 t -153.02 143.59 22.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.343 1.057 . . . . 0.0 113.309 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -57.82 -26.2 61.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.571 1.548 . . . . 0.0 113.673 170.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -59.02 -35.68 73.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.202 1.001 . . . . 0.0 111.809 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.75 -47.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.052 0.941 . . . . 0.0 110.418 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.7 t -58.4 -37.56 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.635 1.174 . . . . 0.0 111.146 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.69 -48.71 74.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.036 0.835 . . . . 0.0 113.218 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.63 -42.1 82.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.082 0.855 . . . . 0.0 111.676 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.79 -39.16 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.512 0.596 . . . . 0.0 111.241 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 88.9 m -73.62 -38.48 65.04 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.29 -35.61 80.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.21 116.36 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -68.94 -56.2 8.58 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.278 -0.889 . . . . 0.0 111.77 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.315 50.9 m-85 -104.12 136.82 43.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -130.81 137.42 49.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.787 2.035 . . . . 0.0 110.629 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -84.31 131.19 34.74 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.76 -0.588 . . . . 0.0 111.731 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.98 122.29 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.546 1.939 . . . . 0.0 109.546 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 49.62 40.01 18.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.555 1.142 . . . . 0.0 112.855 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 62.43 -8.01 0.12 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 128.688 2.795 . . . . 0.0 116.259 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -77.17 154.62 32.98 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.276 -1.515 . . . . 0.0 108.532 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 22.6 ptm -100.29 139.74 35.53 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.238 -0.914 . . . . 0.0 111.769 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.45 162.0 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.709 2.004 . . . . 0.0 111.719 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.82 162.55 17.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.5 p -144.06 154.27 43.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.695 1.198 . . . . 0.0 113.675 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -144.06 165.43 27.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.681 1.993 . . . . 0.0 111.758 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.54 134.67 57.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.024 0.93 . . . . 0.0 111.655 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.36 63.97 5.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.17 0.988 . . . . 0.0 112.988 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 54.29 74.67 0.71 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.579 1.951 . . . . 0.0 111.264 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.32 156.02 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.781 2.987 . . . . 0.0 116.545 -166.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -144.12 128.81 18.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.253 2.621 . . . . 0.0 108.028 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.17 104.92 0.98 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.853 0.861 . . . . 0.0 112.89 -169.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 19.1 t -144.24 128.37 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.114 1.765 . . . . 0.0 110.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 54.1 ttm -136.69 144.36 43.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.285 1.434 . . . . 0.0 111.622 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.4 t -148.91 92.35 4.4 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.775 1.23 . . . . 0.0 110.395 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.45 147.41 41.21 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.294 2.663 . . . . 0.0 112.987 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.319 0.2 OUTLIER -73.19 41.1 0.1 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.59 142.85 47.36 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.627 1.108 . . . . 0.0 113.915 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.4 t -156.95 159.77 38.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.664 1.585 . . . . 0.0 111.263 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.08 140.03 57.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.304 1.041 . . . . 0.0 112.877 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -80.54 156.56 26.44 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.071 1.349 . . . . 0.0 113.024 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.96 175.83 47.26 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.479 1.037 . . . . 0.0 113.825 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -145.87 169.33 18.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.653 1.581 . . . . 0.0 112.549 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 49.6 p . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.113 1.765 . . . . 0.0 115.429 -179.023 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.0 m -128.07 28.12 5.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.023 1.729 . . . . 0.0 112.189 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -86.3 62.3 7.35 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.32 1.848 . . . . 0.0 112.425 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -135.86 148.6 48.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.525 1.13 . . . . 0.0 112.751 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -98.03 32.58 2.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.897 1.679 . . . . 0.0 112.738 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -141.13 149.65 41.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.724 1.61 . . . . 0.0 111.431 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.84 151.3 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.344 1.058 . . . . 0.0 113.763 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -88.72 145.64 25.51 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.526 1.931 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.3 138.05 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.471 1.509 . . . . 0.0 110.627 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.77 153.52 25.16 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.861 0.743 . . . . 0.0 114.33 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.81 34.88 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.034 1.302 . . . . 0.0 114.602 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.0 mt -64.21 136.24 57.02 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.106 1.363 . . . . 0.0 112.18 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -62.62 152.66 34.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.348 1.059 . . . . 0.0 112.37 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.6 -23.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.81 0.844 . . . . 0.0 111.725 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -67.62 -26.68 66.36 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.65 1.18 . . . . 0.0 113.282 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.2 m -76.97 147.64 36.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.074 1.749 . . . . 0.0 115.495 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 t -129.3 162.66 27.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.07 1.748 . . . . 0.0 113.094 168.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -57.72 -30.86 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.14 -33.99 77.33 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.911 0.884 . . . . 0.0 112.42 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.07 -47.24 68.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.23 -45.35 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.58 0.752 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -60.91 -47.44 86.38 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.141 0.577 . . . . 0.0 111.65 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -58.9 -45.76 89.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.971 0.908 . . . . 0.0 113.415 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -65.62 -38.68 90.1 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 49.4 m-85 -73.75 -29.18 62.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 171.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -61.19 -17.39 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -64.93 -23.04 67.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.659 0.784 . . . . 0.0 112.8 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -86.1 -29.29 23.46 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.73 174.95 30.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.98 2.228 . . . . 0.0 110.729 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -59.3 126.88 29.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.249 1.025 . . . . 0.0 112.882 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.53 123.25 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.799 1.64 . . . . 0.0 107.502 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.16 -33.73 24.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.325 0.65 . . . . 0.0 110.398 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -160.54 158.08 28.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.683 1.193 . . . . 0.0 110.168 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.01 149.11 30.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.205 1.402 . . . . 0.0 111.165 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.14 159.09 42.67 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.432 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.0 mt -125.98 155.8 40.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.913 1.685 . . . . 0.0 111.028 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.3 mmm -83.46 132.92 34.93 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -118.12 148.49 42.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.97 105.15 17.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.174 0.99 . . . . 0.0 108.977 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -59.96 -25.51 65.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.251 1.3 p -78.17 -17.46 56.79 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -126.58 -15.03 5.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.329 17.0 p30 54.77 17.42 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.897 2.479 . . . . 0.0 115.543 -170.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -81.79 145.82 30.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.974 1.31 . . . . 0.0 110.324 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -79.18 157.82 27.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.259 0.552 . . . . 0.0 112.041 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -84.48 1.55 45.08 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.52 66.8 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.267 1.413 . . . . 0.0 114.597 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -145.22 159.74 42.55 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.94 -164.43 27.49 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.271 0.939 . . . . 0.0 115.129 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -136.59 147.67 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.75 2.02 . . . . 0.0 114.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.26 127.6 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.704 1.202 . . . . 0.0 111.3 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.9 m -96.81 122.67 40.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.343 1.457 . . . . 0.0 111.278 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.29 158.99 16.26 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.617 -0.677 . . . . 0.0 112.597 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -149.73 147.23 27.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.562 1.145 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -62.17 -24.5 67.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.687 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.76 -30.31 71.35 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.22 -47.46 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.549 0.739 . . . . 0.0 109.874 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.65 -34.28 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.383 1.073 . . . . 0.0 110.526 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.24 -40.09 61.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.8 1.24 . . . . 0.0 113.163 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -80.54 -45.24 17.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.615 0.643 . . . . 0.0 112.09 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.8 -44.66 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.845 0.748 . . . . 0.0 112.006 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 22.3 t -73.21 -33.0 65.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.085 1.354 . . . . 0.0 112.145 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -67.42 -38.74 85.03 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.292 -0.88 . . . . 0.0 112.484 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.7 mt -71.66 114.81 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -68.75 -49.63 57.19 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.897 -1.127 . . . . 0.0 112.149 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 62.4 m-85 -108.43 138.85 44.04 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.97 129.45 34.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.919 1.687 . . . . 0.0 111.123 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -77.94 134.15 37.93 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.53 -0.731 . . . . 0.0 112.39 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.9 mt -145.83 118.71 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 127.493 2.317 . . . . 0.0 108.199 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 50.69 45.94 26.38 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.05 0.94 . . . . 0.0 113.359 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 65.86 -18.22 0.1 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 128.045 2.538 . . . . 0.0 116.259 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -75.26 155.33 36.84 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.403 1.881 . . . . 0.0 109.844 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.7 mtm -108.17 125.09 51.23 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.472 -0.768 . . . . 0.0 111.397 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.16 163.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.345 1.858 . . . . 0.0 111.868 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -122.44 155.71 35.56 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.349 0.66 . . . . 0.0 111.112 168.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 30.1 p -139.14 155.84 47.57 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -145.06 173.46 11.88 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.491 1.917 . . . . 0.0 111.775 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -60.34 135.39 57.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.113 0.965 . . . . 0.0 111.315 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.98 139.69 36.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.208 0.603 . . . . 0.0 110.793 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.01 141.47 71.29 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -78.63 -14.08 14.39 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.464 2.776 . . . . 0.0 114.24 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt 51.7 48.72 22.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.082 2.153 . . . . 0.0 114.132 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -145.07 157.1 44.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.644 1.578 . . . . 0.0 111.95 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.93 144.26 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.067 1.347 . . . . 0.0 113.379 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 60.0 tpp -74.01 -31.64 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.459 1.104 . . . . 0.0 113.633 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.8 t -125.95 72.86 70.4 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.086 1.355 . . . . 0.0 111.168 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.83 166.53 28.62 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.988 3.125 . . . . 0.0 112.514 175.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.444 0.6 OUTLIER 61.82 173.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.99 26.97 63.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.534 1.064 . . . . 0.0 114.183 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.3 p -69.45 173.74 5.6 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.387 1.475 . . . . 0.0 113.402 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.3 8.53 1.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? 64.2 -33.69 0.14 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 129.33 3.052 . . . . 0.0 116.412 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.32 -169.31 54.71 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.82 1.2 . . . . 0.0 114.111 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -68.78 164.92 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.966 1.307 . . . . 0.0 113.433 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.187 1.795 . . . . 0.0 115.361 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -64.33 144.59 57.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.472 1.109 . . . . 0.0 113.213 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -62.25 133.2 54.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.331 . . . . 0.0 112.28 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -68.36 135.76 52.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -129.01 24.23 5.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.135 2.174 . . . . 0.0 110.418 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -151.92 154.2 35.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.033 1.333 . . . . 0.0 110.286 -169.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.66 154.81 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.076 . . . . 0.0 112.896 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -91.01 145.57 24.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.399 1.879 . . . . 0.0 112.054 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.03 131.4 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.55 1.54 . . . . 0.0 109.908 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.13 12.66 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.607 0.622 . . . . 0.0 114.5 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.58 10.79 26.42 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.759 1.647 . . . . 0.0 114.717 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 37.7 mt -61.61 136.38 57.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.219 1.408 . . . . 0.0 111.929 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 p -79.92 179.18 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -79.5 -20.17 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.306 1.043 . . . . 0.0 112.56 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.38 -37.75 56.72 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.897 0.879 . . . . 0.0 110.527 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 m -68.96 140.5 55.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.72 1.608 . . . . 0.0 115.295 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 t -144.44 173.71 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.678 1.991 . . . . 0.0 112.218 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.1 -32.28 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -68.44 -39.98 81.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.906 0.882 . . . . 0.0 112.433 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -65.06 -41.89 94.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.97 -53.02 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.374 1.07 . . . . 0.0 109.137 174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -58.86 -48.17 82.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.67 0.668 . . . . 0.0 111.962 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -60.5 -42.01 95.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.737 0.815 . . . . 0.0 112.832 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.14 -46.02 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.329 54.6 m-85 -66.57 -28.0 68.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -59.57 -21.01 59.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -71.51 -25.89 62.44 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.417 -0.802 . . . . 0.0 112.767 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -75.49 -36.26 60.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 177.08 37.86 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.877 2.179 . . . . 0.0 110.963 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -60.01 131.27 50.34 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.12 0.96 . . . . 0.0 112.968 -172.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 36.9 t -108.06 133.46 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.757 2.023 . . . . 0.0 107.446 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -101.32 -23.12 14.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.01 150.9 17.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.892 2.077 . . . . 0.0 113.379 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.0 31.65 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.289 1.036 . . . . 0.0 110.997 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.7 ptm -157.43 158.77 36.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.742 1.217 . . . . 0.0 112.331 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.14 150.13 49.64 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.805 1.642 . . . . 0.0 111.808 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.4 mmt -82.57 143.89 30.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 110.564 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.86 154.33 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -110.12 111.83 23.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.345 1.058 . . . . 0.0 112.548 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -59.14 -21.7 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.68 1.192 . . . . 0.0 114.049 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -18.37 63.29 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -136.36 -18.89 1.47 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 62.1 t30 59.59 22.48 11.14 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.975 2.11 . . . . 0.0 113.864 -171.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -106.9 160.73 15.3 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.409 1.484 . . . . 0.0 110.525 174.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -71.82 153.82 41.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.222 0.534 . . . . 0.0 111.552 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -82.34 2.53 31.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -172.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.7 9.92 82.23 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.56 1.076 . . . . 0.0 113.771 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.27 19.6 p90 -143.47 156.65 44.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.08 -164.69 22.09 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.441 1.019 . . . . 0.0 114.174 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.09 151.72 46.93 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.994 1.718 . . . . 0.0 114.144 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 t -137.26 128.27 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.944 1.298 . . . . 0.0 112.101 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -90.36 139.62 30.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.866 1.666 . . . . 0.0 113.287 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.34 150.5 43.57 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -174.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -67.15 -33.02 74.53 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.4 t -147.4 148.59 31.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.74 1.216 . . . . 0.0 113.192 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -57.44 -29.38 64.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.543 1.137 . . . . 0.0 112.836 171.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -61.64 -30.8 70.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -78.94 -48.67 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 110.249 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.95 -43.06 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.04 1.336 . . . . 0.0 110.434 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -56.4 -47.98 77.87 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.975 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -64.99 -45.13 86.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.019 0.827 . . . . 0.0 111.688 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.48 -36.13 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.629 0.65 . . . . 0.0 111.705 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.6 m -73.24 -39.87 65.11 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -66.4 -35.3 79.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.037 0.935 . . . . 0.0 113.22 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.18 115.0 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -68.29 -58.74 3.93 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.716 -0.615 . . . . 0.0 111.279 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.327 53.4 m-85 -104.71 137.94 41.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.05 125.48 33.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.981 2.112 . . . . 0.0 109.865 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.51 121.57 32.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.416 -0.803 . . . . 0.0 112.535 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.4 mt -139.15 126.44 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.891 1.277 . . . . 0.0 109.91 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.41 40.0 21.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.622 1.169 . . . . 0.0 113.687 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 62.97 -7.91 0.14 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 128.1 2.56 . . . . 0.0 115.876 -171.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -81.58 170.13 16.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.807 2.043 . . . . 0.0 110.37 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.6 mtp -121.21 134.89 55.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.207 1.003 . . . . 0.0 112.105 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.02 159.04 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.849 2.06 . . . . 0.0 112.399 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -124.79 152.3 44.05 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.81 0.844 . . . . 0.0 112.506 172.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.7 m -124.5 144.95 49.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.547 1.139 . . . . 0.0 113.015 -169.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -141.79 169.89 16.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.276 1.43 . . . . 0.0 112.78 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -63.1 150.32 42.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.512 1.125 . . . . 0.0 112.789 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -150.4 152.62 34.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.291 1.436 . . . . 0.0 110.681 171.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -70.33 145.67 93.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.501 -0.75 . . . . 0.0 112.391 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.41 134.32 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.219 2.613 . . . . 0.0 112.385 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -72.13 -35.36 69.1 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -147.96 146.94 29.17 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.695 2.398 . . . . 0.0 110.657 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.8 p -75.61 148.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.134 0.974 . . . . 0.0 113.427 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.3 145.61 55.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.735 0.814 . . . . 0.0 111.668 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 t -149.04 118.5 3.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.405 1.082 . . . . 0.0 110.707 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.27 165.83 27.18 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.683 2.922 . . . . 0.0 113.206 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 t -146.1 157.25 43.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -81.1 -175.84 50.34 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.175 1.369 . . . . 0.0 114.829 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.9 t -151.24 147.51 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.31 1.444 . . . . 0.0 111.908 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.98 -14.07 59.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.464 1.105 . . . . 0.0 113.781 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -71.53 148.85 46.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.556 1.143 . . . . 0.0 112.632 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 174.6 177.36 43.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.072 1.32 . . . . 0.0 113.131 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.295 1.438 . . . . 0.0 111.33 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.878 2.071 . . . . 0.0 113.535 -177.073 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.33 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.5 m -133.2 129.45 37.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.848 1.259 . . . . 0.0 113.306 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -73.8 97.02 2.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.305 1.442 . . . . 0.0 109.422 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -152.33 140.26 20.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.5 1.12 . . . . 0.0 110.983 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -105.7 4.6 30.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.83 1.252 . . . . 0.0 113.485 -171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.85 149.5 37.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.345 1.458 . . . . 0.0 111.859 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -139.38 151.03 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.406 1.083 . . . . 0.0 113.919 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.13 148.39 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.97 2.108 . . . . 0.0 112.782 167.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.0 t -134.89 134.99 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 109.645 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.48 155.85 26.72 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.016 0.817 . . . . 0.0 114.327 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.79 7.56 66.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.798 1.19 . . . . 0.0 113.784 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.76 143.56 57.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 111.656 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -69.47 154.08 42.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.174 0.589 . . . . 0.0 110.041 167.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.59 -15.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.771 -0.581 . . . . 0.0 111.708 168.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -73.75 -28.85 61.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.074 1.35 . . . . 0.0 113.126 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 m -67.06 123.89 21.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.265 0.8 OUTLIER -80.86 160.58 24.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.52 -29.85 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -75.23 -36.78 61.3 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.02 -43.37 98.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.78 -50.44 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.85 0.86 . . . . 0.0 109.681 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.49 -46.8 88.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.686 0.675 . . . . 0.0 112.313 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -59.15 -40.15 84.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.534 1.134 . . . . 0.0 112.237 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.41 -54.56 34.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 171.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 48.6 m-85 -63.41 -23.7 67.52 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -60.93 -13.85 18.6 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.31 -29.13 69.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.886 1.221 . . . . 0.0 112.726 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -85.1 -34.43 22.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.214 1.005 . . . . 0.0 112.248 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.21 -179.8 41.63 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 127.077 2.275 . . . . 0.0 110.788 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.71 122.72 16.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.19 0.995 . . . . 0.0 112.315 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.7 t -95.65 123.81 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -82.08 -39.94 22.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.753 -0.592 . . . . 0.0 109.547 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -157.91 159.89 37.03 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.63 1.172 . . . . 0.0 110.152 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.62 34.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.383 1.473 . . . . 0.0 110.955 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 mmt -148.65 159.37 44.17 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.654 1.582 . . . . 0.0 113.003 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.0 mt -126.84 143.57 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.983 2.113 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 43.0 mtm -97.62 132.5 43.21 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -126.08 144.37 50.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.925 2.09 . . . . 0.0 116.206 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.0 111.57 19.4 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -61.42 -36.22 79.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.845 0.858 . . . . 0.0 112.991 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 p -75.31 -16.16 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.264 1.4 p -123.17 -5.41 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.292 1.0 OUTLIER 52.18 39.41 26.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.208 2.603 . . . . 0.0 115.367 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.82 158.53 43.62 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -59.55 145.83 42.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.318 2.247 . . . . 0.0 113.349 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.56 -11.31 49.1 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.22 14.35 66.7 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.175 0.893 . . . . 0.0 113.99 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.38 4.7 p90 -141.09 162.45 35.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.89 -169.88 28.02 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.089 1.328 . . . . 0.0 114.604 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.05 150.26 52.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.262 2.225 . . . . 0.0 114.394 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -136.32 125.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.209 1.404 . . . . 0.0 111.82 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 94.4 m -98.31 128.92 44.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.353 1.461 . . . . 0.0 110.767 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -104.85 150.69 24.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -67.0 -38.13 85.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.575 0.75 . . . . 0.0 112.673 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 t -143.11 134.69 26.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 122.201 1.0 . . . . 0.0 112.904 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -58.34 -27.25 63.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.53 1.932 . . . . 0.0 113.256 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.55 -26.26 68.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -76.75 -50.81 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.904 0.882 . . . . 0.0 109.489 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.08 -36.62 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 111.987 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.19 -30.88 60.82 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -84.0 -49.08 9.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.552 0.741 . . . . 0.0 111.668 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.66 -43.58 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.315 0.961 . . . . 0.0 113.433 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.9 t -77.59 -19.17 56.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.446 1.098 . . . . 0.0 112.514 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -81.54 -31.19 32.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.254 1.021 . . . . 0.0 112.215 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.15 142.06 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.19 0.996 . . . . 0.0 109.519 168.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -131.23 161.43 32.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.743 1.217 . . . . 0.0 111.728 171.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.581 2.1 p90 58.31 45.17 17.46 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -57.41 142.65 43.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 110.688 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.53 106.92 16.38 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.596 1.089 . . . . 0.0 112.978 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.53 122.93 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.765 1.226 . . . . 0.0 110.528 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 50.97 41.36 27.09 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.461 1.104 . . . . 0.0 112.634 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 62.97 -10.59 0.1 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.379 2.672 . . . . 0.0 116.191 -171.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.51 139.92 38.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.166 1.787 . . . . 0.0 109.723 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 20.4 ptm -91.96 140.54 29.57 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.59 -0.694 . . . . 0.0 111.716 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.19 149.5 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.249 1.82 . . . . 0.0 113.289 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -119.83 151.58 38.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.785 1.234 . . . . 0.0 111.093 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 p -129.34 156.11 44.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -143.59 170.37 15.96 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.449 1.899 . . . . 0.0 110.954 -175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.66 153.68 19.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.732 0.813 . . . . 0.0 112.174 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.2 18.89 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.555 1.142 . . . . 0.0 113.979 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.51 165.11 13.1 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.539 1.936 . . . . 0.0 110.759 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -64.25 156.47 59.42 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.902 2.401 . . . . 0.0 111.747 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -66.55 120.5 13.52 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.909 0.884 . . . . 0.0 110.561 172.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.93 161.83 19.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.8 m -82.83 -3.42 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.941 1.696 . . . . 0.0 114.486 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 98.4 mmm -61.86 140.29 58.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 114.146 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -153.32 86.76 3.98 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 109.424 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.12 155.67 56.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.478 2.785 . . . . 0.0 113.199 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -70.26 159.63 33.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 174.18 -40.19 0.13 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.952 0.787 . . . . 0.0 113.694 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 73.8 p -73.74 152.55 40.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.444 1.097 . . . . 0.0 112.525 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.78 33.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.929 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -70.79 116.96 11.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.629 1.172 . . . . 0.0 110.633 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.96 -23.18 77.17 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 114.836 0.695 . . . . 0.0 114.836 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -77.31 -21.45 53.45 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.219 1.408 . . . . 0.0 113.949 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.308 1.443 . . . . 0.0 113.801 -179.35 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 p -81.45 -1.08 44.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -71.55 -6.05 37.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.085 1.754 . . . . 0.0 115.272 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 21.6 mmt -60.5 118.76 6.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.618 1.167 . . . . 0.0 111.86 -170.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -121.33 26.36 8.94 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.79 1.236 . . . . 0.0 111.286 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -153.36 138.71 17.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.125 1.37 . . . . 0.0 110.324 -168.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.1 pt -140.61 149.16 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -87.88 147.93 24.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.039 1.736 . . . . 0.0 112.658 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.29 132.3 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.603 1.561 . . . . 0.0 109.777 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.96 11.64 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 115.026 0.771 . . . . 0.0 115.026 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.92 11.12 35.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.549 1.547 . . . . 0.0 114.453 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.44 140.82 58.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.031 1.333 . . . . 0.0 112.168 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 t -66.47 155.37 37.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.004 0.921 . . . . 0.0 111.625 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 m -72.26 -14.8 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.696 -0.628 . . . . 0.0 111.656 169.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.04 -39.88 93.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.05 0.94 . . . . 0.0 111.969 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.15 127.86 33.83 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.15 165.38 13.52 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -62.82 -30.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.34 -37.49 60.65 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.42 0.688 . . . . 0.0 111.509 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.73 -47.18 86.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 t -57.94 -49.22 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 109.039 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -61.52 -44.28 97.35 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.079 0.854 . . . . 0.0 112.355 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -60.71 -46.18 91.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.349 1.06 . . . . 0.0 112.507 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.13 -44.66 96.98 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 48.0 m-85 -66.48 -31.22 71.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -62.28 -12.98 23.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.78 -31.42 72.05 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.248 0.931 . . . . 0.0 113.216 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.81 -39.86 66.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.63 168.5 28.92 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.849 2.643 . . . . 0.0 109.539 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.81 135.59 57.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.483 1.141 . . . . 0.0 113.192 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.47 128.78 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.081 1.753 . . . . 0.0 109.025 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.85 -49.38 30.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.625 1.17 . . . . 0.0 113.891 172.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -154.7 157.29 37.86 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.003 2.121 . . . . 0.0 114.811 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.6 39.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.683 1.193 . . . . 0.0 110.959 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.4 ptm -155.43 148.15 24.22 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.774 1.229 . . . . 0.0 112.095 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.98 151.9 49.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.887 1.675 . . . . 0.0 111.297 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 mmt -78.38 69.02 4.51 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.226 1.01 . . . . 0.0 112.77 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.254 54.6 m-85 -58.05 140.04 53.36 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 170.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -133.51 113.84 12.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 113.425 -175.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -59.99 -24.57 64.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.322 . . . . 0.0 113.287 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -24.4 67.66 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 172.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p -131.06 -8.25 3.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.04 30.65 20.12 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.861 2.064 . . . . 0.0 114.199 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -150.79 176.72 10.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.473 1.909 . . . . 0.0 109.953 172.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -87.73 154.31 20.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.45 0.643 . . . . 0.0 112.599 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.23 8.14 3.6 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.22 14.85 58.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.842 1.21 . . . . 0.0 115.099 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -145.56 158.49 43.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.86 -160.94 24.26 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -134.16 148.3 50.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.542 1.937 . . . . 0.0 114.751 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -136.28 133.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.267 1.427 . . . . 0.0 111.162 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.8 m -107.23 134.21 50.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 0.0 112.709 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.19 149.51 28.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 118.433 2.753 . . . . 0.0 118.433 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -67.91 -27.48 66.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.662 0.785 . . . . 0.0 112.932 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.4 t -147.76 138.74 23.41 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.876 1.27 . . . . 0.0 112.766 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -60.84 -27.63 68.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.697 1.599 . . . . 0.0 113.461 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -62.45 -26.53 68.56 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.2 mm -75.03 -50.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.962 0.905 . . . . 0.0 110.272 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 31.3 t -57.49 -34.51 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.348 1.459 . . . . 0.0 111.235 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -52.64 -42.68 64.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 113.165 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.58 -41.83 62.37 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.2 0.909 . . . . 0.0 112.127 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.42 -31.43 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 98.8 m -79.74 -40.28 29.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.171 1.388 . . . . 0.0 113.811 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.19 -43.27 95.59 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.407 0.683 . . . . 0.0 111.873 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.5 114.26 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.54 -51.71 26.8 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.087 -1.008 . . . . 0.0 111.81 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -94.8 139.28 31.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -133.49 132.64 41.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.654 1.582 . . . . 0.0 111.044 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -81.05 127.63 32.82 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.744 -0.598 . . . . 0.0 111.365 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 25.1 mt -140.46 125.0 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 109.136 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 50.47 40.24 22.76 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.219 1.008 . . . . 0.0 112.585 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.7 t30 63.22 -10.7 0.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 128.39 2.676 . . . . 0.0 115.912 -172.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -77.0 143.11 39.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.856 1.662 . . . . 0.0 109.426 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 23.1 ptm -97.15 138.35 34.78 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.424 -0.797 . . . . 0.0 111.458 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.89 146.69 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.731 2.012 . . . . 0.0 112.378 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -89.11 142.88 27.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.519 0.728 . . . . 0.0 111.324 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.87 148.63 52.56 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.626 1.17 . . . . 0.0 112.572 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -158.38 164.66 36.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.406 1.482 . . . . 0.0 112.179 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -61.79 143.28 56.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.019 0.927 . . . . 0.0 112.305 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -101.66 14.85 30.75 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . 0.253 14.0 pt20 43.57 50.81 6.67 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 127.392 2.277 . . . . 0.0 116.42 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -61.64 165.51 13.47 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.357 2.704 . . . . 0.0 113.431 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.43 143.41 19.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.475 1.51 . . . . 0.0 112.766 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -59.31 130.68 48.11 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.856 1.662 . . . . 0.0 112.937 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.8 t -143.04 136.2 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.557 1.943 . . . . 0.0 108.98 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.4 tpp -153.26 146.7 24.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.356 1.063 . . . . 0.0 111.902 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.9 t -154.71 119.89 2.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.111 1.364 . . . . 0.0 109.704 170.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 147.68 58.52 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.054 2.502 . . . . 0.0 112.447 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.2 t -151.67 162.91 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -176.4 158.28 24.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.584 1.564 . . . . 0.0 112.643 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.9 t -156.76 153.8 28.95 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.802 1.241 . . . . 0.0 111.922 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.42 153.22 34.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.87 1.668 . . . . 0.0 111.331 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -149.94 147.52 27.99 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.528 1.531 . . . . 0.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -175.67 -175.52 43.15 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.857 1.217 . . . . 0.0 113.175 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -148.26 147.87 29.83 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.819 1.648 . . . . 0.0 111.152 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.588 1.555 . . . . 0.0 113.283 172.759 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.25 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 m -147.6 161.28 41.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.095 1.358 . . . . 0.0 112.727 -172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -75.92 -27.57 57.69 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.475 -0.766 . . . . 0.0 112.814 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -65.44 126.47 28.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.232 1.013 . . . . 0.0 113.154 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -122.69 7.87 9.45 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.761 2.025 . . . . 0.0 112.909 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.73 154.5 48.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.222 1.409 . . . . 0.0 112.063 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.98 154.54 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.996 1.318 . . . . 0.0 113.313 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.4 149.25 21.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.671 1.988 . . . . 0.0 112.979 167.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.85 131.91 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.858 1.663 . . . . 0.0 109.981 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.5 139.62 7.74 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.47 9.51 21.36 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.236 1.874 . . . . 0.0 114.771 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.75 136.3 57.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.369 1.468 . . . . 0.0 112.518 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -64.64 153.83 38.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.458 1.103 . . . . 0.0 112.05 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.19 -17.07 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.281 0.632 . . . . 0.0 112.332 169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -67.81 -37.5 82.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.938 0.895 . . . . 0.0 111.724 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -70.12 147.39 49.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.311 1.844 . . . . 0.0 114.484 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t -140.05 171.54 14.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.688 1.595 . . . . 0.0 112.846 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -57.21 -31.99 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.2 -40.92 86.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.169 0.988 . . . . 0.0 112.325 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -64.04 -42.46 97.06 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.1 -51.23 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.163 0.985 . . . . 0.0 109.653 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -61.86 -45.85 92.01 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.022 0.828 . . . . 0.0 112.105 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -59.03 -41.79 88.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.761 0.824 . . . . 0.0 112.851 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.46 -46.74 68.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.355 49.9 m-85 -66.43 -26.31 67.16 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.2 -24.95 66.7 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -65.96 -22.95 66.51 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.486 1.039 . . . . 0.0 112.765 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -71.94 -24.88 61.69 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.58 -98.62 0.13 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.617 1.103 . . . . 0.0 112.573 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -154.23 137.23 15.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.272 1.429 . . . . 0.0 112.031 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.33 130.5 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.194 1.798 . . . . 0.0 108.834 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 -46.97 19.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 112.869 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -158.55 161.21 37.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 110.452 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.05 155.17 41.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.433 1.493 . . . . 0.0 111.48 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.55 155.14 32.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.392 1.077 . . . . 0.0 112.741 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.23 152.58 47.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.6 mtp -83.66 144.83 29.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.399 0.68 . . . . 0.0 111.261 171.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.66 156.45 43.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 -172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -111.77 108.48 17.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.719 1.208 . . . . 0.0 112.173 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.2 -16.0 50.31 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -17.41 64.46 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 t -144.29 -14.89 0.59 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 57.17 39.66 28.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.319 1.848 . . . . 0.0 113.297 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -117.35 139.83 50.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.734 2.013 . . . . 0.0 109.355 175.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -70.31 156.52 39.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.29 0.567 . . . . 0.0 111.985 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -80.7 1.63 29.33 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.25 84.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.689 1.138 . . . . 0.0 114.115 -171.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.277 9.1 p90 -143.86 155.23 44.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.59 -160.93 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.978 0.799 . . . . 0.0 114.936 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -137.82 150.69 47.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.297 1.839 . . . . 0.0 114.14 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.41 129.57 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.081 1.352 . . . . 0.0 111.407 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.1 m -97.69 122.83 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.275 1.43 . . . . 0.0 112.055 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -95.05 154.83 16.99 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -70.08 -31.82 69.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.922 0.889 . . . . 0.0 113.387 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.2 t -152.07 140.26 20.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -53.21 -33.87 54.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.752 2.021 . . . . 0.0 113.615 170.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.73 -22.25 66.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.13 -54.31 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.099 0.96 . . . . 0.0 109.509 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.7 -39.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.766 1.626 . . . . 0.0 111.506 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.7 -40.81 66.34 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -75.48 -42.43 53.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.054 0.843 . . . . 0.0 112.361 173.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.58 -30.78 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.02 -40.53 24.12 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.018 1.727 . . . . 0.0 113.287 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.35 -39.77 94.2 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.028 -1.045 . . . . 0.0 111.712 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.6 mt -74.48 108.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 168.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.28 -45.86 44.92 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.999 -1.063 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.44 133.59 42.6 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -131.03 130.12 42.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.872 1.669 . . . . 0.0 110.624 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -91.39 130.56 37.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.829 0.852 . . . . 0.0 111.997 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.95 126.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.538 1.535 . . . . 0.0 109.253 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 49.91 42.18 23.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.39 1.076 . . . . 0.0 113.422 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.97 -13.62 0.15 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 127.313 2.245 . . . . 0.0 115.932 -172.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.74 168.3 20.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.168 1.787 . . . . 0.0 110.609 169.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 97.5 mtp -127.18 139.89 52.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.333 1.053 . . . . 0.0 112.151 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.67 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.614 1.966 . . . . 0.0 112.005 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -87.91 141.71 28.37 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.683 0.393 . . . . 0.0 110.876 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.85 146.69 50.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.966 1.306 . . . . 0.0 111.356 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -158.05 171.12 20.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.55 1.14 . . . . 0.0 111.847 174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -59.96 140.68 56.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.71 1.204 . . . . 0.0 111.992 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -108.12 8.06 27.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.718 1.207 . . . . 0.0 113.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -149.52 152.86 36.1 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.66 2.384 . . . . 0.0 111.304 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.55 179.74 6.23 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.244 3.296 . . . . 0.0 112.802 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -132.02 155.11 48.6 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.835 1.254 . . . . 0.0 111.878 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.61 163.84 26.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 110.901 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.98 -22.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.4 ptm -80.27 162.25 24.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.896 1.678 . . . . 0.0 113.757 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 t -161.97 129.83 2.77 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.758 2.023 . . . . 0.0 108.516 168.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.21 144.68 42.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.906 2.404 . . . . 0.0 113.153 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 p -82.91 152.91 25.34 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -80.97 143.63 24.32 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.216 0.912 . . . . 0.0 113.216 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.4 p -75.23 156.47 35.72 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.588 1.155 . . . . 0.0 113.168 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.26 161.04 42.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.496 1.518 . . . . 0.0 111.865 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -136.4 18.5 3.14 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.0 -172.03 53.57 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.522 1.058 . . . . 0.0 113.701 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -63.08 153.39 34.26 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.829 173.646 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.5 t -153.16 159.31 42.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.438 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -71.06 107.71 4.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.433 1.093 . . . . 0.0 110.892 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 17.2 ptm -158.36 121.28 3.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.849 1.259 . . . . 0.0 111.358 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -117.81 20.84 13.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.852 1.661 . . . . 0.0 110.868 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -154.91 144.29 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.198 1.399 . . . . 0.0 111.374 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -140.41 155.01 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.586 1.155 . . . . 0.0 113.301 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -94.5 145.77 24.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.198 2.199 . . . . 0.0 112.789 167.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.1 138.77 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.051 1.74 . . . . 0.0 109.726 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.51 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.93 13.65 54.23 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.375 1.464 . . . . 0.0 114.215 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.5 mt -62.79 138.6 58.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.422 . . . . 0.0 112.215 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.44 155.15 33.56 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.112 0.965 . . . . 0.0 111.734 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 p -67.97 -21.07 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.868 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -69.95 -30.89 68.37 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.478 1.111 . . . . 0.0 112.911 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.4 m -79.7 128.69 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.393 1.477 . . . . 0.0 114.236 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.51 166.21 12.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.02 -30.12 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 169.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.76 -35.94 62.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.486 0.715 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.7 -46.87 87.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.632 0.651 . . . . 0.0 112.364 170.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.73 -50.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.595 1.158 . . . . 0.0 109.422 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.7 -48.59 81.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.82 0.736 . . . . 0.0 112.177 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -60.73 -39.45 88.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.789 0.836 . . . . 0.0 112.553 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.61 -48.66 66.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 50.4 m-85 -62.92 -29.5 70.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -59.91 -20.84 59.62 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -70.29 -25.66 63.43 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.14 0.882 . . . . 0.0 112.674 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.42 -38.28 59.91 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.17 37.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.518 2.008 . . . . 0.0 111.326 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -58.55 119.41 6.99 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.109 0.964 . . . . 0.0 112.995 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -93.93 131.4 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.0 107.987 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -86.44 -35.1 19.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -163.87 158.6 20.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.249 1.419 . . . . 0.0 109.398 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.21 139.52 22.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.067 1.347 . . . . 0.0 110.608 172.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.1 mmt -148.8 151.12 34.23 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.421 1.488 . . . . 0.0 112.254 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.62 151.73 41.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.487 1.515 . . . . 0.0 111.074 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtp -81.3 75.42 8.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.711 0.804 . . . . 0.0 112.35 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -61.07 143.13 55.99 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -129.18 122.42 29.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.42 -23.92 66.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -79.38 -13.67 59.46 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 174.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.0 p -123.67 -19.53 5.76 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 59.0 25.66 14.11 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.58 1.952 . . . . 0.0 114.828 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -145.9 171.07 15.36 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.632 1.573 . . . . 0.0 110.879 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -78.18 150.07 33.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 112.077 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -78.96 12.8 2.01 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.63 15.15 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.786 1.184 . . . . 0.0 114.674 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.266 8.5 p90 -146.91 159.09 43.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.28 -160.59 22.74 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.192 0.901 . . . . 0.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.35 150.65 44.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.029 1.731 . . . . 0.0 114.207 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.27 130.32 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.354 1.461 . . . . 0.0 111.938 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -93.75 144.73 25.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.401 1.88 . . . . 0.0 114.431 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -125.95 151.08 47.47 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 118.167 2.654 . . . . 0.0 118.167 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -61.57 -37.2 82.96 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.004 1.322 . . . . 0.0 113.636 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 t -153.94 148.19 25.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.321 1.049 . . . . 0.0 112.496 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -61.8 -24.73 67.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.184 0.994 . . . . 0.0 112.583 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.46 -35.92 68.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.545 1.138 . . . . 0.0 111.909 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.44 -51.42 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.954 0.902 . . . . 0.0 110.057 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.9 t -57.77 -38.41 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.351 1.06 . . . . 0.0 111.716 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -54.12 -45.75 72.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.021 0.928 . . . . 0.0 112.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -72.31 -43.36 64.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.828 0.74 . . . . 0.0 112.023 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.0 -43.33 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.057 0.844 . . . . 0.0 111.465 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.5 t -74.87 -33.64 62.12 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.083 1.353 . . . . 0.0 113.074 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -64.67 -42.05 95.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.44 107.62 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 169.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.69 -43.63 65.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.39 -1.444 . . . . 0.0 112.544 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -99.82 138.61 36.66 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.502 ' CD2' ' HG ' ' A' ' 181' ' ' CYS . 78.2 m-70 -138.88 136.51 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.993 1.717 . . . . 0.0 110.836 -173.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -103.15 130.6 50.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.089 0.956 . . . . 0.0 112.738 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.4 130.61 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.567 1.547 . . . . 0.0 109.285 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 52.33 37.14 21.56 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.33 1.052 . . . . 0.0 113.413 -175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 61.68 -5.47 0.14 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 127.946 2.498 . . . . 0.0 115.768 -170.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.43 167.33 20.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.697 2.399 . . . . 0.0 109.216 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 98.1 mtp -123.21 143.61 49.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.968 0.907 . . . . 0.0 112.909 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.78 164.54 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.226 2.61 . . . . 0.0 111.653 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -109.31 155.43 21.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.807 0.843 . . . . 0.0 110.826 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.502 ' HG ' ' CD2' ' A' ' 172' ' ' HIS . 14.4 p -141.85 154.67 45.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.285 0.634 . . . . 0.0 110.747 168.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -159.96 -175.36 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.749 1.22 . . . . 0.0 111.729 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -53.39 149.61 7.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.559 1.544 . . . . 0.0 114.637 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.06 155.48 42.24 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.698 1.999 . . . . 0.0 109.458 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.43 139.6 92.04 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.491 -0.766 . . . . 0.0 112.796 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.63 155.49 36.76 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.856 3.037 . . . . 0.0 116.53 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -140.81 30.4 1.86 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.052 2.141 . . . . 0.0 113.064 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -71.56 169.96 14.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.196 1.398 . . . . 0.0 113.284 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.38 142.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.527 1.531 . . . . 0.0 112.707 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 96.9 mtp -75.32 154.78 37.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.333 1.053 . . . . 0.0 112.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 42.5 t -157.48 133.43 6.0 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.09 1.356 . . . . 0.0 110.864 172.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.81 -10.72 9.33 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.464 2.776 . . . . 0.0 113.883 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.287 1.1 p -72.19 159.94 33.27 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 -174.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.61 175.41 41.32 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.347 1.451 . . . . 0.0 112.88 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.5 p -70.03 153.31 43.36 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.467 1.107 . . . . 0.0 113.788 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.29 161.47 41.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.887 1.675 . . . . 0.0 111.554 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -69.82 144.17 52.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.154 0.982 . . . . 0.0 112.237 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.01 -10.63 85.37 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.419 1.009 . . . . 0.0 115.431 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -148.7 143.95 26.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.28 1.832 . . . . 0.0 111.267 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.379 1.471 . . . . 0.0 113.285 177.333 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.3 p -137.94 11.62 2.87 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.714 1.606 . . . . 0.0 113.878 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -73.68 -20.1 60.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.979 1.711 . . . . 0.0 114.465 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -72.25 159.95 33.21 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -126.29 23.06 7.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.696 1.998 . . . . 0.0 110.917 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -148.55 155.3 40.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.222 -0.924 . . . . 0.0 112.542 -167.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.31 153.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.908 1.283 . . . . 0.0 113.137 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -93.71 145.55 24.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.274 2.23 . . . . 0.0 112.237 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.43 139.93 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.759 1.624 . . . . 0.0 110.213 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.77 147.72 17.45 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 118.785 0.72 . . . . 0.0 114.652 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.55 12.04 34.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.667 1.603 . . . . 0.0 114.323 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.49 136.57 55.87 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.121 1.368 . . . . 0.0 112.117 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -65.89 154.98 37.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.169 0.988 . . . . 0.0 112.139 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.96 -17.0 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.655 -0.653 . . . . 0.0 111.327 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -69.73 -30.07 67.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.243 1.017 . . . . 0.0 112.54 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -74.96 131.39 40.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.814 1.645 . . . . 0.0 114.884 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -97.54 167.75 10.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 115.318 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.55 -28.75 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.01 -35.91 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.632 0.773 . . . . 0.0 111.795 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.49 -45.15 94.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 169.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -61.01 -51.25 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.206 1.002 . . . . 0.0 109.232 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.23 -49.49 75.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.436 0.694 . . . . 0.0 112.063 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -60.47 -41.72 94.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.065 0.946 . . . . 0.0 112.554 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -66.48 -48.21 70.58 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.316 54.5 m-85 -65.46 -29.47 70.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.37 -20.91 61.28 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -69.14 -26.47 64.9 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.184 0.902 . . . . 0.0 112.635 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -77.62 -38.52 47.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.65 179.9 41.16 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.406 1.955 . . . . 0.0 111.208 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -64.66 121.82 15.4 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.2 132.54 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.683 1.993 . . . . 0.0 107.827 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.85 -55.96 5.12 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 113.18 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.69 169.54 21.35 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.18 0.992 . . . . 0.0 109.872 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.4 152.95 47.51 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.557 1.543 . . . . 0.0 111.842 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 48.9 mmm -149.2 158.26 44.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.501 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.6 mt -124.19 152.33 43.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.58 1.552 . . . . 0.0 111.581 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.09 101.68 7.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.104 0.962 . . . . 0.0 110.317 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.279 62.8 m-85 -82.07 130.17 35.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -83.15 103.68 12.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 108.167 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.27 -22.6 61.41 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -69.43 -25.59 64.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.356 0.2 OUTLIER -133.86 -4.35 2.84 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 176.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.2 t30 58.32 42.38 21.68 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.372 1.869 . . . . 0.0 113.229 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -118.83 148.71 42.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.555 1.942 . . . . 0.0 110.206 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -76.95 151.04 35.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.258 0.935 . . . . 0.0 112.539 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -81.96 7.32 13.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.19 10.54 71.21 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.773 1.177 . . . . 0.0 114.598 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.29 11.8 p90 -141.75 159.69 41.7 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.84 -162.43 23.17 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.99 0.805 . . . . 0.0 114.506 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.22 150.12 46.43 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.497 1.919 . . . . 0.0 113.891 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.4 t -133.72 128.14 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.921 1.288 . . . . 0.0 111.59 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.6 m -92.33 140.39 29.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.146 1.378 . . . . 0.0 113.067 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -122.53 152.65 40.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.056 2.142 . . . . 0.0 116.641 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -76.6 -29.13 56.42 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 t -135.83 129.95 33.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.187 0.995 . . . . 0.0 113.577 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 pm0 -62.88 -29.93 71.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.119 1.768 . . . . 0.0 112.791 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.57 -31.51 72.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.45 -46.41 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.766 0.826 . . . . 0.0 110.118 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.1 t -54.46 -43.5 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.265 1.026 . . . . 0.0 109.836 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.2 -53.13 61.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.0 0.92 . . . . 0.0 113.337 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -64.87 -43.0 94.39 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.22 0.918 . . . . 0.0 111.836 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.84 -42.12 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.777 0.717 . . . . 0.0 110.153 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.42 -31.38 68.56 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.87 -36.13 79.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.29 0.95 . . . . 0.0 112.892 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.9 136.13 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.985 0.914 . . . . 0.0 110.235 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.09 160.18 35.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.984 1.314 . . . . 0.0 111.67 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.477 5.3 m-85 63.34 46.79 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -62.29 134.92 57.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.374 1.869 . . . . 0.0 110.885 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -93.34 112.83 24.86 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.463 -0.773 . . . . 0.0 112.57 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.0 mt -132.62 120.34 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.556 0.742 . . . . 0.0 111.311 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 49.62 44.16 24.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.769 1.227 . . . . 0.0 113.109 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.4 m120 62.64 -8.04 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 128.076 2.55 . . . . 0.0 115.852 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -84.56 154.02 22.89 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.593 1.957 . . . . 0.0 109.471 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 57.5 mmm -99.64 139.91 34.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.175 0.59 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.37 160.44 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.815 1.646 . . . . 0.0 114.004 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -123.12 159.2 29.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.706 1.202 . . . . 0.0 111.482 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -144.99 159.18 43.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.245 1.018 . . . . 0.0 112.954 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -145.22 162.14 37.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.422 1.889 . . . . 0.0 111.037 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -58.64 145.82 38.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.673 0.789 . . . . 0.0 112.939 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.37 46.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.683 1.593 . . . . 0.0 110.012 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -70.49 144.53 91.73 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.195 -0.94 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.74 135.41 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.187 2.591 . . . . 0.0 112.275 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -76.84 -25.43 53.17 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.11 161.93 41.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.51 2.324 . . . . 0.0 110.895 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.05 143.36 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.967 1.307 . . . . 0.0 112.436 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -153.98 151.06 28.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.997 1.319 . . . . 0.0 111.077 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.4 t -151.07 123.32 4.02 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.871 1.268 . . . . 0.0 109.252 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.68 147.91 46.02 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.042 2.495 . . . . 0.0 112.705 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.2 p -72.32 -18.48 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 175.59 175.27 42.87 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.227 1.394 . . . . 0.0 113.193 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 46.5 t -159.0 -47.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.839 1.255 . . . . 0.0 112.155 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.3 153.26 41.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.212 1.005 . . . . 0.0 112.657 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 160.63 43.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 111.493 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.35 144.6 47.75 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.003 0.811 . . . . 0.0 113.622 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.47 142.24 48.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.904 1.282 . . . . 0.0 110.572 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.05 1.74 . . . . 0.0 113.696 176.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.9 m -69.35 140.31 54.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.031 0.932 . . . . 0.0 113.114 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -72.45 128.74 36.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.487 0.715 . . . . 0.0 112.5 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.19 58.7 1.73 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.441 1.896 . . . . 0.0 110.128 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -91.27 2.01 56.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.369 1.468 . . . . 0.0 112.151 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -133.73 167.51 20.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.457 1.903 . . . . 0.0 110.825 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 pt -140.88 148.74 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.709 1.204 . . . . 0.0 112.848 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -81.5 148.85 28.99 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.797 1.639 . . . . 0.0 111.189 164.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.35 135.2 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.533 1.533 . . . . 0.0 109.854 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.1 149.27 21.24 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.592 0.633 . . . . 0.0 114.674 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.86 9.03 55.06 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.535 1.54 . . . . 0.0 114.526 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.79 138.48 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.929 1.292 . . . . 0.0 112.018 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -65.23 152.09 44.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.508 0.723 . . . . 0.0 111.192 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 m -72.32 -14.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.579 -0.701 . . . . 0.0 111.696 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -70.43 -31.59 68.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.983 0.913 . . . . 0.0 112.199 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -73.83 141.0 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.794 1.638 . . . . 0.0 113.406 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -123.59 166.3 15.7 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.23 -31.21 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -65.84 -38.09 87.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.053 0.941 . . . . 0.0 112.334 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.8 -43.24 84.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.856 . . . . 0.0 109.547 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.47 -49.42 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.562 1.145 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -62.46 -46.4 88.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.575 0.625 . . . . 0.0 111.781 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -59.7 -42.25 92.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 112.368 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -66.03 -49.47 67.6 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.299 42.5 m-85 -62.93 -27.67 69.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.62 -16.44 48.4 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -65.41 -31.55 72.71 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.51 -35.71 58.18 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.9 175.51 36.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.117 2.294 . . . . 0.0 110.553 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -63.3 133.3 53.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.3 t -112.34 122.54 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.492 1.917 . . . . 0.0 109.492 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -77.31 -45.2 26.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.235 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.83 159.46 41.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.608 1.963 . . . . 0.0 115.18 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.68 152.33 40.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.084 1.354 . . . . 0.0 110.762 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.3 ptp -157.78 147.57 20.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.505 1.122 . . . . 0.0 112.19 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.6 mt -126.93 153.27 46.03 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.593 1.557 . . . . 0.0 111.593 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.5 mmm -78.37 67.67 4.21 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 112.641 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -59.24 141.0 55.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -133.84 114.77 13.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 113.985 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -62.5 -19.1 63.25 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -22.16 65.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 171.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -133.3 -9.05 2.94 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.17 26.04 15.62 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.747 2.019 . . . . 0.0 114.746 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -148.58 175.93 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.187 1.795 . . . . 0.0 110.282 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -86.24 156.55 20.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.471 0.653 . . . . 0.0 112.544 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -74.53 6.3 3.91 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.06 13.5 58.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.023 1.297 . . . . 0.0 114.862 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 16.0 p90 -145.69 161.1 40.67 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.32 -160.38 23.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.216 0.912 . . . . 0.0 114.72 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -136.9 151.97 49.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.245 1.818 . . . . 0.0 114.342 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.15 131.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.505 1.522 . . . . 0.0 111.042 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.8 m -99.06 126.42 44.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.037 1.735 . . . . 0.0 113.243 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -104.2 154.09 20.18 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -74.41 -18.46 60.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.5 t -153.04 141.14 20.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.327 1.051 . . . . 0.0 113.11 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -62.87 -27.4 69.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 112.817 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.34 -28.11 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.47 -48.7 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.765 0.826 . . . . 0.0 110.102 170.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.05 -40.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.065 1.346 . . . . 0.0 110.554 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -56.93 -43.7 81.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.041 0.837 . . . . 0.0 113.134 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -70.63 -43.18 69.76 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.109 0.868 . . . . 0.0 111.994 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.45 -37.54 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.717 0.69 . . . . 0.0 111.477 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 50.4 t -73.6 -41.56 62.69 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 113.092 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -62.43 -38.37 89.48 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.219 -0.925 . . . . 0.0 112.491 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.69 106.5 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -65.53 -55.63 16.74 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.158 -0.963 . . . . 0.0 111.671 -174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.361 63.9 m-85 -103.27 137.0 41.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -131.47 159.66 37.43 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.081 2.553 . . . . 0.0 109.655 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -126.66 125.24 41.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.629 1.104 . . . . 0.0 113.533 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.37 125.75 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.325 1.45 . . . . 0.0 109.757 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 50.17 40.19 21.37 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.237 1.015 . . . . 0.0 112.871 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.05 -8.61 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.308 2.643 . . . . 0.0 116.32 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -79.44 140.64 37.31 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.834 1.654 . . . . 0.0 109.232 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 39.5 mtm -92.33 147.78 22.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 m -138.24 153.49 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.769 2.428 . . . . 0.0 111.533 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.35 150.31 28.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.631 0.773 . . . . 0.0 111.293 170.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.26 142.91 31.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.827 0.851 . . . . 0.0 112.906 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -144.51 156.42 44.16 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.023 1.329 . . . . 0.0 111.626 -168.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -54.9 141.49 33.22 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.91 146.99 41.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.917 1.687 . . . . 0.0 111.59 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.09 133.49 28.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.052 0.941 . . . . 0.0 113.528 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -68.92 165.56 29.52 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.996 3.131 . . . . 0.0 114.233 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.27 -9.43 55.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -156.19 163.53 39.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.936 1.694 . . . . 0.0 112.578 -176.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.5 139.92 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.619 1.167 . . . . 0.0 112.465 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 73.2 mtp -137.44 129.73 29.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.495 1.518 . . . . 0.0 110.095 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.3 t -164.0 126.45 1.61 Allowed Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.988 0.915 . . . . 0.0 110.654 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.78 146.55 33.78 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.905 2.403 . . . . 0.0 112.115 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -152.37 166.3 32.31 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.03 -170.01 54.77 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.102 1.334 . . . . 0.0 114.716 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 t -155.28 173.69 16.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.825 1.65 . . . . 0.0 110.984 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.46 169.13 7.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.025 1.73 . . . . 0.0 114.113 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.82 160.71 38.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.586 1.555 . . . . 0.0 111.545 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 87.33 166.9 43.06 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.113 1.34 . . . . 0.0 114.32 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.83 129.5 39.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.376 1.471 . . . . 0.0 110.343 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.647 1.579 . . . . 0.0 112.769 178.732 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -139.61 160.62 39.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.224 1.41 . . . . 0.0 112.196 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.07 151.71 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.907 1.283 . . . . 0.0 112.675 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.57 149.78 25.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.044 1.738 . . . . 0.0 112.519 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.24 138.22 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.417 1.487 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.56 15.0 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.033 0.773 . . . . 0.0 115.033 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.02 14.13 25.45 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.749 1.642 . . . . 0.0 114.397 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.6 139.25 57.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.37 1.468 . . . . 0.0 112.325 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.87 151.67 44.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.72 0.808 . . . . 0.0 111.165 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 t -68.37 -20.67 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.553 -0.717 . . . . 0.0 111.346 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -68.07 -28.94 67.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.528 1.131 . . . . 0.0 113.214 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 60.1 m -79.36 132.77 36.52 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.542 1.537 . . . . 0.0 112.827 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.69 165.9 13.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.17 -31.59 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -74.21 -33.47 63.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.38 0.672 . . . . 0.0 111.735 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.55 -47.98 83.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.099 0.56 . . . . 0.0 112.14 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.94 -45.47 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.106 0.562 . . . . 0.0 110.725 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -42.54 91.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.094 0.558 . . . . 0.0 111.813 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.71 -53.58 32.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.526 1.131 . . . . 0.0 112.774 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -59.2 -34.57 72.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 117.633 2.456 . . . . 0.0 117.633 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.32 38.0 m-85 -70.75 -15.8 62.71 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 173.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.42 -10.97 58.86 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -62.52 -25.6 68.11 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.159 -0.963 . . . . 0.0 113.59 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.77 -30.51 18.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.399 1.08 . . . . 0.0 113.284 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 177.83 36.74 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.97 2.224 . . . . 0.0 110.765 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -61.89 124.96 22.21 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.996 . . . . 0.0 112.375 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.3 t -95.87 125.24 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.753 1.621 . . . . 0.0 107.019 168.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.64 -41.03 19.95 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.835 -0.541 . . . . 0.0 109.688 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -162.69 165.72 25.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.317 2.247 . . . . 0.0 114.987 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.66 154.25 45.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.169 1.388 . . . . 0.0 110.748 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.1 mtp -148.95 152.96 37.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.655 1.582 . . . . 0.0 111.462 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -125.85 150.97 47.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.321 1.448 . . . . 0.0 111.742 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.601 0.76 . . . . 0.0 111.386 179.519 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.7 p80 . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.242 0.544 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -80.64 8.81 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.17 11.59 69.37 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.631 1.11 . . . . 0.0 114.503 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.273 12.3 p90 -144.56 158.75 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.93 -158.22 18.38 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.187 0.899 . . . . 0.0 114.739 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -139.78 151.36 45.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.953 2.101 . . . . 0.0 114.18 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.6 129.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.125 1.37 . . . . 0.0 111.804 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.0 m -94.44 128.89 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.28 1.832 . . . . 0.0 113.045 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -104.98 150.31 25.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.14 -35.7 81.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 113.048 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.1 t -147.45 141.22 25.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.667 1.187 . . . . 0.0 112.652 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.35 -26.25 68.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.292 1.437 . . . . 0.0 113.474 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.9 -27.43 66.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.6 mm -77.74 -50.1 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.777 0.831 . . . . 0.0 109.89 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 66.9 t -54.84 -35.12 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.155 1.382 . . . . 0.0 111.576 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -48.91 -51.05 32.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -70.36 -44.18 68.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.555 0.616 . . . . 0.0 111.606 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.25 -47.18 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 18.9 t -74.51 -29.58 61.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.558 1.143 . . . . 0.0 112.53 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.52 -41.4 93.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.947 -1.096 . . . . 0.0 112.047 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.75 119.85 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -68.39 -59.14 3.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.993 -1.067 . . . . 0.0 111.36 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.302 61.3 m-85 -101.81 139.18 37.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -176.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -135.79 135.53 39.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.554 1.942 . . . . 0.0 110.819 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -80.85 135.84 36.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.309 0.644 . . . . 0.0 111.904 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.7 mt -144.89 122.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.732 2.013 . . . . 0.0 108.383 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 50.48 38.65 18.94 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.3 t30 62.78 -12.5 0.07 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 128.112 2.565 . . . . 0.0 115.942 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -73.36 141.81 47.04 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.307 -1.495 . . . . 0.0 108.594 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 51.8 mtm -94.32 142.45 27.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.078 0.854 . . . . 0.0 112.346 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.67 153.35 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.325 2.25 . . . . 0.0 111.311 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.44 157.06 16.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 112.106 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.7 p -133.93 157.27 46.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.537 0.735 . . . . 0.0 112.063 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -145.9 171.59 14.59 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.981 1.712 . . . . 0.0 111.327 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -61.07 149.51 36.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.124 0.97 . . . . 0.0 113.217 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 125.137 1.375 . . . . 0.0 111.275 172.571 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -133.22 159.31 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.547 1.139 . . . . 0.0 112.865 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.94 152.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 112.861 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -86.44 148.71 25.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 112.317 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.5 135.88 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.428 1.491 . . . . 0.0 109.421 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.41 146.71 15.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.97 10.29 32.66 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.828 1.68 . . . . 0.0 114.287 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.06 141.09 58.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.342 1.457 . . . . 0.0 112.321 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -68.81 156.77 37.77 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.791 0.836 . . . . 0.0 112.588 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.38 -27.72 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.649 0.78 . . . . 0.0 110.067 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -64.91 -31.84 73.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.972 0.909 . . . . 0.0 112.696 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 135.53 50.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.015 1.326 . . . . 0.0 113.426 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.88 166.64 13.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.177 1.391 . . . . 0.0 114.635 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.74 -32.75 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -34.84 78.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.85 0.86 . . . . 0.0 112.744 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -67.18 -45.37 77.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.698 0.799 . . . . 0.0 109.853 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.85 -48.08 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.702 1.201 . . . . 0.0 110.428 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -62.53 -47.33 84.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 111.93 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.13 -40.98 87.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.747 0.819 . . . . 0.0 112.419 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -65.89 -51.55 57.72 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 46.9 m-85 -64.17 -25.85 68.26 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -60.74 -17.51 49.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.21 -29.47 70.28 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.369 -0.832 . . . . 0.0 113.058 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.53 -36.19 38.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.5 33.43 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.219 2.342 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.81 124.64 21.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.349 1.074 . . . . 0.0 112.723 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.46 118.45 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.251 1.42 . . . . 0.0 108.637 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.19 -31.6 43.89 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -162.05 160.4 27.46 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.938 1.295 . . . . 0.0 109.516 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.87 152.29 31.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.15 1.38 . . . . 0.0 111.093 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -156.77 156.05 32.64 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.377 1.071 . . . . 0.0 112.323 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.03 149.54 44.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.619 1.568 . . . . 0.0 110.391 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 70.3 mtp . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 112.201 -176.689 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 p80 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.364 0.602 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.06 8.76 2.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.49 13.9 66.93 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.855 1.217 . . . . 0.0 114.329 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.269 8.9 p90 -146.49 160.09 42.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.16 -162.15 21.94 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.221 0.915 . . . . 0.0 114.797 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -138.24 147.3 43.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.88 2.072 . . . . 0.0 114.447 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.71 125.47 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 111.159 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 m -96.42 123.3 40.03 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 111.739 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.29 152.59 18.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -67.67 -34.16 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.541 -0.724 . . . . 0.0 112.399 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.5 t -142.87 137.73 29.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.464 1.126 . . . . 0.0 113.845 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -56.3 -27.36 55.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.117 2.167 . . . . 0.0 112.972 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.92 -28.38 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.72 -48.62 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.893 0.877 . . . . 0.0 109.786 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.02 -38.98 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.075 1.35 . . . . 0.0 110.998 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.62 -34.34 67.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.93 -48.36 14.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.02 0.827 . . . . 0.0 111.713 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.89 -44.73 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.964 0.802 . . . . 0.0 112.558 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.12 -21.45 58.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.011 1.324 . . . . 0.0 112.907 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -78.02 -34.68 50.52 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.946 -1.096 . . . . 0.0 112.396 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.56 139.94 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.691 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -127.08 156.69 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 0.0 113.108 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.466 24.9 m-85 60.31 49.27 7.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -58.86 133.47 56.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.858 2.063 . . . . 0.0 110.993 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -98.66 126.51 44.29 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.287 0.948 . . . . 0.0 113.155 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 mt -142.57 123.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.951 1.7 . . . . 0.0 109.392 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 50.36 41.54 24.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.39 1.076 . . . . 0.0 113.55 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 64.89 -13.41 0.11 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 127.822 2.449 . . . . 0.0 116.002 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -73.9 155.43 38.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.069 1.748 . . . . 0.0 109.283 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.4 ptm -120.77 136.06 54.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.874 0.87 . . . . 0.0 111.188 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.77 143.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.808 1.643 . . . . 0.0 113.602 -169.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -87.02 159.24 19.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.268 0.556 . . . . 0.0 111.353 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.5 p -138.13 155.96 48.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.122 0.969 . . . . 0.0 111.583 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -146.15 167.73 22.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.682 1.593 . . . . 0.0 110.865 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -58.9 151.47 21.62 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.591 -0.693 . . . . 0.0 112.248 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 125.283 1.433 . . . . 0.0 110.138 173.905 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.591 0.71 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -149.29 154.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.612 1.165 . . . . 0.0 110.641 -171.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.51 150.77 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.361 1.064 . . . . 0.0 112.884 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.44 145.51 25.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.367 1.867 . . . . 0.0 111.912 166.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.21 137.83 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.614 1.566 . . . . 0.0 110.117 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.28 147.18 17.07 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 114.688 0.635 . . . . 0.0 114.688 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.96 13.21 29.9 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.693 1.616 . . . . 0.0 114.649 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.54 137.95 58.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.729 1.264 . . . . 0.0 112.205 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -64.72 156.43 30.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.714 1.206 . . . . 0.0 112.821 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 m -71.86 -16.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.252 0.621 . . . . 0.0 111.349 168.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.02 -38.12 85.37 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 111.739 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.15 146.97 54.28 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 t -133.2 166.45 22.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.388 1.875 . . . . 0.0 112.76 169.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.73 -33.33 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.0 -39.89 87.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.436 0.694 . . . . 0.0 112.149 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.9 -43.52 95.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.77 -47.2 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.204 0.602 . . . . 0.0 110.467 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.77 -48.19 82.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.591 0.632 . . . . 0.0 111.803 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -60.8 -39.03 87.38 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -68.3 -40.74 81.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.323 52.8 m-85 -71.32 -29.82 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.44 -18.1 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -65.71 -24.9 67.09 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.295 -0.878 . . . . 0.0 112.884 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.27 -29.32 26.54 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.94 178.87 36.21 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.57 2.033 . . . . 0.0 110.921 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.86 116.3 6.21 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.654 -0.91 . . . . 0.0 112.549 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.65 130.68 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.844 1.658 . . . . 0.0 107.146 169.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.38 -54.07 7.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.673 0.789 . . . . 0.0 112.918 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.84 165.94 29.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.528 1.131 . . . . 0.0 110.003 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.93 149.8 37.38 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.588 1.555 . . . . 0.0 111.647 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.9 mtp -148.41 152.17 36.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.555 1.542 . . . . 0.0 111.713 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.8 mt -125.88 154.11 43.2 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.04 1.336 . . . . 0.0 111.92 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 123.642 0.777 . . . . 0.0 110.664 178.869 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 p80 . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.508 0.67 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -73.73 0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.691 1.996 . . . . 0.0 115.603 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.19 9.01 65.91 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.714 1.15 . . . . 0.0 113.88 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 17.6 p90 -144.99 158.82 43.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.74 -158.66 19.36 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.228 0.918 . . . . 0.0 114.693 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.69 148.95 47.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.605 1.962 . . . . 0.0 114.02 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 t -133.81 132.0 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.132 1.373 . . . . 0.0 111.38 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.8 m -98.52 139.83 33.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.353 1.861 . . . . 0.0 113.954 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.56 154.96 34.66 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.49 -32.58 70.15 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -150.02 146.55 27.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.44 1.096 . . . . 0.0 113.14 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.15 -28.43 69.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.809 1.244 . . . . 0.0 112.613 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.57 -31.79 71.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.9 mm -76.86 -46.12 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.711 0.804 . . . . 0.0 110.152 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.38 -41.13 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.688 1.195 . . . . 0.0 110.252 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -57.72 -49.93 74.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.038 0.836 . . . . 0.0 113.137 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.53 -44.78 81.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.764 0.711 . . . . 0.0 111.779 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.15 -45.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.534 0.607 . . . . 0.0 110.138 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.5 t -67.83 -36.19 79.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.391 1.077 . . . . 0.0 112.745 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -66.68 -41.03 88.77 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.13 -0.981 . . . . 0.0 112.657 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mt -67.01 134.42 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.682 0.793 . . . . 0.0 110.496 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -112.12 148.64 33.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.128 1.371 . . . . 0.0 111.586 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.49 29.3 m-85 57.16 57.02 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -175.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -63.59 128.92 38.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.471 1.508 . . . . 0.0 111.405 173.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.06 133.46 36.12 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.84 0.745 . . . . 0.0 112.264 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.4 mt -146.34 124.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.974 2.11 . . . . 0.0 108.235 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.6 m120 50.98 43.23 28.94 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.175 0.99 . . . . 0.0 113.167 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.78 -13.99 0.08 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.262 2.625 . . . . 0.0 116.485 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.08 169.97 17.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.819 2.047 . . . . 0.0 109.28 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.2 ptp -127.33 146.11 50.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.852 0.861 . . . . 0.0 113.193 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.38 164.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.935 2.494 . . . . 0.0 112.894 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -128.25 158.38 38.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.504 0.722 . . . . 0.0 111.893 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.53 157.42 44.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 113.37 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -142.27 159.07 42.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.167 1.787 . . . . 0.0 111.256 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.15 144.5 45.62 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.577 0.626 . . . . 0.0 112.542 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 C-N-CA 125.346 1.458 . . . . 0.0 111.07 178.496 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 pttp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 122.121 0.962 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -136.4 155.99 49.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.755 1.622 . . . . 0.0 112.485 -168.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.43 ' CG2' HG13 ' A' ' 163' ' ' VAL . 7.5 pt -136.26 157.52 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.571 1.549 . . . . 0.0 113.379 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -94.09 147.34 23.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.173 2.189 . . . . 0.0 113.29 167.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.4 t -137.31 138.93 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.727 1.611 . . . . 0.0 110.061 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.77 154.16 25.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.704 0.669 . . . . 0.0 114.414 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.12 15.02 31.83 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.379 1.466 . . . . 0.0 114.596 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.66 143.03 58.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.004 1.322 . . . . 0.0 112.493 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 p -76.51 175.5 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.453 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 m -81.61 -24.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 0.0 112.684 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -77.32 -33.3 55.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.194 0.998 . . . . 0.0 111.663 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.8 m -65.44 143.97 57.35 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.246 1.418 . . . . 0.0 113.356 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 t -142.72 173.42 11.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.26 1.824 . . . . 0.0 112.715 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.52 -34.15 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.58 -38.67 84.39 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.879 0.872 . . . . 0.0 112.165 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.64 -43.24 85.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.1 t -58.66 -46.88 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.388 0.675 . . . . 0.0 109.867 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -60.57 -46.94 88.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.427 0.558 . . . . 0.0 111.887 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -61.43 -45.09 95.76 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -66.61 -38.75 87.63 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.333 46.7 m-85 -71.62 -29.84 65.12 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.91 -18.93 48.64 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -66.17 -24.96 66.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.494 0.718 . . . . 0.0 112.746 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.67 -34.86 30.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.43 169.54 28.13 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.059 2.266 . . . . 0.0 110.466 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -57.49 130.42 46.23 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.953 0.901 . . . . 0.0 112.768 -170.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.81 122.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.465 1.506 . . . . 0.0 108.249 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.08 -40.02 63.05 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -156.52 154.84 30.97 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.062 2.145 . . . . 0.0 114.646 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.38 142.72 30.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.359 1.064 . . . . 0.0 110.7 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.2 mtm -150.38 151.83 33.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.499 1.52 . . . . 0.0 111.649 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.98 156.86 31.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.173 1.389 . . . . 0.0 111.694 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.4 tpp . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.752 0.821 . . . . 0.0 110.205 170.793 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.1 p80 . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -86.37 8.23 22.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.85 6.37 67.41 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.136 1.35 . . . . 0.0 115.035 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -146.38 162.77 37.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.03 -158.14 20.24 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.186 0.898 . . . . 0.0 114.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -135.97 151.06 49.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.28 1.832 . . . . 0.0 114.547 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -135.42 123.74 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.151 1.38 . . . . 0.0 111.468 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 m -87.79 129.04 35.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.163 1.385 . . . . 0.0 113.125 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.86 160.26 14.44 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -62.24 -39.69 93.7 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.418 -0.801 . . . . 0.0 112.038 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.2 t -149.21 148.57 29.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.728 1.211 . . . . 0.0 113.592 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -57.83 -27.5 63.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 112.674 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.82 -21.86 66.22 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.46 -50.38 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.739 0.816 . . . . 0.0 109.819 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.43 HG13 ' CG2' ' A' ' 111' ' ' ILE . 38.8 t -52.94 -38.67 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.281 1.433 . . . . 0.0 111.275 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -60.33 -43.17 96.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -68.29 -37.76 80.98 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.666 0.667 . . . . 0.0 111.552 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.67 -37.74 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.482 0.583 . . . . 0.0 110.996 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 85.6 m -77.65 -28.85 51.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.243 1.417 . . . . 0.0 114.585 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -69.06 -38.41 79.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.048 0.84 . . . . 0.0 112.939 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.8 mt -74.61 140.86 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.796 0.838 . . . . 0.0 109.94 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -130.44 164.04 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.478 1.111 . . . . 0.0 112.666 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.331 57.5 m-85 60.87 40.67 15.43 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -57.39 131.87 51.4 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 111.584 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.22 128.97 34.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.368 -0.833 . . . . 0.0 112.27 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.26 120.86 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.358 1.863 . . . . 0.0 108.812 172.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 50.58 40.6 24.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.844 0.858 . . . . 0.0 113.04 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 63.25 -12.97 0.08 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 128.203 2.601 . . . . 0.0 116.421 -171.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -74.02 142.91 45.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.829 1.652 . . . . 0.0 109.052 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 34.3 mtt -89.06 141.0 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.244 -0.91 . . . . 0.0 112.487 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.3 159.49 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.297 2.239 . . . . 0.0 111.916 173.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.83 154.64 44.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 110.166 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.4 p -140.31 159.62 41.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.027 0.931 . . . . 0.0 113.292 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -141.48 158.94 43.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.735 1.614 . . . . 0.0 110.653 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -62.4 140.19 58.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.707 1.603 . . . . 0.0 110.71 170.153 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 49.7 pttt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.829 1.299 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -137.18 151.95 49.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.407 1.883 . . . . 0.0 111.325 -167.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -134.01 153.76 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.658 1.183 . . . . 0.0 113.285 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -88.93 146.47 24.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.613 1.965 . . . . 0.0 112.747 166.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.48 132.87 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.694 1.598 . . . . 0.0 109.769 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.04 145.91 14.52 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 114.623 0.609 . . . . 0.0 114.623 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.09 11.37 32.19 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.633 1.587 . . . . 0.0 114.436 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.75 138.44 58.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.196 1.398 . . . . 0.0 111.947 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -69.4 156.93 38.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.507 1.123 . . . . 0.0 112.447 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.36 -16.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.618 -0.676 . . . . 0.0 111.62 168.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -73.47 -7.57 52.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.604 1.562 . . . . 0.0 114.238 169.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER -92.02 151.67 20.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -139.64 161.31 37.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.887 1.275 . . . . 0.0 113.953 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.39 -33.23 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -68.37 -38.85 81.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.541 0.736 . . . . 0.0 112.318 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -67.44 -38.86 85.18 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.55 -51.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.398 1.079 . . . . 0.0 109.322 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.78 -43.56 98.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.008 0.822 . . . . 0.0 112.352 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -59.89 -39.29 84.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.752 0.821 . . . . 0.0 112.665 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -66.79 -48.37 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.313 55.6 m-85 -64.16 -29.97 71.06 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -57.37 -22.64 44.04 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.476 1.51 . . . . 0.0 114.65 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.66 -24.85 62.77 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.192 -0.943 . . . . 0.0 112.761 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -79.25 -37.91 36.83 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.58 172.04 35.03 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.593 2.044 . . . . 0.0 110.895 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.07 130.76 48.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.766 0.783 . . . . 0.0 112.579 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.4 t -99.12 131.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.138 1.775 . . . . 0.0 108.493 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -79.12 -54.14 6.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.82 0.848 . . . . 0.0 112.952 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -152.86 157.27 40.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.019 1.327 . . . . 0.0 110.57 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.4 141.08 23.52 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.022 1.329 . . . . 0.0 110.915 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 54.5 mmm -149.85 153.21 36.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.666 1.586 . . . . 0.0 112.341 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.38 152.98 39.63 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.423 1.489 . . . . 0.0 110.648 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.47 0.542 0 O-C-N 121.894 -0.503 . . . . 0.0 110.36 176.242 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 121.529 0.681 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -79.26 5.52 12.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.294 1.838 . . . . 0.0 114.643 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.34 6.11 63.08 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.468 1.509 . . . . 0.0 114.334 -170.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.255 10.9 p90 -147.69 157.0 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.67 -162.3 22.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.507 1.051 . . . . 0.0 114.63 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -138.54 148.62 44.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.338 1.855 . . . . 0.0 114.112 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.34 124.3 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.138 1.375 . . . . 0.0 111.64 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 135.7 33.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.504 1.522 . . . . 0.0 113.741 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.19 156.0 20.39 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.14 -28.87 65.71 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.2 t -150.39 141.52 23.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.57 1.148 . . . . 0.0 112.89 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -59.63 -26.56 65.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 113.234 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.59 -29.33 69.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.3 mm -78.24 -46.36 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.771 0.828 . . . . 0.0 110.074 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.23 -43.09 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.965 1.306 . . . . 0.0 110.522 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.9 -46.36 65.6 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.64 -0.662 . . . . 0.0 112.076 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.65 -37.24 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.042 0.837 . . . . 0.0 111.638 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.83 -35.1 67.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.887 1.275 . . . . 0.0 112.765 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -68.8 -37.95 79.61 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.208 -0.932 . . . . 0.0 112.661 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.19 139.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 110.636 174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -129.88 161.97 29.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.399 1.48 . . . . 0.0 111.426 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.44 8.1 m-30 64.46 46.07 3.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -68.13 122.42 18.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.974 2.11 . . . . 0.0 111.056 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -86.93 121.34 29.27 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.545 1.066 . . . . 0.0 113.467 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.5 mt -143.21 124.74 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.277 1.431 . . . . 0.0 109.6 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 48.04 49.84 16.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.33 1.452 . . . . 0.0 113.02 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 64.92 -12.32 0.13 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.905 2.882 . . . . 0.0 116.575 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -86.08 165.37 16.68 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.361 2.264 . . . . 0.0 110.304 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 44.5 mtm -122.09 143.13 49.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.639 0.775 . . . . 0.0 112.485 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.72 163.58 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.912 2.085 . . . . 0.0 113.642 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -115.18 148.75 38.67 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.138 1.375 . . . . 0.0 111.896 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 81.2 m -120.57 152.35 38.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.857 1.263 . . . . 0.0 112.508 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.92 158.24 43.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.579 1.552 . . . . 0.0 111.2 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.662 -0.649 . . . . 0.0 111.002 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.68 . . . . 0.0 110.571 174.458 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.68 0.752 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -152.82 146.36 24.98 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.442 1.497 . . . . 0.0 111.031 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.2 pt -138.21 149.66 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -83.32 147.89 27.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.411 1.885 . . . . 0.0 111.724 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.35 136.5 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.266 1.426 . . . . 0.0 109.584 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.37 147.76 18.25 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.52 39.27 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.706 1.622 . . . . 0.0 114.552 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.4 mt -65.01 139.88 58.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 112.494 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 t -64.76 156.8 29.36 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.575 1.15 . . . . 0.0 112.4 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.91 -25.28 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.899 0.88 . . . . 0.0 109.504 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.741 0.816 . . . . 0.0 112.592 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -75.23 125.51 29.1 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.52 1.528 . . . . 0.0 115.095 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -91.91 167.82 11.85 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.95 -29.71 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.23 -38.3 63.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.313 0.645 . . . . 0.0 111.537 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.28 -44.93 92.44 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.31 -50.81 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.37 1.068 . . . . 0.0 109.115 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -62.01 -45.86 91.74 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.842 0.746 . . . . 0.0 111.88 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.62 -42.38 98.81 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.97 0.908 . . . . 0.0 112.592 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -63.55 -48.63 76.67 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.305 52.0 m-85 -65.29 -30.54 71.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -61.6 -19.12 61.87 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 172.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -68.59 -24.64 64.61 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.143 0.883 . . . . 0.0 112.712 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -80.86 -38.22 28.52 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.98 0.912 . . . . 0.0 113.012 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 170.37 30.82 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.904 2.192 . . . . 0.0 110.981 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -169.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.32 120.36 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 109.109 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.92 -42.44 69.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.829 1.252 . . . . 0.0 114.24 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -155.94 155.25 32.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.074 2.15 . . . . 0.0 114.874 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.65 141.7 27.14 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.426 1.09 . . . . 0.0 110.692 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.1 mtm -151.0 146.12 26.01 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.343 1.457 . . . . 0.0 111.713 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.9 mt -125.15 156.15 38.81 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.268 1.427 . . . . 0.0 111.49 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.471 0.586 0 C-N-CA 124.155 0.982 . . . . 0.0 113.01 -175.839 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.784 0.802 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -75.7 3.96 8.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.973 1.709 . . . . 0.0 115.138 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.16 12.06 59.21 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.243 1.401 . . . . 0.0 114.804 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -147.58 159.88 43.26 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.85 -156.16 15.78 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 114.957 0.743 . . . . 0.0 114.957 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -134.47 147.12 50.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.612 1.965 . . . . 0.0 115.202 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.48 126.47 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.63 1.572 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.1 m -99.69 130.39 45.91 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.307 1.443 . . . . 0.0 112.693 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.6 152.72 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -67.17 -33.49 75.52 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.4 t -148.06 143.88 27.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.608 1.163 . . . . 0.0 113.035 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -58.51 -26.67 63.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 113.143 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -58.7 -27.94 65.32 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.33 -50.51 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.47 0.708 . . . . 0.0 110.163 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.12 -37.3 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.855 1.262 . . . . 0.0 112.492 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -55.07 -38.17 67.71 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.79 -48.05 27.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.765 0.711 . . . . 0.0 111.721 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.45 -44.52 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 118.739 0.7 . . . . 0.0 112.651 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 25.1 t -73.26 -29.84 63.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.659 1.184 . . . . 0.0 112.427 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -70.34 -38.03 74.76 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.077 -1.014 . . . . 0.0 112.677 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.3 mt -66.06 139.57 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.752 0.821 . . . . 0.0 110.577 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -125.54 149.9 47.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.353 1.461 . . . . 0.0 111.104 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.458 24.6 m-85 58.31 53.3 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -59.0 124.72 20.85 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.803 2.041 . . . . 0.0 111.423 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -93.6 124.22 37.45 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.3 mt -143.53 125.65 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.548 1.539 . . . . 0.0 109.324 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 49.73 42.7 23.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.398 1.079 . . . . 0.0 113.443 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 63.06 -11.05 0.09 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 128.212 2.605 . . . . 0.0 116.236 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -77.9 161.52 27.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.149 1.78 . . . . 0.0 109.336 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.1 ptp -122.32 144.33 49.07 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.8 164.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.678 2.391 . . . . 0.0 112.949 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -133.66 160.79 36.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.664 0.786 . . . . 0.0 112.278 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.46 157.6 45.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 0.0 113.679 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -144.07 162.82 35.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.666 1.986 . . . . 0.0 110.646 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -63.46 152.15 39.18 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.402 1.001 . . . . 0.0 111.621 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.765 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -142.07 154.4 44.91 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.901 -1.125 . . . . 0.0 112.464 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.42 154.32 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 113.425 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -91.61 146.2 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.361 2.264 . . . . 0.0 112.768 167.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.29 135.98 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.354 1.462 . . . . 0.0 109.595 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.74 154.64 25.84 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.785 0.707 . . . . 0.0 114.256 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.59 16.05 41.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.675 1.131 . . . . 0.0 114.0 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -67.2 159.47 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.228 . . . . 0.0 111.314 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.6 p -128.92 -168.8 1.98 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.332 1.053 . . . . 0.0 111.847 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.7 m -75.82 -15.44 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.127 0.971 . . . . 0.0 112.622 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -75.55 -32.34 60.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.261 0.2 OUTLIER -77.32 145.04 37.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.7 t -140.58 158.21 44.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.123 1.369 . . . . 0.0 113.73 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.37 -34.56 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -67.54 -39.37 85.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.445 0.698 . . . . 0.0 111.836 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.65 -34.99 67.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.18 -50.15 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.776 0.83 . . . . 0.0 109.318 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.86 -49.37 77.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.592 0.633 . . . . 0.0 111.501 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -59.07 -40.83 86.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.854 0.862 . . . . 0.0 112.803 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -65.71 -49.0 70.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 50.7 m-85 -64.58 -29.14 70.15 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -59.44 -22.76 61.96 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.23 -26.04 64.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.21 0.913 . . . . 0.0 112.953 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.68 -35.8 57.69 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.34 168.33 30.27 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.506 2.479 . . . . 0.0 109.992 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -65.58 125.12 24.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.363 1.082 . . . . 0.0 113.003 -168.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.37 133.86 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.629 1.972 . . . . 0.0 107.629 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -70.2 -52.12 25.73 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -163.99 161.28 22.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.389 2.276 . . . . 0.0 114.101 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -131.81 150.81 52.04 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.96 1.304 . . . . 0.0 110.18 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 91.3 mtp -148.36 152.42 37.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.964 1.305 . . . . 0.0 111.907 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.3 mt -122.41 133.2 54.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.753 1.621 . . . . 0.0 109.286 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 122.097 0.951 . . . . 0.0 112.077 -176.176 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.1 p80 . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -97.43 21.96 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.308 1.443 . . . . 0.0 114.56 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.12 14.47 62.37 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.914 1.245 . . . . 0.0 114.45 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.293 4.8 p90 -146.82 158.18 43.85 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.38 -160.27 17.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.108 1.337 . . . . 0.0 114.009 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -138.88 152.22 47.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.433 1.893 . . . . 0.0 114.914 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -135.94 126.36 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.352 1.461 . . . . 0.0 112.048 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.2 m -94.18 127.73 40.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 112.022 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -106.73 151.46 25.1 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -71.55 -36.33 70.94 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 t -135.47 137.98 42.7 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.449 1.1 . . . . 0.0 113.438 -171.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -65.32 -30.64 71.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.828 1.251 . . . . 0.0 112.597 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -60.41 -30.26 69.49 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.28 -47.9 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.817 0.847 . . . . 0.0 110.256 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 24.7 t -56.28 -42.47 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.636 1.174 . . . . 0.0 110.327 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.28 -50.8 72.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.743 0.701 . . . . 0.0 112.458 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -66.59 -45.03 80.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.273 0.942 . . . . 0.0 112.145 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.84 -40.62 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.221 0.919 . . . . 0.0 110.66 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.7 t -74.41 -31.32 62.28 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.148 0.979 . . . . 0.0 113.253 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -66.29 -37.41 85.35 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.777 -1.202 . . . . 0.0 113.246 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.1 mt -72.45 136.32 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.859 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.88 158.66 37.19 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.45 1.1 . . . . 0.0 112.701 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.525 22.3 m-85 60.43 45.27 11.11 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -56.36 153.94 8.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.949 1.7 . . . . 0.0 110.825 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -132.62 133.95 44.27 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.971 -1.081 . . . . 0.0 113.294 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . 0.272 4.5 mt -121.52 -127.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.483 1.113 . . . . 0.0 109.144 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -69.14 73.67 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.208 1.803 . . . . 0.0 112.126 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 61.41 -30.28 0.07 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 129.215 3.006 . . . . 0.0 115.389 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -75.56 140.53 42.76 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.295 2.238 . . . . 0.0 111.398 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 13.2 ptm -97.6 150.27 21.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.619 1.168 . . . . 0.0 111.925 171.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.07 162.14 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.402 2.281 . . . . 0.0 112.759 -169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -125.91 163.33 23.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.007 1.323 . . . . 0.0 111.687 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.5 p -143.14 161.35 38.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -144.77 164.55 30.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.632 1.973 . . . . 0.0 110.859 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -61.33 150.18 35.84 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.487 -0.758 . . . . 0.0 111.277 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 124.158 0.983 . . . . 0.0 112.484 177.189 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 122.98 1.372 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -159.74 142.37 13.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.268 2.627 . . . . 0.0 107.855 -168.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.19 154.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.241 1.016 . . . . 0.0 112.496 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.36 148.71 25.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.992 1.717 . . . . 0.0 113.025 166.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.3 t -135.91 137.53 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.627 1.571 . . . . 0.0 109.576 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.01 149.3 20.98 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.89 11.83 36.31 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.714 1.626 . . . . 0.0 114.296 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.8 mt -64.38 135.38 56.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.36 1.464 . . . . 0.0 112.103 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.5 t -64.98 156.53 30.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.487 1.115 . . . . 0.0 112.402 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.44 -16.37 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.279 0.632 . . . . 0.0 111.188 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -68.71 -33.98 74.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.025 0.93 . . . . 0.0 111.895 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -71.84 144.46 49.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.327 1.851 . . . . 0.0 115.41 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 t -135.69 171.1 14.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.204 1.802 . . . . 0.0 112.469 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.57 -33.0 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.59 -39.41 88.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.189 0.996 . . . . 0.0 112.337 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -64.15 -41.37 97.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.35 -50.46 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.852 0.861 . . . . 0.0 110.367 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.64 -44.16 96.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.485 0.584 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.62 -42.37 92.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.783 0.833 . . . . 0.0 112.586 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.28 -53.41 44.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 47.3 m-85 -63.79 -21.1 66.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -64.05 -12.25 36.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.32 -28.6 69.42 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.431 1.014 . . . . 0.0 112.766 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.74 -32.98 21.58 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.235 1.014 . . . . 0.0 112.051 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.93 -178.83 40.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.903 2.192 . . . . 0.0 110.874 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 120.56 12.28 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.585 -0.95 . . . . 0.0 112.571 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.32 121.53 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.381 1.473 . . . . 0.0 108.023 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -76.06 -36.93 58.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -165.36 165.78 19.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 109.28 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.81 43.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.317 1.447 . . . . 0.0 111.284 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.6 ptm -156.56 157.03 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.882 1.273 . . . . 0.0 112.2 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.79 151.99 48.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.267 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 53.6 mtp . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 123.696 0.798 . . . . 0.0 110.745 174.266 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.6 p80 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.482 0.658 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.97 -0.52 24.66 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.823 1.649 . . . . 0.0 115.385 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.64 10.47 81.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.301 0.953 . . . . 0.0 113.417 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.285 15.6 p90 -143.6 157.7 44.22 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.28 -161.73 20.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.684 1.135 . . . . 0.0 114.153 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -138.64 152.56 48.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.938 1.695 . . . . 0.0 113.883 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.91 129.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.293 1.437 . . . . 0.0 111.499 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -91.38 138.59 31.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.15 1.78 . . . . 0.0 114.541 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -120.22 152.44 37.72 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -70.04 -30.17 67.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.1 t -155.7 149.69 25.46 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.609 1.163 . . . . 0.0 112.728 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.46 -29.68 66.37 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.029 0.932 . . . . 0.0 112.096 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -56.91 -26.41 59.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 24.1 mm -80.87 -52.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.815 0.846 . . . . 0.0 110.129 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.4 t -53.87 -36.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.617 1.567 . . . . 0.0 112.271 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -53.4 -47.16 69.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.886 0.874 . . . . 0.0 112.937 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -68.08 -44.84 75.37 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.074 0.852 . . . . 0.0 111.392 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.2 t -54.46 -41.93 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 96.7 m -72.21 -37.44 69.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.278 1.431 . . . . 0.0 114.453 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -66.31 -33.66 76.24 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.4 mt -73.0 112.05 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -70.64 -61.12 1.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.179 -0.951 . . . . 0.0 111.648 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 52.8 m-85 -94.66 133.41 38.36 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -127.23 124.2 38.36 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.499 1.92 . . . . 0.0 110.382 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.23 107.7 19.38 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.339 -0.851 . . . . 0.0 112.718 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.14 122.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.377 1.071 . . . . 0.0 110.832 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.37 45.02 23.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.472 1.109 . . . . 0.0 112.818 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 63.31 -9.75 0.12 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 128.502 2.721 . . . . 0.0 116.158 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -87.89 142.47 27.77 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 126.322 1.849 . . . . 0.0 109.83 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 58.5 mtt -86.09 129.96 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.416 -0.803 . . . . 0.0 112.512 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.9 163.14 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.046 2.138 . . . . 0.0 111.718 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -128.26 162.94 25.85 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.519 0.727 . . . . 0.0 110.899 169.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.5 158.19 43.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.374 1.07 . . . . 0.0 113.196 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -144.25 165.53 27.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.631 1.573 . . . . 0.0 111.242 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.48 152.13 18.69 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 169.713 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -148.57 149.32 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.15 1.78 . . . . 0.0 111.232 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.55 149.3 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 111.316 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.88 134.58 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.781 1.233 . . . . 0.0 109.58 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.43 145.95 14.95 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 114.518 0.567 . . . . 0.0 114.518 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.6 7.16 32.34 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.689 1.614 . . . . 0.0 114.609 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.5 139.48 58.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.164 1.385 . . . . 0.0 112.183 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -62.66 155.02 27.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.235 1.014 . . . . 0.0 112.506 171.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.57 -20.1 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.479 0.712 . . . . 0.0 112.214 169.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -71.76 -26.9 62.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.065 0.946 . . . . 0.0 113.151 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.0 m -73.59 143.49 46.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.735 1.614 . . . . 0.0 113.812 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 t -123.94 163.71 20.78 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 0.0 114.207 169.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.6 p -57.9 -30.61 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.78 -34.51 78.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.832 0.853 . . . . 0.0 112.458 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -68.27 -47.19 68.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.85 -45.25 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.662 0.785 . . . . 0.0 111.025 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -61.01 -46.29 91.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 118.952 -0.547 . . . . 0.0 112.151 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -59.7 -42.8 93.8 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -65.03 -38.8 92.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -75.97 -29.19 58.17 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -58.71 -18.9 35.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.334 1.454 . . . . 0.0 114.572 171.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -66.19 -23.88 66.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.388 -0.82 . . . . 0.0 112.777 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -89.28 -37.76 14.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.04 176.47 39.69 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.175 1.845 . . . . 0.0 111.45 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.44 127.82 34.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.6 t -100.39 118.27 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.184 1.794 . . . . 0.0 108.397 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -78.27 -37.33 45.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -152.15 153.26 33.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.958 2.103 . . . . 0.0 114.684 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.18 29.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.4 ptp -157.85 147.59 20.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.248 1.019 . . . . 0.0 112.3 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.6 mt -127.83 153.87 46.1 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.521 1.529 . . . . 0.0 111.673 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 124.358 1.063 . . . . 0.0 112.52 -178.126 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 p80 . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -70.5 -0.21 8.0 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.57 63.44 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.769 1.176 . . . . 0.0 114.376 -172.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -144.8 159.82 42.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -176.17 -160.15 23.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.0 0.81 . . . . 0.0 114.909 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -132.8 149.29 52.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.608 1.963 . . . . 0.0 115.357 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 t -135.09 128.11 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.254 1.421 . . . . 0.0 111.749 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 61.6 m -96.55 127.34 42.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.668 1.587 . . . . 0.0 111.418 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.43 157.95 15.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -61.81 -37.96 86.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.745 0.818 . . . . 0.0 112.84 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -151.79 143.52 23.65 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -57.14 -26.78 61.1 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.573 1.549 . . . . 0.0 113.051 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.91 -26.92 68.46 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.72 -50.28 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.628 0.771 . . . . 0.0 109.458 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.96 -33.11 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.664 1.186 . . . . 0.0 111.201 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -48.16 -43.1 31.17 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -76.41 -45.51 31.29 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.639 -0.663 . . . . 0.0 111.764 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.35 -36.95 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.1 t -84.07 -24.27 30.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.583 1.153 . . . . 0.0 112.567 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -72.7 -35.61 67.66 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.02 -1.05 . . . . 0.0 112.155 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.14 138.41 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.022 0.929 . . . . 0.0 110.465 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -127.37 156.14 42.49 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.863 1.265 . . . . 0.0 111.951 169.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.443 18.2 m-85 61.04 47.15 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 -171.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -56.96 129.47 41.77 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.83 1.652 . . . . 0.0 111.201 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.29 125.0 28.62 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.446 0.566 . . . . 0.0 111.803 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.68 117.06 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.245 1.818 . . . . 0.0 108.781 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 50.03 43.79 25.61 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.287 1.035 . . . . 0.0 112.95 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.74 -13.88 0.08 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 128.173 2.589 . . . . 0.0 116.4 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.48 157.16 36.06 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.81 1.644 . . . . 0.0 109.265 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 26.7 mtt -109.6 141.06 42.65 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.73 151.24 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.122 1.769 . . . . 0.0 114.031 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.72 144.98 26.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.842 0.857 . . . . 0.0 112.14 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 4.9 t -108.77 143.67 37.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.627 1.571 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -140.8 157.7 45.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.728 1.611 . . . . 0.0 111.123 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.74 129.81 41.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.549 0.739 . . . . 0.0 111.894 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 123.906 0.882 . . . . 0.0 112.364 -179.097 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.74 147.76 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.785 1.634 . . . . 0.0 111.672 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.29 152.85 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.27 148.25 22.28 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.375 2.27 . . . . 0.0 111.86 167.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.0 t -137.79 135.1 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.015 1.326 . . . . 0.0 109.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.23 155.84 26.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.977 0.798 . . . . 0.0 114.288 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.94 10.01 41.16 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.558 1.551 . . . . 0.0 114.725 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -67.13 137.67 56.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.866 1.266 . . . . 0.0 112.532 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 t -65.93 152.46 44.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.256 1.023 . . . . 0.0 111.76 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -70.53 -15.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.574 -0.704 . . . . 0.0 111.796 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -70.38 -29.85 66.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.303 1.041 . . . . 0.0 112.689 170.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.3 m -78.85 139.12 38.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.992 1.717 . . . . 0.0 113.605 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 t -118.82 165.14 14.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.44 1.496 . . . . 0.0 114.726 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.93 -33.98 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -72.63 -27.01 61.87 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.72 -46.88 64.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.977 0.808 . . . . 0.0 109.169 171.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.44 -46.61 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.686 0.794 . . . . 0.0 110.493 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -57.18 -50.77 71.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.005 0.922 . . . . 0.0 111.855 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -60.21 -44.29 95.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 112.973 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.07 -38.8 92.37 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.306 48.6 m-85 -73.07 -31.2 64.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -60.42 -18.07 48.49 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.45 -24.88 67.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.55 0.74 . . . . 0.0 112.718 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -85.55 -35.64 20.97 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.85 175.3 36.19 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.668 2.08 . . . . 0.0 111.139 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -58.81 125.03 21.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.761 -0.847 . . . . 0.0 112.98 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.1 t -94.01 124.01 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.835 1.654 . . . . 0.0 107.234 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.85 -31.5 20.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.987 0.515 . . . . 0.0 110.356 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -161.51 155.56 22.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.884 1.274 . . . . 0.0 109.767 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.83 149.51 34.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.048 1.339 . . . . 0.0 111.268 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.4 ptp -156.07 154.9 31.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.634 1.174 . . . . 0.0 112.166 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.41 152.3 46.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.302 1.441 . . . . 0.0 111.419 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.764 0.826 . . . . 0.0 111.788 -176.293 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.3 p80 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.602 0.715 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -80.87 7.47 10.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.193 1.797 . . . . 0.0 115.096 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.46 11.84 63.74 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.992 1.282 . . . . 0.0 114.414 -172.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -145.98 160.78 41.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.66 -162.16 23.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.54 1.066 . . . . 0.0 114.77 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.07 148.12 44.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.653 1.981 . . . . 0.0 113.84 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.56 123.59 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.422 1.489 . . . . 0.0 111.606 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 90.4 m -93.25 128.47 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.026 1.33 . . . . 0.0 110.501 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.91 153.15 19.39 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.2 -33.29 75.47 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -152.94 143.65 22.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 112.815 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -55.83 -27.16 50.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 113.185 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.38 -27.12 69.09 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.3 mm -77.54 -48.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.254 0.621 . . . . 0.0 109.686 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.08 -34.07 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.292 1.037 . . . . 0.0 111.244 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -50.23 -42.85 52.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.476 1.51 . . . . 0.0 113.54 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -77.35 -47.61 19.47 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.497 0.719 . . . . 0.0 111.595 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.3 -43.3 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.9 t -76.01 -24.47 55.29 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 112.19 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -78.27 -33.27 49.7 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.041 -1.037 . . . . 0.0 112.539 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 30.2 mt -67.97 148.47 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.429 1.091 . . . . 0.0 110.748 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -134.84 152.03 51.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.368 26.6 m-85 58.42 50.6 9.17 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -171.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -60.13 133.55 56.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.334 . . . . 0.0 111.971 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -82.93 133.47 35.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.805 -0.56 . . . . 0.0 111.896 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.1 mt -145.24 125.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 126.695 1.998 . . . . 0.0 108.842 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 50.08 36.28 11.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.56 1.144 . . . . 0.0 113.495 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.07 -7.73 0.14 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 128.242 2.617 . . . . 0.0 116.058 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.17 173.62 11.65 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 109.33 167.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.3 mtt -120.85 145.78 47.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.42 161.75 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.366 2.266 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.27 152.25 50.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.403 1.081 . . . . 0.0 110.017 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.06 157.97 44.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -147.44 160.93 42.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.88 2.072 . . . . 0.0 111.14 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 146.95 42.59 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.988 0.813 . . . . 0.0 111.844 172.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.887 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 122.768 1.27 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -147.27 142.17 26.91 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.745 2.018 . . . . 0.0 109.393 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 pt -139.52 151.87 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.948 0.899 . . . . 0.0 113.236 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -92.67 145.71 24.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.17 2.188 . . . . 0.0 112.404 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.27 134.97 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 109.952 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.98 148.22 19.77 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.784 0.72 . . . . 0.0 114.256 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.77 9.57 59.72 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.936 1.255 . . . . 0.0 114.261 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.45 144.01 54.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.976 1.31 . . . . 0.0 111.575 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -67.15 158.03 32.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.155 0.582 . . . . 0.0 110.993 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.21 -26.3 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -71.31 -25.92 62.63 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.56 1.144 . . . . 0.0 113.712 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -70.2 119.15 13.96 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.299 1.3 t -98.5 164.18 12.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.45 -33.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -174.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.19 -32.49 72.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.1 0.96 . . . . 0.0 113.052 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.59 -46.06 73.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.849 0.75 . . . . 0.0 110.364 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.43 -48.97 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.303 1.041 . . . . 0.0 110.567 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.87 -49.07 79.15 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.869 0.867 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -60.0 -39.55 86.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 112.773 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -68.87 -49.07 61.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.324 49.4 m-85 -63.23 -29.22 70.6 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.44 -21.48 60.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -70.36 -25.73 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.019 0.827 . . . . 0.0 112.846 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -76.32 -38.81 55.46 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.63 167.65 29.57 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.328 2.394 . . . . 0.0 110.276 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.02 131.86 51.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.135 0.968 . . . . 0.0 113.294 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -93.69 138.26 20.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 126.565 1.946 . . . . 0.0 108.335 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.99 -45.11 10.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.932 1.293 . . . . 0.0 112.946 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -158.9 161.53 36.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.295 1.438 . . . . 0.0 109.881 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.11 156.86 42.82 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.148 1.379 . . . . 0.0 111.767 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -157.09 159.34 37.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.54 1.136 . . . . 0.0 113.163 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 73.3 mt -124.05 146.64 48.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.889 2.076 . . . . 0.0 111.136 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.474 0.71 . . . . 0.0 111.884 176.038 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.53 -8.49 15.0 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.11 76.45 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.384 0.993 . . . . 0.0 114.767 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.292 15.3 p90 -142.48 161.2 38.67 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.25 -168.41 25.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.689 1.138 . . . . 0.0 113.761 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -141.27 153.66 45.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.125 1.37 . . . . 0.0 112.965 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.0 130.98 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.356 1.462 . . . . 0.0 112.094 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.3 m -93.48 138.04 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.77 1.628 . . . . 0.0 113.85 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.51 148.8 32.4 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -69.76 -28.95 66.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.107 0.963 . . . . 0.0 112.738 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.2 t -143.45 130.36 20.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.937 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.6 pm0 -57.85 -28.55 64.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.741 2.016 . . . . 0.0 113.378 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.32 -28.25 69.18 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -74.7 -45.01 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 110.094 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.8 t -58.63 -37.59 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.435 1.094 . . . . 0.0 110.516 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -56.14 -45.51 79.57 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.987 0.812 . . . . 0.0 113.128 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -69.33 -45.95 68.24 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.923 0.783 . . . . 0.0 111.836 173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.88 -44.11 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 118.851 0.75 . . . . 0.0 110.834 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.67 -36.61 76.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.331 1.452 . . . . 0.0 113.033 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -37.32 86.25 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.116 -0.99 . . . . 0.0 112.816 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.01 117.38 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.54 0.736 . . . . 0.0 109.232 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -70.28 -61.44 1.77 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.486 -0.759 . . . . 0.0 111.777 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.335 53.5 m-85 -95.71 139.55 31.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -137.28 153.08 50.39 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.716 2.406 . . . . 0.0 109.606 -174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -124.2 115.93 21.89 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.129 -0.982 . . . . 0.0 112.82 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.4 126.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.108 0.963 . . . . 0.0 111.049 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 51.0 38.23 19.89 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 112.826 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.12 -7.1 0.12 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.914 2.486 . . . . 0.0 115.86 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -78.52 140.52 38.55 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.128 1.771 . . . . 0.0 109.178 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 96.5 mtp -88.64 143.26 27.06 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.546 -0.721 . . . . 0.0 111.879 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.0 164.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.566 2.346 . . . . 0.0 111.628 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -124.9 158.29 33.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.818 0.847 . . . . 0.0 110.867 168.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.1 p -141.41 158.27 44.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.637 0.732 . . . . 0.0 112.58 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -155.78 163.07 40.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.62 1.568 . . . . 0.0 111.702 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -57.69 147.14 28.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.494 1.118 . . . . 0.0 112.416 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 125.704 1.601 . . . . 0.0 110.965 178.216 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -140.56 151.78 44.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.21 1.404 . . . . 0.0 111.921 -172.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -139.8 151.57 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.608 1.163 . . . . 0.0 113.648 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -90.12 146.95 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.252 2.221 . . . . 0.0 112.973 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.28 138.06 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.099 1.76 . . . . 0.0 110.348 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.52 142.41 9.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.887 0.767 . . . . 0.0 114.85 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.54 4.92 30.16 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.089 1.804 . . . . 0.0 114.649 -175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.22 140.05 58.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.368 1.467 . . . . 0.0 112.277 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -66.23 152.47 44.81 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.802 0.841 . . . . 0.0 111.741 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.15 -14.81 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.43 -0.793 . . . . 0.0 111.552 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -71.03 -28.81 64.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.133 0.973 . . . . 0.0 112.68 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.0 m -74.08 140.54 45.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.658 1.583 . . . . 0.0 112.78 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.53 164.48 15.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.404 1.482 . . . . 0.0 114.572 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.81 -32.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -67.24 -32.1 72.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.893 0.877 . . . . 0.0 112.739 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -67.25 -50.06 61.98 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.5 -45.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 111.207 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.16 -47.76 84.58 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 111.747 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.16 -43.79 98.04 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -64.13 -38.6 91.64 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 48.1 m-85 -73.51 -29.68 62.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -60.76 -17.09 46.76 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -65.52 -24.14 67.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.61 0.764 . . . . 0.0 112.794 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -83.49 -34.4 25.36 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.06 174.64 34.98 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.849 2.166 . . . . 0.0 110.798 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -59.23 126.5 27.93 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.951 0.876 . . . . 0.0 113.162 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.92 126.83 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.707 1.603 . . . . 0.0 108.628 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -76.69 -46.3 26.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.071 0.948 . . . . 0.0 112.631 175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -158.72 161.11 37.03 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.22 1.008 . . . . 0.0 110.894 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.83 156.27 41.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.508 1.523 . . . . 0.0 111.818 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -154.47 158.88 40.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.81 1.244 . . . . 0.0 112.629 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.1 mt -126.8 147.79 49.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.874 1.67 . . . . 0.0 111.445 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.997 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.2 p80 . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.577 0.703 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -78.23 7.26 6.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.853 1.661 . . . . 0.0 115.314 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.24 14.89 67.9 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.554 1.073 . . . . 0.0 114.41 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.311 14.6 p90 -139.52 158.26 44.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.07 -171.75 30.71 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.224 0.916 . . . . 0.0 114.845 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -134.23 149.4 50.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.923 2.089 . . . . 0.0 114.246 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.81 129.37 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.246 1.418 . . . . 0.0 111.209 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 76.8 m -100.53 124.1 45.63 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.409 1.484 . . . . 0.0 111.434 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -97.16 155.9 16.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -68.91 -30.86 69.43 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.2 t -153.02 143.59 22.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.343 1.057 . . . . 0.0 113.309 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -57.82 -26.2 61.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.571 1.548 . . . . 0.0 113.673 170.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -59.02 -35.68 73.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.202 1.001 . . . . 0.0 111.809 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.75 -47.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.052 0.941 . . . . 0.0 110.418 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.7 t -58.4 -37.56 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.635 1.174 . . . . 0.0 111.146 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.69 -48.71 74.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.036 0.835 . . . . 0.0 113.218 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.63 -42.1 82.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.082 0.855 . . . . 0.0 111.676 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.79 -39.16 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.512 0.596 . . . . 0.0 111.241 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 88.9 m -73.62 -38.48 65.04 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.29 -35.61 80.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.21 116.36 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -68.94 -56.2 8.58 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.278 -0.889 . . . . 0.0 111.77 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.315 50.9 m-85 -104.12 136.82 43.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -130.81 137.42 49.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.787 2.035 . . . . 0.0 110.629 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -84.31 131.19 34.74 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.76 -0.588 . . . . 0.0 111.731 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.98 122.29 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.546 1.939 . . . . 0.0 109.546 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 49.62 40.01 18.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.555 1.142 . . . . 0.0 112.855 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 62.43 -8.01 0.12 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 128.688 2.795 . . . . 0.0 116.259 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -77.17 154.62 32.98 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.276 -1.515 . . . . 0.0 108.532 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 22.6 ptm -100.29 139.74 35.53 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.238 -0.914 . . . . 0.0 111.769 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.45 162.0 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.709 2.004 . . . . 0.0 111.719 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.82 162.55 17.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.5 p -144.06 154.27 43.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.695 1.198 . . . . 0.0 113.675 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -144.06 165.43 27.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.681 1.993 . . . . 0.0 111.758 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.54 134.67 57.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.024 0.93 . . . . 0.0 111.655 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.17 0.988 . . . . 0.0 112.988 -176.874 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -141.13 149.65 41.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.724 1.61 . . . . 0.0 111.431 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.84 151.3 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.344 1.058 . . . . 0.0 113.763 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -88.72 145.64 25.51 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.526 1.931 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.3 138.05 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.471 1.509 . . . . 0.0 110.627 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.77 153.52 25.16 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.861 0.743 . . . . 0.0 114.33 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.81 34.88 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.034 1.302 . . . . 0.0 114.602 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.0 mt -64.21 136.24 57.02 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.106 1.363 . . . . 0.0 112.18 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -62.62 152.66 34.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.348 1.059 . . . . 0.0 112.37 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.6 -23.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.81 0.844 . . . . 0.0 111.725 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -67.62 -26.68 66.36 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.65 1.18 . . . . 0.0 113.282 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.2 m -76.97 147.64 36.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.074 1.749 . . . . 0.0 115.495 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 t -129.3 162.66 27.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.07 1.748 . . . . 0.0 113.094 168.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -57.72 -30.86 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.14 -33.99 77.33 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.911 0.884 . . . . 0.0 112.42 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.07 -47.24 68.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.23 -45.35 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.58 0.752 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -60.91 -47.44 86.38 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.141 0.577 . . . . 0.0 111.65 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -58.9 -45.76 89.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.971 0.908 . . . . 0.0 113.415 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -65.62 -38.68 90.1 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 49.4 m-85 -73.75 -29.18 62.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 171.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -61.19 -17.39 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -64.93 -23.04 67.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.659 0.784 . . . . 0.0 112.8 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -86.1 -29.29 23.46 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.73 174.95 30.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.98 2.228 . . . . 0.0 110.729 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -59.3 126.88 29.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.249 1.025 . . . . 0.0 112.882 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.53 123.25 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.799 1.64 . . . . 0.0 107.502 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.16 -33.73 24.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.325 0.65 . . . . 0.0 110.398 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -160.54 158.08 28.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.683 1.193 . . . . 0.0 110.168 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.01 149.11 30.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.205 1.402 . . . . 0.0 111.165 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.14 159.09 42.67 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.432 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.0 mt -125.98 155.8 40.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.913 1.685 . . . . 0.0 111.028 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.3 mmm . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.381 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 p80 . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.259 0.552 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -84.48 1.55 45.08 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.52 66.8 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.267 1.413 . . . . 0.0 114.597 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -145.22 159.74 42.55 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.94 -164.43 27.49 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.271 0.939 . . . . 0.0 115.129 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -136.59 147.67 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.75 2.02 . . . . 0.0 114.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.26 127.6 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.704 1.202 . . . . 0.0 111.3 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.9 m -96.81 122.67 40.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.343 1.457 . . . . 0.0 111.278 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.29 158.99 16.26 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.617 -0.677 . . . . 0.0 112.597 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -149.73 147.23 27.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.562 1.145 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -62.17 -24.5 67.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.687 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.76 -30.31 71.35 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.22 -47.46 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.549 0.739 . . . . 0.0 109.874 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.65 -34.28 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.383 1.073 . . . . 0.0 110.526 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.24 -40.09 61.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.8 1.24 . . . . 0.0 113.163 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -80.54 -45.24 17.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.615 0.643 . . . . 0.0 112.09 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.8 -44.66 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.845 0.748 . . . . 0.0 112.006 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 22.3 t -73.21 -33.0 65.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.085 1.354 . . . . 0.0 112.145 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -67.42 -38.74 85.03 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.292 -0.88 . . . . 0.0 112.484 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.7 mt -71.66 114.81 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -68.75 -49.63 57.19 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.897 -1.127 . . . . 0.0 112.149 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 62.4 m-85 -108.43 138.85 44.04 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.97 129.45 34.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.919 1.687 . . . . 0.0 111.123 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -77.94 134.15 37.93 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.53 -0.731 . . . . 0.0 112.39 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.9 mt -145.83 118.71 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 127.493 2.317 . . . . 0.0 108.199 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 50.69 45.94 26.38 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.05 0.94 . . . . 0.0 113.359 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 65.86 -18.22 0.1 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 128.045 2.538 . . . . 0.0 116.259 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -75.26 155.33 36.84 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.403 1.881 . . . . 0.0 109.844 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.7 mtm -108.17 125.09 51.23 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.472 -0.768 . . . . 0.0 111.397 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.16 163.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.345 1.858 . . . . 0.0 111.868 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -122.44 155.71 35.56 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.349 0.66 . . . . 0.0 111.112 168.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 30.1 p -139.14 155.84 47.57 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -145.06 173.46 11.88 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.491 1.917 . . . . 0.0 111.775 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -60.34 135.39 57.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.113 0.965 . . . . 0.0 111.315 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 123.208 0.603 . . . . 0.0 110.793 174.76 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.35 0.595 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -151.92 154.2 35.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.033 1.333 . . . . 0.0 110.286 -169.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.66 154.81 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.076 . . . . 0.0 112.896 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -91.01 145.57 24.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.399 1.879 . . . . 0.0 112.054 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.03 131.4 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.55 1.54 . . . . 0.0 109.908 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.13 12.66 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.607 0.622 . . . . 0.0 114.5 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.58 10.79 26.42 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.759 1.647 . . . . 0.0 114.717 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 37.7 mt -61.61 136.38 57.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.219 1.408 . . . . 0.0 111.929 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 p -79.92 179.18 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -79.5 -20.17 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.306 1.043 . . . . 0.0 112.56 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.38 -37.75 56.72 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.897 0.879 . . . . 0.0 110.527 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 m -68.96 140.5 55.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.72 1.608 . . . . 0.0 115.295 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 t -144.44 173.71 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.678 1.991 . . . . 0.0 112.218 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.1 -32.28 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -68.44 -39.98 81.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.906 0.882 . . . . 0.0 112.433 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -65.06 -41.89 94.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.97 -53.02 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.374 1.07 . . . . 0.0 109.137 174.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -58.86 -48.17 82.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.67 0.668 . . . . 0.0 111.962 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -60.5 -42.01 95.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.737 0.815 . . . . 0.0 112.832 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.14 -46.02 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.329 54.6 m-85 -66.57 -28.0 68.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -59.57 -21.01 59.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -71.51 -25.89 62.44 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.417 -0.802 . . . . 0.0 112.767 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -75.49 -36.26 60.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 177.08 37.86 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.877 2.179 . . . . 0.0 110.963 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -60.01 131.27 50.34 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.12 0.96 . . . . 0.0 112.968 -172.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 36.9 t -108.06 133.46 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.757 2.023 . . . . 0.0 107.446 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -101.32 -23.12 14.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.01 150.9 17.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.892 2.077 . . . . 0.0 113.379 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.0 31.65 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.289 1.036 . . . . 0.0 110.997 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.7 ptm -157.43 158.77 36.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.742 1.217 . . . . 0.0 112.331 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.14 150.13 49.64 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.805 1.642 . . . . 0.0 111.808 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 110.564 169.518 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 p80 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 121.222 0.534 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -82.34 2.53 31.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -172.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.7 9.92 82.23 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.56 1.076 . . . . 0.0 113.771 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.27 19.6 p90 -143.47 156.65 44.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.08 -164.69 22.09 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.441 1.019 . . . . 0.0 114.174 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.09 151.72 46.93 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.994 1.718 . . . . 0.0 114.144 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 t -137.26 128.27 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.944 1.298 . . . . 0.0 112.101 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -90.36 139.62 30.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.866 1.666 . . . . 0.0 113.287 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.34 150.5 43.57 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -174.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -67.15 -33.02 74.53 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.4 t -147.4 148.59 31.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.74 1.216 . . . . 0.0 113.192 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -57.44 -29.38 64.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.543 1.137 . . . . 0.0 112.836 171.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -61.64 -30.8 70.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -78.94 -48.67 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 110.249 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.95 -43.06 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.04 1.336 . . . . 0.0 110.434 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -56.4 -47.98 77.87 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.975 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -64.99 -45.13 86.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.019 0.827 . . . . 0.0 111.688 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.48 -36.13 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.629 0.65 . . . . 0.0 111.705 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.6 m -73.24 -39.87 65.11 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -66.4 -35.3 79.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.037 0.935 . . . . 0.0 113.22 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.18 115.0 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -68.29 -58.74 3.93 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.716 -0.615 . . . . 0.0 111.279 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.327 53.4 m-85 -104.71 137.94 41.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.05 125.48 33.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.981 2.112 . . . . 0.0 109.865 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.51 121.57 32.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.416 -0.803 . . . . 0.0 112.535 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.4 mt -139.15 126.44 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.891 1.277 . . . . 0.0 109.91 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.41 40.0 21.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.622 1.169 . . . . 0.0 113.687 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 62.97 -7.91 0.14 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 128.1 2.56 . . . . 0.0 115.876 -171.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -81.58 170.13 16.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.807 2.043 . . . . 0.0 110.37 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.6 mtp -121.21 134.89 55.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.207 1.003 . . . . 0.0 112.105 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.02 159.04 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.849 2.06 . . . . 0.0 112.399 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -124.79 152.3 44.05 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.81 0.844 . . . . 0.0 112.506 172.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.7 m -124.5 144.95 49.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.547 1.139 . . . . 0.0 113.015 -169.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -141.79 169.89 16.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.276 1.43 . . . . 0.0 112.78 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -63.1 150.32 42.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.512 1.125 . . . . 0.0 112.789 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.291 1.436 . . . . 0.0 110.681 171.932 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.85 149.5 37.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.345 1.458 . . . . 0.0 111.859 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -139.38 151.03 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.406 1.083 . . . . 0.0 113.919 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.13 148.39 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.97 2.108 . . . . 0.0 112.782 167.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.0 t -134.89 134.99 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 109.645 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.48 155.85 26.72 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.016 0.817 . . . . 0.0 114.327 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.79 7.56 66.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.798 1.19 . . . . 0.0 113.784 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.76 143.56 57.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 111.656 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -69.47 154.08 42.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.174 0.589 . . . . 0.0 110.041 167.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.59 -15.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.771 -0.581 . . . . 0.0 111.708 168.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -73.75 -28.85 61.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.074 1.35 . . . . 0.0 113.126 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 m -67.06 123.89 21.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.265 0.8 OUTLIER -80.86 160.58 24.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.52 -29.85 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -75.23 -36.78 61.3 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.02 -43.37 98.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.78 -50.44 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.85 0.86 . . . . 0.0 109.681 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.49 -46.8 88.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.686 0.675 . . . . 0.0 112.313 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -59.15 -40.15 84.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.534 1.134 . . . . 0.0 112.237 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.41 -54.56 34.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 171.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 48.6 m-85 -63.41 -23.7 67.52 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -60.93 -13.85 18.6 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.31 -29.13 69.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.886 1.221 . . . . 0.0 112.726 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -85.1 -34.43 22.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.214 1.005 . . . . 0.0 112.248 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.21 -179.8 41.63 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 127.077 2.275 . . . . 0.0 110.788 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.71 122.72 16.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.19 0.995 . . . . 0.0 112.315 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.7 t -95.65 123.81 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -82.08 -39.94 22.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.753 -0.592 . . . . 0.0 109.547 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -157.91 159.89 37.03 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.63 1.172 . . . . 0.0 110.152 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.62 34.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.383 1.473 . . . . 0.0 110.955 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 mmt -148.65 159.37 44.17 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.654 1.582 . . . . 0.0 113.003 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.0 mt -126.84 143.57 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.983 2.113 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 43.0 mtm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.38 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.56 -11.31 49.1 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.22 14.35 66.7 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.175 0.893 . . . . 0.0 113.99 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.38 4.7 p90 -141.09 162.45 35.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.89 -169.88 28.02 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.089 1.328 . . . . 0.0 114.604 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.05 150.26 52.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.262 2.225 . . . . 0.0 114.394 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -136.32 125.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.209 1.404 . . . . 0.0 111.82 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 94.4 m -98.31 128.92 44.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.353 1.461 . . . . 0.0 110.767 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -104.85 150.69 24.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -67.0 -38.13 85.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.575 0.75 . . . . 0.0 112.673 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 t -143.11 134.69 26.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 122.201 1.0 . . . . 0.0 112.904 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -58.34 -27.25 63.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.53 1.932 . . . . 0.0 113.256 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.55 -26.26 68.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -76.75 -50.81 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.904 0.882 . . . . 0.0 109.489 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.08 -36.62 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 111.987 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.19 -30.88 60.82 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -84.0 -49.08 9.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.552 0.741 . . . . 0.0 111.668 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.66 -43.58 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.315 0.961 . . . . 0.0 113.433 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.9 t -77.59 -19.17 56.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.446 1.098 . . . . 0.0 112.514 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -81.54 -31.19 32.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.254 1.021 . . . . 0.0 112.215 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.15 142.06 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.19 0.996 . . . . 0.0 109.519 168.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -131.23 161.43 32.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.743 1.217 . . . . 0.0 111.728 171.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.581 2.1 p90 58.31 45.17 17.46 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -57.41 142.65 43.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 110.688 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.53 106.92 16.38 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.596 1.089 . . . . 0.0 112.978 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.53 122.93 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.765 1.226 . . . . 0.0 110.528 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 50.97 41.36 27.09 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.461 1.104 . . . . 0.0 112.634 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 62.97 -10.59 0.1 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.379 2.672 . . . . 0.0 116.191 -171.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.51 139.92 38.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.166 1.787 . . . . 0.0 109.723 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 20.4 ptm -91.96 140.54 29.57 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.59 -0.694 . . . . 0.0 111.716 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.19 149.5 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.249 1.82 . . . . 0.0 113.289 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -119.83 151.58 38.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.785 1.234 . . . . 0.0 111.093 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 p -129.34 156.11 44.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -143.59 170.37 15.96 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.449 1.899 . . . . 0.0 110.954 -175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.66 153.68 19.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.732 0.813 . . . . 0.0 112.174 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 124.555 1.142 . . . . 0.0 113.979 176.48 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.212 0.53 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -153.36 138.71 17.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.125 1.37 . . . . 0.0 110.324 -168.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.1 pt -140.61 149.16 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -87.88 147.93 24.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.039 1.736 . . . . 0.0 112.658 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.29 132.3 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.603 1.561 . . . . 0.0 109.777 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.96 11.64 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 115.026 0.771 . . . . 0.0 115.026 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.92 11.12 35.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.549 1.547 . . . . 0.0 114.453 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.44 140.82 58.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.031 1.333 . . . . 0.0 112.168 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 t -66.47 155.37 37.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.004 0.921 . . . . 0.0 111.625 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 m -72.26 -14.8 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.696 -0.628 . . . . 0.0 111.656 169.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.04 -39.88 93.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.05 0.94 . . . . 0.0 111.969 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.15 127.86 33.83 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.15 165.38 13.52 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -62.82 -30.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.34 -37.49 60.65 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.42 0.688 . . . . 0.0 111.509 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.73 -47.18 86.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 t -57.94 -49.22 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 109.039 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -61.52 -44.28 97.35 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.079 0.854 . . . . 0.0 112.355 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -60.71 -46.18 91.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.349 1.06 . . . . 0.0 112.507 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.13 -44.66 96.98 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 48.0 m-85 -66.48 -31.22 71.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -62.28 -12.98 23.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.78 -31.42 72.05 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.248 0.931 . . . . 0.0 113.216 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.81 -39.86 66.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.63 168.5 28.92 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.849 2.643 . . . . 0.0 109.539 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.81 135.59 57.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.483 1.141 . . . . 0.0 113.192 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.47 128.78 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.081 1.753 . . . . 0.0 109.025 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.85 -49.38 30.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.625 1.17 . . . . 0.0 113.891 172.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -154.7 157.29 37.86 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.003 2.121 . . . . 0.0 114.811 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.6 39.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.683 1.193 . . . . 0.0 110.959 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.4 ptm -155.43 148.15 24.22 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.774 1.229 . . . . 0.0 112.095 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.98 151.9 49.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.887 1.675 . . . . 0.0 111.297 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 124.226 1.01 . . . . 0.0 112.77 -177.591 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 p80 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 121.45 0.643 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.23 8.14 3.6 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.22 14.85 58.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.842 1.21 . . . . 0.0 115.099 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -145.56 158.49 43.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.86 -160.94 24.26 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -134.16 148.3 50.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.542 1.937 . . . . 0.0 114.751 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -136.28 133.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.267 1.427 . . . . 0.0 111.162 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.8 m -107.23 134.21 50.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 0.0 112.709 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.19 149.51 28.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 118.433 2.753 . . . . 0.0 118.433 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -67.91 -27.48 66.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.662 0.785 . . . . 0.0 112.932 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.4 t -147.76 138.74 23.41 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.876 1.27 . . . . 0.0 112.766 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -60.84 -27.63 68.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.697 1.599 . . . . 0.0 113.461 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -62.45 -26.53 68.56 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.2 mm -75.03 -50.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.962 0.905 . . . . 0.0 110.272 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 31.3 t -57.49 -34.51 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.348 1.459 . . . . 0.0 111.235 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -52.64 -42.68 64.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 113.165 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.58 -41.83 62.37 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.2 0.909 . . . . 0.0 112.127 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.42 -31.43 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 98.8 m -79.74 -40.28 29.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.171 1.388 . . . . 0.0 113.811 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.19 -43.27 95.59 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.407 0.683 . . . . 0.0 111.873 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.5 114.26 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.54 -51.71 26.8 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.087 -1.008 . . . . 0.0 111.81 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -94.8 139.28 31.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -133.49 132.64 41.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.654 1.582 . . . . 0.0 111.044 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -81.05 127.63 32.82 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.744 -0.598 . . . . 0.0 111.365 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 25.1 mt -140.46 125.0 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 109.136 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 50.47 40.24 22.76 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.219 1.008 . . . . 0.0 112.585 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.7 t30 63.22 -10.7 0.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 128.39 2.676 . . . . 0.0 115.912 -172.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -77.0 143.11 39.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.856 1.662 . . . . 0.0 109.426 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 23.1 ptm -97.15 138.35 34.78 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.424 -0.797 . . . . 0.0 111.458 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.89 146.69 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.731 2.012 . . . . 0.0 112.378 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -89.11 142.88 27.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.519 0.728 . . . . 0.0 111.324 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.87 148.63 52.56 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.626 1.17 . . . . 0.0 112.572 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -158.38 164.66 36.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.406 1.482 . . . . 0.0 112.179 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -61.79 143.28 56.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.019 0.927 . . . . 0.0 112.305 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.882 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.73 154.5 48.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.222 1.409 . . . . 0.0 112.063 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.98 154.54 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.996 1.318 . . . . 0.0 113.313 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.4 149.25 21.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.671 1.988 . . . . 0.0 112.979 167.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.85 131.91 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.858 1.663 . . . . 0.0 109.981 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.5 139.62 7.74 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.47 9.51 21.36 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.236 1.874 . . . . 0.0 114.771 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.75 136.3 57.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.369 1.468 . . . . 0.0 112.518 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -64.64 153.83 38.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.458 1.103 . . . . 0.0 112.05 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.19 -17.07 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.281 0.632 . . . . 0.0 112.332 169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -67.81 -37.5 82.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.938 0.895 . . . . 0.0 111.724 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -70.12 147.39 49.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.311 1.844 . . . . 0.0 114.484 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t -140.05 171.54 14.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.688 1.595 . . . . 0.0 112.846 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -57.21 -31.99 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.2 -40.92 86.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.169 0.988 . . . . 0.0 112.325 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -64.04 -42.46 97.06 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.1 -51.23 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.163 0.985 . . . . 0.0 109.653 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -61.86 -45.85 92.01 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.022 0.828 . . . . 0.0 112.105 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -59.03 -41.79 88.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.761 0.824 . . . . 0.0 112.851 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.46 -46.74 68.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.404 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS 0.355 49.9 m-85 -66.43 -26.31 67.16 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 178.038 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.2 -24.95 66.7 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -65.96 -22.95 66.51 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.486 1.039 . . . . 0.0 112.765 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -71.94 -24.88 61.69 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.58 -98.62 0.13 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.617 1.103 . . . . 0.0 112.573 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -154.23 137.23 15.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.272 1.429 . . . . 0.0 112.031 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.33 130.5 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.194 1.798 . . . . 0.0 108.834 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 -46.97 19.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 112.869 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -158.55 161.21 37.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 110.452 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.05 155.17 41.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.433 1.493 . . . . 0.0 111.48 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.55 155.14 32.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.392 1.077 . . . . 0.0 112.741 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.23 152.58 47.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.399 0.68 . . . . 0.0 111.261 171.719 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.7 p80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.29 0.567 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -80.7 1.63 29.33 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.25 84.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.689 1.138 . . . . 0.0 114.115 -171.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.277 9.1 p90 -143.86 155.23 44.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.59 -160.93 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.978 0.799 . . . . 0.0 114.936 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -137.82 150.69 47.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.297 1.839 . . . . 0.0 114.14 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.41 129.57 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.081 1.352 . . . . 0.0 111.407 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.1 m -97.69 122.83 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.275 1.43 . . . . 0.0 112.055 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -95.05 154.83 16.99 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -70.08 -31.82 69.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.922 0.889 . . . . 0.0 113.387 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.2 t -152.07 140.26 20.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -53.21 -33.87 54.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.752 2.021 . . . . 0.0 113.615 170.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.73 -22.25 66.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.13 -54.31 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.099 0.96 . . . . 0.0 109.509 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.7 -39.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.766 1.626 . . . . 0.0 111.506 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.7 -40.81 66.34 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -75.48 -42.43 53.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.054 0.843 . . . . 0.0 112.361 173.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.58 -30.78 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.02 -40.53 24.12 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.018 1.727 . . . . 0.0 113.287 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.35 -39.77 94.2 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.028 -1.045 . . . . 0.0 111.712 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.6 mt -74.48 108.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 168.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.28 -45.86 44.92 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.999 -1.063 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.44 133.59 42.6 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -131.03 130.12 42.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.872 1.669 . . . . 0.0 110.624 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -91.39 130.56 37.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.829 0.852 . . . . 0.0 111.997 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.95 126.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.538 1.535 . . . . 0.0 109.253 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 49.91 42.18 23.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.39 1.076 . . . . 0.0 113.422 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.97 -13.62 0.15 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 127.313 2.245 . . . . 0.0 115.932 -172.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.74 168.3 20.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.168 1.787 . . . . 0.0 110.609 169.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 97.5 mtp -127.18 139.89 52.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.333 1.053 . . . . 0.0 112.151 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.67 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.614 1.966 . . . . 0.0 112.005 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -87.91 141.71 28.37 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.683 0.393 . . . . 0.0 110.876 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.404 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 85.6 m -133.85 146.69 50.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.966 1.306 . . . . 0.0 111.356 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -158.05 171.12 20.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.55 1.14 . . . . 0.0 111.847 174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -59.96 140.68 56.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.71 1.204 . . . . 0.0 111.992 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 124.718 1.207 . . . . 0.0 113.713 178.046 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 mptt . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.904 0.859 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -154.91 144.29 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.198 1.399 . . . . 0.0 111.374 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -140.41 155.01 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.586 1.155 . . . . 0.0 113.301 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -94.5 145.77 24.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.198 2.199 . . . . 0.0 112.789 167.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.1 138.77 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.051 1.74 . . . . 0.0 109.726 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.51 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.93 13.65 54.23 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.375 1.464 . . . . 0.0 114.215 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.5 mt -62.79 138.6 58.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.422 . . . . 0.0 112.215 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.44 155.15 33.56 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.112 0.965 . . . . 0.0 111.734 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 p -67.97 -21.07 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.868 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -69.95 -30.89 68.37 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.478 1.111 . . . . 0.0 112.911 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.4 m -79.7 128.69 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.393 1.477 . . . . 0.0 114.236 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.51 166.21 12.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.02 -30.12 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 169.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.76 -35.94 62.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.486 0.715 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.7 -46.87 87.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.632 0.651 . . . . 0.0 112.364 170.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.73 -50.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.595 1.158 . . . . 0.0 109.422 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.7 -48.59 81.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.82 0.736 . . . . 0.0 112.177 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -60.73 -39.45 88.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.789 0.836 . . . . 0.0 112.553 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.61 -48.66 66.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 50.4 m-85 -62.92 -29.5 70.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -59.91 -20.84 59.62 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -70.29 -25.66 63.43 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.14 0.882 . . . . 0.0 112.674 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.42 -38.28 59.91 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.17 37.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.518 2.008 . . . . 0.0 111.326 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -58.55 119.41 6.99 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.109 0.964 . . . . 0.0 112.995 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -93.93 131.4 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.0 107.987 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -86.44 -35.1 19.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -163.87 158.6 20.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.249 1.419 . . . . 0.0 109.398 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.21 139.52 22.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.067 1.347 . . . . 0.0 110.608 172.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.1 mmt -148.8 151.12 34.23 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.421 1.488 . . . . 0.0 112.254 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.62 151.73 41.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.487 1.515 . . . . 0.0 111.074 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtp . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 123.711 0.804 . . . . 0.0 112.35 -175.605 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.7 p80 . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 112.077 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -78.96 12.8 2.01 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.63 15.15 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.786 1.184 . . . . 0.0 114.674 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.266 8.5 p90 -146.91 159.09 43.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.28 -160.59 22.74 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.192 0.901 . . . . 0.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.35 150.65 44.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.029 1.731 . . . . 0.0 114.207 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.27 130.32 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.354 1.461 . . . . 0.0 111.938 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -93.75 144.73 25.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.401 1.88 . . . . 0.0 114.431 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -125.95 151.08 47.47 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 118.167 2.654 . . . . 0.0 118.167 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -61.57 -37.2 82.96 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.004 1.322 . . . . 0.0 113.636 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 t -153.94 148.19 25.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.321 1.049 . . . . 0.0 112.496 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -61.8 -24.73 67.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.184 0.994 . . . . 0.0 112.583 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.46 -35.92 68.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.545 1.138 . . . . 0.0 111.909 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.44 -51.42 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.954 0.902 . . . . 0.0 110.057 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.9 t -57.77 -38.41 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.351 1.06 . . . . 0.0 111.716 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -54.12 -45.75 72.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.021 0.928 . . . . 0.0 112.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -72.31 -43.36 64.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.828 0.74 . . . . 0.0 112.023 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.0 -43.33 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.057 0.844 . . . . 0.0 111.465 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.5 t -74.87 -33.64 62.12 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.083 1.353 . . . . 0.0 113.074 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -64.67 -42.05 95.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.44 107.62 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 169.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.69 -43.63 65.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.39 -1.444 . . . . 0.0 112.544 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -99.82 138.61 36.66 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -138.88 136.51 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.993 1.717 . . . . 0.0 110.836 -173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -103.15 130.6 50.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.089 0.956 . . . . 0.0 112.738 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.4 130.61 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.567 1.547 . . . . 0.0 109.285 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 52.33 37.14 21.56 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.33 1.052 . . . . 0.0 113.413 -175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 61.68 -5.47 0.14 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 127.946 2.498 . . . . 0.0 115.768 -170.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.43 167.33 20.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.697 2.399 . . . . 0.0 109.216 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 98.1 mtp -123.21 143.61 49.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.968 0.907 . . . . 0.0 112.909 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.78 164.54 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.226 2.61 . . . . 0.0 111.653 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -109.31 155.43 21.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.807 0.843 . . . . 0.0 110.826 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.4 p -141.85 154.67 45.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.285 0.634 . . . . 0.0 110.747 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -159.96 -175.36 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.749 1.22 . . . . 0.0 111.729 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -53.39 149.61 7.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.559 1.544 . . . . 0.0 114.637 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 126.698 1.999 . . . . 0.0 109.458 169.874 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.471 0.177 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -148.55 155.3 40.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.222 -0.924 . . . . 0.0 112.542 -167.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.31 153.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.908 1.283 . . . . 0.0 113.137 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -93.71 145.55 24.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.274 2.23 . . . . 0.0 112.237 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.43 139.93 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.759 1.624 . . . . 0.0 110.213 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.77 147.72 17.45 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 118.785 0.72 . . . . 0.0 114.652 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.55 12.04 34.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.667 1.603 . . . . 0.0 114.323 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.49 136.57 55.87 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.121 1.368 . . . . 0.0 112.117 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -65.89 154.98 37.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.169 0.988 . . . . 0.0 112.139 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.96 -17.0 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.655 -0.653 . . . . 0.0 111.327 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -69.73 -30.07 67.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.243 1.017 . . . . 0.0 112.54 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -74.96 131.39 40.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.814 1.645 . . . . 0.0 114.884 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -97.54 167.75 10.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 115.318 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.55 -28.75 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.01 -35.91 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.632 0.773 . . . . 0.0 111.795 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.49 -45.15 94.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 169.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -61.01 -51.25 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.206 1.002 . . . . 0.0 109.232 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.23 -49.49 75.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.436 0.694 . . . . 0.0 112.063 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -60.47 -41.72 94.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.065 0.946 . . . . 0.0 112.554 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -66.48 -48.21 70.58 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.316 54.5 m-85 -65.46 -29.47 70.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.37 -20.91 61.28 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -69.14 -26.47 64.9 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.184 0.902 . . . . 0.0 112.635 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -77.62 -38.52 47.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.65 179.9 41.16 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.406 1.955 . . . . 0.0 111.208 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -64.66 121.82 15.4 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.2 132.54 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.683 1.993 . . . . 0.0 107.827 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.85 -55.96 5.12 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 113.18 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.69 169.54 21.35 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.18 0.992 . . . . 0.0 109.872 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.4 152.95 47.51 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.557 1.543 . . . . 0.0 111.842 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 48.9 mmm -149.2 158.26 44.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.501 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.6 mt -124.19 152.33 43.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.58 1.552 . . . . 0.0 111.581 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 124.104 0.962 . . . . 0.0 110.317 173.759 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -81.96 7.32 13.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.19 10.54 71.21 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.773 1.177 . . . . 0.0 114.598 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.29 11.8 p90 -141.75 159.69 41.7 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.84 -162.43 23.17 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.99 0.805 . . . . 0.0 114.506 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.22 150.12 46.43 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.497 1.919 . . . . 0.0 113.891 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.4 t -133.72 128.14 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.921 1.288 . . . . 0.0 111.59 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.6 m -92.33 140.39 29.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.146 1.378 . . . . 0.0 113.067 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -122.53 152.65 40.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.056 2.142 . . . . 0.0 116.641 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -76.6 -29.13 56.42 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 t -135.83 129.95 33.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.187 0.995 . . . . 0.0 113.577 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 pm0 -62.88 -29.93 71.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.119 1.768 . . . . 0.0 112.791 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.57 -31.51 72.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.45 -46.41 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.766 0.826 . . . . 0.0 110.118 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.1 t -54.46 -43.5 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.265 1.026 . . . . 0.0 109.836 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.2 -53.13 61.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.0 0.92 . . . . 0.0 113.337 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -64.87 -43.0 94.39 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.22 0.918 . . . . 0.0 111.836 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.84 -42.12 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.777 0.717 . . . . 0.0 110.153 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.42 -31.38 68.56 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.87 -36.13 79.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.29 0.95 . . . . 0.0 112.892 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.9 136.13 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.985 0.914 . . . . 0.0 110.235 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.09 160.18 35.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.984 1.314 . . . . 0.0 111.67 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.477 5.3 m-85 63.34 46.79 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -62.29 134.92 57.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.374 1.869 . . . . 0.0 110.885 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -93.34 112.83 24.86 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.463 -0.773 . . . . 0.0 112.57 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.0 mt -132.62 120.34 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.556 0.742 . . . . 0.0 111.311 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 49.62 44.16 24.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.769 1.227 . . . . 0.0 113.109 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.4 m120 62.64 -8.04 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 128.076 2.55 . . . . 0.0 115.852 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -84.56 154.02 22.89 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.593 1.957 . . . . 0.0 109.471 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 57.5 mmm -99.64 139.91 34.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.175 0.59 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.37 160.44 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.815 1.646 . . . . 0.0 114.004 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -123.12 159.2 29.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.706 1.202 . . . . 0.0 111.482 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -144.99 159.18 43.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.245 1.018 . . . . 0.0 112.954 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -145.22 162.14 37.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.422 1.889 . . . . 0.0 111.037 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -58.64 145.82 38.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.673 0.789 . . . . 0.0 112.939 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.683 1.593 . . . . 0.0 110.012 174.529 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -133.73 167.51 20.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.457 1.903 . . . . 0.0 110.825 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 pt -140.88 148.74 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.709 1.204 . . . . 0.0 112.848 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -81.5 148.85 28.99 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.797 1.639 . . . . 0.0 111.189 164.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.35 135.2 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.533 1.533 . . . . 0.0 109.854 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.1 149.27 21.24 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.592 0.633 . . . . 0.0 114.674 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.86 9.03 55.06 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.535 1.54 . . . . 0.0 114.526 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.79 138.48 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.929 1.292 . . . . 0.0 112.018 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -65.23 152.09 44.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.508 0.723 . . . . 0.0 111.192 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 m -72.32 -14.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.579 -0.701 . . . . 0.0 111.696 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -70.43 -31.59 68.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.983 0.913 . . . . 0.0 112.199 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -73.83 141.0 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.794 1.638 . . . . 0.0 113.406 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -123.59 166.3 15.7 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.23 -31.21 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -65.84 -38.09 87.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.053 0.941 . . . . 0.0 112.334 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.8 -43.24 84.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.856 . . . . 0.0 109.547 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.47 -49.42 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.562 1.145 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -62.46 -46.4 88.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.575 0.625 . . . . 0.0 111.781 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -59.7 -42.25 92.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 112.368 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -66.03 -49.47 67.6 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.299 42.5 m-85 -62.93 -27.67 69.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.62 -16.44 48.4 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -65.41 -31.55 72.71 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.51 -35.71 58.18 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.9 175.51 36.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.117 2.294 . . . . 0.0 110.553 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -63.3 133.3 53.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.3 t -112.34 122.54 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.492 1.917 . . . . 0.0 109.492 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -77.31 -45.2 26.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.235 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.83 159.46 41.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.608 1.963 . . . . 0.0 115.18 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.68 152.33 40.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.084 1.354 . . . . 0.0 110.762 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.3 ptp -157.78 147.57 20.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.505 1.122 . . . . 0.0 112.19 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.6 mt -126.93 153.27 46.03 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.593 1.557 . . . . 0.0 111.593 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.5 mmm . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 112.641 -177.358 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.471 0.653 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -74.53 6.3 3.91 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.06 13.5 58.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.023 1.297 . . . . 0.0 114.862 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 16.0 p90 -145.69 161.1 40.67 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.32 -160.38 23.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.216 0.912 . . . . 0.0 114.72 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -136.9 151.97 49.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.245 1.818 . . . . 0.0 114.342 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.15 131.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.505 1.522 . . . . 0.0 111.042 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.8 m -99.06 126.42 44.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.037 1.735 . . . . 0.0 113.243 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -104.2 154.09 20.18 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -74.41 -18.46 60.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.5 t -153.04 141.14 20.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.327 1.051 . . . . 0.0 113.11 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -62.87 -27.4 69.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 112.817 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.34 -28.11 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.47 -48.7 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.765 0.826 . . . . 0.0 110.102 170.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.05 -40.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.065 1.346 . . . . 0.0 110.554 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -56.93 -43.7 81.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.041 0.837 . . . . 0.0 113.134 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -70.63 -43.18 69.76 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.109 0.868 . . . . 0.0 111.994 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.45 -37.54 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.717 0.69 . . . . 0.0 111.477 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 50.4 t -73.6 -41.56 62.69 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 113.092 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -62.43 -38.37 89.48 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.219 -0.925 . . . . 0.0 112.491 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.69 106.5 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -65.53 -55.63 16.74 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.158 -0.963 . . . . 0.0 111.671 -174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.361 63.9 m-85 -103.27 137.0 41.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -131.47 159.66 37.43 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.081 2.553 . . . . 0.0 109.655 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -126.66 125.24 41.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.629 1.104 . . . . 0.0 113.533 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.37 125.75 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.325 1.45 . . . . 0.0 109.757 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 50.17 40.19 21.37 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.237 1.015 . . . . 0.0 112.871 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.05 -8.61 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.308 2.643 . . . . 0.0 116.32 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -79.44 140.64 37.31 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.834 1.654 . . . . 0.0 109.232 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 39.5 mtm -92.33 147.78 22.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 m -138.24 153.49 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.769 2.428 . . . . 0.0 111.533 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.35 150.31 28.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.631 0.773 . . . . 0.0 111.293 170.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.26 142.91 31.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.827 0.851 . . . . 0.0 112.906 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -144.51 156.42 44.16 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.023 1.329 . . . . 0.0 111.626 -168.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -54.9 141.49 33.22 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.917 1.687 . . . . 0.0 111.59 -179.736 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.914 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 m 63.36 21.48 12.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.601 1.96 . . . . 0.0 116.037 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -81.17 178.05 8.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.368 1.067 . . . . 0.0 110.53 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 76.5 mtm -86.94 163.72 16.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.07 1.348 . . . . 0.0 112.412 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -97.64 2.68 50.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -139.61 160.62 39.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.224 1.41 . . . . 0.0 112.196 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.07 151.71 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.907 1.283 . . . . 0.0 112.675 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.57 149.78 25.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.044 1.738 . . . . 0.0 112.519 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.24 138.22 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.417 1.487 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.56 15.0 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.033 0.773 . . . . 0.0 115.033 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.02 14.13 25.45 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.749 1.642 . . . . 0.0 114.397 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.6 139.25 57.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.37 1.468 . . . . 0.0 112.325 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.87 151.67 44.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.72 0.808 . . . . 0.0 111.165 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 t -68.37 -20.67 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.553 -0.717 . . . . 0.0 111.346 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -68.07 -28.94 67.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.528 1.131 . . . . 0.0 113.214 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 60.1 m -79.36 132.77 36.52 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.542 1.537 . . . . 0.0 112.827 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.69 165.9 13.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.17 -31.59 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -74.21 -33.47 63.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.38 0.672 . . . . 0.0 111.735 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.55 -47.98 83.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.099 0.56 . . . . 0.0 112.14 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.94 -45.47 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.106 0.562 . . . . 0.0 110.725 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -42.54 91.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.094 0.558 . . . . 0.0 111.813 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.71 -53.58 32.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.526 1.131 . . . . 0.0 112.774 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -59.2 -34.57 72.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 117.633 2.456 . . . . 0.0 117.633 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.32 38.0 m-85 -70.75 -15.8 62.71 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 173.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.42 -10.97 58.86 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -62.52 -25.6 68.11 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.159 -0.963 . . . . 0.0 113.59 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.77 -30.51 18.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.399 1.08 . . . . 0.0 113.284 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 177.83 36.74 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.97 2.224 . . . . 0.0 110.765 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -61.89 124.96 22.21 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.996 . . . . 0.0 112.375 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.3 t -95.87 125.24 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.753 1.621 . . . . 0.0 107.019 168.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.64 -41.03 19.95 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.835 -0.541 . . . . 0.0 109.688 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -162.69 165.72 25.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.317 2.247 . . . . 0.0 114.987 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.66 154.25 45.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.169 1.388 . . . . 0.0 110.748 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.1 mtp -148.95 152.96 37.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.655 1.582 . . . . 0.0 111.462 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -125.85 150.97 47.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.321 1.448 . . . . 0.0 111.742 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.82 101.08 12.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.601 0.76 . . . . 0.0 111.386 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.263 61.2 m-85 -78.58 137.36 37.84 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -93.24 115.09 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.454 1.102 . . . . 0.0 108.764 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.31 -10.46 59.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.9 p -79.93 -17.12 53.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -128.61 -20.68 3.56 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.27 76.2 m-20 58.24 25.29 12.47 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.828 2.051 . . . . 0.0 114.337 -169.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -109.7 158.48 18.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.366 1.866 . . . . 0.0 110.055 169.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.33 152.61 32.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.62 -0.675 . . . . 0.0 111.871 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -80.64 8.81 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.17 11.59 69.37 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.631 1.11 . . . . 0.0 114.503 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.273 12.3 p90 -144.56 158.75 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.93 -158.22 18.38 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.187 0.899 . . . . 0.0 114.739 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -139.78 151.36 45.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.953 2.101 . . . . 0.0 114.18 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.6 129.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.125 1.37 . . . . 0.0 111.804 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.0 m -94.44 128.89 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.28 1.832 . . . . 0.0 113.045 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -104.98 150.31 25.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.14 -35.7 81.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 113.048 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.1 t -147.45 141.22 25.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.667 1.187 . . . . 0.0 112.652 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.35 -26.25 68.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.292 1.437 . . . . 0.0 113.474 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.9 -27.43 66.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.6 mm -77.74 -50.1 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.777 0.831 . . . . 0.0 109.89 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 66.9 t -54.84 -35.12 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.155 1.382 . . . . 0.0 111.576 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -48.91 -51.05 32.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -70.36 -44.18 68.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.555 0.616 . . . . 0.0 111.606 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.25 -47.18 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 18.9 t -74.51 -29.58 61.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.558 1.143 . . . . 0.0 112.53 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.52 -41.4 93.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.947 -1.096 . . . . 0.0 112.047 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.75 119.85 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -68.39 -59.14 3.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.993 -1.067 . . . . 0.0 111.36 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.302 61.3 m-85 -101.81 139.18 37.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -176.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -135.79 135.53 39.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.554 1.942 . . . . 0.0 110.819 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -80.85 135.84 36.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.309 0.644 . . . . 0.0 111.904 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.7 mt -144.89 122.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.732 2.013 . . . . 0.0 108.383 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 50.48 38.65 18.94 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.3 t30 62.78 -12.5 0.07 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 128.112 2.565 . . . . 0.0 115.942 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -73.36 141.81 47.04 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.307 -1.495 . . . . 0.0 108.594 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 51.8 mtm -94.32 142.45 27.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.078 0.854 . . . . 0.0 112.346 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.67 153.35 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.325 2.25 . . . . 0.0 111.311 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.44 157.06 16.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 112.106 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.7 p -133.93 157.27 46.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.537 0.735 . . . . 0.0 112.063 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -145.9 171.59 14.59 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.981 1.712 . . . . 0.0 111.327 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -61.07 149.51 36.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.124 0.97 . . . . 0.0 113.217 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -150.24 149.28 29.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.137 1.375 . . . . 0.0 111.275 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.63 145.17 96.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.57 169.15 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.853 3.035 . . . . 0.0 112.434 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -140.95 130.33 23.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.282 1.433 . . . . 0.0 110.69 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.06 123.47 25.84 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.96 0.904 . . . . 0.0 111.776 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 p -152.02 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 27.7 ptm -74.69 168.8 19.11 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.427 1.491 . . . . 0.0 112.746 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.4 t -145.91 122.49 5.91 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.692 1.197 . . . . 0.0 110.77 170.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -82.09 -10.07 11.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.445 2.764 . . . . 0.0 113.713 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.362 0.2 OUTLIER -71.24 35.97 0.05 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -169.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -73.55 175.17 47.02 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.562 1.077 . . . . 0.0 113.406 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 t -151.85 141.41 21.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.419 1.088 . . . . 0.0 112.152 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.93 55.9 1.84 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.899 1.68 . . . . 0.0 112.733 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -63.82 148.03 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.189 1.396 . . . . 0.0 112.909 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 175.46 -173.04 46.0 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.963 1.268 . . . . 0.0 113.334 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -151.69 169.11 22.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.763 1.625 . . . . 0.0 112.565 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.404 1.482 . . . . 0.0 113.122 168.272 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 143.57 51.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.31 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -80.51 157.76 26.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.966 1.306 . . . . 0.0 113.129 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 148.7 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.372 1.069 . . . . 0.0 112.748 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.21 7.82 44.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.465 1.506 . . . . 0.0 113.719 170.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -133.22 159.31 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.547 1.139 . . . . 0.0 112.865 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.94 152.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 112.861 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -86.44 148.71 25.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 112.317 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.5 135.88 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.428 1.491 . . . . 0.0 109.421 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.41 146.71 15.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.97 10.29 32.66 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.828 1.68 . . . . 0.0 114.287 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.06 141.09 58.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.342 1.457 . . . . 0.0 112.321 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -68.81 156.77 37.77 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.791 0.836 . . . . 0.0 112.588 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.38 -27.72 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.649 0.78 . . . . 0.0 110.067 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -64.91 -31.84 73.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.972 0.909 . . . . 0.0 112.696 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 135.53 50.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.015 1.326 . . . . 0.0 113.426 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.88 166.64 13.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.177 1.391 . . . . 0.0 114.635 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.74 -32.75 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -34.84 78.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.85 0.86 . . . . 0.0 112.744 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -67.18 -45.37 77.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.698 0.799 . . . . 0.0 109.853 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.85 -48.08 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.702 1.201 . . . . 0.0 110.428 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -62.53 -47.33 84.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 111.93 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.13 -40.98 87.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.747 0.819 . . . . 0.0 112.419 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -65.89 -51.55 57.72 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 46.9 m-85 -64.17 -25.85 68.26 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -60.74 -17.51 49.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.21 -29.47 70.28 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.369 -0.832 . . . . 0.0 113.058 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.53 -36.19 38.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.5 33.43 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.219 2.342 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.81 124.64 21.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.349 1.074 . . . . 0.0 112.723 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.46 118.45 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.251 1.42 . . . . 0.0 108.637 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.19 -31.6 43.89 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -162.05 160.4 27.46 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.938 1.295 . . . . 0.0 109.516 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.87 152.29 31.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.15 1.38 . . . . 0.0 111.093 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -156.77 156.05 32.64 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.377 1.071 . . . . 0.0 112.323 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.03 149.54 44.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.619 1.568 . . . . 0.0 110.391 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 70.3 mtp -79.33 72.45 5.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 112.201 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -59.78 141.85 54.46 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -132.35 116.97 17.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 113.051 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -64.08 -19.49 65.27 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.5 p -79.39 -13.47 59.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 172.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -125.23 -16.12 6.05 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 58.84 25.86 14.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.653 1.981 . . . . 0.0 114.648 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -149.27 172.1 15.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.553 1.941 . . . . 0.0 110.749 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -81.8 153.28 26.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.364 0.602 . . . . 0.0 111.839 170.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.06 8.76 2.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.49 13.9 66.93 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.855 1.217 . . . . 0.0 114.329 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.269 8.9 p90 -146.49 160.09 42.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.16 -162.15 21.94 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.221 0.915 . . . . 0.0 114.797 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -138.24 147.3 43.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.88 2.072 . . . . 0.0 114.447 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.71 125.47 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 111.159 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 m -96.42 123.3 40.03 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 111.739 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.29 152.59 18.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -67.67 -34.16 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.541 -0.724 . . . . 0.0 112.399 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.5 t -142.87 137.73 29.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.464 1.126 . . . . 0.0 113.845 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -56.3 -27.36 55.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.117 2.167 . . . . 0.0 112.972 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.92 -28.38 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.72 -48.62 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.893 0.877 . . . . 0.0 109.786 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.02 -38.98 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.075 1.35 . . . . 0.0 110.998 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.62 -34.34 67.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.93 -48.36 14.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.02 0.827 . . . . 0.0 111.713 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.89 -44.73 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.964 0.802 . . . . 0.0 112.558 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.12 -21.45 58.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.011 1.324 . . . . 0.0 112.907 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -78.02 -34.68 50.52 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.946 -1.096 . . . . 0.0 112.396 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.56 139.94 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.691 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -127.08 156.69 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 0.0 113.108 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.466 24.9 m-85 60.31 49.27 7.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -58.86 133.47 56.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.858 2.063 . . . . 0.0 110.993 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -98.66 126.51 44.29 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.287 0.948 . . . . 0.0 113.155 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 mt -142.57 123.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.951 1.7 . . . . 0.0 109.392 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 50.36 41.54 24.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.39 1.076 . . . . 0.0 113.55 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 64.89 -13.41 0.11 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 127.822 2.449 . . . . 0.0 116.002 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -73.9 155.43 38.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.069 1.748 . . . . 0.0 109.283 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.4 ptm -120.77 136.06 54.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.874 0.87 . . . . 0.0 111.188 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.77 143.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.808 1.643 . . . . 0.0 113.602 -169.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -87.02 159.24 19.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.268 0.556 . . . . 0.0 111.353 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.5 p -138.13 155.96 48.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.122 0.969 . . . . 0.0 111.583 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -146.15 167.73 22.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.682 1.593 . . . . 0.0 110.865 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -58.9 151.47 21.62 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.591 -0.693 . . . . 0.0 112.248 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.07 144.29 50.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.283 1.433 . . . . 0.0 110.138 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.71 142.84 97.78 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -68.54 164.75 31.67 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.729 2.953 . . . . 0.0 112.989 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -142.78 155.41 44.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.196 1.798 . . . . 0.0 110.729 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -74.03 61.56 0.83 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.631 1.572 . . . . 0.0 113.366 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.7 t -67.4 142.56 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.939 1.295 . . . . 0.0 111.768 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.45 167.36 8.82 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.437 1.095 . . . . 0.0 113.117 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.2 t -135.54 117.89 12.36 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.005 1.322 . . . . 0.0 109.358 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.44 145.22 26.48 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.97 2.446 . . . . 0.0 112.993 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.7 t -154.57 158.76 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.547 1.539 . . . . 0.0 114.075 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 174.03 155.92 12.78 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.508 1.051 . . . . 0.0 113.755 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.7 t -159.35 152.54 22.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.686 1.594 . . . . 0.0 110.838 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.988 1.315 . . . . 0.0 112.079 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 45.8 ttm105 -77.52 141.22 39.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 111.423 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 175.92 177.04 44.63 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.229 0.919 . . . . 0.0 114.025 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ttt-85 -68.2 147.14 52.66 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.675 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.255 1.357 0 C-N-CA 124.992 1.317 . . . . 0.0 112.361 168.571 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.176 -0.369 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 81.2 p -146.31 20.5 1.37 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.264 1.426 . . . . 0.0 113.483 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -77.7 48.85 0.71 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.389 2.275 . . . . 0.0 113.772 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 75.1 mtm -68.51 151.97 46.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.844 1.658 . . . . 0.0 113.078 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -130.49 35.57 4.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.644 1.577 . . . . 0.0 112.137 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -149.29 154.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.612 1.165 . . . . 0.0 110.641 -171.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.51 150.77 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.361 1.064 . . . . 0.0 112.884 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.44 145.51 25.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.367 1.867 . . . . 0.0 111.912 166.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.21 137.83 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.614 1.566 . . . . 0.0 110.117 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.28 147.18 17.07 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 114.688 0.635 . . . . 0.0 114.688 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.96 13.21 29.9 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.693 1.616 . . . . 0.0 114.649 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.54 137.95 58.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.729 1.264 . . . . 0.0 112.205 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -64.72 156.43 30.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.714 1.206 . . . . 0.0 112.821 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 m -71.86 -16.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.252 0.621 . . . . 0.0 111.349 168.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.02 -38.12 85.37 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 111.739 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.15 146.97 54.28 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 t -133.2 166.45 22.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.388 1.875 . . . . 0.0 112.76 169.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.73 -33.33 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.0 -39.89 87.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.436 0.694 . . . . 0.0 112.149 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.9 -43.52 95.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.77 -47.2 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.204 0.602 . . . . 0.0 110.467 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.77 -48.19 82.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.591 0.632 . . . . 0.0 111.803 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -60.8 -39.03 87.38 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -68.3 -40.74 81.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.323 52.8 m-85 -71.32 -29.82 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.44 -18.1 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -65.71 -24.9 67.09 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.295 -0.878 . . . . 0.0 112.884 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.27 -29.32 26.54 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.94 178.87 36.21 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.57 2.033 . . . . 0.0 110.921 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.86 116.3 6.21 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.654 -0.91 . . . . 0.0 112.549 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.65 130.68 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.844 1.658 . . . . 0.0 107.146 169.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.38 -54.07 7.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.673 0.789 . . . . 0.0 112.918 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.84 165.94 29.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.528 1.131 . . . . 0.0 110.003 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.93 149.8 37.38 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.588 1.555 . . . . 0.0 111.647 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.9 mtp -148.41 152.17 36.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.555 1.542 . . . . 0.0 111.713 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.8 mt -125.88 154.11 43.2 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.04 1.336 . . . . 0.0 111.92 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.1 mmm -84.12 103.98 13.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.642 0.777 . . . . 0.0 110.664 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.337 58.7 m-85 -77.18 145.65 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -111.49 114.2 27.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.202 1.801 . . . . 0.0 111.199 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -60.19 -23.29 63.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.609 1.164 . . . . 0.0 113.538 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -24.46 65.09 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 p -136.92 -15.94 1.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -171.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 60.55 14.91 5.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.62 1.968 . . . . 0.0 114.366 -169.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -101.12 174.08 6.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.199 1.8 . . . . 0.0 110.705 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -79.22 158.37 27.64 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.508 0.67 . . . . 0.0 112.346 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -73.73 0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.691 1.996 . . . . 0.0 115.603 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.19 9.01 65.91 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.714 1.15 . . . . 0.0 113.88 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 17.6 p90 -144.99 158.82 43.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.74 -158.66 19.36 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.228 0.918 . . . . 0.0 114.693 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.69 148.95 47.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.605 1.962 . . . . 0.0 114.02 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 t -133.81 132.0 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.132 1.373 . . . . 0.0 111.38 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.8 m -98.52 139.83 33.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.353 1.861 . . . . 0.0 113.954 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.56 154.96 34.66 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.49 -32.58 70.15 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -150.02 146.55 27.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.44 1.096 . . . . 0.0 113.14 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.15 -28.43 69.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.809 1.244 . . . . 0.0 112.613 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.57 -31.79 71.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.9 mm -76.86 -46.12 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.711 0.804 . . . . 0.0 110.152 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.38 -41.13 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.688 1.195 . . . . 0.0 110.252 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -57.72 -49.93 74.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.038 0.836 . . . . 0.0 113.137 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.53 -44.78 81.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.764 0.711 . . . . 0.0 111.779 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.15 -45.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.534 0.607 . . . . 0.0 110.138 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.5 t -67.83 -36.19 79.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.391 1.077 . . . . 0.0 112.745 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -66.68 -41.03 88.77 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.13 -0.981 . . . . 0.0 112.657 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mt -67.01 134.42 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.682 0.793 . . . . 0.0 110.496 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -112.12 148.64 33.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.128 1.371 . . . . 0.0 111.586 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.49 29.3 m-85 57.16 57.02 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -175.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -63.59 128.92 38.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.471 1.508 . . . . 0.0 111.405 173.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.06 133.46 36.12 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.84 0.745 . . . . 0.0 112.264 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.4 mt -146.34 124.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.974 2.11 . . . . 0.0 108.235 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.6 m120 50.98 43.23 28.94 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.175 0.99 . . . . 0.0 113.167 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.78 -13.99 0.08 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.262 2.625 . . . . 0.0 116.485 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.08 169.97 17.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.819 2.047 . . . . 0.0 109.28 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.2 ptp -127.33 146.11 50.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.852 0.861 . . . . 0.0 113.193 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.38 164.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.935 2.494 . . . . 0.0 112.894 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -128.25 158.38 38.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.504 0.722 . . . . 0.0 111.893 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.53 157.42 44.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 113.37 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -142.27 159.07 42.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.167 1.787 . . . . 0.0 111.256 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.15 144.5 45.62 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.577 0.626 . . . . 0.0 112.542 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.63 148.81 46.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.346 1.458 . . . . 0.0 111.07 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -71.31 138.09 84.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 121.728 -0.608 . . . . 0.0 111.74 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.51 148.44 83.73 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.207 2.605 . . . . 0.0 112.123 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -120.94 13.79 11.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.513 1.925 . . . . 0.0 112.265 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -156.45 161.99 40.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.297 2.639 . . . . 0.0 110.181 -171.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.47 145.45 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.7 ptm -71.76 163.68 27.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.519 1.128 . . . . 0.0 112.458 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.1 t -113.62 101.91 54.23 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.727 1.211 . . . . 0.0 109.922 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.15 -12.55 11.7 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.328 2.686 . . . . 0.0 114.006 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.273 1.0 OUTLIER -72.8 160.44 32.17 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 74.65 -162.8 54.16 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.339 0.971 . . . . 0.0 114.195 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 41.0 t -154.98 150.67 27.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.188 1.395 . . . . 0.0 112.031 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.15 -2.69 35.64 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.071 1.348 . . . . 0.0 114.117 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -60.58 156.67 15.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.3 1.44 . . . . 0.0 113.431 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -173.98 -168.68 35.25 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.87 1.224 . . . . 0.0 113.355 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 65.13 146.88 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 128.21 2.604 . . . . 0.0 114.438 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.206 1.802 . . . . 0.0 113.695 -178.829 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 64.1 m -74.87 -16.17 60.69 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -75.02 66.92 1.65 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.524 1.53 . . . . 0.0 112.176 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 24.9 ptp -82.55 -11.07 58.7 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -152.79 56.01 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.058 1.343 . . . . 0.0 111.538 -170.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -136.4 155.99 49.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.755 1.622 . . . . 0.0 112.485 -168.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.43 ' CG2' HG13 ' A' ' 163' ' ' VAL . 7.5 pt -136.26 157.52 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.571 1.549 . . . . 0.0 113.379 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -94.09 147.34 23.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.173 2.189 . . . . 0.0 113.29 167.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.4 t -137.31 138.93 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.727 1.611 . . . . 0.0 110.061 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.77 154.16 25.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.704 0.669 . . . . 0.0 114.414 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.12 15.02 31.83 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.379 1.466 . . . . 0.0 114.596 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.66 143.03 58.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.004 1.322 . . . . 0.0 112.493 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 p -76.51 175.5 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.453 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 m -81.61 -24.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 0.0 112.684 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -77.32 -33.3 55.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.194 0.998 . . . . 0.0 111.663 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.8 m -65.44 143.97 57.35 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.246 1.418 . . . . 0.0 113.356 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 t -142.72 173.42 11.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.26 1.824 . . . . 0.0 112.715 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.52 -34.15 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.58 -38.67 84.39 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.879 0.872 . . . . 0.0 112.165 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.64 -43.24 85.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.1 t -58.66 -46.88 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.388 0.675 . . . . 0.0 109.867 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -60.57 -46.94 88.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.427 0.558 . . . . 0.0 111.887 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -61.43 -45.09 95.76 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -66.61 -38.75 87.63 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.333 46.7 m-85 -71.62 -29.84 65.12 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.91 -18.93 48.64 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -66.17 -24.96 66.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.494 0.718 . . . . 0.0 112.746 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.67 -34.86 30.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.43 169.54 28.13 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.059 2.266 . . . . 0.0 110.466 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -57.49 130.42 46.23 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.953 0.901 . . . . 0.0 112.768 -170.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.81 122.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.465 1.506 . . . . 0.0 108.249 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.08 -40.02 63.05 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -156.52 154.84 30.97 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.062 2.145 . . . . 0.0 114.646 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.38 142.72 30.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.359 1.064 . . . . 0.0 110.7 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.2 mtm -150.38 151.83 33.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.499 1.52 . . . . 0.0 111.649 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.98 156.86 31.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.173 1.389 . . . . 0.0 111.694 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.4 tpp -79.3 127.51 32.15 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.752 0.821 . . . . 0.0 110.205 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -111.75 155.61 23.23 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 117.603 2.446 . . . . 0.0 117.603 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -111.99 106.83 15.6 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.881 1.272 . . . . 0.0 112.053 168.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -61.74 -16.67 51.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 -22.51 66.05 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.9 p -139.01 -15.74 1.12 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.49 15.35 5.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.058 2.143 . . . . 0.0 114.95 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -83.29 150.31 26.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 110.609 169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -79.41 156.43 27.92 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -86.37 8.23 22.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.85 6.37 67.41 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.136 1.35 . . . . 0.0 115.035 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -146.38 162.77 37.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.03 -158.14 20.24 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.186 0.898 . . . . 0.0 114.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -135.97 151.06 49.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.28 1.832 . . . . 0.0 114.547 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -135.42 123.74 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.151 1.38 . . . . 0.0 111.468 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 m -87.79 129.04 35.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.163 1.385 . . . . 0.0 113.125 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.86 160.26 14.44 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -62.24 -39.69 93.7 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.418 -0.801 . . . . 0.0 112.038 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.2 t -149.21 148.57 29.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.728 1.211 . . . . 0.0 113.592 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -57.83 -27.5 63.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 112.674 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.82 -21.86 66.22 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.46 -50.38 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.739 0.816 . . . . 0.0 109.819 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.43 HG13 ' CG2' ' A' ' 111' ' ' ILE . 38.8 t -52.94 -38.67 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.281 1.433 . . . . 0.0 111.275 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -60.33 -43.17 96.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -68.29 -37.76 80.98 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.666 0.667 . . . . 0.0 111.552 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.67 -37.74 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.482 0.583 . . . . 0.0 110.996 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 85.6 m -77.65 -28.85 51.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.243 1.417 . . . . 0.0 114.585 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -69.06 -38.41 79.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.048 0.84 . . . . 0.0 112.939 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.8 mt -74.61 140.86 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.796 0.838 . . . . 0.0 109.94 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -130.44 164.04 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.478 1.111 . . . . 0.0 112.666 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.331 57.5 m-85 60.87 40.67 15.43 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -57.39 131.87 51.4 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 111.584 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.22 128.97 34.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.368 -0.833 . . . . 0.0 112.27 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.26 120.86 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.358 1.863 . . . . 0.0 108.812 172.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 50.58 40.6 24.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.844 0.858 . . . . 0.0 113.04 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 63.25 -12.97 0.08 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 128.203 2.601 . . . . 0.0 116.421 -171.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -74.02 142.91 45.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.829 1.652 . . . . 0.0 109.052 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 34.3 mtt -89.06 141.0 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.244 -0.91 . . . . 0.0 112.487 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.3 159.49 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.297 2.239 . . . . 0.0 111.916 173.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.83 154.64 44.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 110.166 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.4 p -140.31 159.62 41.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.027 0.931 . . . . 0.0 113.292 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -141.48 158.94 43.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.735 1.614 . . . . 0.0 110.653 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -62.4 140.19 58.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -122.43 24.57 9.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.707 1.603 . . . . 0.0 110.71 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.21 157.68 39.34 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 127.666 2.386 . . . . 0.0 110.791 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.4 133.14 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.791 2.994 . . . . 0.0 112.334 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -56.45 135.08 54.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.435 -0.79 . . . . 0.0 112.107 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -123.56 150.77 43.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.17 1.388 . . . . 0.0 110.935 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.87 127.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.469 1.508 . . . . 0.0 110.369 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 63.4 mtt -144.98 153.14 41.19 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.437 1.495 . . . . 0.0 111.492 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.8 m -134.55 60.34 41.99 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.808 1.243 . . . . 0.0 112.799 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.2 146.97 87.75 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.097 2.531 . . . . 0.0 111.992 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.1 t -152.87 159.39 43.02 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 176.67 148.3 7.01 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.707 1.622 . . . . 0.0 112.231 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.3 p -158.64 164.22 36.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.626 1.17 . . . . 0.0 112.935 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -149.65 156.25 41.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.61 153.87 42.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.034 0.934 . . . . 0.0 113.245 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -77.57 169.63 54.81 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.443 1.021 . . . . 0.0 113.308 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -65.93 148.34 51.95 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.506 1.122 . . . . 0.0 112.749 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.52 1.528 . . . . 0.0 113.407 -178.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.6 m -78.83 -8.35 58.72 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -67.8 151.76 46.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.2 1.4 . . . . 0.0 113.07 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -79.38 155.97 28.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.004 0.922 . . . . 0.0 111.341 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -148.61 63.35 1.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.819 1.648 . . . . 0.0 108.996 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -137.18 151.95 49.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.407 1.883 . . . . 0.0 111.325 -167.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -134.01 153.76 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.658 1.183 . . . . 0.0 113.285 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -88.93 146.47 24.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.613 1.965 . . . . 0.0 112.747 166.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.48 132.87 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.694 1.598 . . . . 0.0 109.769 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.04 145.91 14.52 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 114.623 0.609 . . . . 0.0 114.623 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.09 11.37 32.19 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.633 1.587 . . . . 0.0 114.436 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.75 138.44 58.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.196 1.398 . . . . 0.0 111.947 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -69.4 156.93 38.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.507 1.123 . . . . 0.0 112.447 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.36 -16.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.618 -0.676 . . . . 0.0 111.62 168.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -73.47 -7.57 52.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.604 1.562 . . . . 0.0 114.238 169.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER -92.02 151.67 20.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -139.64 161.31 37.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.887 1.275 . . . . 0.0 113.953 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.39 -33.23 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -68.37 -38.85 81.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.541 0.736 . . . . 0.0 112.318 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -67.44 -38.86 85.18 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.55 -51.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.398 1.079 . . . . 0.0 109.322 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.78 -43.56 98.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.008 0.822 . . . . 0.0 112.352 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -59.89 -39.29 84.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.752 0.821 . . . . 0.0 112.665 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -66.79 -48.37 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.313 55.6 m-85 -64.16 -29.97 71.06 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -57.37 -22.64 44.04 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.476 1.51 . . . . 0.0 114.65 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.66 -24.85 62.77 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.192 -0.943 . . . . 0.0 112.761 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -79.25 -37.91 36.83 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.58 172.04 35.03 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.593 2.044 . . . . 0.0 110.895 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.07 130.76 48.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.766 0.783 . . . . 0.0 112.579 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.4 t -99.12 131.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.138 1.775 . . . . 0.0 108.493 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -79.12 -54.14 6.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.82 0.848 . . . . 0.0 112.952 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -152.86 157.27 40.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.019 1.327 . . . . 0.0 110.57 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.4 141.08 23.52 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.022 1.329 . . . . 0.0 110.915 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 54.5 mmm -149.85 153.21 36.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.666 1.586 . . . . 0.0 112.341 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.38 152.98 39.63 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.423 1.489 . . . . 0.0 110.648 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.2 mtp -85.08 116.23 23.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.894 -0.503 . . . . 0.0 110.36 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.293 58.3 m-85 -90.57 148.33 22.76 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.417 2.747 . . . . 0.0 118.417 -173.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -102.6 112.94 25.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.518 1.527 . . . . 0.0 110.357 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.21 -32.64 71.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.686 1.195 . . . . 0.0 114.008 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.252 1.2 p -72.86 -20.06 61.18 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.5 p -118.63 -19.73 8.61 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.4 t30 57.2 26.25 11.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.928 1.691 . . . . 0.0 113.245 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -107.68 158.86 16.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.7 1.6 . . . . 0.0 110.506 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -75.04 159.04 32.21 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.529 0.681 . . . . 0.0 111.607 173.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -79.26 5.52 12.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.294 1.838 . . . . 0.0 114.643 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.34 6.11 63.08 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.468 1.509 . . . . 0.0 114.334 -170.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.255 10.9 p90 -147.69 157.0 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.67 -162.3 22.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.507 1.051 . . . . 0.0 114.63 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -138.54 148.62 44.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.338 1.855 . . . . 0.0 114.112 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.34 124.3 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.138 1.375 . . . . 0.0 111.64 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 135.7 33.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.504 1.522 . . . . 0.0 113.741 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.19 156.0 20.39 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.14 -28.87 65.71 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.2 t -150.39 141.52 23.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.57 1.148 . . . . 0.0 112.89 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -59.63 -26.56 65.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 113.234 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.59 -29.33 69.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.3 mm -78.24 -46.36 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.771 0.828 . . . . 0.0 110.074 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.23 -43.09 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.965 1.306 . . . . 0.0 110.522 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.9 -46.36 65.6 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.64 -0.662 . . . . 0.0 112.076 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.65 -37.24 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.042 0.837 . . . . 0.0 111.638 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.83 -35.1 67.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.887 1.275 . . . . 0.0 112.765 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -68.8 -37.95 79.61 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.208 -0.932 . . . . 0.0 112.661 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.19 139.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 110.636 174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -129.88 161.97 29.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.399 1.48 . . . . 0.0 111.426 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.44 8.1 m-30 64.46 46.07 3.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -68.13 122.42 18.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.974 2.11 . . . . 0.0 111.056 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -86.93 121.34 29.27 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.545 1.066 . . . . 0.0 113.467 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.5 mt -143.21 124.74 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.277 1.431 . . . . 0.0 109.6 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 48.04 49.84 16.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.33 1.452 . . . . 0.0 113.02 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 64.92 -12.32 0.13 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.905 2.882 . . . . 0.0 116.575 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -86.08 165.37 16.68 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.361 2.264 . . . . 0.0 110.304 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 44.5 mtm -122.09 143.13 49.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.639 0.775 . . . . 0.0 112.485 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.72 163.58 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.912 2.085 . . . . 0.0 113.642 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -115.18 148.75 38.67 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.138 1.375 . . . . 0.0 111.896 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 81.2 m -120.57 152.35 38.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.857 1.263 . . . . 0.0 112.508 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.92 158.24 43.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.579 1.552 . . . . 0.0 111.2 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.662 -0.649 . . . . 0.0 111.002 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.22 32.2 5.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.68 . . . . 0.0 110.571 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.72 31.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 127.647 2.379 . . . . 0.0 110.764 -173.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -59.84 162.62 15.47 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.713 2.942 . . . . 0.0 116.257 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -79.6 56.9 2.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.283 1.433 . . . . 0.0 110.317 169.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.65 135.19 51.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.848 1.259 . . . . 0.0 112.474 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.7 136.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.816 1.246 . . . . 0.0 113.21 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.83 155.18 37.05 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.624 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.9 t -145.21 80.67 10.92 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.556 1.142 . . . . 0.0 110.486 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.98 152.71 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.453 2.769 . . . . 0.0 112.335 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 t -150.56 159.36 44.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.216 1.407 . . . . 0.0 114.655 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 172.97 -179.77 44.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.821 1.201 . . . . 0.0 113.784 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.1 t -154.37 162.37 41.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 110.815 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.15 135.29 56.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.038 0.935 . . . . 0.0 112.451 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -78.51 -5.84 53.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 63.74 -146.16 50.22 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.193 0.902 . . . . 0.0 113.458 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.09 154.01 51.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.923 1.689 . . . . 0.0 112.125 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.809 1.643 . . . . 0.0 114.1 176.724 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p -85.78 -165.89 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.488 1.115 . . . . 0.0 111.796 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -64.83 -7.82 12.7 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 25.4 ptm -142.09 145.89 34.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.723 1.209 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -151.67 31.68 0.57 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.625 1.57 . . . . 0.0 110.034 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -152.82 146.36 24.98 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.442 1.497 . . . . 0.0 111.031 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.2 pt -138.21 149.66 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -83.32 147.89 27.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.411 1.885 . . . . 0.0 111.724 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.35 136.5 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.266 1.426 . . . . 0.0 109.584 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.37 147.76 18.25 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.52 39.27 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.706 1.622 . . . . 0.0 114.552 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.4 mt -65.01 139.88 58.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 112.494 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 t -64.76 156.8 29.36 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.575 1.15 . . . . 0.0 112.4 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.91 -25.28 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.899 0.88 . . . . 0.0 109.504 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.741 0.816 . . . . 0.0 112.592 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -75.23 125.51 29.1 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.52 1.528 . . . . 0.0 115.095 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -91.91 167.82 11.85 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.95 -29.71 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.23 -38.3 63.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.313 0.645 . . . . 0.0 111.537 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.28 -44.93 92.44 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.31 -50.81 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.37 1.068 . . . . 0.0 109.115 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -62.01 -45.86 91.74 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.842 0.746 . . . . 0.0 111.88 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.62 -42.38 98.81 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.97 0.908 . . . . 0.0 112.592 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -63.55 -48.63 76.67 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.305 52.0 m-85 -65.29 -30.54 71.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -61.6 -19.12 61.87 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 172.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -68.59 -24.64 64.61 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.143 0.883 . . . . 0.0 112.712 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -80.86 -38.22 28.52 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.98 0.912 . . . . 0.0 113.012 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 170.37 30.82 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.904 2.192 . . . . 0.0 110.981 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -169.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.32 120.36 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 109.109 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.92 -42.44 69.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.829 1.252 . . . . 0.0 114.24 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -155.94 155.25 32.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.074 2.15 . . . . 0.0 114.874 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.65 141.7 27.14 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.426 1.09 . . . . 0.0 110.692 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.1 mtm -151.0 146.12 26.01 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.343 1.457 . . . . 0.0 111.713 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.9 mt -125.15 156.15 38.81 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.268 1.427 . . . . 0.0 111.49 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 mmt -78.53 67.76 4.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.155 0.982 . . . . 0.0 113.01 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -58.83 147.06 35.0 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -122.35 122.69 39.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.903 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -32.29 70.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.219 1.408 . . . . 0.0 113.751 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.259 1.1 p -75.33 -21.88 58.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.6 p -108.12 -19.14 13.59 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 58.17 25.65 12.79 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.233 1.813 . . . . 0.0 114.445 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -142.89 164.78 29.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.146 1.778 . . . . 0.0 111.241 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -89.33 161.03 16.57 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.876 0.87 . . . . 0.0 112.888 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -75.7 3.96 8.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.973 1.709 . . . . 0.0 115.138 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.16 12.06 59.21 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.243 1.401 . . . . 0.0 114.804 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -147.58 159.88 43.26 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.85 -156.16 15.78 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 114.957 0.743 . . . . 0.0 114.957 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -134.47 147.12 50.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.612 1.965 . . . . 0.0 115.202 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.48 126.47 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.63 1.572 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.1 m -99.69 130.39 45.91 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.307 1.443 . . . . 0.0 112.693 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.6 152.72 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -67.17 -33.49 75.52 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.4 t -148.06 143.88 27.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.608 1.163 . . . . 0.0 113.035 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -58.51 -26.67 63.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 113.143 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -58.7 -27.94 65.32 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.33 -50.51 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.47 0.708 . . . . 0.0 110.163 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.12 -37.3 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.855 1.262 . . . . 0.0 112.492 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -55.07 -38.17 67.71 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.79 -48.05 27.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.765 0.711 . . . . 0.0 111.721 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.45 -44.52 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 118.739 0.7 . . . . 0.0 112.651 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 25.1 t -73.26 -29.84 63.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.659 1.184 . . . . 0.0 112.427 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -70.34 -38.03 74.76 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.077 -1.014 . . . . 0.0 112.677 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.3 mt -66.06 139.57 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.752 0.821 . . . . 0.0 110.577 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -125.54 149.9 47.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.353 1.461 . . . . 0.0 111.104 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.458 24.6 m-85 58.31 53.3 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -59.0 124.72 20.85 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.803 2.041 . . . . 0.0 111.423 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -93.6 124.22 37.45 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.3 mt -143.53 125.65 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.548 1.539 . . . . 0.0 109.324 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 49.73 42.7 23.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.398 1.079 . . . . 0.0 113.443 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 63.06 -11.05 0.09 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 128.212 2.605 . . . . 0.0 116.236 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -77.9 161.52 27.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.149 1.78 . . . . 0.0 109.336 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.1 ptp -122.32 144.33 49.07 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.8 164.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.678 2.391 . . . . 0.0 112.949 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -133.66 160.79 36.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.664 0.786 . . . . 0.0 112.278 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.46 157.6 45.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 0.0 113.679 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -144.07 162.82 35.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.666 1.986 . . . . 0.0 110.646 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -63.46 152.15 39.18 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.402 1.001 . . . . 0.0 111.621 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -120.4 15.52 12.12 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -141.42 152.83 64.88 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.691 1.596 . . . . 0.0 112.001 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.35 139.5 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.239 2.626 . . . . 0.0 111.861 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -76.34 161.37 28.77 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -142.27 150.35 40.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.718 1.607 . . . . 0.0 110.629 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.7 42.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.836 2.055 . . . . 0.0 113.787 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 55.7 mtt -60.76 151.8 28.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.502 1.521 . . . . 0.0 113.162 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.2 p -134.87 68.84 71.41 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 111.868 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.02 -14.2 26.22 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.722 2.948 . . . . 0.0 114.431 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.267 1.2 p -65.15 152.28 43.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 173.37 -166.87 39.4 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.551 1.072 . . . . 0.0 113.333 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.7 t -151.75 158.19 43.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.26 1.424 . . . . 0.0 111.492 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -147.53 159.59 43.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.845 1.658 . . . . 0.0 111.521 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -120.46 158.71 26.64 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.493 1.917 . . . . 0.0 111.702 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -176.01 169.84 42.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.715 1.15 . . . . 0.0 113.342 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -69.5 156.18 39.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.716 1.206 . . . . 0.0 112.887 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.4 p . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.821 1.648 . . . . 0.0 114.406 174.663 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -66.54 151.42 47.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.552 1.141 . . . . 0.0 113.501 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -63.46 150.23 44.2 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.341 1.456 . . . . 0.0 111.553 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 70.4 mtp -135.94 134.36 38.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.396 1.078 . . . . 0.0 111.424 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -115.45 7.23 14.95 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -142.07 154.4 44.91 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.901 -1.125 . . . . 0.0 112.464 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.42 154.32 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 113.425 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -91.61 146.2 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.361 2.264 . . . . 0.0 112.768 167.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.29 135.98 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.354 1.462 . . . . 0.0 109.595 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.74 154.64 25.84 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.785 0.707 . . . . 0.0 114.256 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.59 16.05 41.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.675 1.131 . . . . 0.0 114.0 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -67.2 159.47 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.228 . . . . 0.0 111.314 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.6 p -128.92 -168.8 1.98 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.332 1.053 . . . . 0.0 111.847 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.7 m -75.82 -15.44 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.127 0.971 . . . . 0.0 112.622 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -75.55 -32.34 60.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.261 0.2 OUTLIER -77.32 145.04 37.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.7 t -140.58 158.21 44.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.123 1.369 . . . . 0.0 113.73 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.37 -34.56 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -67.54 -39.37 85.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.445 0.698 . . . . 0.0 111.836 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.65 -34.99 67.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.18 -50.15 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.776 0.83 . . . . 0.0 109.318 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.86 -49.37 77.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.592 0.633 . . . . 0.0 111.501 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -59.07 -40.83 86.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.854 0.862 . . . . 0.0 112.803 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -65.71 -49.0 70.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 50.7 m-85 -64.58 -29.14 70.15 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -59.44 -22.76 61.96 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.23 -26.04 64.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.21 0.913 . . . . 0.0 112.953 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.68 -35.8 57.69 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.34 168.33 30.27 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.506 2.479 . . . . 0.0 109.992 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -65.58 125.12 24.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.363 1.082 . . . . 0.0 113.003 -168.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.37 133.86 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.629 1.972 . . . . 0.0 107.629 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -70.2 -52.12 25.73 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -163.99 161.28 22.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.389 2.276 . . . . 0.0 114.101 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -131.81 150.81 52.04 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.96 1.304 . . . . 0.0 110.18 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 91.3 mtp -148.36 152.42 37.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.964 1.305 . . . . 0.0 111.907 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.3 mt -122.41 133.2 54.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.753 1.621 . . . . 0.0 109.286 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.9 ptm -82.27 81.34 8.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.097 0.951 . . . . 0.0 112.077 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.44 130.66 47.98 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -102.39 126.4 49.41 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.092 0.957 . . . . 0.0 112.893 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -59.09 -24.93 63.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -77.92 -13.88 59.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 p -122.78 -23.44 5.07 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 58.38 24.4 11.64 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.502 1.921 . . . . 0.0 114.528 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -146.27 170.11 17.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.671 1.589 . . . . 0.0 111.88 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -73.58 159.72 32.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.875 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -97.43 21.96 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.308 1.443 . . . . 0.0 114.56 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.12 14.47 62.37 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.914 1.245 . . . . 0.0 114.45 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.293 4.8 p90 -146.82 158.18 43.85 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.38 -160.27 17.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.108 1.337 . . . . 0.0 114.009 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -138.88 152.22 47.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.433 1.893 . . . . 0.0 114.914 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -135.94 126.36 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.352 1.461 . . . . 0.0 112.048 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.2 m -94.18 127.73 40.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 112.022 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -106.73 151.46 25.1 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -71.55 -36.33 70.94 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 t -135.47 137.98 42.7 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.449 1.1 . . . . 0.0 113.438 -171.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -65.32 -30.64 71.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.828 1.251 . . . . 0.0 112.597 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -60.41 -30.26 69.49 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.28 -47.9 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.817 0.847 . . . . 0.0 110.256 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 24.7 t -56.28 -42.47 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.636 1.174 . . . . 0.0 110.327 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.28 -50.8 72.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.743 0.701 . . . . 0.0 112.458 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -66.59 -45.03 80.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.273 0.942 . . . . 0.0 112.145 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.84 -40.62 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.221 0.919 . . . . 0.0 110.66 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.7 t -74.41 -31.32 62.28 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.148 0.979 . . . . 0.0 113.253 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -66.29 -37.41 85.35 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.777 -1.202 . . . . 0.0 113.246 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.1 mt -72.45 136.32 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.859 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.88 158.66 37.19 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.45 1.1 . . . . 0.0 112.701 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.525 22.3 m-85 60.43 45.27 11.11 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -56.36 153.94 8.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.949 1.7 . . . . 0.0 110.825 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -132.62 133.95 44.27 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.971 -1.081 . . . . 0.0 113.294 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . 0.272 4.5 mt -121.52 -127.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.483 1.113 . . . . 0.0 109.144 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -69.14 73.67 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.208 1.803 . . . . 0.0 112.126 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 61.41 -30.28 0.07 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 129.215 3.006 . . . . 0.0 115.389 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -75.56 140.53 42.76 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.295 2.238 . . . . 0.0 111.398 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 13.2 ptm -97.6 150.27 21.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.619 1.168 . . . . 0.0 111.925 171.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.07 162.14 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.402 2.281 . . . . 0.0 112.759 -169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -125.91 163.33 23.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.007 1.323 . . . . 0.0 111.687 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.5 p -143.14 161.35 38.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -144.77 164.55 30.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.632 1.973 . . . . 0.0 110.859 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -61.33 150.18 35.84 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.487 -0.758 . . . . 0.0 111.277 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.8 148.1 50.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.158 0.983 . . . . 0.0 112.484 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.31 136.64 78.55 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.411 1.084 . . . . 0.0 113.688 -168.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.02 124.94 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.634 2.222 . . . . 0.0 109.266 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -140.76 12.93 2.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.441 1.897 . . . . 0.0 113.188 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.6 160.39 43.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.772 2.029 . . . . 0.0 111.28 -173.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.0 p -147.69 143.15 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.04 1.336 . . . . 0.0 112.429 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 77.5 mtm -143.91 152.62 41.35 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.624 1.57 . . . . 0.0 111.656 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.5 t -159.48 129.09 3.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.363 1.465 . . . . 0.0 109.517 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.47 153.73 44.75 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.948 2.432 . . . . 0.0 112.844 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.27 1.1 p -131.82 154.23 49.34 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.766 1.626 . . . . 0.0 115.091 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.0 -178.26 37.22 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.324 0.964 . . . . 0.0 114.165 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.5 t -158.45 161.54 37.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.312 1.445 . . . . 0.0 111.239 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.47 153.94 41.56 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.385 1.074 . . . . 0.0 112.678 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -136.79 154.87 50.43 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.807 1.643 . . . . 0.0 112.156 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.15 -9.09 87.38 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.59 1.091 . . . . 0.0 115.257 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -68.52 150.84 47.58 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.223 1.409 . . . . 0.0 112.944 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.898 1.679 . . . . 0.0 113.547 178.381 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -140.45 25.39 2.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.706 2.002 . . . . 0.0 112.149 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.7 t60 60.31 22.47 11.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.382 1.873 . . . . 0.0 113.818 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.45 136.8 44.25 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.05 -1.031 . . . . 0.0 110.82 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -138.18 34.52 2.33 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.403 1.481 . . . . 0.0 109.875 -174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -159.74 142.37 13.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.268 2.627 . . . . 0.0 107.855 -168.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.19 154.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.241 1.016 . . . . 0.0 112.496 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.36 148.71 25.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.992 1.717 . . . . 0.0 113.025 166.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.3 t -135.91 137.53 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.627 1.571 . . . . 0.0 109.576 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.01 149.3 20.98 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.89 11.83 36.31 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.714 1.626 . . . . 0.0 114.296 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.8 mt -64.38 135.38 56.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.36 1.464 . . . . 0.0 112.103 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.5 t -64.98 156.53 30.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.487 1.115 . . . . 0.0 112.402 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.44 -16.37 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.279 0.632 . . . . 0.0 111.188 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -68.71 -33.98 74.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.025 0.93 . . . . 0.0 111.895 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -71.84 144.46 49.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.327 1.851 . . . . 0.0 115.41 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 t -135.69 171.1 14.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.204 1.802 . . . . 0.0 112.469 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.57 -33.0 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.59 -39.41 88.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.189 0.996 . . . . 0.0 112.337 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -64.15 -41.37 97.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.35 -50.46 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.852 0.861 . . . . 0.0 110.367 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.64 -44.16 96.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.485 0.584 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.62 -42.37 92.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.783 0.833 . . . . 0.0 112.586 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.28 -53.41 44.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 47.3 m-85 -63.79 -21.1 66.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -64.05 -12.25 36.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.32 -28.6 69.42 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.431 1.014 . . . . 0.0 112.766 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.74 -32.98 21.58 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.235 1.014 . . . . 0.0 112.051 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.93 -178.83 40.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.903 2.192 . . . . 0.0 110.874 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 120.56 12.28 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.585 -0.95 . . . . 0.0 112.571 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.32 121.53 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.381 1.473 . . . . 0.0 108.023 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -76.06 -36.93 58.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -165.36 165.78 19.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 109.28 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.81 43.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.317 1.447 . . . . 0.0 111.284 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.6 ptm -156.56 157.03 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.882 1.273 . . . . 0.0 112.2 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.79 151.99 48.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.267 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 53.6 mtp -89.91 137.43 32.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.696 0.798 . . . . 0.0 110.745 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -121.56 158.51 28.37 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -132.04 135.83 46.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 169.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.7 -40.99 75.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.145 0.978 . . . . 0.0 112.674 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -69.81 -32.14 70.43 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 p -85.02 -22.47 29.04 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.95 28.58 12.87 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.394 2.278 . . . . 0.0 113.423 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -153.14 174.38 14.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.315 1.446 . . . . 0.0 111.843 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -74.45 156.99 36.38 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.482 0.658 . . . . 0.0 112.266 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.97 -0.52 24.66 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.823 1.649 . . . . 0.0 115.385 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.64 10.47 81.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.301 0.953 . . . . 0.0 113.417 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.285 15.6 p90 -143.6 157.7 44.22 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.28 -161.73 20.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.684 1.135 . . . . 0.0 114.153 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -138.64 152.56 48.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.938 1.695 . . . . 0.0 113.883 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.91 129.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.293 1.437 . . . . 0.0 111.499 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -91.38 138.59 31.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.15 1.78 . . . . 0.0 114.541 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -120.22 152.44 37.72 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -70.04 -30.17 67.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.1 t -155.7 149.69 25.46 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.609 1.163 . . . . 0.0 112.728 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.46 -29.68 66.37 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.029 0.932 . . . . 0.0 112.096 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -56.91 -26.41 59.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 24.1 mm -80.87 -52.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.815 0.846 . . . . 0.0 110.129 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.4 t -53.87 -36.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.617 1.567 . . . . 0.0 112.271 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -53.4 -47.16 69.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.886 0.874 . . . . 0.0 112.937 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -68.08 -44.84 75.37 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.074 0.852 . . . . 0.0 111.392 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.2 t -54.46 -41.93 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 96.7 m -72.21 -37.44 69.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.278 1.431 . . . . 0.0 114.453 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -66.31 -33.66 76.24 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.4 mt -73.0 112.05 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -70.64 -61.12 1.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.179 -0.951 . . . . 0.0 111.648 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 52.8 m-85 -94.66 133.41 38.36 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -127.23 124.2 38.36 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.499 1.92 . . . . 0.0 110.382 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.23 107.7 19.38 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.339 -0.851 . . . . 0.0 112.718 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.14 122.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.377 1.071 . . . . 0.0 110.832 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.37 45.02 23.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.472 1.109 . . . . 0.0 112.818 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 63.31 -9.75 0.12 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 128.502 2.721 . . . . 0.0 116.158 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -87.89 142.47 27.77 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 126.322 1.849 . . . . 0.0 109.83 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 58.5 mtt -86.09 129.96 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.416 -0.803 . . . . 0.0 112.512 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.9 163.14 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.046 2.138 . . . . 0.0 111.718 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -128.26 162.94 25.85 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.519 0.727 . . . . 0.0 110.899 169.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.5 158.19 43.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.374 1.07 . . . . 0.0 113.196 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -144.25 165.53 27.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.631 1.573 . . . . 0.0 111.242 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.48 152.13 18.69 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.16 155.22 45.3 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.91 144.93 99.0 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -168.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -67.65 168.53 18.11 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.279 3.32 . . . . 0.0 114.694 -171.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -136.59 163.02 31.52 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.415 2.286 . . . . 0.0 111.2 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -63.13 153.61 33.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.136 1.374 . . . . 0.0 113.155 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 p -82.65 152.71 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.221 1.408 . . . . 0.0 113.815 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.5 ptp -152.09 162.07 41.67 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.478 1.511 . . . . 0.0 111.709 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.6 t -155.69 131.56 5.63 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.997 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -83.39 -9.83 10.16 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.558 2.838 . . . . 0.0 114.014 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.285 1.1 p -70.11 159.32 34.12 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.05 175.39 40.95 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.058 1.313 . . . . 0.0 113.179 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.6 m -69.52 143.28 53.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.71 160.1 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.016 1.726 . . . . 0.0 111.366 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -151.29 154.25 36.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -83.15 172.7 51.49 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.616 1.103 . . . . 0.0 113.456 170.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -73.39 168.41 19.27 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.397 1.079 . . . . 0.0 112.924 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.5 p . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 112.768 168.053 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.784 -0.527 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -95.68 153.37 17.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.127 1.371 . . . . 0.0 113.32 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -128.2 25.35 5.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.385 1.874 . . . . 0.0 110.851 169.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 46.3 tpp -138.48 137.1 36.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.212 1.805 . . . . 0.0 111.394 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -89.78 31.54 0.95 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.617 1.567 . . . . 0.0 112.979 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -148.57 149.32 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.15 1.78 . . . . 0.0 111.232 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.55 149.3 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 111.316 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.88 134.58 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.781 1.233 . . . . 0.0 109.58 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.43 145.95 14.95 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 114.518 0.567 . . . . 0.0 114.518 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.6 7.16 32.34 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.689 1.614 . . . . 0.0 114.609 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.5 139.48 58.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.164 1.385 . . . . 0.0 112.183 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -62.66 155.02 27.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.235 1.014 . . . . 0.0 112.506 171.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.57 -20.1 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.479 0.712 . . . . 0.0 112.214 169.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -71.76 -26.9 62.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.065 0.946 . . . . 0.0 113.151 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.0 m -73.59 143.49 46.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.735 1.614 . . . . 0.0 113.812 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 t -123.94 163.71 20.78 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 0.0 114.207 169.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.6 p -57.9 -30.61 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.78 -34.51 78.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.832 0.853 . . . . 0.0 112.458 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -68.27 -47.19 68.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.85 -45.25 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.662 0.785 . . . . 0.0 111.025 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -61.01 -46.29 91.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 118.952 -0.547 . . . . 0.0 112.151 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -59.7 -42.8 93.8 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -65.03 -38.8 92.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -75.97 -29.19 58.17 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -58.71 -18.9 35.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.334 1.454 . . . . 0.0 114.572 171.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -66.19 -23.88 66.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.388 -0.82 . . . . 0.0 112.777 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -89.28 -37.76 14.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.04 176.47 39.69 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.175 1.845 . . . . 0.0 111.45 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.44 127.82 34.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.6 t -100.39 118.27 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.184 1.794 . . . . 0.0 108.397 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -78.27 -37.33 45.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -152.15 153.26 33.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.958 2.103 . . . . 0.0 114.684 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.18 29.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.4 ptp -157.85 147.59 20.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.248 1.019 . . . . 0.0 112.3 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.6 mt -127.83 153.87 46.1 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.521 1.529 . . . . 0.0 111.673 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 mmt -78.39 70.68 4.78 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.358 1.063 . . . . 0.0 112.52 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -60.33 140.98 56.83 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.48 119.51 29.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.899 1.279 . . . . 0.0 112.461 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -21.91 66.91 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.72 60.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -119.89 -19.31 7.96 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.17 26.19 13.46 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.571 1.948 . . . . 0.0 113.57 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -144.68 173.46 11.82 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.069 1.747 . . . . 0.0 110.93 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -92.12 158.82 15.99 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -70.5 -0.21 8.0 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.57 63.44 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.769 1.176 . . . . 0.0 114.376 -172.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -144.8 159.82 42.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -176.17 -160.15 23.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.0 0.81 . . . . 0.0 114.909 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -132.8 149.29 52.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.608 1.963 . . . . 0.0 115.357 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 t -135.09 128.11 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.254 1.421 . . . . 0.0 111.749 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 61.6 m -96.55 127.34 42.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.668 1.587 . . . . 0.0 111.418 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.43 157.95 15.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -61.81 -37.96 86.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.745 0.818 . . . . 0.0 112.84 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -151.79 143.52 23.65 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -57.14 -26.78 61.1 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.573 1.549 . . . . 0.0 113.051 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.91 -26.92 68.46 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.72 -50.28 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.628 0.771 . . . . 0.0 109.458 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.96 -33.11 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.664 1.186 . . . . 0.0 111.201 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -48.16 -43.1 31.17 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -76.41 -45.51 31.29 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.639 -0.663 . . . . 0.0 111.764 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.35 -36.95 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.1 t -84.07 -24.27 30.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.583 1.153 . . . . 0.0 112.567 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -72.7 -35.61 67.66 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.02 -1.05 . . . . 0.0 112.155 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.14 138.41 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.022 0.929 . . . . 0.0 110.465 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -127.37 156.14 42.49 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.863 1.265 . . . . 0.0 111.951 169.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.443 18.2 m-85 61.04 47.15 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 -171.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -56.96 129.47 41.77 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.83 1.652 . . . . 0.0 111.201 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.29 125.0 28.62 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.446 0.566 . . . . 0.0 111.803 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.68 117.06 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.245 1.818 . . . . 0.0 108.781 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 50.03 43.79 25.61 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.287 1.035 . . . . 0.0 112.95 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.74 -13.88 0.08 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 128.173 2.589 . . . . 0.0 116.4 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.48 157.16 36.06 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.81 1.644 . . . . 0.0 109.265 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 26.7 mtt -109.6 141.06 42.65 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.73 151.24 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.122 1.769 . . . . 0.0 114.031 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.72 144.98 26.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.842 0.857 . . . . 0.0 112.14 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 4.9 t -108.77 143.67 37.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.627 1.571 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -140.8 157.7 45.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.728 1.611 . . . . 0.0 111.123 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.74 129.81 41.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.549 0.739 . . . . 0.0 111.894 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.43 70.9 10.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.906 0.882 . . . . 0.0 112.364 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 49.87 71.76 1.47 Allowed Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 126.994 2.118 . . . . 0.0 114.721 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.71 161.7 20.57 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.603 2.869 . . . . 0.0 114.505 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -130.8 150.69 51.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.101 1.76 . . . . 0.0 110.938 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -78.88 46.05 0.65 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.294 1.438 . . . . 0.0 113.617 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.78 140.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.781 1.232 . . . . 0.0 114.116 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 66.2 mtt -84.3 160.24 20.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.553 1.141 . . . . 0.0 112.344 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -145.19 79.31 11.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 110.782 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.94 -13.57 17.44 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.664 2.91 . . . . 0.0 113.709 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 140.44 51.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 117.187 2.291 . . . . 0.0 117.187 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -176.33 -175.8 43.98 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.789 1.185 . . . . 0.0 113.123 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.7 t -152.09 158.69 43.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.174 1.389 . . . . 0.0 111.464 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.8 148.16 52.3 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.281 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -66.89 133.54 50.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 111.887 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.46 139.04 27.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.249 0.928 . . . . 0.0 112.883 173.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.44 137.78 24.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.833 1.653 . . . . 0.0 111.412 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.253 1.276 0 C-N-CA 125.836 1.654 . . . . 0.0 114.484 -173.185 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.9 t -152.4 152.28 31.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.009 1.324 . . . . 0.0 111.482 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -145.95 38.26 1.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.165 1.786 . . . . 0.0 111.623 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -134.71 139.31 45.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.058 2.143 . . . . 0.0 109.444 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -108.42 10.72 27.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.74 147.76 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.785 1.634 . . . . 0.0 111.672 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.29 152.85 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.27 148.25 22.28 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.375 2.27 . . . . 0.0 111.86 167.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.0 t -137.79 135.1 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.015 1.326 . . . . 0.0 109.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.23 155.84 26.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.977 0.798 . . . . 0.0 114.288 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.94 10.01 41.16 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.558 1.551 . . . . 0.0 114.725 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -67.13 137.67 56.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.866 1.266 . . . . 0.0 112.532 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 t -65.93 152.46 44.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.256 1.023 . . . . 0.0 111.76 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -70.53 -15.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.574 -0.704 . . . . 0.0 111.796 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -70.38 -29.85 66.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.303 1.041 . . . . 0.0 112.689 170.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.3 m -78.85 139.12 38.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.992 1.717 . . . . 0.0 113.605 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 t -118.82 165.14 14.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.44 1.496 . . . . 0.0 114.726 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.93 -33.98 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -72.63 -27.01 61.87 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.72 -46.88 64.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.977 0.808 . . . . 0.0 109.169 171.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.44 -46.61 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.686 0.794 . . . . 0.0 110.493 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -57.18 -50.77 71.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.005 0.922 . . . . 0.0 111.855 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -60.21 -44.29 95.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 112.973 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.07 -38.8 92.37 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.306 48.6 m-85 -73.07 -31.2 64.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -60.42 -18.07 48.49 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.45 -24.88 67.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.55 0.74 . . . . 0.0 112.718 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -85.55 -35.64 20.97 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.85 175.3 36.19 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.668 2.08 . . . . 0.0 111.139 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -58.81 125.03 21.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.761 -0.847 . . . . 0.0 112.98 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.1 t -94.01 124.01 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.835 1.654 . . . . 0.0 107.234 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.85 -31.5 20.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.987 0.515 . . . . 0.0 110.356 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -161.51 155.56 22.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.884 1.274 . . . . 0.0 109.767 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.83 149.51 34.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.048 1.339 . . . . 0.0 111.268 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.4 ptp -156.07 154.9 31.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.634 1.174 . . . . 0.0 112.166 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.41 152.3 46.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.302 1.441 . . . . 0.0 111.419 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -83.31 84.13 7.61 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.764 0.826 . . . . 0.0 111.788 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.262 28.0 m-85 -67.18 119.27 11.81 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.1 115.46 21.9 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 111.811 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -66.44 -16.79 64.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.15 0.98 . . . . 0.0 112.821 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -22.75 60.4 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 171.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -130.29 -11.61 4.09 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.36 27.16 16.72 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.159 1.783 . . . . 0.0 114.515 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -134.13 167.33 20.86 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.905 1.682 . . . . 0.0 111.24 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -72.28 154.51 40.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.602 0.715 . . . . 0.0 112.32 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -80.87 7.47 10.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.193 1.797 . . . . 0.0 115.096 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.46 11.84 63.74 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.992 1.282 . . . . 0.0 114.414 -172.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -145.98 160.78 41.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.66 -162.16 23.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.54 1.066 . . . . 0.0 114.77 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.07 148.12 44.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.653 1.981 . . . . 0.0 113.84 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.56 123.59 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.422 1.489 . . . . 0.0 111.606 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 90.4 m -93.25 128.47 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.026 1.33 . . . . 0.0 110.501 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.91 153.15 19.39 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.2 -33.29 75.47 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -152.94 143.65 22.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 112.815 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -55.83 -27.16 50.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 113.185 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.38 -27.12 69.09 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.3 mm -77.54 -48.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.254 0.621 . . . . 0.0 109.686 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.08 -34.07 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.292 1.037 . . . . 0.0 111.244 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -50.23 -42.85 52.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.476 1.51 . . . . 0.0 113.54 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -77.35 -47.61 19.47 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.497 0.719 . . . . 0.0 111.595 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.3 -43.3 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.9 t -76.01 -24.47 55.29 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 112.19 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -78.27 -33.27 49.7 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.041 -1.037 . . . . 0.0 112.539 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 30.2 mt -67.97 148.47 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.429 1.091 . . . . 0.0 110.748 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -134.84 152.03 51.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.368 26.6 m-85 58.42 50.6 9.17 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -171.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -60.13 133.55 56.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.334 . . . . 0.0 111.971 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -82.93 133.47 35.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.805 -0.56 . . . . 0.0 111.896 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.1 mt -145.24 125.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 126.695 1.998 . . . . 0.0 108.842 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 50.08 36.28 11.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.56 1.144 . . . . 0.0 113.495 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.07 -7.73 0.14 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 128.242 2.617 . . . . 0.0 116.058 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.17 173.62 11.65 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 109.33 167.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.3 mtt -120.85 145.78 47.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.42 161.75 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.366 2.266 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.27 152.25 50.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.403 1.081 . . . . 0.0 110.017 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.06 157.97 44.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -147.44 160.93 42.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.88 2.072 . . . . 0.0 111.14 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 146.95 42.59 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.988 0.813 . . . . 0.0 111.844 172.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.73 23.83 5.03 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.51 164.19 21.32 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.397 1.079 . . . . 0.0 111.561 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.0 167.13 9.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.226 2.617 . . . . 0.0 113.49 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -56.46 142.98 36.73 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 0.0 112.458 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -147.66 156.21 42.55 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.286 1.435 . . . . 0.0 110.824 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -61.35 153.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.381 -0.824 . . . . 0.0 113.123 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 85.0 mmm -64.8 146.92 54.17 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.312 0.645 . . . . 0.0 111.661 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -63.88 -52.56 56.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.844 1.257 . . . . 0.0 113.16 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.6 138.83 35.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.204 1.936 . . . . 0.0 111.684 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 p -73.78 -19.7 60.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 175.72 163.88 29.21 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.884 1.707 . . . . 0.0 112.34 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.1 t -74.63 136.2 41.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.605 0.762 . . . . 0.0 111.882 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.13 39.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.194 0.997 . . . . 0.0 112.74 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -68.75 141.91 55.1 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.128 0.971 . . . . 0.0 111.063 174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -71.27 174.13 41.8 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.843 0.735 . . . . 0.0 113.631 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -64.7 139.18 58.74 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.94 0.896 . . . . 0.0 110.729 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.485 1.514 . . . . 0.0 113.731 -179.607 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.7 t -152.02 137.6 17.79 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.815 1.246 . . . . 0.0 111.447 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.19 -5.41 58.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.703 1.201 . . . . 0.0 113.788 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 56.3 mtt -69.08 141.63 54.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.774 0.829 . . . . 0.0 112.597 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -150.16 50.87 0.9 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.527 1.531 . . . . 0.0 110.768 -172.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -147.27 142.17 26.91 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.745 2.018 . . . . 0.0 109.393 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 pt -139.52 151.87 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.948 0.899 . . . . 0.0 113.236 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -92.67 145.71 24.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.17 2.188 . . . . 0.0 112.404 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.27 134.97 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 109.952 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.98 148.22 19.77 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.784 0.72 . . . . 0.0 114.256 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.77 9.57 59.72 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.936 1.255 . . . . 0.0 114.261 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.45 144.01 54.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.976 1.31 . . . . 0.0 111.575 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -67.15 158.03 32.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.155 0.582 . . . . 0.0 110.993 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.21 -26.3 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -71.31 -25.92 62.63 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.56 1.144 . . . . 0.0 113.712 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -70.2 119.15 13.96 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.299 1.3 t -98.5 164.18 12.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.45 -33.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -174.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.19 -32.49 72.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.1 0.96 . . . . 0.0 113.052 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.59 -46.06 73.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.849 0.75 . . . . 0.0 110.364 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.43 -48.97 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.303 1.041 . . . . 0.0 110.567 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.87 -49.07 79.15 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.869 0.867 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -60.0 -39.55 86.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 112.773 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -68.87 -49.07 61.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.324 49.4 m-85 -63.23 -29.22 70.6 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.44 -21.48 60.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -70.36 -25.73 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.019 0.827 . . . . 0.0 112.846 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -76.32 -38.81 55.46 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.63 167.65 29.57 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.328 2.394 . . . . 0.0 110.276 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.02 131.86 51.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.135 0.968 . . . . 0.0 113.294 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -93.69 138.26 20.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 126.565 1.946 . . . . 0.0 108.335 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.99 -45.11 10.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.932 1.293 . . . . 0.0 112.946 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -158.9 161.53 36.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.295 1.438 . . . . 0.0 109.881 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.11 156.86 42.82 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.148 1.379 . . . . 0.0 111.767 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -157.09 159.34 37.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.54 1.136 . . . . 0.0 113.163 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 73.3 mt -124.05 146.64 48.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.889 2.076 . . . . 0.0 111.136 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.9 mmm -85.56 128.76 34.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.474 0.71 . . . . 0.0 111.884 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.65 148.28 50.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.879 2.472 . . . . 0.0 114.064 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.61 116.77 30.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.081 0.952 . . . . 0.0 112.88 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -68.18 -22.47 64.83 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 p -76.04 -29.57 58.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 p -98.1 -16.45 19.55 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.622 1.569 . . . . 0.0 114.905 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 58.16 36.31 25.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.148 2.579 . . . . 0.0 113.812 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -152.52 169.34 22.87 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -56.11 154.63 7.47 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.362 3.065 . . . . 0.0 112.428 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.53 -8.49 15.0 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.11 76.45 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.384 0.993 . . . . 0.0 114.767 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.292 15.3 p90 -142.48 161.2 38.67 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.25 -168.41 25.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.689 1.138 . . . . 0.0 113.761 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -141.27 153.66 45.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.125 1.37 . . . . 0.0 112.965 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.0 130.98 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.356 1.462 . . . . 0.0 112.094 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.3 m -93.48 138.04 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.77 1.628 . . . . 0.0 113.85 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.51 148.8 32.4 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -69.76 -28.95 66.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.107 0.963 . . . . 0.0 112.738 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.2 t -143.45 130.36 20.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.937 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.6 pm0 -57.85 -28.55 64.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.741 2.016 . . . . 0.0 113.378 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.32 -28.25 69.18 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -74.7 -45.01 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 110.094 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.8 t -58.63 -37.59 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.435 1.094 . . . . 0.0 110.516 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -56.14 -45.51 79.57 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.987 0.812 . . . . 0.0 113.128 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -69.33 -45.95 68.24 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.923 0.783 . . . . 0.0 111.836 173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.88 -44.11 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 118.851 0.75 . . . . 0.0 110.834 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.67 -36.61 76.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.331 1.452 . . . . 0.0 113.033 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -37.32 86.25 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.116 -0.99 . . . . 0.0 112.816 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.01 117.38 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.54 0.736 . . . . 0.0 109.232 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -70.28 -61.44 1.77 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.486 -0.759 . . . . 0.0 111.777 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.335 53.5 m-85 -95.71 139.55 31.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -137.28 153.08 50.39 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.716 2.406 . . . . 0.0 109.606 -174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -124.2 115.93 21.89 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.129 -0.982 . . . . 0.0 112.82 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.4 126.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.108 0.963 . . . . 0.0 111.049 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 51.0 38.23 19.89 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 112.826 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.12 -7.1 0.12 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.914 2.486 . . . . 0.0 115.86 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -78.52 140.52 38.55 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.128 1.771 . . . . 0.0 109.178 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 96.5 mtp -88.64 143.26 27.06 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.546 -0.721 . . . . 0.0 111.879 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.0 164.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.566 2.346 . . . . 0.0 111.628 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -124.9 158.29 33.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.818 0.847 . . . . 0.0 110.867 168.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.1 p -141.41 158.27 44.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.637 0.732 . . . . 0.0 112.58 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -155.78 163.07 40.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.62 1.568 . . . . 0.0 111.702 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -57.69 147.14 28.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.494 1.118 . . . . 0.0 112.416 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.81 161.62 37.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.704 1.601 . . . . 0.0 110.965 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -98.89 115.84 65.58 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.64 0.776 . . . . 0.0 112.222 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.54 166.71 21.72 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.684 2.922 . . . . 0.0 112.287 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 151.58 30.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.006 0.923 . . . . 0.0 111.487 168.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.55 135.72 50.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.71 0.804 . . . . 0.0 112.229 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.7 p -155.13 157.17 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.899 1.68 . . . . 0.0 113.11 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 76.6 mtm -126.77 152.11 47.33 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.65 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.0 p -145.01 59.8 6.46 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.496 1.119 . . . . 0.0 113.852 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.69 -16.81 29.95 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.49 2.793 . . . . 0.0 114.129 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.4 0.1 OUTLIER 62.88 -48.69 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -177.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 64.56 18.33 63.43 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.695 1.14 . . . . 0.0 114.494 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 139.08 58.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.399 1.099 . . . . 0.0 113.151 -172.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.15 29.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.06 1.344 . . . . 0.0 113.692 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -148.08 150.81 34.57 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.031 1.732 . . . . 0.0 111.019 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 79.63 -162.84 47.61 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.413 1.006 . . . . 0.0 113.814 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.9 ttm-85 -144.07 145.07 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.825 1.65 . . . . 0.0 111.498 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.093 1.757 . . . . 0.0 113.666 -179.851 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.5 p -150.4 153.41 35.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.979 1.311 . . . . 0.0 112.738 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -78.35 154.89 30.4 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.144 1.378 . . . . 0.0 113.208 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.09 151.16 26.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.697 1.199 . . . . 0.0 110.437 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.29 2.17 50.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.867 1.267 . . . . 0.0 113.528 173.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -140.56 151.78 44.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.21 1.404 . . . . 0.0 111.921 -172.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -139.8 151.57 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.608 1.163 . . . . 0.0 113.648 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -90.12 146.95 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.252 2.221 . . . . 0.0 112.973 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.28 138.06 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.099 1.76 . . . . 0.0 110.348 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.52 142.41 9.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.887 0.767 . . . . 0.0 114.85 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.54 4.92 30.16 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.089 1.804 . . . . 0.0 114.649 -175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.22 140.05 58.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.368 1.467 . . . . 0.0 112.277 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -66.23 152.47 44.81 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.802 0.841 . . . . 0.0 111.741 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.15 -14.81 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.43 -0.793 . . . . 0.0 111.552 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -71.03 -28.81 64.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.133 0.973 . . . . 0.0 112.68 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.0 m -74.08 140.54 45.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.658 1.583 . . . . 0.0 112.78 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.53 164.48 15.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.404 1.482 . . . . 0.0 114.572 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.81 -32.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -67.24 -32.1 72.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.893 0.877 . . . . 0.0 112.739 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -67.25 -50.06 61.98 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.5 -45.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 111.207 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.16 -47.76 84.58 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 111.747 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.16 -43.79 98.04 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -64.13 -38.6 91.64 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 48.1 m-85 -73.51 -29.68 62.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -60.76 -17.09 46.76 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -65.52 -24.14 67.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.61 0.764 . . . . 0.0 112.794 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -83.49 -34.4 25.36 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.06 174.64 34.98 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.849 2.166 . . . . 0.0 110.798 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -59.23 126.5 27.93 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.951 0.876 . . . . 0.0 113.162 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.92 126.83 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.707 1.603 . . . . 0.0 108.628 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -76.69 -46.3 26.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.071 0.948 . . . . 0.0 112.631 175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -158.72 161.11 37.03 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.22 1.008 . . . . 0.0 110.894 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.83 156.27 41.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.508 1.523 . . . . 0.0 111.818 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -154.47 158.88 40.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.81 1.244 . . . . 0.0 112.629 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.1 mt -126.8 147.79 49.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.874 1.67 . . . . 0.0 111.445 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.64 85.45 6.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.997 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.283 42.3 m-85 -65.11 128.14 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 171.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.36 134.02 34.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.33 1.052 . . . . 0.0 111.293 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.13 -39.4 93.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.35 1.06 . . . . 0.0 113.641 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.33 -39.96 18.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.268 1.4 p -93.17 -12.75 29.57 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 58.1 27.91 15.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.785 2.034 . . . . 0.0 114.619 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -138.33 164.53 29.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.446 1.898 . . . . 0.0 110.521 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -73.92 148.87 41.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.577 0.703 . . . . 0.0 112.726 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -78.23 7.26 6.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.853 1.661 . . . . 0.0 115.314 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.24 14.89 67.9 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.554 1.073 . . . . 0.0 114.41 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.311 14.6 p90 -139.52 158.26 44.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.07 -171.75 30.71 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.224 0.916 . . . . 0.0 114.845 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -134.23 149.4 50.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.923 2.089 . . . . 0.0 114.246 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.81 129.37 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.246 1.418 . . . . 0.0 111.209 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 76.8 m -100.53 124.1 45.63 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.409 1.484 . . . . 0.0 111.434 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -97.16 155.9 16.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -68.91 -30.86 69.43 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.2 t -153.02 143.59 22.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.343 1.057 . . . . 0.0 113.309 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -57.82 -26.2 61.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.571 1.548 . . . . 0.0 113.673 170.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -59.02 -35.68 73.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.202 1.001 . . . . 0.0 111.809 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.75 -47.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.052 0.941 . . . . 0.0 110.418 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.7 t -58.4 -37.56 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.635 1.174 . . . . 0.0 111.146 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.69 -48.71 74.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.036 0.835 . . . . 0.0 113.218 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.63 -42.1 82.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.082 0.855 . . . . 0.0 111.676 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.79 -39.16 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.512 0.596 . . . . 0.0 111.241 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 88.9 m -73.62 -38.48 65.04 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.29 -35.61 80.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.21 116.36 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -68.94 -56.2 8.58 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.278 -0.889 . . . . 0.0 111.77 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.315 50.9 m-85 -104.12 136.82 43.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -130.81 137.42 49.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.787 2.035 . . . . 0.0 110.629 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -84.31 131.19 34.74 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.76 -0.588 . . . . 0.0 111.731 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.98 122.29 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.546 1.939 . . . . 0.0 109.546 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 49.62 40.01 18.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.555 1.142 . . . . 0.0 112.855 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 62.43 -8.01 0.12 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 128.688 2.795 . . . . 0.0 116.259 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -77.17 154.62 32.98 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.276 -1.515 . . . . 0.0 108.532 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 22.6 ptm -100.29 139.74 35.53 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.238 -0.914 . . . . 0.0 111.769 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.45 162.0 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.709 2.004 . . . . 0.0 111.719 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.82 162.55 17.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.5 p -144.06 154.27 43.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.695 1.198 . . . . 0.0 113.675 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -144.06 165.43 27.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.681 1.993 . . . . 0.0 111.758 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.54 134.67 57.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.024 0.93 . . . . 0.0 111.655 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.36 63.97 5.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.17 0.988 . . . . 0.0 112.988 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 54.29 74.67 0.71 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.579 1.951 . . . . 0.0 111.264 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.32 156.02 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.781 2.987 . . . . 0.0 116.545 -166.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -144.12 128.81 18.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.253 2.621 . . . . 0.0 108.028 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.17 104.92 0.98 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.853 0.861 . . . . 0.0 112.89 -169.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 19.1 t -144.24 128.37 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.114 1.765 . . . . 0.0 110.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 54.1 ttm -136.69 144.36 43.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.285 1.434 . . . . 0.0 111.622 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.4 t -148.91 92.35 4.4 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.775 1.23 . . . . 0.0 110.395 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.45 147.41 41.21 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.294 2.663 . . . . 0.0 112.987 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.319 0.2 OUTLIER -73.19 41.1 0.1 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.59 142.85 47.36 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.627 1.108 . . . . 0.0 113.915 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.4 t -156.95 159.77 38.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.664 1.585 . . . . 0.0 111.263 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.08 140.03 57.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.304 1.041 . . . . 0.0 112.877 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -80.54 156.56 26.44 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.071 1.349 . . . . 0.0 113.024 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.96 175.83 47.26 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.479 1.037 . . . . 0.0 113.825 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -145.87 169.33 18.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.653 1.581 . . . . 0.0 112.549 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 49.6 p . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.113 1.765 . . . . 0.0 115.429 -179.023 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.0 m -128.07 28.12 5.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.023 1.729 . . . . 0.0 112.189 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -86.3 62.3 7.35 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.32 1.848 . . . . 0.0 112.425 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -135.86 148.6 48.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.525 1.13 . . . . 0.0 112.751 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -98.03 32.58 2.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.897 1.679 . . . . 0.0 112.738 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -141.13 149.65 41.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.724 1.61 . . . . 0.0 111.431 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.84 151.3 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.344 1.058 . . . . 0.0 113.763 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -88.72 145.64 25.51 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.526 1.931 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.3 138.05 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.471 1.509 . . . . 0.0 110.627 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.77 153.52 25.16 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.861 0.743 . . . . 0.0 114.33 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.81 34.88 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.034 1.302 . . . . 0.0 114.602 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.0 mt -64.21 136.24 57.02 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.106 1.363 . . . . 0.0 112.18 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -62.62 152.66 34.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.348 1.059 . . . . 0.0 112.37 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.6 -23.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.81 0.844 . . . . 0.0 111.725 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -67.62 -26.68 66.36 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.65 1.18 . . . . 0.0 113.282 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.2 m -76.97 147.64 36.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.074 1.749 . . . . 0.0 115.495 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 t -129.3 162.66 27.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.07 1.748 . . . . 0.0 113.094 168.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -57.72 -30.86 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.14 -33.99 77.33 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.911 0.884 . . . . 0.0 112.42 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.07 -47.24 68.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.23 -45.35 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.58 0.752 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -60.91 -47.44 86.38 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.141 0.577 . . . . 0.0 111.65 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -58.9 -45.76 89.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.971 0.908 . . . . 0.0 113.415 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -65.62 -38.68 90.1 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 49.4 m-85 -73.75 -29.18 62.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 171.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -61.19 -17.39 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -64.93 -23.04 67.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.659 0.784 . . . . 0.0 112.8 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -86.1 -29.29 23.46 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.73 174.95 30.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.98 2.228 . . . . 0.0 110.729 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -59.3 126.88 29.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.249 1.025 . . . . 0.0 112.882 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.53 123.25 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.799 1.64 . . . . 0.0 107.502 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.16 -33.73 24.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.325 0.65 . . . . 0.0 110.398 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -160.54 158.08 28.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.683 1.193 . . . . 0.0 110.168 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.01 149.11 30.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.205 1.402 . . . . 0.0 111.165 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.14 159.09 42.67 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.432 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.0 mt -125.98 155.8 40.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.913 1.685 . . . . 0.0 111.028 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.3 mmm -83.46 132.92 34.93 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -118.12 148.49 42.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.97 105.15 17.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.174 0.99 . . . . 0.0 108.977 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -59.96 -25.51 65.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.251 1.3 p -78.17 -17.46 56.79 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -126.58 -15.03 5.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.329 17.0 p30 54.77 17.42 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.897 2.479 . . . . 0.0 115.543 -170.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -81.79 145.82 30.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.974 1.31 . . . . 0.0 110.324 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -79.18 157.82 27.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.259 0.552 . . . . 0.0 112.041 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -84.48 1.55 45.08 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.52 66.8 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.267 1.413 . . . . 0.0 114.597 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -145.22 159.74 42.55 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.94 -164.43 27.49 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.271 0.939 . . . . 0.0 115.129 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -136.59 147.67 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.75 2.02 . . . . 0.0 114.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.26 127.6 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.704 1.202 . . . . 0.0 111.3 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.9 m -96.81 122.67 40.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.343 1.457 . . . . 0.0 111.278 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.29 158.99 16.26 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.617 -0.677 . . . . 0.0 112.597 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -149.73 147.23 27.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.562 1.145 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -62.17 -24.5 67.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.687 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.76 -30.31 71.35 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.22 -47.46 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.549 0.739 . . . . 0.0 109.874 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.65 -34.28 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.383 1.073 . . . . 0.0 110.526 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.24 -40.09 61.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.8 1.24 . . . . 0.0 113.163 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -80.54 -45.24 17.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.615 0.643 . . . . 0.0 112.09 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.8 -44.66 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.845 0.748 . . . . 0.0 112.006 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 22.3 t -73.21 -33.0 65.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.085 1.354 . . . . 0.0 112.145 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -67.42 -38.74 85.03 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.292 -0.88 . . . . 0.0 112.484 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.7 mt -71.66 114.81 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -68.75 -49.63 57.19 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.897 -1.127 . . . . 0.0 112.149 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 62.4 m-85 -108.43 138.85 44.04 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.97 129.45 34.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.919 1.687 . . . . 0.0 111.123 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -77.94 134.15 37.93 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.53 -0.731 . . . . 0.0 112.39 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.9 mt -145.83 118.71 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 127.493 2.317 . . . . 0.0 108.199 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 50.69 45.94 26.38 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.05 0.94 . . . . 0.0 113.359 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 65.86 -18.22 0.1 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 128.045 2.538 . . . . 0.0 116.259 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -75.26 155.33 36.84 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.403 1.881 . . . . 0.0 109.844 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.7 mtm -108.17 125.09 51.23 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.472 -0.768 . . . . 0.0 111.397 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.16 163.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.345 1.858 . . . . 0.0 111.868 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -122.44 155.71 35.56 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.349 0.66 . . . . 0.0 111.112 168.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 30.1 p -139.14 155.84 47.57 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -145.06 173.46 11.88 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.491 1.917 . . . . 0.0 111.775 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -60.34 135.39 57.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.113 0.965 . . . . 0.0 111.315 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.98 139.69 36.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.208 0.603 . . . . 0.0 110.793 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.01 141.47 71.29 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -78.63 -14.08 14.39 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.464 2.776 . . . . 0.0 114.24 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt 51.7 48.72 22.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.082 2.153 . . . . 0.0 114.132 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -145.07 157.1 44.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.644 1.578 . . . . 0.0 111.95 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.93 144.26 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.067 1.347 . . . . 0.0 113.379 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 60.0 tpp -74.01 -31.64 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.459 1.104 . . . . 0.0 113.633 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.8 t -125.95 72.86 70.4 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.086 1.355 . . . . 0.0 111.168 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.83 166.53 28.62 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.988 3.125 . . . . 0.0 112.514 175.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.444 0.6 OUTLIER 61.82 173.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.99 26.97 63.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.534 1.064 . . . . 0.0 114.183 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.3 p -69.45 173.74 5.6 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.387 1.475 . . . . 0.0 113.402 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.3 8.53 1.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? 64.2 -33.69 0.14 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 129.33 3.052 . . . . 0.0 116.412 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.32 -169.31 54.71 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.82 1.2 . . . . 0.0 114.111 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -68.78 164.92 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.966 1.307 . . . . 0.0 113.433 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.187 1.795 . . . . 0.0 115.361 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -64.33 144.59 57.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.472 1.109 . . . . 0.0 113.213 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -62.25 133.2 54.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.331 . . . . 0.0 112.28 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -68.36 135.76 52.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -129.01 24.23 5.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.135 2.174 . . . . 0.0 110.418 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -151.92 154.2 35.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.033 1.333 . . . . 0.0 110.286 -169.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.66 154.81 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.076 . . . . 0.0 112.896 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -91.01 145.57 24.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.399 1.879 . . . . 0.0 112.054 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.03 131.4 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.55 1.54 . . . . 0.0 109.908 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.13 12.66 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.607 0.622 . . . . 0.0 114.5 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.58 10.79 26.42 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.759 1.647 . . . . 0.0 114.717 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 37.7 mt -61.61 136.38 57.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.219 1.408 . . . . 0.0 111.929 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 p -79.92 179.18 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -79.5 -20.17 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.306 1.043 . . . . 0.0 112.56 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.38 -37.75 56.72 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.897 0.879 . . . . 0.0 110.527 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 m -68.96 140.5 55.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.72 1.608 . . . . 0.0 115.295 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 t -144.44 173.71 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.678 1.991 . . . . 0.0 112.218 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.1 -32.28 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -68.44 -39.98 81.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.906 0.882 . . . . 0.0 112.433 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -65.06 -41.89 94.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.97 -53.02 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.374 1.07 . . . . 0.0 109.137 174.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -58.86 -48.17 82.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.67 0.668 . . . . 0.0 111.962 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -60.5 -42.01 95.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.737 0.815 . . . . 0.0 112.832 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.14 -46.02 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.329 54.6 m-85 -66.57 -28.0 68.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -59.57 -21.01 59.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -71.51 -25.89 62.44 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.417 -0.802 . . . . 0.0 112.767 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -75.49 -36.26 60.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 177.08 37.86 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.877 2.179 . . . . 0.0 110.963 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -60.01 131.27 50.34 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.12 0.96 . . . . 0.0 112.968 -172.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 36.9 t -108.06 133.46 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.757 2.023 . . . . 0.0 107.446 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -101.32 -23.12 14.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.01 150.9 17.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.892 2.077 . . . . 0.0 113.379 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.0 31.65 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.289 1.036 . . . . 0.0 110.997 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.7 ptm -157.43 158.77 36.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.742 1.217 . . . . 0.0 112.331 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.14 150.13 49.64 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.805 1.642 . . . . 0.0 111.808 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.4 mmt -82.57 143.89 30.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 110.564 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.86 154.33 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -110.12 111.83 23.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.345 1.058 . . . . 0.0 112.548 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -59.14 -21.7 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.68 1.192 . . . . 0.0 114.049 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -18.37 63.29 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -136.36 -18.89 1.47 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 62.1 t30 59.59 22.48 11.14 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.975 2.11 . . . . 0.0 113.864 -171.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -106.9 160.73 15.3 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.409 1.484 . . . . 0.0 110.525 174.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -71.82 153.82 41.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.222 0.534 . . . . 0.0 111.552 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -82.34 2.53 31.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -172.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.7 9.92 82.23 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.56 1.076 . . . . 0.0 113.771 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.27 19.6 p90 -143.47 156.65 44.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.08 -164.69 22.09 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.441 1.019 . . . . 0.0 114.174 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.09 151.72 46.93 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.994 1.718 . . . . 0.0 114.144 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 t -137.26 128.27 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.944 1.298 . . . . 0.0 112.101 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -90.36 139.62 30.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.866 1.666 . . . . 0.0 113.287 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.34 150.5 43.57 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -174.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -67.15 -33.02 74.53 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.4 t -147.4 148.59 31.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.74 1.216 . . . . 0.0 113.192 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -57.44 -29.38 64.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.543 1.137 . . . . 0.0 112.836 171.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -61.64 -30.8 70.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -78.94 -48.67 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 110.249 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.95 -43.06 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.04 1.336 . . . . 0.0 110.434 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -56.4 -47.98 77.87 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.975 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -64.99 -45.13 86.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.019 0.827 . . . . 0.0 111.688 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.48 -36.13 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.629 0.65 . . . . 0.0 111.705 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.6 m -73.24 -39.87 65.11 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -66.4 -35.3 79.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.037 0.935 . . . . 0.0 113.22 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.18 115.0 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -68.29 -58.74 3.93 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.716 -0.615 . . . . 0.0 111.279 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.327 53.4 m-85 -104.71 137.94 41.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.05 125.48 33.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.981 2.112 . . . . 0.0 109.865 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.51 121.57 32.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.416 -0.803 . . . . 0.0 112.535 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.4 mt -139.15 126.44 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.891 1.277 . . . . 0.0 109.91 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.41 40.0 21.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.622 1.169 . . . . 0.0 113.687 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 62.97 -7.91 0.14 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 128.1 2.56 . . . . 0.0 115.876 -171.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -81.58 170.13 16.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.807 2.043 . . . . 0.0 110.37 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.6 mtp -121.21 134.89 55.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.207 1.003 . . . . 0.0 112.105 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.02 159.04 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.849 2.06 . . . . 0.0 112.399 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -124.79 152.3 44.05 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.81 0.844 . . . . 0.0 112.506 172.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.7 m -124.5 144.95 49.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.547 1.139 . . . . 0.0 113.015 -169.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -141.79 169.89 16.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.276 1.43 . . . . 0.0 112.78 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -63.1 150.32 42.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.512 1.125 . . . . 0.0 112.789 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -150.4 152.62 34.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.291 1.436 . . . . 0.0 110.681 171.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -70.33 145.67 93.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.501 -0.75 . . . . 0.0 112.391 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.41 134.32 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.219 2.613 . . . . 0.0 112.385 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -72.13 -35.36 69.1 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -147.96 146.94 29.17 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.695 2.398 . . . . 0.0 110.657 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.8 p -75.61 148.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.134 0.974 . . . . 0.0 113.427 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.3 145.61 55.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.735 0.814 . . . . 0.0 111.668 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 t -149.04 118.5 3.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.405 1.082 . . . . 0.0 110.707 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.27 165.83 27.18 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.683 2.922 . . . . 0.0 113.206 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 t -146.1 157.25 43.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -81.1 -175.84 50.34 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.175 1.369 . . . . 0.0 114.829 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.9 t -151.24 147.51 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.31 1.444 . . . . 0.0 111.908 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.98 -14.07 59.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.464 1.105 . . . . 0.0 113.781 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -71.53 148.85 46.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.556 1.143 . . . . 0.0 112.632 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 174.6 177.36 43.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.072 1.32 . . . . 0.0 113.131 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.295 1.438 . . . . 0.0 111.33 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.878 2.071 . . . . 0.0 113.535 -177.073 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.33 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.5 m -133.2 129.45 37.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.848 1.259 . . . . 0.0 113.306 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -73.8 97.02 2.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.305 1.442 . . . . 0.0 109.422 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -152.33 140.26 20.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.5 1.12 . . . . 0.0 110.983 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -105.7 4.6 30.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.83 1.252 . . . . 0.0 113.485 -171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.85 149.5 37.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.345 1.458 . . . . 0.0 111.859 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -139.38 151.03 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.406 1.083 . . . . 0.0 113.919 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.13 148.39 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.97 2.108 . . . . 0.0 112.782 167.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.0 t -134.89 134.99 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 109.645 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.48 155.85 26.72 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.016 0.817 . . . . 0.0 114.327 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.79 7.56 66.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.798 1.19 . . . . 0.0 113.784 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.76 143.56 57.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 111.656 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -69.47 154.08 42.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.174 0.589 . . . . 0.0 110.041 167.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.59 -15.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.771 -0.581 . . . . 0.0 111.708 168.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -73.75 -28.85 61.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.074 1.35 . . . . 0.0 113.126 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 m -67.06 123.89 21.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.265 0.8 OUTLIER -80.86 160.58 24.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.52 -29.85 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -75.23 -36.78 61.3 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.02 -43.37 98.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.78 -50.44 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.85 0.86 . . . . 0.0 109.681 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.49 -46.8 88.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.686 0.675 . . . . 0.0 112.313 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -59.15 -40.15 84.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.534 1.134 . . . . 0.0 112.237 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.41 -54.56 34.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 171.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 48.6 m-85 -63.41 -23.7 67.52 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -60.93 -13.85 18.6 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.31 -29.13 69.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.886 1.221 . . . . 0.0 112.726 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -85.1 -34.43 22.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.214 1.005 . . . . 0.0 112.248 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.21 -179.8 41.63 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 127.077 2.275 . . . . 0.0 110.788 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.71 122.72 16.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.19 0.995 . . . . 0.0 112.315 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.7 t -95.65 123.81 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -82.08 -39.94 22.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.753 -0.592 . . . . 0.0 109.547 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -157.91 159.89 37.03 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.63 1.172 . . . . 0.0 110.152 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.62 34.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.383 1.473 . . . . 0.0 110.955 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 mmt -148.65 159.37 44.17 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.654 1.582 . . . . 0.0 113.003 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.0 mt -126.84 143.57 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.983 2.113 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 43.0 mtm -97.62 132.5 43.21 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -126.08 144.37 50.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.925 2.09 . . . . 0.0 116.206 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.0 111.57 19.4 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -61.42 -36.22 79.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.845 0.858 . . . . 0.0 112.991 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 p -75.31 -16.16 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.264 1.4 p -123.17 -5.41 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.292 1.0 OUTLIER 52.18 39.41 26.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.208 2.603 . . . . 0.0 115.367 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.82 158.53 43.62 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -59.55 145.83 42.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.318 2.247 . . . . 0.0 113.349 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.56 -11.31 49.1 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.22 14.35 66.7 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.175 0.893 . . . . 0.0 113.99 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.38 4.7 p90 -141.09 162.45 35.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.89 -169.88 28.02 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.089 1.328 . . . . 0.0 114.604 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.05 150.26 52.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.262 2.225 . . . . 0.0 114.394 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -136.32 125.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.209 1.404 . . . . 0.0 111.82 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 94.4 m -98.31 128.92 44.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.353 1.461 . . . . 0.0 110.767 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -104.85 150.69 24.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -67.0 -38.13 85.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.575 0.75 . . . . 0.0 112.673 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 t -143.11 134.69 26.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 122.201 1.0 . . . . 0.0 112.904 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -58.34 -27.25 63.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.53 1.932 . . . . 0.0 113.256 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.55 -26.26 68.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -76.75 -50.81 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.904 0.882 . . . . 0.0 109.489 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.08 -36.62 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 111.987 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.19 -30.88 60.82 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -84.0 -49.08 9.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.552 0.741 . . . . 0.0 111.668 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.66 -43.58 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.315 0.961 . . . . 0.0 113.433 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.9 t -77.59 -19.17 56.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.446 1.098 . . . . 0.0 112.514 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -81.54 -31.19 32.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.254 1.021 . . . . 0.0 112.215 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.15 142.06 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.19 0.996 . . . . 0.0 109.519 168.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -131.23 161.43 32.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.743 1.217 . . . . 0.0 111.728 171.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.581 2.1 p90 58.31 45.17 17.46 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -57.41 142.65 43.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 110.688 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.53 106.92 16.38 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.596 1.089 . . . . 0.0 112.978 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.53 122.93 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.765 1.226 . . . . 0.0 110.528 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 50.97 41.36 27.09 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.461 1.104 . . . . 0.0 112.634 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 62.97 -10.59 0.1 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.379 2.672 . . . . 0.0 116.191 -171.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.51 139.92 38.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.166 1.787 . . . . 0.0 109.723 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 20.4 ptm -91.96 140.54 29.57 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.59 -0.694 . . . . 0.0 111.716 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.19 149.5 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.249 1.82 . . . . 0.0 113.289 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -119.83 151.58 38.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.785 1.234 . . . . 0.0 111.093 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 p -129.34 156.11 44.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -143.59 170.37 15.96 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.449 1.899 . . . . 0.0 110.954 -175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.66 153.68 19.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.732 0.813 . . . . 0.0 112.174 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.2 18.89 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.555 1.142 . . . . 0.0 113.979 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.51 165.11 13.1 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.539 1.936 . . . . 0.0 110.759 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -64.25 156.47 59.42 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.902 2.401 . . . . 0.0 111.747 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -66.55 120.5 13.52 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.909 0.884 . . . . 0.0 110.561 172.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.93 161.83 19.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.8 m -82.83 -3.42 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.941 1.696 . . . . 0.0 114.486 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 98.4 mmm -61.86 140.29 58.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 114.146 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -153.32 86.76 3.98 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 109.424 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.12 155.67 56.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.478 2.785 . . . . 0.0 113.199 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -70.26 159.63 33.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 174.18 -40.19 0.13 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.952 0.787 . . . . 0.0 113.694 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 73.8 p -73.74 152.55 40.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.444 1.097 . . . . 0.0 112.525 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.78 33.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.929 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -70.79 116.96 11.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.629 1.172 . . . . 0.0 110.633 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.96 -23.18 77.17 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 114.836 0.695 . . . . 0.0 114.836 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -77.31 -21.45 53.45 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.219 1.408 . . . . 0.0 113.949 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.308 1.443 . . . . 0.0 113.801 -179.35 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 p -81.45 -1.08 44.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -71.55 -6.05 37.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.085 1.754 . . . . 0.0 115.272 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 21.6 mmt -60.5 118.76 6.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.618 1.167 . . . . 0.0 111.86 -170.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -121.33 26.36 8.94 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.79 1.236 . . . . 0.0 111.286 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -153.36 138.71 17.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.125 1.37 . . . . 0.0 110.324 -168.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.1 pt -140.61 149.16 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -87.88 147.93 24.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.039 1.736 . . . . 0.0 112.658 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.29 132.3 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.603 1.561 . . . . 0.0 109.777 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.96 11.64 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 115.026 0.771 . . . . 0.0 115.026 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.92 11.12 35.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.549 1.547 . . . . 0.0 114.453 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.44 140.82 58.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.031 1.333 . . . . 0.0 112.168 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 t -66.47 155.37 37.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.004 0.921 . . . . 0.0 111.625 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 m -72.26 -14.8 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.696 -0.628 . . . . 0.0 111.656 169.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.04 -39.88 93.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.05 0.94 . . . . 0.0 111.969 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.15 127.86 33.83 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.15 165.38 13.52 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -62.82 -30.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.34 -37.49 60.65 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.42 0.688 . . . . 0.0 111.509 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.73 -47.18 86.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 t -57.94 -49.22 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 109.039 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -61.52 -44.28 97.35 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.079 0.854 . . . . 0.0 112.355 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -60.71 -46.18 91.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.349 1.06 . . . . 0.0 112.507 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.13 -44.66 96.98 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 48.0 m-85 -66.48 -31.22 71.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -62.28 -12.98 23.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.78 -31.42 72.05 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.248 0.931 . . . . 0.0 113.216 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.81 -39.86 66.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.63 168.5 28.92 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.849 2.643 . . . . 0.0 109.539 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.81 135.59 57.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.483 1.141 . . . . 0.0 113.192 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.47 128.78 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.081 1.753 . . . . 0.0 109.025 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.85 -49.38 30.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.625 1.17 . . . . 0.0 113.891 172.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -154.7 157.29 37.86 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.003 2.121 . . . . 0.0 114.811 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.6 39.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.683 1.193 . . . . 0.0 110.959 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.4 ptm -155.43 148.15 24.22 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.774 1.229 . . . . 0.0 112.095 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.98 151.9 49.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.887 1.675 . . . . 0.0 111.297 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 mmt -78.38 69.02 4.51 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.226 1.01 . . . . 0.0 112.77 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.254 54.6 m-85 -58.05 140.04 53.36 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 170.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -133.51 113.84 12.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 113.425 -175.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -59.99 -24.57 64.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.322 . . . . 0.0 113.287 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -24.4 67.66 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 172.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p -131.06 -8.25 3.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.04 30.65 20.12 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.861 2.064 . . . . 0.0 114.199 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -150.79 176.72 10.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.473 1.909 . . . . 0.0 109.953 172.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -87.73 154.31 20.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.45 0.643 . . . . 0.0 112.599 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.23 8.14 3.6 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.22 14.85 58.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.842 1.21 . . . . 0.0 115.099 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -145.56 158.49 43.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.86 -160.94 24.26 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -134.16 148.3 50.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.542 1.937 . . . . 0.0 114.751 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -136.28 133.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.267 1.427 . . . . 0.0 111.162 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.8 m -107.23 134.21 50.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 0.0 112.709 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.19 149.51 28.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 118.433 2.753 . . . . 0.0 118.433 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -67.91 -27.48 66.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.662 0.785 . . . . 0.0 112.932 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.4 t -147.76 138.74 23.41 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.876 1.27 . . . . 0.0 112.766 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -60.84 -27.63 68.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.697 1.599 . . . . 0.0 113.461 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -62.45 -26.53 68.56 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.2 mm -75.03 -50.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.962 0.905 . . . . 0.0 110.272 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 31.3 t -57.49 -34.51 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.348 1.459 . . . . 0.0 111.235 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -52.64 -42.68 64.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 113.165 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.58 -41.83 62.37 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.2 0.909 . . . . 0.0 112.127 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.42 -31.43 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 98.8 m -79.74 -40.28 29.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.171 1.388 . . . . 0.0 113.811 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.19 -43.27 95.59 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.407 0.683 . . . . 0.0 111.873 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.5 114.26 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.54 -51.71 26.8 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.087 -1.008 . . . . 0.0 111.81 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -94.8 139.28 31.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -133.49 132.64 41.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.654 1.582 . . . . 0.0 111.044 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -81.05 127.63 32.82 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.744 -0.598 . . . . 0.0 111.365 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 25.1 mt -140.46 125.0 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 109.136 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 50.47 40.24 22.76 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.219 1.008 . . . . 0.0 112.585 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.7 t30 63.22 -10.7 0.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 128.39 2.676 . . . . 0.0 115.912 -172.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -77.0 143.11 39.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.856 1.662 . . . . 0.0 109.426 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 23.1 ptm -97.15 138.35 34.78 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.424 -0.797 . . . . 0.0 111.458 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.89 146.69 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.731 2.012 . . . . 0.0 112.378 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -89.11 142.88 27.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.519 0.728 . . . . 0.0 111.324 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.87 148.63 52.56 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.626 1.17 . . . . 0.0 112.572 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -158.38 164.66 36.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.406 1.482 . . . . 0.0 112.179 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -61.79 143.28 56.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.019 0.927 . . . . 0.0 112.305 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -101.66 14.85 30.75 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . 0.253 14.0 pt20 43.57 50.81 6.67 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 127.392 2.277 . . . . 0.0 116.42 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -61.64 165.51 13.47 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.357 2.704 . . . . 0.0 113.431 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.43 143.41 19.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.475 1.51 . . . . 0.0 112.766 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -59.31 130.68 48.11 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.856 1.662 . . . . 0.0 112.937 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.8 t -143.04 136.2 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.557 1.943 . . . . 0.0 108.98 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.4 tpp -153.26 146.7 24.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.356 1.063 . . . . 0.0 111.902 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.9 t -154.71 119.89 2.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.111 1.364 . . . . 0.0 109.704 170.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 147.68 58.52 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.054 2.502 . . . . 0.0 112.447 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.2 t -151.67 162.91 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -176.4 158.28 24.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.584 1.564 . . . . 0.0 112.643 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.9 t -156.76 153.8 28.95 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.802 1.241 . . . . 0.0 111.922 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.42 153.22 34.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.87 1.668 . . . . 0.0 111.331 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -149.94 147.52 27.99 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.528 1.531 . . . . 0.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -175.67 -175.52 43.15 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.857 1.217 . . . . 0.0 113.175 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -148.26 147.87 29.83 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.819 1.648 . . . . 0.0 111.152 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.588 1.555 . . . . 0.0 113.283 172.759 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.25 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 m -147.6 161.28 41.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.095 1.358 . . . . 0.0 112.727 -172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -75.92 -27.57 57.69 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.475 -0.766 . . . . 0.0 112.814 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -65.44 126.47 28.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.232 1.013 . . . . 0.0 113.154 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -122.69 7.87 9.45 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.761 2.025 . . . . 0.0 112.909 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.73 154.5 48.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.222 1.409 . . . . 0.0 112.063 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.98 154.54 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.996 1.318 . . . . 0.0 113.313 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.4 149.25 21.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.671 1.988 . . . . 0.0 112.979 167.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.85 131.91 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.858 1.663 . . . . 0.0 109.981 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.5 139.62 7.74 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.47 9.51 21.36 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.236 1.874 . . . . 0.0 114.771 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.75 136.3 57.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.369 1.468 . . . . 0.0 112.518 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -64.64 153.83 38.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.458 1.103 . . . . 0.0 112.05 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.19 -17.07 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.281 0.632 . . . . 0.0 112.332 169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -67.81 -37.5 82.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.938 0.895 . . . . 0.0 111.724 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -70.12 147.39 49.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.311 1.844 . . . . 0.0 114.484 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t -140.05 171.54 14.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.688 1.595 . . . . 0.0 112.846 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -57.21 -31.99 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.2 -40.92 86.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.169 0.988 . . . . 0.0 112.325 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -64.04 -42.46 97.06 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.1 -51.23 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.163 0.985 . . . . 0.0 109.653 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -61.86 -45.85 92.01 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.022 0.828 . . . . 0.0 112.105 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -59.03 -41.79 88.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.761 0.824 . . . . 0.0 112.851 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.46 -46.74 68.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS 0.355 49.9 m-85 -66.43 -26.31 67.16 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 178.038 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.2 -24.95 66.7 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -65.96 -22.95 66.51 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.486 1.039 . . . . 0.0 112.765 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -71.94 -24.88 61.69 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.58 -98.62 0.13 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.617 1.103 . . . . 0.0 112.573 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -154.23 137.23 15.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.272 1.429 . . . . 0.0 112.031 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.33 130.5 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.194 1.798 . . . . 0.0 108.834 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 -46.97 19.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 112.869 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -158.55 161.21 37.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 110.452 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.05 155.17 41.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.433 1.493 . . . . 0.0 111.48 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.55 155.14 32.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.392 1.077 . . . . 0.0 112.741 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.23 152.58 47.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.6 mtp -83.66 144.83 29.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.399 0.68 . . . . 0.0 111.261 171.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.66 156.45 43.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 -172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -111.77 108.48 17.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.719 1.208 . . . . 0.0 112.173 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.2 -16.0 50.31 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -17.41 64.46 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 t -144.29 -14.89 0.59 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 57.17 39.66 28.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.319 1.848 . . . . 0.0 113.297 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -117.35 139.83 50.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.734 2.013 . . . . 0.0 109.355 175.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -70.31 156.52 39.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.29 0.567 . . . . 0.0 111.985 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -80.7 1.63 29.33 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.25 84.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.689 1.138 . . . . 0.0 114.115 -171.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.277 9.1 p90 -143.86 155.23 44.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.59 -160.93 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.978 0.799 . . . . 0.0 114.936 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -137.82 150.69 47.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.297 1.839 . . . . 0.0 114.14 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.41 129.57 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.081 1.352 . . . . 0.0 111.407 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.1 m -97.69 122.83 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.275 1.43 . . . . 0.0 112.055 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -95.05 154.83 16.99 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -70.08 -31.82 69.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.922 0.889 . . . . 0.0 113.387 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.2 t -152.07 140.26 20.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -53.21 -33.87 54.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.752 2.021 . . . . 0.0 113.615 170.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.73 -22.25 66.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.13 -54.31 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.099 0.96 . . . . 0.0 109.509 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.7 -39.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.766 1.626 . . . . 0.0 111.506 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.7 -40.81 66.34 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -75.48 -42.43 53.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.054 0.843 . . . . 0.0 112.361 173.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.58 -30.78 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.02 -40.53 24.12 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.018 1.727 . . . . 0.0 113.287 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.35 -39.77 94.2 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.028 -1.045 . . . . 0.0 111.712 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.6 mt -74.48 108.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 168.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.28 -45.86 44.92 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.999 -1.063 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.44 133.59 42.6 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -131.03 130.12 42.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.872 1.669 . . . . 0.0 110.624 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -91.39 130.56 37.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.829 0.852 . . . . 0.0 111.997 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.95 126.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.538 1.535 . . . . 0.0 109.253 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 49.91 42.18 23.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.39 1.076 . . . . 0.0 113.422 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.97 -13.62 0.15 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 127.313 2.245 . . . . 0.0 115.932 -172.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.74 168.3 20.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.168 1.787 . . . . 0.0 110.609 169.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 97.5 mtp -127.18 139.89 52.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.333 1.053 . . . . 0.0 112.151 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.67 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.614 1.966 . . . . 0.0 112.005 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -87.91 141.71 28.37 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.683 0.393 . . . . 0.0 110.876 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.404 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 85.6 m -133.85 146.69 50.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.966 1.306 . . . . 0.0 111.356 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -158.05 171.12 20.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.55 1.14 . . . . 0.0 111.847 174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -59.96 140.68 56.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.71 1.204 . . . . 0.0 111.992 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -108.12 8.06 27.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.718 1.207 . . . . 0.0 113.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -149.52 152.86 36.1 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.66 2.384 . . . . 0.0 111.304 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.55 179.74 6.23 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.244 3.296 . . . . 0.0 112.802 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -132.02 155.11 48.6 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.835 1.254 . . . . 0.0 111.878 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.61 163.84 26.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 110.901 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.98 -22.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.4 ptm -80.27 162.25 24.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.896 1.678 . . . . 0.0 113.757 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 t -161.97 129.83 2.77 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.758 2.023 . . . . 0.0 108.516 168.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.21 144.68 42.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.906 2.404 . . . . 0.0 113.153 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 p -82.91 152.91 25.34 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -80.97 143.63 24.32 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.216 0.912 . . . . 0.0 113.216 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.4 p -75.23 156.47 35.72 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.588 1.155 . . . . 0.0 113.168 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.26 161.04 42.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.496 1.518 . . . . 0.0 111.865 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -136.4 18.5 3.14 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.0 -172.03 53.57 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.522 1.058 . . . . 0.0 113.701 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -63.08 153.39 34.26 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.829 173.646 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.5 t -153.16 159.31 42.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.438 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -71.06 107.71 4.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.433 1.093 . . . . 0.0 110.892 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 17.2 ptm -158.36 121.28 3.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.849 1.259 . . . . 0.0 111.358 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -117.81 20.84 13.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.852 1.661 . . . . 0.0 110.868 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -154.91 144.29 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.198 1.399 . . . . 0.0 111.374 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -140.41 155.01 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.586 1.155 . . . . 0.0 113.301 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -94.5 145.77 24.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.198 2.199 . . . . 0.0 112.789 167.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.1 138.77 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.051 1.74 . . . . 0.0 109.726 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.51 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.93 13.65 54.23 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.375 1.464 . . . . 0.0 114.215 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.5 mt -62.79 138.6 58.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.422 . . . . 0.0 112.215 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.44 155.15 33.56 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.112 0.965 . . . . 0.0 111.734 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 p -67.97 -21.07 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.868 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -69.95 -30.89 68.37 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.478 1.111 . . . . 0.0 112.911 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.4 m -79.7 128.69 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.393 1.477 . . . . 0.0 114.236 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.51 166.21 12.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.02 -30.12 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 169.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.76 -35.94 62.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.486 0.715 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.7 -46.87 87.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.632 0.651 . . . . 0.0 112.364 170.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.73 -50.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.595 1.158 . . . . 0.0 109.422 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.7 -48.59 81.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.82 0.736 . . . . 0.0 112.177 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -60.73 -39.45 88.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.789 0.836 . . . . 0.0 112.553 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.61 -48.66 66.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 50.4 m-85 -62.92 -29.5 70.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -59.91 -20.84 59.62 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -70.29 -25.66 63.43 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.14 0.882 . . . . 0.0 112.674 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.42 -38.28 59.91 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.17 37.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.518 2.008 . . . . 0.0 111.326 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -58.55 119.41 6.99 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.109 0.964 . . . . 0.0 112.995 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -93.93 131.4 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.0 107.987 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -86.44 -35.1 19.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -163.87 158.6 20.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.249 1.419 . . . . 0.0 109.398 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.21 139.52 22.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.067 1.347 . . . . 0.0 110.608 172.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.1 mmt -148.8 151.12 34.23 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.421 1.488 . . . . 0.0 112.254 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.62 151.73 41.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.487 1.515 . . . . 0.0 111.074 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtp -81.3 75.42 8.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.711 0.804 . . . . 0.0 112.35 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -61.07 143.13 55.99 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -129.18 122.42 29.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.42 -23.92 66.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -79.38 -13.67 59.46 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 174.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.0 p -123.67 -19.53 5.76 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 59.0 25.66 14.11 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.58 1.952 . . . . 0.0 114.828 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -145.9 171.07 15.36 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.632 1.573 . . . . 0.0 110.879 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -78.18 150.07 33.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 112.077 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -78.96 12.8 2.01 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.63 15.15 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.786 1.184 . . . . 0.0 114.674 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.266 8.5 p90 -146.91 159.09 43.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.28 -160.59 22.74 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.192 0.901 . . . . 0.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.35 150.65 44.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.029 1.731 . . . . 0.0 114.207 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.27 130.32 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.354 1.461 . . . . 0.0 111.938 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -93.75 144.73 25.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.401 1.88 . . . . 0.0 114.431 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -125.95 151.08 47.47 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 118.167 2.654 . . . . 0.0 118.167 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -61.57 -37.2 82.96 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.004 1.322 . . . . 0.0 113.636 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 t -153.94 148.19 25.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.321 1.049 . . . . 0.0 112.496 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -61.8 -24.73 67.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.184 0.994 . . . . 0.0 112.583 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.46 -35.92 68.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.545 1.138 . . . . 0.0 111.909 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.44 -51.42 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.954 0.902 . . . . 0.0 110.057 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.9 t -57.77 -38.41 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.351 1.06 . . . . 0.0 111.716 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -54.12 -45.75 72.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.021 0.928 . . . . 0.0 112.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -72.31 -43.36 64.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.828 0.74 . . . . 0.0 112.023 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.0 -43.33 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.057 0.844 . . . . 0.0 111.465 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.5 t -74.87 -33.64 62.12 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.083 1.353 . . . . 0.0 113.074 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -64.67 -42.05 95.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.44 107.62 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 169.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.69 -43.63 65.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.39 -1.444 . . . . 0.0 112.544 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -99.82 138.61 36.66 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -138.88 136.51 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.993 1.717 . . . . 0.0 110.836 -173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -103.15 130.6 50.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.089 0.956 . . . . 0.0 112.738 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.4 130.61 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.567 1.547 . . . . 0.0 109.285 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 52.33 37.14 21.56 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.33 1.052 . . . . 0.0 113.413 -175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 61.68 -5.47 0.14 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 127.946 2.498 . . . . 0.0 115.768 -170.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.43 167.33 20.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.697 2.399 . . . . 0.0 109.216 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 98.1 mtp -123.21 143.61 49.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.968 0.907 . . . . 0.0 112.909 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.78 164.54 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.226 2.61 . . . . 0.0 111.653 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -109.31 155.43 21.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.807 0.843 . . . . 0.0 110.826 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.4 p -141.85 154.67 45.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.285 0.634 . . . . 0.0 110.747 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -159.96 -175.36 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.749 1.22 . . . . 0.0 111.729 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -53.39 149.61 7.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.559 1.544 . . . . 0.0 114.637 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.06 155.48 42.24 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.698 1.999 . . . . 0.0 109.458 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.43 139.6 92.04 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.491 -0.766 . . . . 0.0 112.796 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.63 155.49 36.76 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.856 3.037 . . . . 0.0 116.53 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -140.81 30.4 1.86 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.052 2.141 . . . . 0.0 113.064 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -71.56 169.96 14.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.196 1.398 . . . . 0.0 113.284 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.38 142.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.527 1.531 . . . . 0.0 112.707 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 96.9 mtp -75.32 154.78 37.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.333 1.053 . . . . 0.0 112.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 42.5 t -157.48 133.43 6.0 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.09 1.356 . . . . 0.0 110.864 172.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.81 -10.72 9.33 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.464 2.776 . . . . 0.0 113.883 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.287 1.1 p -72.19 159.94 33.27 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 -174.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.61 175.41 41.32 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.347 1.451 . . . . 0.0 112.88 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.5 p -70.03 153.31 43.36 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.467 1.107 . . . . 0.0 113.788 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.29 161.47 41.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.887 1.675 . . . . 0.0 111.554 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -69.82 144.17 52.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.154 0.982 . . . . 0.0 112.237 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.01 -10.63 85.37 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.419 1.009 . . . . 0.0 115.431 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -148.7 143.95 26.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.28 1.832 . . . . 0.0 111.267 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.379 1.471 . . . . 0.0 113.285 177.333 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.3 p -137.94 11.62 2.87 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.714 1.606 . . . . 0.0 113.878 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -73.68 -20.1 60.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.979 1.711 . . . . 0.0 114.465 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -72.25 159.95 33.21 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -126.29 23.06 7.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.696 1.998 . . . . 0.0 110.917 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -148.55 155.3 40.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.222 -0.924 . . . . 0.0 112.542 -167.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.31 153.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.908 1.283 . . . . 0.0 113.137 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -93.71 145.55 24.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.274 2.23 . . . . 0.0 112.237 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.43 139.93 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.759 1.624 . . . . 0.0 110.213 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.77 147.72 17.45 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 118.785 0.72 . . . . 0.0 114.652 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.55 12.04 34.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.667 1.603 . . . . 0.0 114.323 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.49 136.57 55.87 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.121 1.368 . . . . 0.0 112.117 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -65.89 154.98 37.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.169 0.988 . . . . 0.0 112.139 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.96 -17.0 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.655 -0.653 . . . . 0.0 111.327 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -69.73 -30.07 67.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.243 1.017 . . . . 0.0 112.54 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -74.96 131.39 40.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.814 1.645 . . . . 0.0 114.884 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -97.54 167.75 10.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 115.318 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.55 -28.75 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.01 -35.91 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.632 0.773 . . . . 0.0 111.795 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.49 -45.15 94.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 169.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -61.01 -51.25 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.206 1.002 . . . . 0.0 109.232 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.23 -49.49 75.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.436 0.694 . . . . 0.0 112.063 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -60.47 -41.72 94.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.065 0.946 . . . . 0.0 112.554 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -66.48 -48.21 70.58 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.316 54.5 m-85 -65.46 -29.47 70.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.37 -20.91 61.28 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -69.14 -26.47 64.9 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.184 0.902 . . . . 0.0 112.635 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -77.62 -38.52 47.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.65 179.9 41.16 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.406 1.955 . . . . 0.0 111.208 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -64.66 121.82 15.4 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.2 132.54 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.683 1.993 . . . . 0.0 107.827 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.85 -55.96 5.12 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 113.18 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.69 169.54 21.35 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.18 0.992 . . . . 0.0 109.872 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.4 152.95 47.51 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.557 1.543 . . . . 0.0 111.842 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 48.9 mmm -149.2 158.26 44.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.501 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.6 mt -124.19 152.33 43.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.58 1.552 . . . . 0.0 111.581 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.09 101.68 7.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.104 0.962 . . . . 0.0 110.317 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.279 62.8 m-85 -82.07 130.17 35.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -83.15 103.68 12.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 108.167 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.27 -22.6 61.41 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -69.43 -25.59 64.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.356 0.2 OUTLIER -133.86 -4.35 2.84 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 176.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.2 t30 58.32 42.38 21.68 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.372 1.869 . . . . 0.0 113.229 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -118.83 148.71 42.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.555 1.942 . . . . 0.0 110.206 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -76.95 151.04 35.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.258 0.935 . . . . 0.0 112.539 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -81.96 7.32 13.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.19 10.54 71.21 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.773 1.177 . . . . 0.0 114.598 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.29 11.8 p90 -141.75 159.69 41.7 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.84 -162.43 23.17 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.99 0.805 . . . . 0.0 114.506 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.22 150.12 46.43 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.497 1.919 . . . . 0.0 113.891 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.4 t -133.72 128.14 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.921 1.288 . . . . 0.0 111.59 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.6 m -92.33 140.39 29.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.146 1.378 . . . . 0.0 113.067 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -122.53 152.65 40.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.056 2.142 . . . . 0.0 116.641 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -76.6 -29.13 56.42 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 t -135.83 129.95 33.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.187 0.995 . . . . 0.0 113.577 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 pm0 -62.88 -29.93 71.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.119 1.768 . . . . 0.0 112.791 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.57 -31.51 72.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.45 -46.41 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.766 0.826 . . . . 0.0 110.118 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.1 t -54.46 -43.5 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.265 1.026 . . . . 0.0 109.836 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.2 -53.13 61.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.0 0.92 . . . . 0.0 113.337 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -64.87 -43.0 94.39 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.22 0.918 . . . . 0.0 111.836 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.84 -42.12 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.777 0.717 . . . . 0.0 110.153 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.42 -31.38 68.56 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.87 -36.13 79.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.29 0.95 . . . . 0.0 112.892 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.9 136.13 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.985 0.914 . . . . 0.0 110.235 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.09 160.18 35.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.984 1.314 . . . . 0.0 111.67 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.477 5.3 m-85 63.34 46.79 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -62.29 134.92 57.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.374 1.869 . . . . 0.0 110.885 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -93.34 112.83 24.86 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.463 -0.773 . . . . 0.0 112.57 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.0 mt -132.62 120.34 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.556 0.742 . . . . 0.0 111.311 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 49.62 44.16 24.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.769 1.227 . . . . 0.0 113.109 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.4 m120 62.64 -8.04 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 128.076 2.55 . . . . 0.0 115.852 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -84.56 154.02 22.89 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.593 1.957 . . . . 0.0 109.471 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 57.5 mmm -99.64 139.91 34.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.175 0.59 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.37 160.44 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.815 1.646 . . . . 0.0 114.004 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -123.12 159.2 29.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.706 1.202 . . . . 0.0 111.482 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -144.99 159.18 43.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.245 1.018 . . . . 0.0 112.954 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -145.22 162.14 37.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.422 1.889 . . . . 0.0 111.037 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -58.64 145.82 38.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.673 0.789 . . . . 0.0 112.939 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.37 46.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.683 1.593 . . . . 0.0 110.012 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -70.49 144.53 91.73 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.195 -0.94 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.74 135.41 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.187 2.591 . . . . 0.0 112.275 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -76.84 -25.43 53.17 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.11 161.93 41.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.51 2.324 . . . . 0.0 110.895 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.05 143.36 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.967 1.307 . . . . 0.0 112.436 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -153.98 151.06 28.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.997 1.319 . . . . 0.0 111.077 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.4 t -151.07 123.32 4.02 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.871 1.268 . . . . 0.0 109.252 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.68 147.91 46.02 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.042 2.495 . . . . 0.0 112.705 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.2 p -72.32 -18.48 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 175.59 175.27 42.87 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.227 1.394 . . . . 0.0 113.193 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 46.5 t -159.0 -47.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.839 1.255 . . . . 0.0 112.155 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.3 153.26 41.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.212 1.005 . . . . 0.0 112.657 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 160.63 43.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 111.493 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.35 144.6 47.75 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.003 0.811 . . . . 0.0 113.622 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.47 142.24 48.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.904 1.282 . . . . 0.0 110.572 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.05 1.74 . . . . 0.0 113.696 176.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.9 m -69.35 140.31 54.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.031 0.932 . . . . 0.0 113.114 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -72.45 128.74 36.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.487 0.715 . . . . 0.0 112.5 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.19 58.7 1.73 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.441 1.896 . . . . 0.0 110.128 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -91.27 2.01 56.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.369 1.468 . . . . 0.0 112.151 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -133.73 167.51 20.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.457 1.903 . . . . 0.0 110.825 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 pt -140.88 148.74 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.709 1.204 . . . . 0.0 112.848 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -81.5 148.85 28.99 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.797 1.639 . . . . 0.0 111.189 164.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.35 135.2 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.533 1.533 . . . . 0.0 109.854 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.1 149.27 21.24 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.592 0.633 . . . . 0.0 114.674 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.86 9.03 55.06 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.535 1.54 . . . . 0.0 114.526 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.79 138.48 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.929 1.292 . . . . 0.0 112.018 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -65.23 152.09 44.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.508 0.723 . . . . 0.0 111.192 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 m -72.32 -14.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.579 -0.701 . . . . 0.0 111.696 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -70.43 -31.59 68.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.983 0.913 . . . . 0.0 112.199 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -73.83 141.0 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.794 1.638 . . . . 0.0 113.406 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -123.59 166.3 15.7 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.23 -31.21 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -65.84 -38.09 87.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.053 0.941 . . . . 0.0 112.334 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.8 -43.24 84.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.856 . . . . 0.0 109.547 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.47 -49.42 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.562 1.145 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -62.46 -46.4 88.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.575 0.625 . . . . 0.0 111.781 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -59.7 -42.25 92.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 112.368 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -66.03 -49.47 67.6 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.299 42.5 m-85 -62.93 -27.67 69.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.62 -16.44 48.4 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -65.41 -31.55 72.71 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.51 -35.71 58.18 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.9 175.51 36.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.117 2.294 . . . . 0.0 110.553 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -63.3 133.3 53.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.3 t -112.34 122.54 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.492 1.917 . . . . 0.0 109.492 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -77.31 -45.2 26.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.235 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.83 159.46 41.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.608 1.963 . . . . 0.0 115.18 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.68 152.33 40.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.084 1.354 . . . . 0.0 110.762 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.3 ptp -157.78 147.57 20.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.505 1.122 . . . . 0.0 112.19 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.6 mt -126.93 153.27 46.03 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.593 1.557 . . . . 0.0 111.593 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.5 mmm -78.37 67.67 4.21 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 112.641 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -59.24 141.0 55.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -133.84 114.77 13.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 113.985 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -62.5 -19.1 63.25 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -22.16 65.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 171.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -133.3 -9.05 2.94 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.17 26.04 15.62 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.747 2.019 . . . . 0.0 114.746 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -148.58 175.93 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.187 1.795 . . . . 0.0 110.282 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -86.24 156.55 20.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.471 0.653 . . . . 0.0 112.544 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -74.53 6.3 3.91 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.06 13.5 58.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.023 1.297 . . . . 0.0 114.862 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 16.0 p90 -145.69 161.1 40.67 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.32 -160.38 23.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.216 0.912 . . . . 0.0 114.72 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -136.9 151.97 49.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.245 1.818 . . . . 0.0 114.342 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.15 131.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.505 1.522 . . . . 0.0 111.042 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.8 m -99.06 126.42 44.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.037 1.735 . . . . 0.0 113.243 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -104.2 154.09 20.18 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -74.41 -18.46 60.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.5 t -153.04 141.14 20.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.327 1.051 . . . . 0.0 113.11 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -62.87 -27.4 69.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 112.817 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.34 -28.11 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.47 -48.7 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.765 0.826 . . . . 0.0 110.102 170.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.05 -40.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.065 1.346 . . . . 0.0 110.554 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -56.93 -43.7 81.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.041 0.837 . . . . 0.0 113.134 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -70.63 -43.18 69.76 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.109 0.868 . . . . 0.0 111.994 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.45 -37.54 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.717 0.69 . . . . 0.0 111.477 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 50.4 t -73.6 -41.56 62.69 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 113.092 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -62.43 -38.37 89.48 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.219 -0.925 . . . . 0.0 112.491 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.69 106.5 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -65.53 -55.63 16.74 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.158 -0.963 . . . . 0.0 111.671 -174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.361 63.9 m-85 -103.27 137.0 41.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -131.47 159.66 37.43 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.081 2.553 . . . . 0.0 109.655 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -126.66 125.24 41.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.629 1.104 . . . . 0.0 113.533 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.37 125.75 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.325 1.45 . . . . 0.0 109.757 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 50.17 40.19 21.37 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.237 1.015 . . . . 0.0 112.871 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.05 -8.61 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.308 2.643 . . . . 0.0 116.32 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -79.44 140.64 37.31 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.834 1.654 . . . . 0.0 109.232 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 39.5 mtm -92.33 147.78 22.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 m -138.24 153.49 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.769 2.428 . . . . 0.0 111.533 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.35 150.31 28.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.631 0.773 . . . . 0.0 111.293 170.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.26 142.91 31.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.827 0.851 . . . . 0.0 112.906 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -144.51 156.42 44.16 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.023 1.329 . . . . 0.0 111.626 -168.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -54.9 141.49 33.22 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.91 146.99 41.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.917 1.687 . . . . 0.0 111.59 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.09 133.49 28.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.052 0.941 . . . . 0.0 113.528 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -68.92 165.56 29.52 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.996 3.131 . . . . 0.0 114.233 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.27 -9.43 55.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -156.19 163.53 39.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.936 1.694 . . . . 0.0 112.578 -176.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.5 139.92 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.619 1.167 . . . . 0.0 112.465 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 73.2 mtp -137.44 129.73 29.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.495 1.518 . . . . 0.0 110.095 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.3 t -164.0 126.45 1.61 Allowed Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.988 0.915 . . . . 0.0 110.654 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.78 146.55 33.78 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.905 2.403 . . . . 0.0 112.115 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -152.37 166.3 32.31 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.03 -170.01 54.77 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.102 1.334 . . . . 0.0 114.716 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 t -155.28 173.69 16.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.825 1.65 . . . . 0.0 110.984 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.46 169.13 7.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.025 1.73 . . . . 0.0 114.113 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.82 160.71 38.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.586 1.555 . . . . 0.0 111.545 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 87.33 166.9 43.06 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.113 1.34 . . . . 0.0 114.32 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.83 129.5 39.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.376 1.471 . . . . 0.0 110.343 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.647 1.579 . . . . 0.0 112.769 178.732 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -139.61 160.62 39.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.224 1.41 . . . . 0.0 112.196 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.07 151.71 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.907 1.283 . . . . 0.0 112.675 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.57 149.78 25.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.044 1.738 . . . . 0.0 112.519 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.24 138.22 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.417 1.487 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.56 15.0 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.033 0.773 . . . . 0.0 115.033 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.02 14.13 25.45 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.749 1.642 . . . . 0.0 114.397 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.6 139.25 57.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.37 1.468 . . . . 0.0 112.325 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.87 151.67 44.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.72 0.808 . . . . 0.0 111.165 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 t -68.37 -20.67 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.553 -0.717 . . . . 0.0 111.346 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -68.07 -28.94 67.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.528 1.131 . . . . 0.0 113.214 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 60.1 m -79.36 132.77 36.52 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.542 1.537 . . . . 0.0 112.827 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.69 165.9 13.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.17 -31.59 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -74.21 -33.47 63.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.38 0.672 . . . . 0.0 111.735 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.55 -47.98 83.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.099 0.56 . . . . 0.0 112.14 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.94 -45.47 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.106 0.562 . . . . 0.0 110.725 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -42.54 91.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.094 0.558 . . . . 0.0 111.813 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.71 -53.58 32.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.526 1.131 . . . . 0.0 112.774 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -59.2 -34.57 72.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 117.633 2.456 . . . . 0.0 117.633 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.32 38.0 m-85 -70.75 -15.8 62.71 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 173.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.42 -10.97 58.86 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -62.52 -25.6 68.11 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.159 -0.963 . . . . 0.0 113.59 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.77 -30.51 18.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.399 1.08 . . . . 0.0 113.284 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 177.83 36.74 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.97 2.224 . . . . 0.0 110.765 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -61.89 124.96 22.21 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.996 . . . . 0.0 112.375 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.3 t -95.87 125.24 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.753 1.621 . . . . 0.0 107.019 168.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.64 -41.03 19.95 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.835 -0.541 . . . . 0.0 109.688 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -162.69 165.72 25.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.317 2.247 . . . . 0.0 114.987 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.66 154.25 45.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.169 1.388 . . . . 0.0 110.748 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.1 mtp -148.95 152.96 37.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.655 1.582 . . . . 0.0 111.462 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -125.85 150.97 47.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.321 1.448 . . . . 0.0 111.742 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.601 0.76 . . . . 0.0 111.386 179.519 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.7 p80 . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.242 0.544 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -80.64 8.81 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.17 11.59 69.37 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.631 1.11 . . . . 0.0 114.503 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.273 12.3 p90 -144.56 158.75 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.93 -158.22 18.38 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.187 0.899 . . . . 0.0 114.739 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -139.78 151.36 45.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.953 2.101 . . . . 0.0 114.18 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.6 129.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.125 1.37 . . . . 0.0 111.804 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.0 m -94.44 128.89 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.28 1.832 . . . . 0.0 113.045 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -104.98 150.31 25.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.14 -35.7 81.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 113.048 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.1 t -147.45 141.22 25.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.667 1.187 . . . . 0.0 112.652 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.35 -26.25 68.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.292 1.437 . . . . 0.0 113.474 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.9 -27.43 66.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.6 mm -77.74 -50.1 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.777 0.831 . . . . 0.0 109.89 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 66.9 t -54.84 -35.12 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.155 1.382 . . . . 0.0 111.576 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -48.91 -51.05 32.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -70.36 -44.18 68.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.555 0.616 . . . . 0.0 111.606 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.25 -47.18 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 18.9 t -74.51 -29.58 61.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.558 1.143 . . . . 0.0 112.53 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.52 -41.4 93.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.947 -1.096 . . . . 0.0 112.047 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.75 119.85 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -68.39 -59.14 3.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.993 -1.067 . . . . 0.0 111.36 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.302 61.3 m-85 -101.81 139.18 37.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -176.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -135.79 135.53 39.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.554 1.942 . . . . 0.0 110.819 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -80.85 135.84 36.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.309 0.644 . . . . 0.0 111.904 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.7 mt -144.89 122.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.732 2.013 . . . . 0.0 108.383 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 50.48 38.65 18.94 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.3 t30 62.78 -12.5 0.07 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 128.112 2.565 . . . . 0.0 115.942 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -73.36 141.81 47.04 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.307 -1.495 . . . . 0.0 108.594 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 51.8 mtm -94.32 142.45 27.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.078 0.854 . . . . 0.0 112.346 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.67 153.35 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.325 2.25 . . . . 0.0 111.311 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.44 157.06 16.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 112.106 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.7 p -133.93 157.27 46.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.537 0.735 . . . . 0.0 112.063 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -145.9 171.59 14.59 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.981 1.712 . . . . 0.0 111.327 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -61.07 149.51 36.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.124 0.97 . . . . 0.0 113.217 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 125.137 1.375 . . . . 0.0 111.275 172.571 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -133.22 159.31 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.547 1.139 . . . . 0.0 112.865 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.94 152.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 112.861 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -86.44 148.71 25.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 112.317 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.5 135.88 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.428 1.491 . . . . 0.0 109.421 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.41 146.71 15.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.97 10.29 32.66 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.828 1.68 . . . . 0.0 114.287 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.06 141.09 58.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.342 1.457 . . . . 0.0 112.321 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -68.81 156.77 37.77 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.791 0.836 . . . . 0.0 112.588 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.38 -27.72 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.649 0.78 . . . . 0.0 110.067 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -64.91 -31.84 73.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.972 0.909 . . . . 0.0 112.696 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 135.53 50.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.015 1.326 . . . . 0.0 113.426 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.88 166.64 13.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.177 1.391 . . . . 0.0 114.635 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.74 -32.75 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -34.84 78.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.85 0.86 . . . . 0.0 112.744 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -67.18 -45.37 77.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.698 0.799 . . . . 0.0 109.853 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.85 -48.08 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.702 1.201 . . . . 0.0 110.428 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -62.53 -47.33 84.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 111.93 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.13 -40.98 87.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.747 0.819 . . . . 0.0 112.419 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -65.89 -51.55 57.72 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 46.9 m-85 -64.17 -25.85 68.26 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -60.74 -17.51 49.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.21 -29.47 70.28 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.369 -0.832 . . . . 0.0 113.058 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.53 -36.19 38.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.5 33.43 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.219 2.342 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.81 124.64 21.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.349 1.074 . . . . 0.0 112.723 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.46 118.45 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.251 1.42 . . . . 0.0 108.637 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.19 -31.6 43.89 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -162.05 160.4 27.46 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.938 1.295 . . . . 0.0 109.516 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.87 152.29 31.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.15 1.38 . . . . 0.0 111.093 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -156.77 156.05 32.64 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.377 1.071 . . . . 0.0 112.323 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.03 149.54 44.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.619 1.568 . . . . 0.0 110.391 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 70.3 mtp . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 112.201 -176.689 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 p80 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.364 0.602 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.06 8.76 2.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.49 13.9 66.93 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.855 1.217 . . . . 0.0 114.329 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.269 8.9 p90 -146.49 160.09 42.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.16 -162.15 21.94 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.221 0.915 . . . . 0.0 114.797 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -138.24 147.3 43.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.88 2.072 . . . . 0.0 114.447 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.71 125.47 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 111.159 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 m -96.42 123.3 40.03 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 111.739 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.29 152.59 18.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -67.67 -34.16 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.541 -0.724 . . . . 0.0 112.399 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.5 t -142.87 137.73 29.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.464 1.126 . . . . 0.0 113.845 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -56.3 -27.36 55.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.117 2.167 . . . . 0.0 112.972 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.92 -28.38 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.72 -48.62 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.893 0.877 . . . . 0.0 109.786 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.02 -38.98 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.075 1.35 . . . . 0.0 110.998 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.62 -34.34 67.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.93 -48.36 14.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.02 0.827 . . . . 0.0 111.713 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.89 -44.73 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.964 0.802 . . . . 0.0 112.558 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.12 -21.45 58.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.011 1.324 . . . . 0.0 112.907 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -78.02 -34.68 50.52 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.946 -1.096 . . . . 0.0 112.396 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.56 139.94 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.691 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -127.08 156.69 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 0.0 113.108 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.466 24.9 m-85 60.31 49.27 7.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -58.86 133.47 56.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.858 2.063 . . . . 0.0 110.993 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -98.66 126.51 44.29 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.287 0.948 . . . . 0.0 113.155 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 mt -142.57 123.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.951 1.7 . . . . 0.0 109.392 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 50.36 41.54 24.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.39 1.076 . . . . 0.0 113.55 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 64.89 -13.41 0.11 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 127.822 2.449 . . . . 0.0 116.002 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -73.9 155.43 38.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.069 1.748 . . . . 0.0 109.283 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.4 ptm -120.77 136.06 54.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.874 0.87 . . . . 0.0 111.188 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.77 143.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.808 1.643 . . . . 0.0 113.602 -169.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -87.02 159.24 19.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.268 0.556 . . . . 0.0 111.353 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.5 p -138.13 155.96 48.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.122 0.969 . . . . 0.0 111.583 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -146.15 167.73 22.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.682 1.593 . . . . 0.0 110.865 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -58.9 151.47 21.62 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.591 -0.693 . . . . 0.0 112.248 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 125.283 1.433 . . . . 0.0 110.138 173.905 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.591 0.71 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -149.29 154.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.612 1.165 . . . . 0.0 110.641 -171.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.51 150.77 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.361 1.064 . . . . 0.0 112.884 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.44 145.51 25.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.367 1.867 . . . . 0.0 111.912 166.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.21 137.83 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.614 1.566 . . . . 0.0 110.117 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.28 147.18 17.07 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 114.688 0.635 . . . . 0.0 114.688 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.96 13.21 29.9 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.693 1.616 . . . . 0.0 114.649 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.54 137.95 58.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.729 1.264 . . . . 0.0 112.205 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -64.72 156.43 30.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.714 1.206 . . . . 0.0 112.821 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 m -71.86 -16.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.252 0.621 . . . . 0.0 111.349 168.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.02 -38.12 85.37 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 111.739 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.15 146.97 54.28 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 t -133.2 166.45 22.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.388 1.875 . . . . 0.0 112.76 169.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.73 -33.33 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.0 -39.89 87.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.436 0.694 . . . . 0.0 112.149 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.9 -43.52 95.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.77 -47.2 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.204 0.602 . . . . 0.0 110.467 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.77 -48.19 82.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.591 0.632 . . . . 0.0 111.803 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -60.8 -39.03 87.38 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -68.3 -40.74 81.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.323 52.8 m-85 -71.32 -29.82 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.44 -18.1 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -65.71 -24.9 67.09 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.295 -0.878 . . . . 0.0 112.884 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.27 -29.32 26.54 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.94 178.87 36.21 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.57 2.033 . . . . 0.0 110.921 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.86 116.3 6.21 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.654 -0.91 . . . . 0.0 112.549 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.65 130.68 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.844 1.658 . . . . 0.0 107.146 169.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.38 -54.07 7.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.673 0.789 . . . . 0.0 112.918 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.84 165.94 29.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.528 1.131 . . . . 0.0 110.003 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.93 149.8 37.38 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.588 1.555 . . . . 0.0 111.647 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.9 mtp -148.41 152.17 36.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.555 1.542 . . . . 0.0 111.713 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.8 mt -125.88 154.11 43.2 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.04 1.336 . . . . 0.0 111.92 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 123.642 0.777 . . . . 0.0 110.664 178.869 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 p80 . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.508 0.67 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -73.73 0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.691 1.996 . . . . 0.0 115.603 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.19 9.01 65.91 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.714 1.15 . . . . 0.0 113.88 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 17.6 p90 -144.99 158.82 43.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.74 -158.66 19.36 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.228 0.918 . . . . 0.0 114.693 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.69 148.95 47.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.605 1.962 . . . . 0.0 114.02 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 t -133.81 132.0 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.132 1.373 . . . . 0.0 111.38 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.8 m -98.52 139.83 33.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.353 1.861 . . . . 0.0 113.954 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.56 154.96 34.66 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.49 -32.58 70.15 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -150.02 146.55 27.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.44 1.096 . . . . 0.0 113.14 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.15 -28.43 69.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.809 1.244 . . . . 0.0 112.613 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.57 -31.79 71.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.9 mm -76.86 -46.12 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.711 0.804 . . . . 0.0 110.152 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.38 -41.13 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.688 1.195 . . . . 0.0 110.252 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -57.72 -49.93 74.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.038 0.836 . . . . 0.0 113.137 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.53 -44.78 81.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.764 0.711 . . . . 0.0 111.779 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.15 -45.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.534 0.607 . . . . 0.0 110.138 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.5 t -67.83 -36.19 79.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.391 1.077 . . . . 0.0 112.745 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -66.68 -41.03 88.77 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.13 -0.981 . . . . 0.0 112.657 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mt -67.01 134.42 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.682 0.793 . . . . 0.0 110.496 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -112.12 148.64 33.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.128 1.371 . . . . 0.0 111.586 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.49 29.3 m-85 57.16 57.02 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -175.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -63.59 128.92 38.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.471 1.508 . . . . 0.0 111.405 173.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.06 133.46 36.12 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.84 0.745 . . . . 0.0 112.264 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.4 mt -146.34 124.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.974 2.11 . . . . 0.0 108.235 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.6 m120 50.98 43.23 28.94 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.175 0.99 . . . . 0.0 113.167 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.78 -13.99 0.08 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.262 2.625 . . . . 0.0 116.485 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.08 169.97 17.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.819 2.047 . . . . 0.0 109.28 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.2 ptp -127.33 146.11 50.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.852 0.861 . . . . 0.0 113.193 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.38 164.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.935 2.494 . . . . 0.0 112.894 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -128.25 158.38 38.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.504 0.722 . . . . 0.0 111.893 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.53 157.42 44.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 113.37 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -142.27 159.07 42.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.167 1.787 . . . . 0.0 111.256 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.15 144.5 45.62 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.577 0.626 . . . . 0.0 112.542 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 C-N-CA 125.346 1.458 . . . . 0.0 111.07 178.496 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 pttp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 122.121 0.962 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -136.4 155.99 49.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.755 1.622 . . . . 0.0 112.485 -168.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.43 ' CG2' HG13 ' A' ' 163' ' ' VAL . 7.5 pt -136.26 157.52 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.571 1.549 . . . . 0.0 113.379 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -94.09 147.34 23.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.173 2.189 . . . . 0.0 113.29 167.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.4 t -137.31 138.93 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.727 1.611 . . . . 0.0 110.061 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.77 154.16 25.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.704 0.669 . . . . 0.0 114.414 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.12 15.02 31.83 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.379 1.466 . . . . 0.0 114.596 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.66 143.03 58.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.004 1.322 . . . . 0.0 112.493 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 p -76.51 175.5 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.453 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 m -81.61 -24.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 0.0 112.684 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -77.32 -33.3 55.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.194 0.998 . . . . 0.0 111.663 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.8 m -65.44 143.97 57.35 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.246 1.418 . . . . 0.0 113.356 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 t -142.72 173.42 11.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.26 1.824 . . . . 0.0 112.715 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.52 -34.15 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.58 -38.67 84.39 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.879 0.872 . . . . 0.0 112.165 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.64 -43.24 85.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.1 t -58.66 -46.88 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.388 0.675 . . . . 0.0 109.867 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -60.57 -46.94 88.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.427 0.558 . . . . 0.0 111.887 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -61.43 -45.09 95.76 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -66.61 -38.75 87.63 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.333 46.7 m-85 -71.62 -29.84 65.12 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.91 -18.93 48.64 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -66.17 -24.96 66.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.494 0.718 . . . . 0.0 112.746 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.67 -34.86 30.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.43 169.54 28.13 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.059 2.266 . . . . 0.0 110.466 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -57.49 130.42 46.23 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.953 0.901 . . . . 0.0 112.768 -170.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.81 122.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.465 1.506 . . . . 0.0 108.249 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.08 -40.02 63.05 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -156.52 154.84 30.97 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.062 2.145 . . . . 0.0 114.646 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.38 142.72 30.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.359 1.064 . . . . 0.0 110.7 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.2 mtm -150.38 151.83 33.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.499 1.52 . . . . 0.0 111.649 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.98 156.86 31.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.173 1.389 . . . . 0.0 111.694 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.4 tpp . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.752 0.821 . . . . 0.0 110.205 170.793 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.1 p80 . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -86.37 8.23 22.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.85 6.37 67.41 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.136 1.35 . . . . 0.0 115.035 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -146.38 162.77 37.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.03 -158.14 20.24 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.186 0.898 . . . . 0.0 114.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -135.97 151.06 49.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.28 1.832 . . . . 0.0 114.547 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -135.42 123.74 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.151 1.38 . . . . 0.0 111.468 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 m -87.79 129.04 35.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.163 1.385 . . . . 0.0 113.125 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.86 160.26 14.44 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -62.24 -39.69 93.7 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.418 -0.801 . . . . 0.0 112.038 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.2 t -149.21 148.57 29.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.728 1.211 . . . . 0.0 113.592 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -57.83 -27.5 63.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 112.674 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.82 -21.86 66.22 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.46 -50.38 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.739 0.816 . . . . 0.0 109.819 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.43 HG13 ' CG2' ' A' ' 111' ' ' ILE . 38.8 t -52.94 -38.67 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.281 1.433 . . . . 0.0 111.275 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -60.33 -43.17 96.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -68.29 -37.76 80.98 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.666 0.667 . . . . 0.0 111.552 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.67 -37.74 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.482 0.583 . . . . 0.0 110.996 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 85.6 m -77.65 -28.85 51.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.243 1.417 . . . . 0.0 114.585 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -69.06 -38.41 79.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.048 0.84 . . . . 0.0 112.939 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.8 mt -74.61 140.86 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.796 0.838 . . . . 0.0 109.94 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -130.44 164.04 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.478 1.111 . . . . 0.0 112.666 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.331 57.5 m-85 60.87 40.67 15.43 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -57.39 131.87 51.4 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 111.584 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.22 128.97 34.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.368 -0.833 . . . . 0.0 112.27 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.26 120.86 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.358 1.863 . . . . 0.0 108.812 172.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 50.58 40.6 24.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.844 0.858 . . . . 0.0 113.04 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 63.25 -12.97 0.08 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 128.203 2.601 . . . . 0.0 116.421 -171.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -74.02 142.91 45.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.829 1.652 . . . . 0.0 109.052 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 34.3 mtt -89.06 141.0 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.244 -0.91 . . . . 0.0 112.487 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.3 159.49 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.297 2.239 . . . . 0.0 111.916 173.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.83 154.64 44.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 110.166 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.4 p -140.31 159.62 41.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.027 0.931 . . . . 0.0 113.292 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -141.48 158.94 43.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.735 1.614 . . . . 0.0 110.653 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -62.4 140.19 58.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 125.707 1.603 . . . . 0.0 110.71 170.153 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 49.7 pttt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.829 1.299 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -137.18 151.95 49.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.407 1.883 . . . . 0.0 111.325 -167.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -134.01 153.76 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.658 1.183 . . . . 0.0 113.285 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -88.93 146.47 24.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.613 1.965 . . . . 0.0 112.747 166.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.48 132.87 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.694 1.598 . . . . 0.0 109.769 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.04 145.91 14.52 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 114.623 0.609 . . . . 0.0 114.623 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.09 11.37 32.19 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.633 1.587 . . . . 0.0 114.436 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.75 138.44 58.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.196 1.398 . . . . 0.0 111.947 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -69.4 156.93 38.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.507 1.123 . . . . 0.0 112.447 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.36 -16.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.618 -0.676 . . . . 0.0 111.62 168.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -73.47 -7.57 52.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.604 1.562 . . . . 0.0 114.238 169.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER -92.02 151.67 20.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -139.64 161.31 37.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.887 1.275 . . . . 0.0 113.953 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.39 -33.23 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -68.37 -38.85 81.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.541 0.736 . . . . 0.0 112.318 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -67.44 -38.86 85.18 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.55 -51.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.398 1.079 . . . . 0.0 109.322 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.78 -43.56 98.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.008 0.822 . . . . 0.0 112.352 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -59.89 -39.29 84.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.752 0.821 . . . . 0.0 112.665 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -66.79 -48.37 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.313 55.6 m-85 -64.16 -29.97 71.06 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -57.37 -22.64 44.04 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.476 1.51 . . . . 0.0 114.65 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.66 -24.85 62.77 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.192 -0.943 . . . . 0.0 112.761 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -79.25 -37.91 36.83 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.58 172.04 35.03 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.593 2.044 . . . . 0.0 110.895 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.07 130.76 48.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.766 0.783 . . . . 0.0 112.579 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.4 t -99.12 131.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.138 1.775 . . . . 0.0 108.493 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -79.12 -54.14 6.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.82 0.848 . . . . 0.0 112.952 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -152.86 157.27 40.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.019 1.327 . . . . 0.0 110.57 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.4 141.08 23.52 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.022 1.329 . . . . 0.0 110.915 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 54.5 mmm -149.85 153.21 36.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.666 1.586 . . . . 0.0 112.341 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.38 152.98 39.63 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.423 1.489 . . . . 0.0 110.648 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.47 0.542 0 O-C-N 121.894 -0.503 . . . . 0.0 110.36 176.242 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 121.529 0.681 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -79.26 5.52 12.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.294 1.838 . . . . 0.0 114.643 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.34 6.11 63.08 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.468 1.509 . . . . 0.0 114.334 -170.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.255 10.9 p90 -147.69 157.0 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.67 -162.3 22.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.507 1.051 . . . . 0.0 114.63 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -138.54 148.62 44.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.338 1.855 . . . . 0.0 114.112 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.34 124.3 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.138 1.375 . . . . 0.0 111.64 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 135.7 33.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.504 1.522 . . . . 0.0 113.741 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.19 156.0 20.39 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.14 -28.87 65.71 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.2 t -150.39 141.52 23.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.57 1.148 . . . . 0.0 112.89 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -59.63 -26.56 65.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 113.234 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.59 -29.33 69.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.3 mm -78.24 -46.36 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.771 0.828 . . . . 0.0 110.074 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.23 -43.09 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.965 1.306 . . . . 0.0 110.522 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.9 -46.36 65.6 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.64 -0.662 . . . . 0.0 112.076 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.65 -37.24 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.042 0.837 . . . . 0.0 111.638 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.83 -35.1 67.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.887 1.275 . . . . 0.0 112.765 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -68.8 -37.95 79.61 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.208 -0.932 . . . . 0.0 112.661 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.19 139.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 110.636 174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -129.88 161.97 29.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.399 1.48 . . . . 0.0 111.426 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.44 8.1 m-30 64.46 46.07 3.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -68.13 122.42 18.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.974 2.11 . . . . 0.0 111.056 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -86.93 121.34 29.27 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.545 1.066 . . . . 0.0 113.467 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.5 mt -143.21 124.74 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.277 1.431 . . . . 0.0 109.6 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 48.04 49.84 16.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.33 1.452 . . . . 0.0 113.02 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 64.92 -12.32 0.13 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.905 2.882 . . . . 0.0 116.575 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -86.08 165.37 16.68 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.361 2.264 . . . . 0.0 110.304 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 44.5 mtm -122.09 143.13 49.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.639 0.775 . . . . 0.0 112.485 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.72 163.58 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.912 2.085 . . . . 0.0 113.642 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -115.18 148.75 38.67 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.138 1.375 . . . . 0.0 111.896 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 81.2 m -120.57 152.35 38.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.857 1.263 . . . . 0.0 112.508 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.92 158.24 43.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.579 1.552 . . . . 0.0 111.2 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.662 -0.649 . . . . 0.0 111.002 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.68 . . . . 0.0 110.571 174.458 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.68 0.752 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -152.82 146.36 24.98 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.442 1.497 . . . . 0.0 111.031 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.2 pt -138.21 149.66 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -83.32 147.89 27.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.411 1.885 . . . . 0.0 111.724 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.35 136.5 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.266 1.426 . . . . 0.0 109.584 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.37 147.76 18.25 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.52 39.27 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.706 1.622 . . . . 0.0 114.552 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.4 mt -65.01 139.88 58.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 112.494 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 t -64.76 156.8 29.36 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.575 1.15 . . . . 0.0 112.4 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.91 -25.28 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.899 0.88 . . . . 0.0 109.504 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.741 0.816 . . . . 0.0 112.592 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -75.23 125.51 29.1 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.52 1.528 . . . . 0.0 115.095 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -91.91 167.82 11.85 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.95 -29.71 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.23 -38.3 63.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.313 0.645 . . . . 0.0 111.537 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.28 -44.93 92.44 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.31 -50.81 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.37 1.068 . . . . 0.0 109.115 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -62.01 -45.86 91.74 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.842 0.746 . . . . 0.0 111.88 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.62 -42.38 98.81 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.97 0.908 . . . . 0.0 112.592 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -63.55 -48.63 76.67 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.305 52.0 m-85 -65.29 -30.54 71.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -61.6 -19.12 61.87 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 172.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -68.59 -24.64 64.61 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.143 0.883 . . . . 0.0 112.712 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -80.86 -38.22 28.52 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.98 0.912 . . . . 0.0 113.012 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 170.37 30.82 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.904 2.192 . . . . 0.0 110.981 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -169.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.32 120.36 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 109.109 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.92 -42.44 69.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.829 1.252 . . . . 0.0 114.24 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -155.94 155.25 32.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.074 2.15 . . . . 0.0 114.874 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.65 141.7 27.14 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.426 1.09 . . . . 0.0 110.692 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.1 mtm -151.0 146.12 26.01 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.343 1.457 . . . . 0.0 111.713 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.9 mt -125.15 156.15 38.81 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.268 1.427 . . . . 0.0 111.49 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.471 0.586 0 C-N-CA 124.155 0.982 . . . . 0.0 113.01 -175.839 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.784 0.802 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -75.7 3.96 8.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.973 1.709 . . . . 0.0 115.138 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.16 12.06 59.21 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.243 1.401 . . . . 0.0 114.804 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -147.58 159.88 43.26 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.85 -156.16 15.78 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 114.957 0.743 . . . . 0.0 114.957 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -134.47 147.12 50.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.612 1.965 . . . . 0.0 115.202 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.48 126.47 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.63 1.572 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.1 m -99.69 130.39 45.91 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.307 1.443 . . . . 0.0 112.693 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.6 152.72 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -67.17 -33.49 75.52 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.4 t -148.06 143.88 27.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.608 1.163 . . . . 0.0 113.035 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -58.51 -26.67 63.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 113.143 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -58.7 -27.94 65.32 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.33 -50.51 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.47 0.708 . . . . 0.0 110.163 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.12 -37.3 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.855 1.262 . . . . 0.0 112.492 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -55.07 -38.17 67.71 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.79 -48.05 27.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.765 0.711 . . . . 0.0 111.721 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.45 -44.52 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 118.739 0.7 . . . . 0.0 112.651 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 25.1 t -73.26 -29.84 63.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.659 1.184 . . . . 0.0 112.427 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -70.34 -38.03 74.76 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.077 -1.014 . . . . 0.0 112.677 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.3 mt -66.06 139.57 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.752 0.821 . . . . 0.0 110.577 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -125.54 149.9 47.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.353 1.461 . . . . 0.0 111.104 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.458 24.6 m-85 58.31 53.3 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -59.0 124.72 20.85 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.803 2.041 . . . . 0.0 111.423 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -93.6 124.22 37.45 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.3 mt -143.53 125.65 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.548 1.539 . . . . 0.0 109.324 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 49.73 42.7 23.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.398 1.079 . . . . 0.0 113.443 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 63.06 -11.05 0.09 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 128.212 2.605 . . . . 0.0 116.236 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -77.9 161.52 27.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.149 1.78 . . . . 0.0 109.336 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.1 ptp -122.32 144.33 49.07 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.8 164.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.678 2.391 . . . . 0.0 112.949 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -133.66 160.79 36.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.664 0.786 . . . . 0.0 112.278 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.46 157.6 45.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 0.0 113.679 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -144.07 162.82 35.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.666 1.986 . . . . 0.0 110.646 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -63.46 152.15 39.18 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.402 1.001 . . . . 0.0 111.621 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.765 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -142.07 154.4 44.91 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.901 -1.125 . . . . 0.0 112.464 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.42 154.32 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 113.425 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -91.61 146.2 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.361 2.264 . . . . 0.0 112.768 167.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.29 135.98 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.354 1.462 . . . . 0.0 109.595 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.74 154.64 25.84 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.785 0.707 . . . . 0.0 114.256 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.59 16.05 41.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.675 1.131 . . . . 0.0 114.0 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -67.2 159.47 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.228 . . . . 0.0 111.314 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.6 p -128.92 -168.8 1.98 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.332 1.053 . . . . 0.0 111.847 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.7 m -75.82 -15.44 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.127 0.971 . . . . 0.0 112.622 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -75.55 -32.34 60.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.261 0.2 OUTLIER -77.32 145.04 37.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.7 t -140.58 158.21 44.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.123 1.369 . . . . 0.0 113.73 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.37 -34.56 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -67.54 -39.37 85.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.445 0.698 . . . . 0.0 111.836 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.65 -34.99 67.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.18 -50.15 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.776 0.83 . . . . 0.0 109.318 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.86 -49.37 77.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.592 0.633 . . . . 0.0 111.501 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -59.07 -40.83 86.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.854 0.862 . . . . 0.0 112.803 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -65.71 -49.0 70.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 50.7 m-85 -64.58 -29.14 70.15 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -59.44 -22.76 61.96 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.23 -26.04 64.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.21 0.913 . . . . 0.0 112.953 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.68 -35.8 57.69 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.34 168.33 30.27 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.506 2.479 . . . . 0.0 109.992 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -65.58 125.12 24.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.363 1.082 . . . . 0.0 113.003 -168.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.37 133.86 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.629 1.972 . . . . 0.0 107.629 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -70.2 -52.12 25.73 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -163.99 161.28 22.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.389 2.276 . . . . 0.0 114.101 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -131.81 150.81 52.04 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.96 1.304 . . . . 0.0 110.18 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 91.3 mtp -148.36 152.42 37.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.964 1.305 . . . . 0.0 111.907 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.3 mt -122.41 133.2 54.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.753 1.621 . . . . 0.0 109.286 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 122.097 0.951 . . . . 0.0 112.077 -176.176 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.1 p80 . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -97.43 21.96 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.308 1.443 . . . . 0.0 114.56 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.12 14.47 62.37 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.914 1.245 . . . . 0.0 114.45 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.293 4.8 p90 -146.82 158.18 43.85 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.38 -160.27 17.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.108 1.337 . . . . 0.0 114.009 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -138.88 152.22 47.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.433 1.893 . . . . 0.0 114.914 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -135.94 126.36 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.352 1.461 . . . . 0.0 112.048 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.2 m -94.18 127.73 40.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 112.022 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -106.73 151.46 25.1 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -71.55 -36.33 70.94 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 t -135.47 137.98 42.7 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.449 1.1 . . . . 0.0 113.438 -171.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -65.32 -30.64 71.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.828 1.251 . . . . 0.0 112.597 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -60.41 -30.26 69.49 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.28 -47.9 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.817 0.847 . . . . 0.0 110.256 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 24.7 t -56.28 -42.47 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.636 1.174 . . . . 0.0 110.327 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.28 -50.8 72.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.743 0.701 . . . . 0.0 112.458 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -66.59 -45.03 80.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.273 0.942 . . . . 0.0 112.145 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.84 -40.62 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.221 0.919 . . . . 0.0 110.66 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.7 t -74.41 -31.32 62.28 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.148 0.979 . . . . 0.0 113.253 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -66.29 -37.41 85.35 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.777 -1.202 . . . . 0.0 113.246 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.1 mt -72.45 136.32 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.859 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.88 158.66 37.19 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.45 1.1 . . . . 0.0 112.701 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.525 22.3 m-85 60.43 45.27 11.11 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -56.36 153.94 8.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.949 1.7 . . . . 0.0 110.825 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -132.62 133.95 44.27 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.971 -1.081 . . . . 0.0 113.294 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . 0.272 4.5 mt -121.52 -127.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.483 1.113 . . . . 0.0 109.144 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -69.14 73.67 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.208 1.803 . . . . 0.0 112.126 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 61.41 -30.28 0.07 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 129.215 3.006 . . . . 0.0 115.389 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -75.56 140.53 42.76 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.295 2.238 . . . . 0.0 111.398 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 13.2 ptm -97.6 150.27 21.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.619 1.168 . . . . 0.0 111.925 171.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.07 162.14 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.402 2.281 . . . . 0.0 112.759 -169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -125.91 163.33 23.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.007 1.323 . . . . 0.0 111.687 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.5 p -143.14 161.35 38.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -144.77 164.55 30.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.632 1.973 . . . . 0.0 110.859 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -61.33 150.18 35.84 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.487 -0.758 . . . . 0.0 111.277 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 124.158 0.983 . . . . 0.0 112.484 177.189 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 122.98 1.372 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -159.74 142.37 13.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.268 2.627 . . . . 0.0 107.855 -168.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.19 154.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.241 1.016 . . . . 0.0 112.496 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.36 148.71 25.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.992 1.717 . . . . 0.0 113.025 166.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.3 t -135.91 137.53 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.627 1.571 . . . . 0.0 109.576 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.01 149.3 20.98 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.89 11.83 36.31 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.714 1.626 . . . . 0.0 114.296 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.8 mt -64.38 135.38 56.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.36 1.464 . . . . 0.0 112.103 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.5 t -64.98 156.53 30.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.487 1.115 . . . . 0.0 112.402 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.44 -16.37 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.279 0.632 . . . . 0.0 111.188 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -68.71 -33.98 74.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.025 0.93 . . . . 0.0 111.895 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -71.84 144.46 49.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.327 1.851 . . . . 0.0 115.41 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 t -135.69 171.1 14.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.204 1.802 . . . . 0.0 112.469 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.57 -33.0 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.59 -39.41 88.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.189 0.996 . . . . 0.0 112.337 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -64.15 -41.37 97.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.35 -50.46 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.852 0.861 . . . . 0.0 110.367 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.64 -44.16 96.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.485 0.584 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.62 -42.37 92.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.783 0.833 . . . . 0.0 112.586 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.28 -53.41 44.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 47.3 m-85 -63.79 -21.1 66.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -64.05 -12.25 36.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.32 -28.6 69.42 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.431 1.014 . . . . 0.0 112.766 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.74 -32.98 21.58 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.235 1.014 . . . . 0.0 112.051 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.93 -178.83 40.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.903 2.192 . . . . 0.0 110.874 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 120.56 12.28 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.585 -0.95 . . . . 0.0 112.571 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.32 121.53 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.381 1.473 . . . . 0.0 108.023 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -76.06 -36.93 58.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -165.36 165.78 19.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 109.28 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.81 43.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.317 1.447 . . . . 0.0 111.284 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.6 ptm -156.56 157.03 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.882 1.273 . . . . 0.0 112.2 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.79 151.99 48.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.267 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 53.6 mtp . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 123.696 0.798 . . . . 0.0 110.745 174.266 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.6 p80 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.482 0.658 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.97 -0.52 24.66 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.823 1.649 . . . . 0.0 115.385 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.64 10.47 81.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.301 0.953 . . . . 0.0 113.417 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.285 15.6 p90 -143.6 157.7 44.22 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.28 -161.73 20.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.684 1.135 . . . . 0.0 114.153 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -138.64 152.56 48.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.938 1.695 . . . . 0.0 113.883 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.91 129.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.293 1.437 . . . . 0.0 111.499 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -91.38 138.59 31.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.15 1.78 . . . . 0.0 114.541 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -120.22 152.44 37.72 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -70.04 -30.17 67.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.1 t -155.7 149.69 25.46 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.609 1.163 . . . . 0.0 112.728 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.46 -29.68 66.37 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.029 0.932 . . . . 0.0 112.096 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -56.91 -26.41 59.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 24.1 mm -80.87 -52.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.815 0.846 . . . . 0.0 110.129 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.4 t -53.87 -36.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.617 1.567 . . . . 0.0 112.271 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -53.4 -47.16 69.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.886 0.874 . . . . 0.0 112.937 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -68.08 -44.84 75.37 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.074 0.852 . . . . 0.0 111.392 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.2 t -54.46 -41.93 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 96.7 m -72.21 -37.44 69.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.278 1.431 . . . . 0.0 114.453 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -66.31 -33.66 76.24 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.4 mt -73.0 112.05 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -70.64 -61.12 1.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.179 -0.951 . . . . 0.0 111.648 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 52.8 m-85 -94.66 133.41 38.36 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -127.23 124.2 38.36 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.499 1.92 . . . . 0.0 110.382 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.23 107.7 19.38 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.339 -0.851 . . . . 0.0 112.718 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.14 122.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.377 1.071 . . . . 0.0 110.832 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.37 45.02 23.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.472 1.109 . . . . 0.0 112.818 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 63.31 -9.75 0.12 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 128.502 2.721 . . . . 0.0 116.158 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -87.89 142.47 27.77 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 126.322 1.849 . . . . 0.0 109.83 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 58.5 mtt -86.09 129.96 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.416 -0.803 . . . . 0.0 112.512 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.9 163.14 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.046 2.138 . . . . 0.0 111.718 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -128.26 162.94 25.85 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.519 0.727 . . . . 0.0 110.899 169.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.5 158.19 43.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.374 1.07 . . . . 0.0 113.196 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -144.25 165.53 27.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.631 1.573 . . . . 0.0 111.242 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.48 152.13 18.69 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 169.713 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -148.57 149.32 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.15 1.78 . . . . 0.0 111.232 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.55 149.3 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 111.316 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.88 134.58 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.781 1.233 . . . . 0.0 109.58 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.43 145.95 14.95 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 114.518 0.567 . . . . 0.0 114.518 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.6 7.16 32.34 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.689 1.614 . . . . 0.0 114.609 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.5 139.48 58.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.164 1.385 . . . . 0.0 112.183 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -62.66 155.02 27.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.235 1.014 . . . . 0.0 112.506 171.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.57 -20.1 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.479 0.712 . . . . 0.0 112.214 169.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -71.76 -26.9 62.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.065 0.946 . . . . 0.0 113.151 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.0 m -73.59 143.49 46.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.735 1.614 . . . . 0.0 113.812 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 t -123.94 163.71 20.78 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 0.0 114.207 169.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.6 p -57.9 -30.61 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.78 -34.51 78.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.832 0.853 . . . . 0.0 112.458 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -68.27 -47.19 68.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.85 -45.25 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.662 0.785 . . . . 0.0 111.025 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -61.01 -46.29 91.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 118.952 -0.547 . . . . 0.0 112.151 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -59.7 -42.8 93.8 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -65.03 -38.8 92.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -75.97 -29.19 58.17 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -58.71 -18.9 35.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.334 1.454 . . . . 0.0 114.572 171.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -66.19 -23.88 66.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.388 -0.82 . . . . 0.0 112.777 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -89.28 -37.76 14.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.04 176.47 39.69 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.175 1.845 . . . . 0.0 111.45 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.44 127.82 34.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.6 t -100.39 118.27 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.184 1.794 . . . . 0.0 108.397 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -78.27 -37.33 45.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -152.15 153.26 33.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.958 2.103 . . . . 0.0 114.684 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.18 29.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.4 ptp -157.85 147.59 20.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.248 1.019 . . . . 0.0 112.3 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.6 mt -127.83 153.87 46.1 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.521 1.529 . . . . 0.0 111.673 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 124.358 1.063 . . . . 0.0 112.52 -178.126 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 p80 . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -70.5 -0.21 8.0 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.57 63.44 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.769 1.176 . . . . 0.0 114.376 -172.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -144.8 159.82 42.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -176.17 -160.15 23.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.0 0.81 . . . . 0.0 114.909 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -132.8 149.29 52.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.608 1.963 . . . . 0.0 115.357 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 t -135.09 128.11 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.254 1.421 . . . . 0.0 111.749 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 61.6 m -96.55 127.34 42.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.668 1.587 . . . . 0.0 111.418 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.43 157.95 15.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -61.81 -37.96 86.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.745 0.818 . . . . 0.0 112.84 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -151.79 143.52 23.65 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -57.14 -26.78 61.1 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.573 1.549 . . . . 0.0 113.051 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.91 -26.92 68.46 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.72 -50.28 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.628 0.771 . . . . 0.0 109.458 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.96 -33.11 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.664 1.186 . . . . 0.0 111.201 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -48.16 -43.1 31.17 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -76.41 -45.51 31.29 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.639 -0.663 . . . . 0.0 111.764 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.35 -36.95 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.1 t -84.07 -24.27 30.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.583 1.153 . . . . 0.0 112.567 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -72.7 -35.61 67.66 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.02 -1.05 . . . . 0.0 112.155 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.14 138.41 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.022 0.929 . . . . 0.0 110.465 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -127.37 156.14 42.49 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.863 1.265 . . . . 0.0 111.951 169.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.443 18.2 m-85 61.04 47.15 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 -171.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -56.96 129.47 41.77 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.83 1.652 . . . . 0.0 111.201 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.29 125.0 28.62 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.446 0.566 . . . . 0.0 111.803 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.68 117.06 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.245 1.818 . . . . 0.0 108.781 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 50.03 43.79 25.61 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.287 1.035 . . . . 0.0 112.95 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.74 -13.88 0.08 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 128.173 2.589 . . . . 0.0 116.4 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.48 157.16 36.06 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.81 1.644 . . . . 0.0 109.265 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 26.7 mtt -109.6 141.06 42.65 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.73 151.24 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.122 1.769 . . . . 0.0 114.031 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.72 144.98 26.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.842 0.857 . . . . 0.0 112.14 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 4.9 t -108.77 143.67 37.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.627 1.571 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -140.8 157.7 45.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.728 1.611 . . . . 0.0 111.123 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.74 129.81 41.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.549 0.739 . . . . 0.0 111.894 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 123.906 0.882 . . . . 0.0 112.364 -179.097 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.74 147.76 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.785 1.634 . . . . 0.0 111.672 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.29 152.85 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.27 148.25 22.28 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.375 2.27 . . . . 0.0 111.86 167.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.0 t -137.79 135.1 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.015 1.326 . . . . 0.0 109.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.23 155.84 26.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.977 0.798 . . . . 0.0 114.288 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.94 10.01 41.16 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.558 1.551 . . . . 0.0 114.725 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -67.13 137.67 56.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.866 1.266 . . . . 0.0 112.532 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 t -65.93 152.46 44.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.256 1.023 . . . . 0.0 111.76 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -70.53 -15.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.574 -0.704 . . . . 0.0 111.796 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -70.38 -29.85 66.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.303 1.041 . . . . 0.0 112.689 170.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.3 m -78.85 139.12 38.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.992 1.717 . . . . 0.0 113.605 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 t -118.82 165.14 14.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.44 1.496 . . . . 0.0 114.726 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.93 -33.98 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -72.63 -27.01 61.87 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.72 -46.88 64.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.977 0.808 . . . . 0.0 109.169 171.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.44 -46.61 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.686 0.794 . . . . 0.0 110.493 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -57.18 -50.77 71.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.005 0.922 . . . . 0.0 111.855 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -60.21 -44.29 95.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 112.973 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.07 -38.8 92.37 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.306 48.6 m-85 -73.07 -31.2 64.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -60.42 -18.07 48.49 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.45 -24.88 67.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.55 0.74 . . . . 0.0 112.718 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -85.55 -35.64 20.97 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.85 175.3 36.19 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.668 2.08 . . . . 0.0 111.139 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -58.81 125.03 21.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.761 -0.847 . . . . 0.0 112.98 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.1 t -94.01 124.01 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.835 1.654 . . . . 0.0 107.234 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.85 -31.5 20.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.987 0.515 . . . . 0.0 110.356 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -161.51 155.56 22.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.884 1.274 . . . . 0.0 109.767 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.83 149.51 34.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.048 1.339 . . . . 0.0 111.268 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.4 ptp -156.07 154.9 31.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.634 1.174 . . . . 0.0 112.166 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.41 152.3 46.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.302 1.441 . . . . 0.0 111.419 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.764 0.826 . . . . 0.0 111.788 -176.293 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.3 p80 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.602 0.715 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -80.87 7.47 10.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.193 1.797 . . . . 0.0 115.096 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.46 11.84 63.74 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.992 1.282 . . . . 0.0 114.414 -172.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -145.98 160.78 41.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.66 -162.16 23.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.54 1.066 . . . . 0.0 114.77 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.07 148.12 44.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.653 1.981 . . . . 0.0 113.84 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.56 123.59 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.422 1.489 . . . . 0.0 111.606 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 90.4 m -93.25 128.47 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.026 1.33 . . . . 0.0 110.501 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.91 153.15 19.39 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.2 -33.29 75.47 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -152.94 143.65 22.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 112.815 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -55.83 -27.16 50.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 113.185 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.38 -27.12 69.09 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.3 mm -77.54 -48.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.254 0.621 . . . . 0.0 109.686 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.08 -34.07 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.292 1.037 . . . . 0.0 111.244 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -50.23 -42.85 52.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.476 1.51 . . . . 0.0 113.54 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -77.35 -47.61 19.47 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.497 0.719 . . . . 0.0 111.595 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.3 -43.3 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.9 t -76.01 -24.47 55.29 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 112.19 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -78.27 -33.27 49.7 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.041 -1.037 . . . . 0.0 112.539 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 30.2 mt -67.97 148.47 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.429 1.091 . . . . 0.0 110.748 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -134.84 152.03 51.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.368 26.6 m-85 58.42 50.6 9.17 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -171.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -60.13 133.55 56.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.334 . . . . 0.0 111.971 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -82.93 133.47 35.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.805 -0.56 . . . . 0.0 111.896 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.1 mt -145.24 125.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 126.695 1.998 . . . . 0.0 108.842 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 50.08 36.28 11.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.56 1.144 . . . . 0.0 113.495 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.07 -7.73 0.14 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 128.242 2.617 . . . . 0.0 116.058 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.17 173.62 11.65 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 109.33 167.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.3 mtt -120.85 145.78 47.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.42 161.75 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.366 2.266 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.27 152.25 50.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.403 1.081 . . . . 0.0 110.017 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.06 157.97 44.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -147.44 160.93 42.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.88 2.072 . . . . 0.0 111.14 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 146.95 42.59 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.988 0.813 . . . . 0.0 111.844 172.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.887 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 122.768 1.27 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -147.27 142.17 26.91 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.745 2.018 . . . . 0.0 109.393 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 pt -139.52 151.87 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.948 0.899 . . . . 0.0 113.236 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -92.67 145.71 24.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.17 2.188 . . . . 0.0 112.404 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.27 134.97 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 109.952 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.98 148.22 19.77 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.784 0.72 . . . . 0.0 114.256 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.77 9.57 59.72 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.936 1.255 . . . . 0.0 114.261 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.45 144.01 54.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.976 1.31 . . . . 0.0 111.575 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -67.15 158.03 32.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.155 0.582 . . . . 0.0 110.993 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.21 -26.3 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -71.31 -25.92 62.63 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.56 1.144 . . . . 0.0 113.712 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -70.2 119.15 13.96 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.299 1.3 t -98.5 164.18 12.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.45 -33.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -174.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.19 -32.49 72.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.1 0.96 . . . . 0.0 113.052 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.59 -46.06 73.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.849 0.75 . . . . 0.0 110.364 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.43 -48.97 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.303 1.041 . . . . 0.0 110.567 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.87 -49.07 79.15 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.869 0.867 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -60.0 -39.55 86.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 112.773 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -68.87 -49.07 61.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.324 49.4 m-85 -63.23 -29.22 70.6 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.44 -21.48 60.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -70.36 -25.73 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.019 0.827 . . . . 0.0 112.846 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -76.32 -38.81 55.46 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.63 167.65 29.57 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.328 2.394 . . . . 0.0 110.276 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.02 131.86 51.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.135 0.968 . . . . 0.0 113.294 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -93.69 138.26 20.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 126.565 1.946 . . . . 0.0 108.335 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.99 -45.11 10.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.932 1.293 . . . . 0.0 112.946 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -158.9 161.53 36.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.295 1.438 . . . . 0.0 109.881 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.11 156.86 42.82 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.148 1.379 . . . . 0.0 111.767 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -157.09 159.34 37.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.54 1.136 . . . . 0.0 113.163 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 73.3 mt -124.05 146.64 48.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.889 2.076 . . . . 0.0 111.136 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.474 0.71 . . . . 0.0 111.884 176.038 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.53 -8.49 15.0 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.11 76.45 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.384 0.993 . . . . 0.0 114.767 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.292 15.3 p90 -142.48 161.2 38.67 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.25 -168.41 25.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.689 1.138 . . . . 0.0 113.761 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -141.27 153.66 45.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.125 1.37 . . . . 0.0 112.965 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.0 130.98 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.356 1.462 . . . . 0.0 112.094 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.3 m -93.48 138.04 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.77 1.628 . . . . 0.0 113.85 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.51 148.8 32.4 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -69.76 -28.95 66.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.107 0.963 . . . . 0.0 112.738 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.2 t -143.45 130.36 20.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.937 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.6 pm0 -57.85 -28.55 64.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.741 2.016 . . . . 0.0 113.378 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.32 -28.25 69.18 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -74.7 -45.01 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 110.094 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.8 t -58.63 -37.59 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.435 1.094 . . . . 0.0 110.516 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -56.14 -45.51 79.57 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.987 0.812 . . . . 0.0 113.128 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -69.33 -45.95 68.24 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.923 0.783 . . . . 0.0 111.836 173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.88 -44.11 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 118.851 0.75 . . . . 0.0 110.834 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.67 -36.61 76.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.331 1.452 . . . . 0.0 113.033 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -37.32 86.25 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.116 -0.99 . . . . 0.0 112.816 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.01 117.38 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.54 0.736 . . . . 0.0 109.232 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -70.28 -61.44 1.77 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.486 -0.759 . . . . 0.0 111.777 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.335 53.5 m-85 -95.71 139.55 31.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -137.28 153.08 50.39 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.716 2.406 . . . . 0.0 109.606 -174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -124.2 115.93 21.89 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.129 -0.982 . . . . 0.0 112.82 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.4 126.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.108 0.963 . . . . 0.0 111.049 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 51.0 38.23 19.89 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 112.826 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.12 -7.1 0.12 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.914 2.486 . . . . 0.0 115.86 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -78.52 140.52 38.55 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.128 1.771 . . . . 0.0 109.178 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 96.5 mtp -88.64 143.26 27.06 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.546 -0.721 . . . . 0.0 111.879 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.0 164.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.566 2.346 . . . . 0.0 111.628 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -124.9 158.29 33.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.818 0.847 . . . . 0.0 110.867 168.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.1 p -141.41 158.27 44.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.637 0.732 . . . . 0.0 112.58 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -155.78 163.07 40.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.62 1.568 . . . . 0.0 111.702 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -57.69 147.14 28.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.494 1.118 . . . . 0.0 112.416 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 125.704 1.601 . . . . 0.0 110.965 178.216 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -140.56 151.78 44.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.21 1.404 . . . . 0.0 111.921 -172.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -139.8 151.57 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.608 1.163 . . . . 0.0 113.648 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -90.12 146.95 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.252 2.221 . . . . 0.0 112.973 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.28 138.06 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.099 1.76 . . . . 0.0 110.348 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.52 142.41 9.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.887 0.767 . . . . 0.0 114.85 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.54 4.92 30.16 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.089 1.804 . . . . 0.0 114.649 -175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.22 140.05 58.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.368 1.467 . . . . 0.0 112.277 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -66.23 152.47 44.81 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.802 0.841 . . . . 0.0 111.741 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.15 -14.81 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.43 -0.793 . . . . 0.0 111.552 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -71.03 -28.81 64.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.133 0.973 . . . . 0.0 112.68 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.0 m -74.08 140.54 45.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.658 1.583 . . . . 0.0 112.78 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.53 164.48 15.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.404 1.482 . . . . 0.0 114.572 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.81 -32.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -67.24 -32.1 72.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.893 0.877 . . . . 0.0 112.739 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -67.25 -50.06 61.98 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.5 -45.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 111.207 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.16 -47.76 84.58 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 111.747 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.16 -43.79 98.04 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -64.13 -38.6 91.64 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 48.1 m-85 -73.51 -29.68 62.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -60.76 -17.09 46.76 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -65.52 -24.14 67.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.61 0.764 . . . . 0.0 112.794 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -83.49 -34.4 25.36 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.06 174.64 34.98 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.849 2.166 . . . . 0.0 110.798 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -59.23 126.5 27.93 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.951 0.876 . . . . 0.0 113.162 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.92 126.83 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.707 1.603 . . . . 0.0 108.628 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -76.69 -46.3 26.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.071 0.948 . . . . 0.0 112.631 175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -158.72 161.11 37.03 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.22 1.008 . . . . 0.0 110.894 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.83 156.27 41.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.508 1.523 . . . . 0.0 111.818 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -154.47 158.88 40.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.81 1.244 . . . . 0.0 112.629 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.1 mt -126.8 147.79 49.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.874 1.67 . . . . 0.0 111.445 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.997 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.2 p80 . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.577 0.703 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -78.23 7.26 6.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.853 1.661 . . . . 0.0 115.314 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.24 14.89 67.9 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.554 1.073 . . . . 0.0 114.41 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.311 14.6 p90 -139.52 158.26 44.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.07 -171.75 30.71 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.224 0.916 . . . . 0.0 114.845 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -134.23 149.4 50.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.923 2.089 . . . . 0.0 114.246 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.81 129.37 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.246 1.418 . . . . 0.0 111.209 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 76.8 m -100.53 124.1 45.63 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.409 1.484 . . . . 0.0 111.434 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -97.16 155.9 16.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -68.91 -30.86 69.43 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.2 t -153.02 143.59 22.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.343 1.057 . . . . 0.0 113.309 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -57.82 -26.2 61.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.571 1.548 . . . . 0.0 113.673 170.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -59.02 -35.68 73.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.202 1.001 . . . . 0.0 111.809 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.75 -47.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.052 0.941 . . . . 0.0 110.418 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.7 t -58.4 -37.56 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.635 1.174 . . . . 0.0 111.146 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.69 -48.71 74.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.036 0.835 . . . . 0.0 113.218 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.63 -42.1 82.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.082 0.855 . . . . 0.0 111.676 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.79 -39.16 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.512 0.596 . . . . 0.0 111.241 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 88.9 m -73.62 -38.48 65.04 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.29 -35.61 80.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.21 116.36 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -68.94 -56.2 8.58 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.278 -0.889 . . . . 0.0 111.77 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.315 50.9 m-85 -104.12 136.82 43.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -130.81 137.42 49.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.787 2.035 . . . . 0.0 110.629 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -84.31 131.19 34.74 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.76 -0.588 . . . . 0.0 111.731 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.98 122.29 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.546 1.939 . . . . 0.0 109.546 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 49.62 40.01 18.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.555 1.142 . . . . 0.0 112.855 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 62.43 -8.01 0.12 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 128.688 2.795 . . . . 0.0 116.259 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -77.17 154.62 32.98 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.276 -1.515 . . . . 0.0 108.532 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 22.6 ptm -100.29 139.74 35.53 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.238 -0.914 . . . . 0.0 111.769 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.45 162.0 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.709 2.004 . . . . 0.0 111.719 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.82 162.55 17.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.5 p -144.06 154.27 43.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.695 1.198 . . . . 0.0 113.675 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -144.06 165.43 27.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.681 1.993 . . . . 0.0 111.758 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.54 134.67 57.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.024 0.93 . . . . 0.0 111.655 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.17 0.988 . . . . 0.0 112.988 -176.874 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -141.13 149.65 41.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.724 1.61 . . . . 0.0 111.431 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.84 151.3 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.344 1.058 . . . . 0.0 113.763 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -88.72 145.64 25.51 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.526 1.931 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.3 138.05 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.471 1.509 . . . . 0.0 110.627 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.77 153.52 25.16 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.861 0.743 . . . . 0.0 114.33 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.81 34.88 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.034 1.302 . . . . 0.0 114.602 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.0 mt -64.21 136.24 57.02 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.106 1.363 . . . . 0.0 112.18 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -62.62 152.66 34.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.348 1.059 . . . . 0.0 112.37 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.6 -23.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.81 0.844 . . . . 0.0 111.725 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -67.62 -26.68 66.36 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.65 1.18 . . . . 0.0 113.282 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.2 m -76.97 147.64 36.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.074 1.749 . . . . 0.0 115.495 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 t -129.3 162.66 27.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.07 1.748 . . . . 0.0 113.094 168.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -57.72 -30.86 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.14 -33.99 77.33 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.911 0.884 . . . . 0.0 112.42 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.07 -47.24 68.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.23 -45.35 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.58 0.752 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -60.91 -47.44 86.38 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.141 0.577 . . . . 0.0 111.65 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -58.9 -45.76 89.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.971 0.908 . . . . 0.0 113.415 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -65.62 -38.68 90.1 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 49.4 m-85 -73.75 -29.18 62.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 171.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -61.19 -17.39 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -64.93 -23.04 67.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.659 0.784 . . . . 0.0 112.8 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -86.1 -29.29 23.46 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.73 174.95 30.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.98 2.228 . . . . 0.0 110.729 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -59.3 126.88 29.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.249 1.025 . . . . 0.0 112.882 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.53 123.25 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.799 1.64 . . . . 0.0 107.502 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.16 -33.73 24.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.325 0.65 . . . . 0.0 110.398 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -160.54 158.08 28.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.683 1.193 . . . . 0.0 110.168 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.01 149.11 30.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.205 1.402 . . . . 0.0 111.165 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.14 159.09 42.67 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.432 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.0 mt -125.98 155.8 40.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.913 1.685 . . . . 0.0 111.028 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.3 mmm . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.381 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 p80 . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.259 0.552 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -84.48 1.55 45.08 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.52 66.8 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.267 1.413 . . . . 0.0 114.597 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -145.22 159.74 42.55 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.94 -164.43 27.49 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.271 0.939 . . . . 0.0 115.129 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -136.59 147.67 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.75 2.02 . . . . 0.0 114.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.26 127.6 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.704 1.202 . . . . 0.0 111.3 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.9 m -96.81 122.67 40.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.343 1.457 . . . . 0.0 111.278 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.29 158.99 16.26 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.617 -0.677 . . . . 0.0 112.597 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -149.73 147.23 27.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.562 1.145 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -62.17 -24.5 67.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.687 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.76 -30.31 71.35 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.22 -47.46 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.549 0.739 . . . . 0.0 109.874 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.65 -34.28 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.383 1.073 . . . . 0.0 110.526 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.24 -40.09 61.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.8 1.24 . . . . 0.0 113.163 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -80.54 -45.24 17.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.615 0.643 . . . . 0.0 112.09 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.8 -44.66 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.845 0.748 . . . . 0.0 112.006 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 22.3 t -73.21 -33.0 65.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.085 1.354 . . . . 0.0 112.145 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -67.42 -38.74 85.03 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.292 -0.88 . . . . 0.0 112.484 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.7 mt -71.66 114.81 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -68.75 -49.63 57.19 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.897 -1.127 . . . . 0.0 112.149 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 62.4 m-85 -108.43 138.85 44.04 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.97 129.45 34.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.919 1.687 . . . . 0.0 111.123 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -77.94 134.15 37.93 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.53 -0.731 . . . . 0.0 112.39 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.9 mt -145.83 118.71 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 127.493 2.317 . . . . 0.0 108.199 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 50.69 45.94 26.38 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.05 0.94 . . . . 0.0 113.359 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 65.86 -18.22 0.1 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 128.045 2.538 . . . . 0.0 116.259 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -75.26 155.33 36.84 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.403 1.881 . . . . 0.0 109.844 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.7 mtm -108.17 125.09 51.23 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.472 -0.768 . . . . 0.0 111.397 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.16 163.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.345 1.858 . . . . 0.0 111.868 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -122.44 155.71 35.56 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.349 0.66 . . . . 0.0 111.112 168.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 30.1 p -139.14 155.84 47.57 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -145.06 173.46 11.88 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.491 1.917 . . . . 0.0 111.775 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -60.34 135.39 57.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.113 0.965 . . . . 0.0 111.315 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 123.208 0.603 . . . . 0.0 110.793 174.76 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.35 0.595 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -151.92 154.2 35.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.033 1.333 . . . . 0.0 110.286 -169.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.66 154.81 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.076 . . . . 0.0 112.896 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -91.01 145.57 24.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.399 1.879 . . . . 0.0 112.054 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.03 131.4 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.55 1.54 . . . . 0.0 109.908 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.13 12.66 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.607 0.622 . . . . 0.0 114.5 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.58 10.79 26.42 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.759 1.647 . . . . 0.0 114.717 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 37.7 mt -61.61 136.38 57.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.219 1.408 . . . . 0.0 111.929 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 p -79.92 179.18 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -79.5 -20.17 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.306 1.043 . . . . 0.0 112.56 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.38 -37.75 56.72 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.897 0.879 . . . . 0.0 110.527 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 m -68.96 140.5 55.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.72 1.608 . . . . 0.0 115.295 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 t -144.44 173.71 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.678 1.991 . . . . 0.0 112.218 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.1 -32.28 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -68.44 -39.98 81.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.906 0.882 . . . . 0.0 112.433 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -65.06 -41.89 94.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.97 -53.02 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.374 1.07 . . . . 0.0 109.137 174.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -58.86 -48.17 82.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.67 0.668 . . . . 0.0 111.962 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -60.5 -42.01 95.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.737 0.815 . . . . 0.0 112.832 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.14 -46.02 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.329 54.6 m-85 -66.57 -28.0 68.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -59.57 -21.01 59.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -71.51 -25.89 62.44 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.417 -0.802 . . . . 0.0 112.767 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -75.49 -36.26 60.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 177.08 37.86 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.877 2.179 . . . . 0.0 110.963 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -60.01 131.27 50.34 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.12 0.96 . . . . 0.0 112.968 -172.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 36.9 t -108.06 133.46 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.757 2.023 . . . . 0.0 107.446 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -101.32 -23.12 14.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.01 150.9 17.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.892 2.077 . . . . 0.0 113.379 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.0 31.65 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.289 1.036 . . . . 0.0 110.997 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.7 ptm -157.43 158.77 36.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.742 1.217 . . . . 0.0 112.331 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.14 150.13 49.64 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.805 1.642 . . . . 0.0 111.808 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 110.564 169.518 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 p80 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 121.222 0.534 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -82.34 2.53 31.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -172.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.7 9.92 82.23 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.56 1.076 . . . . 0.0 113.771 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.27 19.6 p90 -143.47 156.65 44.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.08 -164.69 22.09 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.441 1.019 . . . . 0.0 114.174 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.09 151.72 46.93 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.994 1.718 . . . . 0.0 114.144 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 t -137.26 128.27 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.944 1.298 . . . . 0.0 112.101 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -90.36 139.62 30.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.866 1.666 . . . . 0.0 113.287 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.34 150.5 43.57 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -174.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -67.15 -33.02 74.53 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.4 t -147.4 148.59 31.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.74 1.216 . . . . 0.0 113.192 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -57.44 -29.38 64.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.543 1.137 . . . . 0.0 112.836 171.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -61.64 -30.8 70.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -78.94 -48.67 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 110.249 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.95 -43.06 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.04 1.336 . . . . 0.0 110.434 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -56.4 -47.98 77.87 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.975 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -64.99 -45.13 86.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.019 0.827 . . . . 0.0 111.688 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.48 -36.13 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.629 0.65 . . . . 0.0 111.705 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.6 m -73.24 -39.87 65.11 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -66.4 -35.3 79.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.037 0.935 . . . . 0.0 113.22 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.18 115.0 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -68.29 -58.74 3.93 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.716 -0.615 . . . . 0.0 111.279 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.327 53.4 m-85 -104.71 137.94 41.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.05 125.48 33.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.981 2.112 . . . . 0.0 109.865 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.51 121.57 32.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.416 -0.803 . . . . 0.0 112.535 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.4 mt -139.15 126.44 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.891 1.277 . . . . 0.0 109.91 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.41 40.0 21.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.622 1.169 . . . . 0.0 113.687 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 62.97 -7.91 0.14 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 128.1 2.56 . . . . 0.0 115.876 -171.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -81.58 170.13 16.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.807 2.043 . . . . 0.0 110.37 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.6 mtp -121.21 134.89 55.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.207 1.003 . . . . 0.0 112.105 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.02 159.04 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.849 2.06 . . . . 0.0 112.399 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -124.79 152.3 44.05 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.81 0.844 . . . . 0.0 112.506 172.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.7 m -124.5 144.95 49.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.547 1.139 . . . . 0.0 113.015 -169.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -141.79 169.89 16.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.276 1.43 . . . . 0.0 112.78 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -63.1 150.32 42.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.512 1.125 . . . . 0.0 112.789 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.291 1.436 . . . . 0.0 110.681 171.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.85 149.5 37.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.345 1.458 . . . . 0.0 111.859 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -139.38 151.03 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.406 1.083 . . . . 0.0 113.919 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.13 148.39 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.97 2.108 . . . . 0.0 112.782 167.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.0 t -134.89 134.99 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 109.645 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.48 155.85 26.72 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.016 0.817 . . . . 0.0 114.327 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.79 7.56 66.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.798 1.19 . . . . 0.0 113.784 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.76 143.56 57.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 111.656 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -69.47 154.08 42.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.174 0.589 . . . . 0.0 110.041 167.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.59 -15.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.771 -0.581 . . . . 0.0 111.708 168.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -73.75 -28.85 61.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.074 1.35 . . . . 0.0 113.126 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 m -67.06 123.89 21.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.265 0.8 OUTLIER -80.86 160.58 24.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.52 -29.85 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -75.23 -36.78 61.3 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.02 -43.37 98.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.78 -50.44 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.85 0.86 . . . . 0.0 109.681 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.49 -46.8 88.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.686 0.675 . . . . 0.0 112.313 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -59.15 -40.15 84.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.534 1.134 . . . . 0.0 112.237 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.41 -54.56 34.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 171.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 48.6 m-85 -63.41 -23.7 67.52 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -60.93 -13.85 18.6 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.31 -29.13 69.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.886 1.221 . . . . 0.0 112.726 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -85.1 -34.43 22.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.214 1.005 . . . . 0.0 112.248 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.21 -179.8 41.63 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 127.077 2.275 . . . . 0.0 110.788 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.71 122.72 16.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.19 0.995 . . . . 0.0 112.315 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.7 t -95.65 123.81 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -82.08 -39.94 22.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.753 -0.592 . . . . 0.0 109.547 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -157.91 159.89 37.03 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.63 1.172 . . . . 0.0 110.152 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.62 34.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.383 1.473 . . . . 0.0 110.955 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 mmt -148.65 159.37 44.17 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.654 1.582 . . . . 0.0 113.003 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.0 mt -126.84 143.57 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.983 2.113 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 43.0 mtm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.38 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.56 -11.31 49.1 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.22 14.35 66.7 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.175 0.893 . . . . 0.0 113.99 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.38 4.7 p90 -141.09 162.45 35.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.89 -169.88 28.02 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.089 1.328 . . . . 0.0 114.604 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.05 150.26 52.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.262 2.225 . . . . 0.0 114.394 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -136.32 125.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.209 1.404 . . . . 0.0 111.82 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 94.4 m -98.31 128.92 44.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.353 1.461 . . . . 0.0 110.767 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -104.85 150.69 24.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -67.0 -38.13 85.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.575 0.75 . . . . 0.0 112.673 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 t -143.11 134.69 26.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 122.201 1.0 . . . . 0.0 112.904 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -58.34 -27.25 63.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.53 1.932 . . . . 0.0 113.256 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.55 -26.26 68.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -76.75 -50.81 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.904 0.882 . . . . 0.0 109.489 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.08 -36.62 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 111.987 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.19 -30.88 60.82 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -84.0 -49.08 9.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.552 0.741 . . . . 0.0 111.668 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.66 -43.58 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.315 0.961 . . . . 0.0 113.433 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.9 t -77.59 -19.17 56.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.446 1.098 . . . . 0.0 112.514 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -81.54 -31.19 32.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.254 1.021 . . . . 0.0 112.215 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.15 142.06 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.19 0.996 . . . . 0.0 109.519 168.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -131.23 161.43 32.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.743 1.217 . . . . 0.0 111.728 171.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.581 2.1 p90 58.31 45.17 17.46 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -57.41 142.65 43.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 110.688 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.53 106.92 16.38 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.596 1.089 . . . . 0.0 112.978 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.53 122.93 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.765 1.226 . . . . 0.0 110.528 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 50.97 41.36 27.09 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.461 1.104 . . . . 0.0 112.634 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 62.97 -10.59 0.1 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.379 2.672 . . . . 0.0 116.191 -171.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.51 139.92 38.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.166 1.787 . . . . 0.0 109.723 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 20.4 ptm -91.96 140.54 29.57 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.59 -0.694 . . . . 0.0 111.716 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.19 149.5 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.249 1.82 . . . . 0.0 113.289 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -119.83 151.58 38.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.785 1.234 . . . . 0.0 111.093 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 p -129.34 156.11 44.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -143.59 170.37 15.96 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.449 1.899 . . . . 0.0 110.954 -175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.66 153.68 19.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.732 0.813 . . . . 0.0 112.174 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 124.555 1.142 . . . . 0.0 113.979 176.48 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.212 0.53 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -153.36 138.71 17.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.125 1.37 . . . . 0.0 110.324 -168.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.1 pt -140.61 149.16 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -87.88 147.93 24.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.039 1.736 . . . . 0.0 112.658 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.29 132.3 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.603 1.561 . . . . 0.0 109.777 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.96 11.64 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 115.026 0.771 . . . . 0.0 115.026 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.92 11.12 35.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.549 1.547 . . . . 0.0 114.453 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.44 140.82 58.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.031 1.333 . . . . 0.0 112.168 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 t -66.47 155.37 37.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.004 0.921 . . . . 0.0 111.625 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 m -72.26 -14.8 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.696 -0.628 . . . . 0.0 111.656 169.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.04 -39.88 93.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.05 0.94 . . . . 0.0 111.969 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.15 127.86 33.83 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.15 165.38 13.52 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -62.82 -30.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.34 -37.49 60.65 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.42 0.688 . . . . 0.0 111.509 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.73 -47.18 86.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 t -57.94 -49.22 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 109.039 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -61.52 -44.28 97.35 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.079 0.854 . . . . 0.0 112.355 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -60.71 -46.18 91.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.349 1.06 . . . . 0.0 112.507 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.13 -44.66 96.98 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 48.0 m-85 -66.48 -31.22 71.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -62.28 -12.98 23.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.78 -31.42 72.05 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.248 0.931 . . . . 0.0 113.216 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.81 -39.86 66.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.63 168.5 28.92 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.849 2.643 . . . . 0.0 109.539 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.81 135.59 57.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.483 1.141 . . . . 0.0 113.192 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.47 128.78 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.081 1.753 . . . . 0.0 109.025 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.85 -49.38 30.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.625 1.17 . . . . 0.0 113.891 172.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -154.7 157.29 37.86 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.003 2.121 . . . . 0.0 114.811 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.6 39.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.683 1.193 . . . . 0.0 110.959 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.4 ptm -155.43 148.15 24.22 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.774 1.229 . . . . 0.0 112.095 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.98 151.9 49.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.887 1.675 . . . . 0.0 111.297 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 124.226 1.01 . . . . 0.0 112.77 -177.591 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 p80 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 121.45 0.643 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.23 8.14 3.6 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.22 14.85 58.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.842 1.21 . . . . 0.0 115.099 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -145.56 158.49 43.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.86 -160.94 24.26 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -134.16 148.3 50.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.542 1.937 . . . . 0.0 114.751 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -136.28 133.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.267 1.427 . . . . 0.0 111.162 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.8 m -107.23 134.21 50.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 0.0 112.709 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.19 149.51 28.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 118.433 2.753 . . . . 0.0 118.433 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -67.91 -27.48 66.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.662 0.785 . . . . 0.0 112.932 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.4 t -147.76 138.74 23.41 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.876 1.27 . . . . 0.0 112.766 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -60.84 -27.63 68.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.697 1.599 . . . . 0.0 113.461 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -62.45 -26.53 68.56 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.2 mm -75.03 -50.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.962 0.905 . . . . 0.0 110.272 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 31.3 t -57.49 -34.51 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.348 1.459 . . . . 0.0 111.235 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -52.64 -42.68 64.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 113.165 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.58 -41.83 62.37 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.2 0.909 . . . . 0.0 112.127 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.42 -31.43 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 98.8 m -79.74 -40.28 29.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.171 1.388 . . . . 0.0 113.811 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.19 -43.27 95.59 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.407 0.683 . . . . 0.0 111.873 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.5 114.26 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.54 -51.71 26.8 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.087 -1.008 . . . . 0.0 111.81 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -94.8 139.28 31.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -133.49 132.64 41.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.654 1.582 . . . . 0.0 111.044 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -81.05 127.63 32.82 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.744 -0.598 . . . . 0.0 111.365 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 25.1 mt -140.46 125.0 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 109.136 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 50.47 40.24 22.76 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.219 1.008 . . . . 0.0 112.585 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.7 t30 63.22 -10.7 0.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 128.39 2.676 . . . . 0.0 115.912 -172.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -77.0 143.11 39.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.856 1.662 . . . . 0.0 109.426 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 23.1 ptm -97.15 138.35 34.78 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.424 -0.797 . . . . 0.0 111.458 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.89 146.69 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.731 2.012 . . . . 0.0 112.378 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -89.11 142.88 27.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.519 0.728 . . . . 0.0 111.324 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.87 148.63 52.56 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.626 1.17 . . . . 0.0 112.572 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -158.38 164.66 36.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.406 1.482 . . . . 0.0 112.179 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -61.79 143.28 56.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.019 0.927 . . . . 0.0 112.305 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.882 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.73 154.5 48.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.222 1.409 . . . . 0.0 112.063 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.98 154.54 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.996 1.318 . . . . 0.0 113.313 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.4 149.25 21.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.671 1.988 . . . . 0.0 112.979 167.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.85 131.91 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.858 1.663 . . . . 0.0 109.981 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.5 139.62 7.74 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.47 9.51 21.36 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.236 1.874 . . . . 0.0 114.771 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.75 136.3 57.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.369 1.468 . . . . 0.0 112.518 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -64.64 153.83 38.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.458 1.103 . . . . 0.0 112.05 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.19 -17.07 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.281 0.632 . . . . 0.0 112.332 169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -67.81 -37.5 82.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.938 0.895 . . . . 0.0 111.724 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -70.12 147.39 49.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.311 1.844 . . . . 0.0 114.484 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t -140.05 171.54 14.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.688 1.595 . . . . 0.0 112.846 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -57.21 -31.99 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.2 -40.92 86.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.169 0.988 . . . . 0.0 112.325 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -64.04 -42.46 97.06 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.1 -51.23 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.163 0.985 . . . . 0.0 109.653 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -61.86 -45.85 92.01 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.022 0.828 . . . . 0.0 112.105 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -59.03 -41.79 88.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.761 0.824 . . . . 0.0 112.851 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.46 -46.74 68.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.404 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS 0.355 49.9 m-85 -66.43 -26.31 67.16 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 178.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.2 -24.95 66.7 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -65.96 -22.95 66.51 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.486 1.039 . . . . 0.0 112.765 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -71.94 -24.88 61.69 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.58 -98.62 0.13 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.617 1.103 . . . . 0.0 112.573 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -154.23 137.23 15.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.272 1.429 . . . . 0.0 112.031 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.33 130.5 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.194 1.798 . . . . 0.0 108.834 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 -46.97 19.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 112.869 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -158.55 161.21 37.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 110.452 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.05 155.17 41.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.433 1.493 . . . . 0.0 111.48 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.55 155.14 32.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.392 1.077 . . . . 0.0 112.741 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.23 152.58 47.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.399 0.68 . . . . 0.0 111.261 171.719 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.7 p80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.29 0.567 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -80.7 1.63 29.33 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.25 84.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.689 1.138 . . . . 0.0 114.115 -171.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.277 9.1 p90 -143.86 155.23 44.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.59 -160.93 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.978 0.799 . . . . 0.0 114.936 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -137.82 150.69 47.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.297 1.839 . . . . 0.0 114.14 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.41 129.57 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.081 1.352 . . . . 0.0 111.407 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.1 m -97.69 122.83 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.275 1.43 . . . . 0.0 112.055 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -95.05 154.83 16.99 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -70.08 -31.82 69.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.922 0.889 . . . . 0.0 113.387 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.2 t -152.07 140.26 20.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -53.21 -33.87 54.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.752 2.021 . . . . 0.0 113.615 170.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.73 -22.25 66.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.13 -54.31 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.099 0.96 . . . . 0.0 109.509 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.7 -39.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.766 1.626 . . . . 0.0 111.506 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.7 -40.81 66.34 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -75.48 -42.43 53.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.054 0.843 . . . . 0.0 112.361 173.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.58 -30.78 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.02 -40.53 24.12 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.018 1.727 . . . . 0.0 113.287 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.35 -39.77 94.2 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.028 -1.045 . . . . 0.0 111.712 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.6 mt -74.48 108.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 168.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.28 -45.86 44.92 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.999 -1.063 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.44 133.59 42.6 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -131.03 130.12 42.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.872 1.669 . . . . 0.0 110.624 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -91.39 130.56 37.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.829 0.852 . . . . 0.0 111.997 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.95 126.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.538 1.535 . . . . 0.0 109.253 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 49.91 42.18 23.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.39 1.076 . . . . 0.0 113.422 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.97 -13.62 0.15 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 127.313 2.245 . . . . 0.0 115.932 -172.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.74 168.3 20.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.168 1.787 . . . . 0.0 110.609 169.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 97.5 mtp -127.18 139.89 52.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.333 1.053 . . . . 0.0 112.151 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.67 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.614 1.966 . . . . 0.0 112.005 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -87.91 141.71 28.37 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.683 0.393 . . . . 0.0 110.876 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.404 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 85.6 m -133.85 146.69 50.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.966 1.306 . . . . 0.0 111.356 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -158.05 171.12 20.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.55 1.14 . . . . 0.0 111.847 174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -59.96 140.68 56.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.71 1.204 . . . . 0.0 111.992 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 124.718 1.207 . . . . 0.0 113.713 178.046 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 mptt . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.904 0.859 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -154.91 144.29 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.198 1.399 . . . . 0.0 111.374 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -140.41 155.01 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.586 1.155 . . . . 0.0 113.301 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -94.5 145.77 24.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.198 2.199 . . . . 0.0 112.789 167.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.1 138.77 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.051 1.74 . . . . 0.0 109.726 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.51 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.93 13.65 54.23 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.375 1.464 . . . . 0.0 114.215 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.5 mt -62.79 138.6 58.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.422 . . . . 0.0 112.215 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.44 155.15 33.56 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.112 0.965 . . . . 0.0 111.734 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 p -67.97 -21.07 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.868 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -69.95 -30.89 68.37 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.478 1.111 . . . . 0.0 112.911 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.4 m -79.7 128.69 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.393 1.477 . . . . 0.0 114.236 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.51 166.21 12.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.02 -30.12 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 169.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.76 -35.94 62.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.486 0.715 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.7 -46.87 87.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.632 0.651 . . . . 0.0 112.364 170.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.73 -50.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.595 1.158 . . . . 0.0 109.422 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.7 -48.59 81.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.82 0.736 . . . . 0.0 112.177 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -60.73 -39.45 88.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.789 0.836 . . . . 0.0 112.553 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.61 -48.66 66.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 50.4 m-85 -62.92 -29.5 70.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -59.91 -20.84 59.62 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -70.29 -25.66 63.43 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.14 0.882 . . . . 0.0 112.674 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.42 -38.28 59.91 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.17 37.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.518 2.008 . . . . 0.0 111.326 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -58.55 119.41 6.99 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.109 0.964 . . . . 0.0 112.995 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -93.93 131.4 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.0 107.987 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -86.44 -35.1 19.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -163.87 158.6 20.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.249 1.419 . . . . 0.0 109.398 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.21 139.52 22.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.067 1.347 . . . . 0.0 110.608 172.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.1 mmt -148.8 151.12 34.23 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.421 1.488 . . . . 0.0 112.254 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.62 151.73 41.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.487 1.515 . . . . 0.0 111.074 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtp . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 123.711 0.804 . . . . 0.0 112.35 -175.605 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.7 p80 . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 112.077 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -78.96 12.8 2.01 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.63 15.15 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.786 1.184 . . . . 0.0 114.674 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.266 8.5 p90 -146.91 159.09 43.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.28 -160.59 22.74 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.192 0.901 . . . . 0.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.35 150.65 44.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.029 1.731 . . . . 0.0 114.207 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.27 130.32 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.354 1.461 . . . . 0.0 111.938 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -93.75 144.73 25.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.401 1.88 . . . . 0.0 114.431 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -125.95 151.08 47.47 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 118.167 2.654 . . . . 0.0 118.167 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -61.57 -37.2 82.96 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.004 1.322 . . . . 0.0 113.636 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 t -153.94 148.19 25.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.321 1.049 . . . . 0.0 112.496 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -61.8 -24.73 67.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.184 0.994 . . . . 0.0 112.583 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.46 -35.92 68.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.545 1.138 . . . . 0.0 111.909 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.44 -51.42 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.954 0.902 . . . . 0.0 110.057 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.9 t -57.77 -38.41 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.351 1.06 . . . . 0.0 111.716 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -54.12 -45.75 72.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.021 0.928 . . . . 0.0 112.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -72.31 -43.36 64.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.828 0.74 . . . . 0.0 112.023 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.0 -43.33 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.057 0.844 . . . . 0.0 111.465 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.5 t -74.87 -33.64 62.12 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.083 1.353 . . . . 0.0 113.074 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -64.67 -42.05 95.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.44 107.62 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 169.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.69 -43.63 65.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.39 -1.444 . . . . 0.0 112.544 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -99.82 138.61 36.66 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -138.88 136.51 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.993 1.717 . . . . 0.0 110.836 -173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -103.15 130.6 50.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.089 0.956 . . . . 0.0 112.738 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.4 130.61 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.567 1.547 . . . . 0.0 109.285 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 52.33 37.14 21.56 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.33 1.052 . . . . 0.0 113.413 -175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 61.68 -5.47 0.14 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 127.946 2.498 . . . . 0.0 115.768 -170.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.43 167.33 20.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.697 2.399 . . . . 0.0 109.216 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 98.1 mtp -123.21 143.61 49.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.968 0.907 . . . . 0.0 112.909 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.78 164.54 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.226 2.61 . . . . 0.0 111.653 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -109.31 155.43 21.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.807 0.843 . . . . 0.0 110.826 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.4 p -141.85 154.67 45.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.285 0.634 . . . . 0.0 110.747 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -159.96 -175.36 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.749 1.22 . . . . 0.0 111.729 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -53.39 149.61 7.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.559 1.544 . . . . 0.0 114.637 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 126.698 1.999 . . . . 0.0 109.458 169.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.471 0.177 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -148.55 155.3 40.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.222 -0.924 . . . . 0.0 112.542 -167.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.31 153.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.908 1.283 . . . . 0.0 113.137 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -93.71 145.55 24.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.274 2.23 . . . . 0.0 112.237 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.43 139.93 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.759 1.624 . . . . 0.0 110.213 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.77 147.72 17.45 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 118.785 0.72 . . . . 0.0 114.652 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.55 12.04 34.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.667 1.603 . . . . 0.0 114.323 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.49 136.57 55.87 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.121 1.368 . . . . 0.0 112.117 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -65.89 154.98 37.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.169 0.988 . . . . 0.0 112.139 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.96 -17.0 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.655 -0.653 . . . . 0.0 111.327 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -69.73 -30.07 67.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.243 1.017 . . . . 0.0 112.54 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -74.96 131.39 40.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.814 1.645 . . . . 0.0 114.884 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -97.54 167.75 10.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 115.318 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.55 -28.75 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.01 -35.91 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.632 0.773 . . . . 0.0 111.795 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.49 -45.15 94.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 169.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -61.01 -51.25 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.206 1.002 . . . . 0.0 109.232 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.23 -49.49 75.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.436 0.694 . . . . 0.0 112.063 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -60.47 -41.72 94.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.065 0.946 . . . . 0.0 112.554 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -66.48 -48.21 70.58 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.316 54.5 m-85 -65.46 -29.47 70.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.37 -20.91 61.28 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -69.14 -26.47 64.9 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.184 0.902 . . . . 0.0 112.635 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -77.62 -38.52 47.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.65 179.9 41.16 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.406 1.955 . . . . 0.0 111.208 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -64.66 121.82 15.4 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.2 132.54 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.683 1.993 . . . . 0.0 107.827 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.85 -55.96 5.12 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 113.18 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.69 169.54 21.35 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.18 0.992 . . . . 0.0 109.872 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.4 152.95 47.51 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.557 1.543 . . . . 0.0 111.842 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 48.9 mmm -149.2 158.26 44.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.501 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.6 mt -124.19 152.33 43.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.58 1.552 . . . . 0.0 111.581 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 124.104 0.962 . . . . 0.0 110.317 173.759 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -81.96 7.32 13.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.19 10.54 71.21 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.773 1.177 . . . . 0.0 114.598 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.29 11.8 p90 -141.75 159.69 41.7 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.84 -162.43 23.17 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.99 0.805 . . . . 0.0 114.506 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.22 150.12 46.43 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.497 1.919 . . . . 0.0 113.891 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.4 t -133.72 128.14 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.921 1.288 . . . . 0.0 111.59 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.6 m -92.33 140.39 29.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.146 1.378 . . . . 0.0 113.067 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -122.53 152.65 40.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.056 2.142 . . . . 0.0 116.641 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -76.6 -29.13 56.42 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 t -135.83 129.95 33.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.187 0.995 . . . . 0.0 113.577 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 pm0 -62.88 -29.93 71.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.119 1.768 . . . . 0.0 112.791 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.57 -31.51 72.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.45 -46.41 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.766 0.826 . . . . 0.0 110.118 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.1 t -54.46 -43.5 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.265 1.026 . . . . 0.0 109.836 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.2 -53.13 61.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.0 0.92 . . . . 0.0 113.337 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -64.87 -43.0 94.39 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.22 0.918 . . . . 0.0 111.836 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.84 -42.12 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.777 0.717 . . . . 0.0 110.153 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.42 -31.38 68.56 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.87 -36.13 79.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.29 0.95 . . . . 0.0 112.892 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.9 136.13 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.985 0.914 . . . . 0.0 110.235 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.09 160.18 35.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.984 1.314 . . . . 0.0 111.67 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.477 5.3 m-85 63.34 46.79 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -62.29 134.92 57.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.374 1.869 . . . . 0.0 110.885 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -93.34 112.83 24.86 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.463 -0.773 . . . . 0.0 112.57 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.0 mt -132.62 120.34 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.556 0.742 . . . . 0.0 111.311 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 49.62 44.16 24.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.769 1.227 . . . . 0.0 113.109 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.4 m120 62.64 -8.04 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 128.076 2.55 . . . . 0.0 115.852 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -84.56 154.02 22.89 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.593 1.957 . . . . 0.0 109.471 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 57.5 mmm -99.64 139.91 34.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.175 0.59 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.37 160.44 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.815 1.646 . . . . 0.0 114.004 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -123.12 159.2 29.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.706 1.202 . . . . 0.0 111.482 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -144.99 159.18 43.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.245 1.018 . . . . 0.0 112.954 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -145.22 162.14 37.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.422 1.889 . . . . 0.0 111.037 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -58.64 145.82 38.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.673 0.789 . . . . 0.0 112.939 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.683 1.593 . . . . 0.0 110.012 174.529 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -133.73 167.51 20.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.457 1.903 . . . . 0.0 110.825 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 pt -140.88 148.74 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.709 1.204 . . . . 0.0 112.848 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -81.5 148.85 28.99 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.797 1.639 . . . . 0.0 111.189 164.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.35 135.2 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.533 1.533 . . . . 0.0 109.854 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.1 149.27 21.24 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.592 0.633 . . . . 0.0 114.674 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.86 9.03 55.06 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.535 1.54 . . . . 0.0 114.526 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.79 138.48 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.929 1.292 . . . . 0.0 112.018 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -65.23 152.09 44.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.508 0.723 . . . . 0.0 111.192 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 m -72.32 -14.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.579 -0.701 . . . . 0.0 111.696 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -70.43 -31.59 68.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.983 0.913 . . . . 0.0 112.199 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -73.83 141.0 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.794 1.638 . . . . 0.0 113.406 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -123.59 166.3 15.7 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.23 -31.21 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -65.84 -38.09 87.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.053 0.941 . . . . 0.0 112.334 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.8 -43.24 84.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.856 . . . . 0.0 109.547 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.47 -49.42 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.562 1.145 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -62.46 -46.4 88.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.575 0.625 . . . . 0.0 111.781 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -59.7 -42.25 92.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 112.368 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -66.03 -49.47 67.6 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.299 42.5 m-85 -62.93 -27.67 69.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.62 -16.44 48.4 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -65.41 -31.55 72.71 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.51 -35.71 58.18 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.9 175.51 36.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.117 2.294 . . . . 0.0 110.553 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -63.3 133.3 53.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.3 t -112.34 122.54 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.492 1.917 . . . . 0.0 109.492 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -77.31 -45.2 26.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.235 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.83 159.46 41.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.608 1.963 . . . . 0.0 115.18 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.68 152.33 40.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.084 1.354 . . . . 0.0 110.762 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.3 ptp -157.78 147.57 20.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.505 1.122 . . . . 0.0 112.19 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.6 mt -126.93 153.27 46.03 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.593 1.557 . . . . 0.0 111.593 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.5 mmm . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 112.641 -177.358 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.471 0.653 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -74.53 6.3 3.91 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.06 13.5 58.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.023 1.297 . . . . 0.0 114.862 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 16.0 p90 -145.69 161.1 40.67 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.32 -160.38 23.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.216 0.912 . . . . 0.0 114.72 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -136.9 151.97 49.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.245 1.818 . . . . 0.0 114.342 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.15 131.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.505 1.522 . . . . 0.0 111.042 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.8 m -99.06 126.42 44.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.037 1.735 . . . . 0.0 113.243 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -104.2 154.09 20.18 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -74.41 -18.46 60.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.5 t -153.04 141.14 20.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.327 1.051 . . . . 0.0 113.11 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -62.87 -27.4 69.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 112.817 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.34 -28.11 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.47 -48.7 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.765 0.826 . . . . 0.0 110.102 170.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.05 -40.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.065 1.346 . . . . 0.0 110.554 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -56.93 -43.7 81.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.041 0.837 . . . . 0.0 113.134 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -70.63 -43.18 69.76 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.109 0.868 . . . . 0.0 111.994 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.45 -37.54 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.717 0.69 . . . . 0.0 111.477 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 50.4 t -73.6 -41.56 62.69 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 113.092 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -62.43 -38.37 89.48 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.219 -0.925 . . . . 0.0 112.491 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.69 106.5 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -65.53 -55.63 16.74 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.158 -0.963 . . . . 0.0 111.671 -174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.361 63.9 m-85 -103.27 137.0 41.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -131.47 159.66 37.43 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.081 2.553 . . . . 0.0 109.655 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -126.66 125.24 41.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.629 1.104 . . . . 0.0 113.533 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.37 125.75 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.325 1.45 . . . . 0.0 109.757 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 50.17 40.19 21.37 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.237 1.015 . . . . 0.0 112.871 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.05 -8.61 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.308 2.643 . . . . 0.0 116.32 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -79.44 140.64 37.31 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.834 1.654 . . . . 0.0 109.232 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 39.5 mtm -92.33 147.78 22.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 m -138.24 153.49 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.769 2.428 . . . . 0.0 111.533 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.35 150.31 28.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.631 0.773 . . . . 0.0 111.293 170.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.26 142.91 31.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.827 0.851 . . . . 0.0 112.906 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -144.51 156.42 44.16 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.023 1.329 . . . . 0.0 111.626 -168.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -54.9 141.49 33.22 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.917 1.687 . . . . 0.0 111.59 -179.736 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.914 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 m 63.36 21.48 12.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.601 1.96 . . . . 0.0 116.037 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -81.17 178.05 8.64 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.368 1.067 . . . . 0.0 110.53 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 76.5 mtm -86.94 163.72 16.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.07 1.348 . . . . 0.0 112.412 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -97.64 2.68 50.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -173.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -139.61 160.62 39.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.224 1.41 . . . . 0.0 112.196 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.07 151.71 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.907 1.283 . . . . 0.0 112.675 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.57 149.78 25.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.044 1.738 . . . . 0.0 112.519 166.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.24 138.22 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.417 1.487 . . . . 0.0 110.025 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.61 146.56 15.0 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.033 0.773 . . . . 0.0 115.033 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.02 14.13 25.45 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 125.749 1.642 . . . . 0.0 114.397 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.6 139.25 57.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.37 1.468 . . . . 0.0 112.325 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.87 151.67 44.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.72 0.808 . . . . 0.0 111.165 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 t -68.37 -20.67 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.553 -0.717 . . . . 0.0 111.346 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -68.07 -28.94 67.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.528 1.131 . . . . 0.0 113.214 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 60.1 m -79.36 132.77 36.52 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.542 1.537 . . . . 0.0 112.827 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.69 165.9 13.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.17 -31.59 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -74.21 -33.47 63.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.38 0.672 . . . . 0.0 111.735 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.55 -47.98 83.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.099 0.56 . . . . 0.0 112.14 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.94 -45.47 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.106 0.562 . . . . 0.0 110.725 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -42.54 91.55 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.094 0.558 . . . . 0.0 111.813 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.71 -53.58 32.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.526 1.131 . . . . 0.0 112.774 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -59.2 -34.57 72.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 117.633 2.456 . . . . 0.0 117.633 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.32 38.0 m-85 -70.75 -15.8 62.71 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 173.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.42 -10.97 58.86 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -62.52 -25.6 68.11 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.159 -0.963 . . . . 0.0 113.59 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.77 -30.51 18.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.399 1.08 . . . . 0.0 113.284 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.56 177.83 36.74 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.97 2.224 . . . . 0.0 110.765 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -61.89 124.96 22.21 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.507 -0.996 . . . . 0.0 112.375 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.3 t -95.87 125.24 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.753 1.621 . . . . 0.0 107.019 168.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.64 -41.03 19.95 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.835 -0.541 . . . . 0.0 109.688 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -162.69 165.72 25.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.317 2.247 . . . . 0.0 114.987 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.66 154.25 45.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.169 1.388 . . . . 0.0 110.748 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.1 mtp -148.95 152.96 37.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.655 1.582 . . . . 0.0 111.462 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -125.85 150.97 47.44 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.321 1.448 . . . . 0.0 111.742 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 85.6 mtp -85.82 101.08 12.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.601 0.76 . . . . 0.0 111.386 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.263 61.2 m-85 -78.58 137.36 37.84 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -93.24 115.09 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.454 1.102 . . . . 0.0 108.764 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.31 -10.46 59.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.9 p -79.93 -17.12 53.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -128.61 -20.68 3.56 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.27 76.2 m-20 58.24 25.29 12.47 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.828 2.051 . . . . 0.0 114.337 -169.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -109.7 158.48 18.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.366 1.866 . . . . 0.0 110.055 169.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.33 152.61 32.28 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.62 -0.675 . . . . 0.0 111.871 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -80.64 8.81 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.17 11.59 69.37 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.631 1.11 . . . . 0.0 114.503 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.273 12.3 p90 -144.56 158.75 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.93 -158.22 18.38 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.187 0.899 . . . . 0.0 114.739 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -139.78 151.36 45.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.953 2.101 . . . . 0.0 114.18 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.6 129.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.125 1.37 . . . . 0.0 111.804 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.0 m -94.44 128.89 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.28 1.832 . . . . 0.0 113.045 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -104.98 150.31 25.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.14 -35.7 81.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 113.048 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.1 t -147.45 141.22 25.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.667 1.187 . . . . 0.0 112.652 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.35 -26.25 68.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.292 1.437 . . . . 0.0 113.474 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.9 -27.43 66.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.6 mm -77.74 -50.1 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.777 0.831 . . . . 0.0 109.89 170.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 66.9 t -54.84 -35.12 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.155 1.382 . . . . 0.0 111.576 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -48.91 -51.05 32.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -70.36 -44.18 68.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.555 0.616 . . . . 0.0 111.606 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.25 -47.18 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 18.9 t -74.51 -29.58 61.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.558 1.143 . . . . 0.0 112.53 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.52 -41.4 93.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.947 -1.096 . . . . 0.0 112.047 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.75 119.85 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -68.39 -59.14 3.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.993 -1.067 . . . . 0.0 111.36 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.302 61.3 m-85 -101.81 139.18 37.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -176.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -135.79 135.53 39.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.554 1.942 . . . . 0.0 110.819 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -80.85 135.84 36.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.309 0.644 . . . . 0.0 111.904 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.7 mt -144.89 122.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.732 2.013 . . . . 0.0 108.383 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 50.48 38.65 18.94 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.3 t30 62.78 -12.5 0.07 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 128.112 2.565 . . . . 0.0 115.942 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -73.36 141.81 47.04 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.307 -1.495 . . . . 0.0 108.594 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 51.8 mtm -94.32 142.45 27.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.078 0.854 . . . . 0.0 112.346 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.67 153.35 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.325 2.25 . . . . 0.0 111.311 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.44 157.06 16.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 112.106 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.7 p -133.93 157.27 46.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.537 0.735 . . . . 0.0 112.063 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -145.9 171.59 14.59 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.981 1.712 . . . . 0.0 111.327 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -61.07 149.51 36.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.124 0.97 . . . . 0.0 113.217 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -150.24 149.28 29.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.137 1.375 . . . . 0.0 111.275 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.63 145.17 96.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.57 169.15 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.853 3.035 . . . . 0.0 112.434 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -140.95 130.33 23.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.282 1.433 . . . . 0.0 110.69 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.06 123.47 25.84 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.96 0.904 . . . . 0.0 111.776 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 p -152.02 -28.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 27.7 ptm -74.69 168.8 19.11 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.427 1.491 . . . . 0.0 112.746 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.4 t -145.91 122.49 5.91 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.692 1.197 . . . . 0.0 110.77 170.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -82.09 -10.07 11.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.445 2.764 . . . . 0.0 113.713 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.362 0.2 OUTLIER -71.24 35.97 0.05 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -169.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -73.55 175.17 47.02 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.562 1.077 . . . . 0.0 113.406 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.4 t -151.85 141.41 21.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.419 1.088 . . . . 0.0 112.152 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.93 55.9 1.84 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.899 1.68 . . . . 0.0 112.733 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 49.4 mtm105 -63.82 148.03 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.189 1.396 . . . . 0.0 112.909 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 175.46 -173.04 46.0 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.963 1.268 . . . . 0.0 113.334 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -151.69 169.11 22.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.763 1.625 . . . . 0.0 112.565 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.404 1.482 . . . . 0.0 113.122 168.272 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 143.57 51.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.31 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -80.51 157.76 26.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.966 1.306 . . . . 0.0 113.129 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 148.7 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.372 1.069 . . . . 0.0 112.748 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.21 7.82 44.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.465 1.506 . . . . 0.0 113.719 170.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -133.22 159.31 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.547 1.139 . . . . 0.0 112.865 -172.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -139.94 152.38 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 112.861 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -86.44 148.71 25.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 112.317 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.5 135.88 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.428 1.491 . . . . 0.0 109.421 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.41 146.71 15.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.97 10.29 32.66 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.828 1.68 . . . . 0.0 114.287 -172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.06 141.09 58.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.342 1.457 . . . . 0.0 112.321 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -68.81 156.77 37.77 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.791 0.836 . . . . 0.0 112.588 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.38 -27.72 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.649 0.78 . . . . 0.0 110.067 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -64.91 -31.84 73.27 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.972 0.909 . . . . 0.0 112.696 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 135.53 50.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.015 1.326 . . . . 0.0 113.426 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.88 166.64 13.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.177 1.391 . . . . 0.0 114.635 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.3 p -57.74 -32.75 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.69 -34.84 78.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.85 0.86 . . . . 0.0 112.744 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -67.18 -45.37 77.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.698 0.799 . . . . 0.0 109.853 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.85 -48.08 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.702 1.201 . . . . 0.0 110.428 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -62.53 -47.33 84.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.48 0.712 . . . . 0.0 111.93 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.13 -40.98 87.14 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.747 0.819 . . . . 0.0 112.419 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -65.89 -51.55 57.72 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 46.9 m-85 -64.17 -25.85 68.26 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -60.74 -17.51 49.05 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.21 -29.47 70.28 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.369 -0.832 . . . . 0.0 113.058 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.53 -36.19 38.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.5 33.43 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 127.219 2.342 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.81 124.64 21.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.349 1.074 . . . . 0.0 112.723 -169.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.46 118.45 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.251 1.42 . . . . 0.0 108.637 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.19 -31.6 43.89 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -162.05 160.4 27.46 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.938 1.295 . . . . 0.0 109.516 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.87 152.29 31.36 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.15 1.38 . . . . 0.0 111.093 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -156.77 156.05 32.64 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.377 1.071 . . . . 0.0 112.323 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.03 149.54 44.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.619 1.568 . . . . 0.0 110.391 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 70.3 mtp -79.33 72.45 5.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 112.201 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -59.78 141.85 54.46 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -132.35 116.97 17.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 113.051 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -64.08 -19.49 65.27 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.5 p -79.39 -13.47 59.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 172.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -125.23 -16.12 6.05 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 58.84 25.86 14.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.653 1.981 . . . . 0.0 114.648 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -149.27 172.1 15.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.553 1.941 . . . . 0.0 110.749 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -81.8 153.28 26.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.364 0.602 . . . . 0.0 111.839 170.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.06 8.76 2.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.49 13.9 66.93 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.855 1.217 . . . . 0.0 114.329 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.269 8.9 p90 -146.49 160.09 42.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.16 -162.15 21.94 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.221 0.915 . . . . 0.0 114.797 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -138.24 147.3 43.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.88 2.072 . . . . 0.0 114.447 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.71 125.47 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 111.159 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 m -96.42 123.3 40.03 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 111.739 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.29 152.59 18.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -67.67 -34.16 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.541 -0.724 . . . . 0.0 112.399 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.5 t -142.87 137.73 29.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.464 1.126 . . . . 0.0 113.845 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -56.3 -27.36 55.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.117 2.167 . . . . 0.0 112.972 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.92 -28.38 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.72 -48.62 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.893 0.877 . . . . 0.0 109.786 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.6 t -55.02 -38.98 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.075 1.35 . . . . 0.0 110.998 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -56.62 -34.34 67.14 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -78.93 -48.36 14.7 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.02 0.827 . . . . 0.0 111.713 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.89 -44.73 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.964 0.802 . . . . 0.0 112.558 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.12 -21.45 58.85 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.011 1.324 . . . . 0.0 112.907 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -78.02 -34.68 50.52 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.946 -1.096 . . . . 0.0 112.396 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.56 139.94 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.691 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -127.08 156.69 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.237 1.015 . . . . 0.0 113.108 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.466 24.9 m-85 60.31 49.27 7.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -58.86 133.47 56.05 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.858 2.063 . . . . 0.0 110.993 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -98.66 126.51 44.29 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.287 0.948 . . . . 0.0 113.155 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 mt -142.57 123.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.951 1.7 . . . . 0.0 109.392 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 50.36 41.54 24.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.39 1.076 . . . . 0.0 113.55 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 64.89 -13.41 0.11 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 127.822 2.449 . . . . 0.0 116.002 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -73.9 155.43 38.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.069 1.748 . . . . 0.0 109.283 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.4 ptm -120.77 136.06 54.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.874 0.87 . . . . 0.0 111.188 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.77 143.5 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.808 1.643 . . . . 0.0 113.602 -169.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -87.02 159.24 19.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.268 0.556 . . . . 0.0 111.353 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.5 p -138.13 155.96 48.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.122 0.969 . . . . 0.0 111.583 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -146.15 167.73 22.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.682 1.593 . . . . 0.0 110.865 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -58.9 151.47 21.62 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.591 -0.693 . . . . 0.0 112.248 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.07 144.29 50.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.283 1.433 . . . . 0.0 110.138 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.71 142.84 97.78 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -68.54 164.75 31.67 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.729 2.953 . . . . 0.0 112.989 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -142.78 155.41 44.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.196 1.798 . . . . 0.0 110.729 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -74.03 61.56 0.83 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.631 1.572 . . . . 0.0 113.366 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.7 t -67.4 142.56 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.939 1.295 . . . . 0.0 111.768 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.45 167.36 8.82 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.437 1.095 . . . . 0.0 113.117 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.2 t -135.54 117.89 12.36 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.005 1.322 . . . . 0.0 109.358 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.44 145.22 26.48 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.97 2.446 . . . . 0.0 112.993 -169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.7 t -154.57 158.76 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.547 1.539 . . . . 0.0 114.075 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 174.03 155.92 12.78 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.508 1.051 . . . . 0.0 113.755 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.7 t -159.35 152.54 22.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.686 1.594 . . . . 0.0 110.838 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.988 1.315 . . . . 0.0 112.079 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 45.8 ttm105 -77.52 141.22 39.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 111.423 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 175.92 177.04 44.63 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.229 0.919 . . . . 0.0 114.025 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ttt-85 -68.2 147.14 52.66 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.675 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.255 1.357 0 C-N-CA 124.992 1.317 . . . . 0.0 112.361 168.571 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.176 -0.369 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 81.2 p -146.31 20.5 1.37 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.264 1.426 . . . . 0.0 113.483 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -77.7 48.85 0.71 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.389 2.275 . . . . 0.0 113.772 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 75.1 mtm -68.51 151.97 46.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.844 1.658 . . . . 0.0 113.078 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -130.49 35.57 4.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.644 1.577 . . . . 0.0 112.137 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -149.29 154.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.612 1.165 . . . . 0.0 110.641 -171.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.51 150.77 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.361 1.064 . . . . 0.0 112.884 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.44 145.51 25.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.367 1.867 . . . . 0.0 111.912 166.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.21 137.83 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.614 1.566 . . . . 0.0 110.117 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.28 147.18 17.07 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 114.688 0.635 . . . . 0.0 114.688 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.96 13.21 29.9 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.693 1.616 . . . . 0.0 114.649 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.54 137.95 58.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.729 1.264 . . . . 0.0 112.205 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -64.72 156.43 30.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.714 1.206 . . . . 0.0 112.821 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 m -71.86 -16.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.252 0.621 . . . . 0.0 111.349 168.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -67.02 -38.12 85.37 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.487 0.715 . . . . 0.0 111.739 169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.15 146.97 54.28 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 t -133.2 166.45 22.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.388 1.875 . . . . 0.0 112.76 169.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.73 -33.33 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.0 -39.89 87.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.436 0.694 . . . . 0.0 112.149 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.9 -43.52 95.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.77 -47.2 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.204 0.602 . . . . 0.0 110.467 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.77 -48.19 82.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.591 0.632 . . . . 0.0 111.803 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -60.8 -39.03 87.38 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -68.3 -40.74 81.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.323 52.8 m-85 -71.32 -29.82 65.48 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -60.44 -18.1 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -65.71 -24.9 67.09 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.295 -0.878 . . . . 0.0 112.884 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.27 -29.32 26.54 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.94 178.87 36.21 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.57 2.033 . . . . 0.0 110.921 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -64.86 116.3 6.21 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.654 -0.91 . . . . 0.0 112.549 -173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.65 130.68 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.844 1.658 . . . . 0.0 107.146 169.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.38 -54.07 7.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.673 0.789 . . . . 0.0 112.918 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.84 165.94 29.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.528 1.131 . . . . 0.0 110.003 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.93 149.8 37.38 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.588 1.555 . . . . 0.0 111.647 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 92.9 mtp -148.41 152.17 36.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.555 1.542 . . . . 0.0 111.713 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.8 mt -125.88 154.11 43.2 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.04 1.336 . . . . 0.0 111.92 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.1 mmm -84.12 103.98 13.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.642 0.777 . . . . 0.0 110.664 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.337 58.7 m-85 -77.18 145.65 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -111.49 114.2 27.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.202 1.801 . . . . 0.0 111.199 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -60.19 -23.29 63.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.609 1.164 . . . . 0.0 113.538 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -24.46 65.09 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 p -136.92 -15.94 1.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -171.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 60.55 14.91 5.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.62 1.968 . . . . 0.0 114.366 -169.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.0 mmm-85 -101.12 174.08 6.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.199 1.8 . . . . 0.0 110.705 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -79.22 158.37 27.64 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.508 0.67 . . . . 0.0 112.346 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -73.73 0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.691 1.996 . . . . 0.0 115.603 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.19 9.01 65.91 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.714 1.15 . . . . 0.0 113.88 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 17.6 p90 -144.99 158.82 43.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.74 -158.66 19.36 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.228 0.918 . . . . 0.0 114.693 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.69 148.95 47.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.605 1.962 . . . . 0.0 114.02 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 t -133.81 132.0 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.132 1.373 . . . . 0.0 111.38 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.8 m -98.52 139.83 33.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.353 1.861 . . . . 0.0 113.954 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.56 154.96 34.66 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.49 -32.58 70.15 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -150.02 146.55 27.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.44 1.096 . . . . 0.0 113.14 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.15 -28.43 69.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.809 1.244 . . . . 0.0 112.613 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.57 -31.79 71.85 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.9 mm -76.86 -46.12 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.711 0.804 . . . . 0.0 110.152 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.38 -41.13 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.688 1.195 . . . . 0.0 110.252 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -57.72 -49.93 74.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.038 0.836 . . . . 0.0 113.137 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.53 -44.78 81.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.764 0.711 . . . . 0.0 111.779 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.15 -45.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.534 0.607 . . . . 0.0 110.138 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.5 t -67.83 -36.19 79.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.391 1.077 . . . . 0.0 112.745 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -66.68 -41.03 88.77 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.13 -0.981 . . . . 0.0 112.657 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.2 mt -67.01 134.42 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.682 0.793 . . . . 0.0 110.496 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -112.12 148.64 33.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.128 1.371 . . . . 0.0 111.586 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.49 29.3 m-85 57.16 57.02 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -175.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -63.59 128.92 38.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.471 1.508 . . . . 0.0 111.405 173.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.06 133.46 36.12 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.84 0.745 . . . . 0.0 112.264 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.4 mt -146.34 124.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.974 2.11 . . . . 0.0 108.235 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.6 m120 50.98 43.23 28.94 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.175 0.99 . . . . 0.0 113.167 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.78 -13.99 0.08 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.262 2.625 . . . . 0.0 116.485 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.08 169.97 17.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.819 2.047 . . . . 0.0 109.28 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.2 ptp -127.33 146.11 50.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.852 0.861 . . . . 0.0 113.193 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.38 164.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.935 2.494 . . . . 0.0 112.894 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -128.25 158.38 38.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.504 0.722 . . . . 0.0 111.893 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.53 157.42 44.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 113.37 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -142.27 159.07 42.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.167 1.787 . . . . 0.0 111.256 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.15 144.5 45.62 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.577 0.626 . . . . 0.0 112.542 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.63 148.81 46.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.346 1.458 . . . . 0.0 111.07 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -71.31 138.09 84.11 Favored Pre-proline 0 CA--C 1.545 0.787 0 O-C-N 121.728 -0.608 . . . . 0.0 111.74 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.51 148.44 83.73 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.207 2.605 . . . . 0.0 112.123 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -120.94 13.79 11.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.513 1.925 . . . . 0.0 112.265 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -156.45 161.99 40.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.297 2.639 . . . . 0.0 110.181 -171.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.47 145.45 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.7 ptm -71.76 163.68 27.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.519 1.128 . . . . 0.0 112.458 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.1 t -113.62 101.91 54.23 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.727 1.211 . . . . 0.0 109.922 171.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.15 -12.55 11.7 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.328 2.686 . . . . 0.0 114.006 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.273 1.0 OUTLIER -72.8 160.44 32.17 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 74.65 -162.8 54.16 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.339 0.971 . . . . 0.0 114.195 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 41.0 t -154.98 150.67 27.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.188 1.395 . . . . 0.0 112.031 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.15 -2.69 35.64 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.071 1.348 . . . . 0.0 114.117 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -60.58 156.67 15.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.3 1.44 . . . . 0.0 113.431 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -173.98 -168.68 35.25 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.87 1.224 . . . . 0.0 113.355 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 65.13 146.88 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 128.21 2.604 . . . . 0.0 114.438 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.206 1.802 . . . . 0.0 113.695 -178.829 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 64.1 m -74.87 -16.17 60.69 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -75.02 66.92 1.65 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.524 1.53 . . . . 0.0 112.176 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 24.9 ptp -82.55 -11.07 58.7 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -152.79 56.01 0.79 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.058 1.343 . . . . 0.0 111.538 -170.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tttp -136.4 155.99 49.24 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.755 1.622 . . . . 0.0 112.485 -168.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.43 ' CG2' HG13 ' A' ' 163' ' ' VAL . 7.5 pt -136.26 157.52 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.571 1.549 . . . . 0.0 113.379 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -94.09 147.34 23.23 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.173 2.189 . . . . 0.0 113.29 167.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.4 t -137.31 138.93 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.727 1.611 . . . . 0.0 110.061 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.77 154.16 25.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.704 0.669 . . . . 0.0 114.414 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.12 15.02 31.83 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.379 1.466 . . . . 0.0 114.596 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.66 143.03 58.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.004 1.322 . . . . 0.0 112.493 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 p -76.51 175.5 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.453 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 m -81.61 -24.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 0.0 112.684 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -77.32 -33.3 55.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.194 0.998 . . . . 0.0 111.663 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.8 m -65.44 143.97 57.35 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.246 1.418 . . . . 0.0 113.356 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 t -142.72 173.42 11.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.26 1.824 . . . . 0.0 112.715 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.52 -34.15 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -67.58 -38.67 84.39 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.879 0.872 . . . . 0.0 112.165 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.64 -43.24 85.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.1 t -58.66 -46.88 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.388 0.675 . . . . 0.0 109.867 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -60.57 -46.94 88.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.427 0.558 . . . . 0.0 111.887 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -61.43 -45.09 95.76 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -66.61 -38.75 87.63 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.333 46.7 m-85 -71.62 -29.84 65.12 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.91 -18.93 48.64 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 172.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -66.17 -24.96 66.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.494 0.718 . . . . 0.0 112.746 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.67 -34.86 30.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.43 169.54 28.13 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.059 2.266 . . . . 0.0 110.466 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -57.49 130.42 46.23 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.953 0.901 . . . . 0.0 112.768 -170.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.81 122.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.465 1.506 . . . . 0.0 108.249 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -74.08 -40.02 63.05 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -156.52 154.84 30.97 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.062 2.145 . . . . 0.0 114.646 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.38 142.72 30.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.359 1.064 . . . . 0.0 110.7 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.2 mtm -150.38 151.83 33.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.499 1.52 . . . . 0.0 111.649 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.7 mt -120.98 156.86 31.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.173 1.389 . . . . 0.0 111.694 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.4 tpp -79.3 127.51 32.15 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.752 0.821 . . . . 0.0 110.205 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -111.75 155.61 23.23 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 117.603 2.446 . . . . 0.0 117.603 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -111.99 106.83 15.6 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.881 1.272 . . . . 0.0 112.053 168.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -61.74 -16.67 51.33 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 -22.51 66.05 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.9 p -139.01 -15.74 1.12 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.49 15.35 5.51 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.058 2.143 . . . . 0.0 114.95 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -83.29 150.31 26.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 110.609 169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -79.41 156.43 27.92 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 0.0 111.015 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -86.37 8.23 22.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -174.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.85 6.37 67.41 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.136 1.35 . . . . 0.0 115.035 -177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -146.38 162.77 37.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.03 -158.14 20.24 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.186 0.898 . . . . 0.0 114.752 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -135.97 151.06 49.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.28 1.832 . . . . 0.0 114.547 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -135.42 123.74 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.151 1.38 . . . . 0.0 111.468 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 m -87.79 129.04 35.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.163 1.385 . . . . 0.0 113.125 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.86 160.26 14.44 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -62.24 -39.69 93.7 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.418 -0.801 . . . . 0.0 112.038 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.2 t -149.21 148.57 29.76 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.728 1.211 . . . . 0.0 113.592 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -57.83 -27.5 63.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 112.674 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.82 -21.86 66.22 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.46 -50.38 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.739 0.816 . . . . 0.0 109.819 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.43 HG13 ' CG2' ' A' ' 111' ' ' ILE . 38.8 t -52.94 -38.67 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.281 1.433 . . . . 0.0 111.275 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -60.33 -43.17 96.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -68.29 -37.76 80.98 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.666 0.667 . . . . 0.0 111.552 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.67 -37.74 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 118.482 0.583 . . . . 0.0 110.996 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 85.6 m -77.65 -28.85 51.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.243 1.417 . . . . 0.0 114.585 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -69.06 -38.41 79.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.048 0.84 . . . . 0.0 112.939 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.8 mt -74.61 140.86 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.796 0.838 . . . . 0.0 109.94 174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -130.44 164.04 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.478 1.111 . . . . 0.0 112.666 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.331 57.5 m-85 60.87 40.67 15.43 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -57.39 131.87 51.4 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.367 1.867 . . . . 0.0 111.584 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.22 128.97 34.9 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.368 -0.833 . . . . 0.0 112.27 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.26 120.86 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.358 1.863 . . . . 0.0 108.812 172.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 50.58 40.6 24.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.844 0.858 . . . . 0.0 113.04 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 63.25 -12.97 0.08 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 128.203 2.601 . . . . 0.0 116.421 -171.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -74.02 142.91 45.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.829 1.652 . . . . 0.0 109.052 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 34.3 mtt -89.06 141.0 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.244 -0.91 . . . . 0.0 112.487 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.3 159.49 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 127.297 2.239 . . . . 0.0 111.916 173.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.83 154.64 44.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 110.166 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.4 p -140.31 159.62 41.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.027 0.931 . . . . 0.0 113.292 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -141.48 158.94 43.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.735 1.614 . . . . 0.0 110.653 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -62.4 140.19 58.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -122.43 24.57 9.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.707 1.603 . . . . 0.0 110.71 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.21 157.68 39.34 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 127.666 2.386 . . . . 0.0 110.791 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.4 133.14 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.791 2.994 . . . . 0.0 112.334 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -56.45 135.08 54.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.435 -0.79 . . . . 0.0 112.107 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -123.56 150.77 43.64 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.17 1.388 . . . . 0.0 110.935 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.87 127.55 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.469 1.508 . . . . 0.0 110.369 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 63.4 mtt -144.98 153.14 41.19 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.437 1.495 . . . . 0.0 111.492 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.8 m -134.55 60.34 41.99 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.808 1.243 . . . . 0.0 112.799 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.2 146.97 87.75 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.097 2.531 . . . . 0.0 111.992 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.1 t -152.87 159.39 43.02 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 176.67 148.3 7.01 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.707 1.622 . . . . 0.0 112.231 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.3 p -158.64 164.22 36.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.626 1.17 . . . . 0.0 112.935 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -149.65 156.25 41.59 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.61 153.87 42.72 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.034 0.934 . . . . 0.0 113.245 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -77.57 169.63 54.81 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.443 1.021 . . . . 0.0 113.308 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -65.93 148.34 51.95 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.506 1.122 . . . . 0.0 112.749 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 125.52 1.528 . . . . 0.0 113.407 -178.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.6 m -78.83 -8.35 58.72 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -67.8 151.76 46.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.2 1.4 . . . . 0.0 113.07 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -79.38 155.97 28.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.004 0.922 . . . . 0.0 111.341 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -148.61 63.35 1.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.819 1.648 . . . . 0.0 108.996 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -137.18 151.95 49.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.407 1.883 . . . . 0.0 111.325 -167.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -134.01 153.76 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.658 1.183 . . . . 0.0 113.285 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -88.93 146.47 24.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.613 1.965 . . . . 0.0 112.747 166.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.48 132.87 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.694 1.598 . . . . 0.0 109.769 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.04 145.91 14.52 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 114.623 0.609 . . . . 0.0 114.623 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.09 11.37 32.19 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.633 1.587 . . . . 0.0 114.436 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.75 138.44 58.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.196 1.398 . . . . 0.0 111.947 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -69.4 156.93 38.03 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.507 1.123 . . . . 0.0 112.447 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.36 -16.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.618 -0.676 . . . . 0.0 111.62 168.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -73.47 -7.57 52.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.604 1.562 . . . . 0.0 114.238 169.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER -92.02 151.67 20.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -139.64 161.31 37.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.887 1.275 . . . . 0.0 113.953 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.39 -33.23 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -68.37 -38.85 81.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.541 0.736 . . . . 0.0 112.318 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -67.44 -38.86 85.18 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.55 -51.9 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.398 1.079 . . . . 0.0 109.322 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.78 -43.56 98.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.008 0.822 . . . . 0.0 112.352 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -59.89 -39.29 84.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.752 0.821 . . . . 0.0 112.665 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -66.79 -48.37 69.23 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.313 55.6 m-85 -64.16 -29.97 71.06 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -57.37 -22.64 44.04 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.476 1.51 . . . . 0.0 114.65 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.66 -24.85 62.77 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.192 -0.943 . . . . 0.0 112.761 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -79.25 -37.91 36.83 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.58 172.04 35.03 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.593 2.044 . . . . 0.0 110.895 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -60.07 130.76 48.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.766 0.783 . . . . 0.0 112.579 -171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.4 t -99.12 131.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.138 1.775 . . . . 0.0 108.493 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -79.12 -54.14 6.29 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.82 0.848 . . . . 0.0 112.952 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -152.86 157.27 40.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.019 1.327 . . . . 0.0 110.57 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.4 141.08 23.52 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.022 1.329 . . . . 0.0 110.915 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 54.5 mmm -149.85 153.21 36.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.666 1.586 . . . . 0.0 112.341 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.38 152.98 39.63 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.423 1.489 . . . . 0.0 110.648 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.2 mtp -85.08 116.23 23.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.894 -0.503 . . . . 0.0 110.36 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.293 58.3 m-85 -90.57 148.33 22.76 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.417 2.747 . . . . 0.0 118.417 -173.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -102.6 112.94 25.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.518 1.527 . . . . 0.0 110.357 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.21 -32.64 71.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.686 1.195 . . . . 0.0 114.008 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.252 1.2 p -72.86 -20.06 61.18 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.5 p -118.63 -19.73 8.61 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.4 t30 57.2 26.25 11.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.928 1.691 . . . . 0.0 113.245 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -107.68 158.86 16.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.7 1.6 . . . . 0.0 110.506 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -75.04 159.04 32.21 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.529 0.681 . . . . 0.0 111.607 173.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -79.26 5.52 12.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.294 1.838 . . . . 0.0 114.643 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.34 6.11 63.08 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.468 1.509 . . . . 0.0 114.334 -170.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.255 10.9 p90 -147.69 157.0 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.67 -162.3 22.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.507 1.051 . . . . 0.0 114.63 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -138.54 148.62 44.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.338 1.855 . . . . 0.0 114.112 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.34 124.3 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.138 1.375 . . . . 0.0 111.64 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 135.7 33.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.504 1.522 . . . . 0.0 113.741 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.19 156.0 20.39 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.14 -28.87 65.71 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.2 t -150.39 141.52 23.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.57 1.148 . . . . 0.0 112.89 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -59.63 -26.56 65.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 113.234 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.59 -29.33 69.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.3 mm -78.24 -46.36 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.771 0.828 . . . . 0.0 110.074 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.23 -43.09 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.965 1.306 . . . . 0.0 110.522 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -69.9 -46.36 65.6 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.64 -0.662 . . . . 0.0 112.076 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.0 t -60.65 -37.24 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.042 0.837 . . . . 0.0 111.638 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.83 -35.1 67.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.887 1.275 . . . . 0.0 112.765 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -68.8 -37.95 79.61 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.208 -0.932 . . . . 0.0 112.661 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.4 mt -70.19 139.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.897 0.879 . . . . 0.0 110.636 174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -129.88 161.97 29.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.399 1.48 . . . . 0.0 111.426 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.44 8.1 m-30 64.46 46.07 3.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -68.13 122.42 18.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.974 2.11 . . . . 0.0 111.056 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -86.93 121.34 29.27 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.545 1.066 . . . . 0.0 113.467 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.5 mt -143.21 124.74 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.277 1.431 . . . . 0.0 109.6 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 48.04 49.84 16.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.33 1.452 . . . . 0.0 113.02 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 64.92 -12.32 0.13 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.905 2.882 . . . . 0.0 116.575 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -86.08 165.37 16.68 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 127.361 2.264 . . . . 0.0 110.304 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 44.5 mtm -122.09 143.13 49.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.639 0.775 . . . . 0.0 112.485 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.72 163.58 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.912 2.085 . . . . 0.0 113.642 -171.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -115.18 148.75 38.67 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.138 1.375 . . . . 0.0 111.896 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 81.2 m -120.57 152.35 38.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.857 1.263 . . . . 0.0 112.508 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -142.92 158.24 43.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.579 1.552 . . . . 0.0 111.2 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.662 -0.649 . . . . 0.0 111.002 173.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.22 32.2 5.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.68 . . . . 0.0 110.571 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.72 31.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 127.647 2.379 . . . . 0.0 110.764 -173.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -59.84 162.62 15.47 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.713 2.942 . . . . 0.0 116.257 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -79.6 56.9 2.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.283 1.433 . . . . 0.0 110.317 169.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.65 135.19 51.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.848 1.259 . . . . 0.0 112.474 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.7 136.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.816 1.246 . . . . 0.0 113.21 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.83 155.18 37.05 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.624 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.9 t -145.21 80.67 10.92 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.556 1.142 . . . . 0.0 110.486 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.98 152.71 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.453 2.769 . . . . 0.0 112.335 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 t -150.56 159.36 44.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.216 1.407 . . . . 0.0 114.655 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 172.97 -179.77 44.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.821 1.201 . . . . 0.0 113.784 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.1 t -154.37 162.37 41.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 110.815 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.15 135.29 56.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.038 0.935 . . . . 0.0 112.451 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -78.51 -5.84 53.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 63.74 -146.16 50.22 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.193 0.902 . . . . 0.0 113.458 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.09 154.01 51.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.923 1.689 . . . . 0.0 112.125 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.809 1.643 . . . . 0.0 114.1 176.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p -85.78 -165.89 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.488 1.115 . . . . 0.0 111.796 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -64.83 -7.82 12.7 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 25.4 ptm -142.09 145.89 34.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.723 1.209 . . . . 0.0 112.934 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -151.67 31.68 0.57 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.625 1.57 . . . . 0.0 110.034 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -152.82 146.36 24.98 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.442 1.497 . . . . 0.0 111.031 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.2 pt -138.21 149.66 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -83.32 147.89 27.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.411 1.885 . . . . 0.0 111.724 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.35 136.5 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.266 1.426 . . . . 0.0 109.584 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.37 147.76 18.25 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.52 39.27 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.706 1.622 . . . . 0.0 114.552 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.4 mt -65.01 139.88 58.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 112.494 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 t -64.76 156.8 29.36 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.575 1.15 . . . . 0.0 112.4 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.91 -25.28 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.899 0.88 . . . . 0.0 109.504 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.741 0.816 . . . . 0.0 112.592 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 m -75.23 125.51 29.1 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.52 1.528 . . . . 0.0 115.095 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -91.91 167.82 11.85 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.95 -29.71 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.23 -38.3 63.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.313 0.645 . . . . 0.0 111.537 174.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.28 -44.93 92.44 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.31 -50.81 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.37 1.068 . . . . 0.0 109.115 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -62.01 -45.86 91.74 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.842 0.746 . . . . 0.0 111.88 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.62 -42.38 98.81 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.97 0.908 . . . . 0.0 112.592 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -63.55 -48.63 76.67 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.305 52.0 m-85 -65.29 -30.54 71.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -61.6 -19.12 61.87 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 172.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -68.59 -24.64 64.61 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.143 0.883 . . . . 0.0 112.712 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -80.86 -38.22 28.52 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.98 0.912 . . . . 0.0 113.012 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 170.37 30.82 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.904 2.192 . . . . 0.0 110.981 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -169.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.32 120.36 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 109.109 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -70.92 -42.44 69.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.829 1.252 . . . . 0.0 114.24 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -155.94 155.25 32.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.074 2.15 . . . . 0.0 114.874 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.65 141.7 27.14 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.426 1.09 . . . . 0.0 110.692 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 78.1 mtm -151.0 146.12 26.01 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.343 1.457 . . . . 0.0 111.713 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.9 mt -125.15 156.15 38.81 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.268 1.427 . . . . 0.0 111.49 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 mmt -78.53 67.76 4.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.155 0.982 . . . . 0.0 113.01 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -58.83 147.06 35.0 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -122.35 122.69 39.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.903 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -32.29 70.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.219 1.408 . . . . 0.0 113.751 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.259 1.1 p -75.33 -21.88 58.05 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.6 p -108.12 -19.14 13.59 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 58.17 25.65 12.79 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.233 1.813 . . . . 0.0 114.445 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -142.89 164.78 29.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.146 1.778 . . . . 0.0 111.241 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -89.33 161.03 16.57 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.876 0.87 . . . . 0.0 112.888 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -75.7 3.96 8.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.973 1.709 . . . . 0.0 115.138 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.16 12.06 59.21 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.243 1.401 . . . . 0.0 114.804 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -147.58 159.88 43.26 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.85 -156.16 15.78 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 114.957 0.743 . . . . 0.0 114.957 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -134.47 147.12 50.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.612 1.965 . . . . 0.0 115.202 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.48 126.47 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.63 1.572 . . . . 0.0 110.974 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.1 m -99.69 130.39 45.91 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.307 1.443 . . . . 0.0 112.693 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.6 152.72 21.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -67.17 -33.49 75.52 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.4 t -148.06 143.88 27.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.608 1.163 . . . . 0.0 113.035 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -58.51 -26.67 63.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 113.143 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -58.7 -27.94 65.32 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.33 -50.51 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.47 0.708 . . . . 0.0 110.163 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.12 -37.3 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.855 1.262 . . . . 0.0 112.492 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -55.07 -38.17 67.71 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.79 -48.05 27.49 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.765 0.711 . . . . 0.0 111.721 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.45 -44.52 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 118.739 0.7 . . . . 0.0 112.651 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 25.1 t -73.26 -29.84 63.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.659 1.184 . . . . 0.0 112.427 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -70.34 -38.03 74.76 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 121.077 -1.014 . . . . 0.0 112.677 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.3 mt -66.06 139.57 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.752 0.821 . . . . 0.0 110.577 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -125.54 149.9 47.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.353 1.461 . . . . 0.0 111.104 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.458 24.6 m-85 58.31 53.3 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -59.0 124.72 20.85 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.803 2.041 . . . . 0.0 111.423 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -93.6 124.22 37.45 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.3 mt -143.53 125.65 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.548 1.539 . . . . 0.0 109.324 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 49.73 42.7 23.98 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.398 1.079 . . . . 0.0 113.443 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 63.06 -11.05 0.09 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 128.212 2.605 . . . . 0.0 116.236 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -77.9 161.52 27.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.149 1.78 . . . . 0.0 109.336 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 10.1 ptp -122.32 144.33 49.07 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.8 164.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.678 2.391 . . . . 0.0 112.949 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -133.66 160.79 36.48 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.664 0.786 . . . . 0.0 112.278 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.46 157.6 45.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 0.0 113.679 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -144.07 162.82 35.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.666 1.986 . . . . 0.0 110.646 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -63.46 152.15 39.18 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 119.402 1.001 . . . . 0.0 111.621 173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -120.4 15.52 12.12 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -141.42 152.83 64.88 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.691 1.596 . . . . 0.0 112.001 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.35 139.5 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.239 2.626 . . . . 0.0 111.861 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -76.34 161.37 28.77 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -142.27 150.35 40.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.718 1.607 . . . . 0.0 110.629 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 28.6 m -73.7 42.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.836 2.055 . . . . 0.0 113.787 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 55.7 mtt -60.76 151.8 28.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.502 1.521 . . . . 0.0 113.162 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.2 p -134.87 68.84 71.41 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 125.522 1.529 . . . . 0.0 111.868 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.02 -14.2 26.22 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.722 2.948 . . . . 0.0 114.431 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.267 1.2 p -65.15 152.28 43.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 173.37 -166.87 39.4 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.551 1.072 . . . . 0.0 113.333 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.7 t -151.75 158.19 43.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.26 1.424 . . . . 0.0 111.492 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -147.53 159.59 43.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.845 1.658 . . . . 0.0 111.521 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -120.46 158.71 26.64 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.493 1.917 . . . . 0.0 111.702 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -176.01 169.84 42.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.715 1.15 . . . . 0.0 113.342 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -69.5 156.18 39.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.716 1.206 . . . . 0.0 112.887 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.4 p . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.821 1.648 . . . . 0.0 114.406 174.663 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -66.54 151.42 47.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.552 1.141 . . . . 0.0 113.501 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -63.46 150.23 44.2 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.341 1.456 . . . . 0.0 111.553 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 70.4 mtp -135.94 134.36 38.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.396 1.078 . . . . 0.0 111.424 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -115.45 7.23 14.95 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -142.07 154.4 44.91 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.901 -1.125 . . . . 0.0 112.464 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.42 154.32 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 113.425 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -91.61 146.2 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.361 2.264 . . . . 0.0 112.768 167.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.29 135.98 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.354 1.462 . . . . 0.0 109.595 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.74 154.64 25.84 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.785 0.707 . . . . 0.0 114.256 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.59 16.05 41.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.675 1.131 . . . . 0.0 114.0 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -67.2 159.47 28.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.228 . . . . 0.0 111.314 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.6 p -128.92 -168.8 1.98 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.332 1.053 . . . . 0.0 111.847 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.7 m -75.82 -15.44 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.127 0.971 . . . . 0.0 112.622 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -75.55 -32.34 60.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.261 0.2 OUTLIER -77.32 145.04 37.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.7 t -140.58 158.21 44.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.123 1.369 . . . . 0.0 113.73 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -57.37 -34.56 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -67.54 -39.37 85.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.445 0.698 . . . . 0.0 111.836 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.65 -34.99 67.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.18 -50.15 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.776 0.83 . . . . 0.0 109.318 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.86 -49.37 77.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.592 0.633 . . . . 0.0 111.501 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -59.07 -40.83 86.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.854 0.862 . . . . 0.0 112.803 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -65.71 -49.0 70.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 50.7 m-85 -64.58 -29.14 70.15 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -59.44 -22.76 61.96 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 170.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.23 -26.04 64.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.21 0.913 . . . . 0.0 112.953 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.68 -35.8 57.69 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.34 168.33 30.27 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.506 2.479 . . . . 0.0 109.992 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -65.58 125.12 24.21 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.363 1.082 . . . . 0.0 113.003 -168.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.6 t -95.37 133.86 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.629 1.972 . . . . 0.0 107.629 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -70.2 -52.12 25.73 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -163.99 161.28 22.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.389 2.276 . . . . 0.0 114.101 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -131.81 150.81 52.04 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.96 1.304 . . . . 0.0 110.18 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 91.3 mtp -148.36 152.42 37.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.964 1.305 . . . . 0.0 111.907 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.3 mt -122.41 133.2 54.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.753 1.621 . . . . 0.0 109.286 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.9 ptm -82.27 81.34 8.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.097 0.951 . . . . 0.0 112.077 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.44 130.66 47.98 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -102.39 126.4 49.41 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.092 0.957 . . . . 0.0 112.893 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -59.09 -24.93 63.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -77.92 -13.88 59.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 p -122.78 -23.44 5.07 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 58.38 24.4 11.64 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.502 1.921 . . . . 0.0 114.528 -171.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -146.27 170.11 17.44 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.671 1.589 . . . . 0.0 111.88 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -73.58 159.72 32.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.875 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -97.43 21.96 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.308 1.443 . . . . 0.0 114.56 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.12 14.47 62.37 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.914 1.245 . . . . 0.0 114.45 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.293 4.8 p90 -146.82 158.18 43.85 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.38 -160.27 17.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.108 1.337 . . . . 0.0 114.009 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -138.88 152.22 47.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.433 1.893 . . . . 0.0 114.914 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -135.94 126.36 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.352 1.461 . . . . 0.0 112.048 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 29.2 m -94.18 127.73 40.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 112.022 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -106.73 151.46 25.1 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -71.55 -36.33 70.94 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 t -135.47 137.98 42.7 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.449 1.1 . . . . 0.0 113.438 -171.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -65.32 -30.64 71.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.828 1.251 . . . . 0.0 112.597 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -60.41 -30.26 69.49 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.28 -47.9 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.817 0.847 . . . . 0.0 110.256 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 24.7 t -56.28 -42.47 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.636 1.174 . . . . 0.0 110.327 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.28 -50.8 72.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.743 0.701 . . . . 0.0 112.458 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -66.59 -45.03 80.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.273 0.942 . . . . 0.0 112.145 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.84 -40.62 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.221 0.919 . . . . 0.0 110.66 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.7 t -74.41 -31.32 62.28 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.148 0.979 . . . . 0.0 113.253 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -66.29 -37.41 85.35 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.777 -1.202 . . . . 0.0 113.246 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.1 mt -72.45 136.32 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.859 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.88 158.66 37.19 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.45 1.1 . . . . 0.0 112.701 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.525 22.3 m-85 60.43 45.27 11.11 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -56.36 153.94 8.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.949 1.7 . . . . 0.0 110.825 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -132.62 133.95 44.27 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.971 -1.081 . . . . 0.0 113.294 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . 0.272 4.5 mt -121.52 -127.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.483 1.113 . . . . 0.0 109.144 -173.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -69.14 73.67 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.208 1.803 . . . . 0.0 112.126 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 61.41 -30.28 0.07 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 129.215 3.006 . . . . 0.0 115.389 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -75.56 140.53 42.76 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.295 2.238 . . . . 0.0 111.398 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 13.2 ptm -97.6 150.27 21.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.619 1.168 . . . . 0.0 111.925 171.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.07 162.14 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.402 2.281 . . . . 0.0 112.759 -169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -125.91 163.33 23.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.007 1.323 . . . . 0.0 111.687 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.5 p -143.14 161.35 38.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -144.77 164.55 30.7 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.632 1.973 . . . . 0.0 110.859 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -61.33 150.18 35.84 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.487 -0.758 . . . . 0.0 111.277 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.8 148.1 50.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.158 0.983 . . . . 0.0 112.484 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.31 136.64 78.55 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.411 1.084 . . . . 0.0 113.688 -168.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.02 124.94 10.48 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.634 2.222 . . . . 0.0 109.266 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -140.76 12.93 2.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.441 1.897 . . . . 0.0 113.188 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.6 160.39 43.53 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.772 2.029 . . . . 0.0 111.28 -173.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.0 p -147.69 143.15 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.04 1.336 . . . . 0.0 112.429 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 77.5 mtm -143.91 152.62 41.35 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.624 1.57 . . . . 0.0 111.656 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.5 t -159.48 129.09 3.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.363 1.465 . . . . 0.0 109.517 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.47 153.73 44.75 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.948 2.432 . . . . 0.0 112.844 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.27 1.1 p -131.82 154.23 49.34 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.766 1.626 . . . . 0.0 115.091 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.0 -178.26 37.22 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.324 0.964 . . . . 0.0 114.165 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.5 t -158.45 161.54 37.46 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.312 1.445 . . . . 0.0 111.239 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.47 153.94 41.56 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.385 1.074 . . . . 0.0 112.678 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -136.79 154.87 50.43 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.807 1.643 . . . . 0.0 112.156 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.15 -9.09 87.38 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.59 1.091 . . . . 0.0 115.257 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -68.52 150.84 47.58 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.223 1.409 . . . . 0.0 112.944 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.898 1.679 . . . . 0.0 113.547 178.381 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -140.45 25.39 2.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.706 2.002 . . . . 0.0 112.149 -174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.7 t60 60.31 22.47 11.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.382 1.873 . . . . 0.0 113.818 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.45 136.8 44.25 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.05 -1.031 . . . . 0.0 110.82 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -138.18 34.52 2.33 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.403 1.481 . . . . 0.0 109.875 -174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -159.74 142.37 13.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.268 2.627 . . . . 0.0 107.855 -168.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.19 154.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.241 1.016 . . . . 0.0 112.496 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.36 148.71 25.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.992 1.717 . . . . 0.0 113.025 166.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.3 t -135.91 137.53 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.627 1.571 . . . . 0.0 109.576 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.01 149.3 20.98 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.89 11.83 36.31 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.714 1.626 . . . . 0.0 114.296 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.8 mt -64.38 135.38 56.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.36 1.464 . . . . 0.0 112.103 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.5 t -64.98 156.53 30.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.487 1.115 . . . . 0.0 112.402 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.44 -16.37 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.279 0.632 . . . . 0.0 111.188 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -68.71 -33.98 74.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.025 0.93 . . . . 0.0 111.895 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -71.84 144.46 49.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.327 1.851 . . . . 0.0 115.41 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 t -135.69 171.1 14.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.204 1.802 . . . . 0.0 112.469 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.57 -33.0 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.59 -39.41 88.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.189 0.996 . . . . 0.0 112.337 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -64.15 -41.37 97.19 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 173.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.35 -50.46 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.852 0.861 . . . . 0.0 110.367 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -62.64 -44.16 96.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.485 0.584 . . . . 0.0 111.962 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.62 -42.37 92.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.783 0.833 . . . . 0.0 112.586 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.28 -53.41 44.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 47.3 m-85 -63.79 -21.1 66.26 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -64.05 -12.25 36.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.32 -28.6 69.42 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.431 1.014 . . . . 0.0 112.766 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.74 -32.98 21.58 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.235 1.014 . . . . 0.0 112.051 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.93 -178.83 40.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.903 2.192 . . . . 0.0 110.874 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 120.56 12.28 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.585 -0.95 . . . . 0.0 112.571 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.32 121.53 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.381 1.473 . . . . 0.0 108.023 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -76.06 -36.93 58.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -165.36 165.78 19.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 109.28 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.81 43.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.317 1.447 . . . . 0.0 111.284 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.6 ptm -156.56 157.03 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.882 1.273 . . . . 0.0 112.2 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.79 151.99 48.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.282 1.833 . . . . 0.0 111.267 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 53.6 mtp -89.91 137.43 32.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.696 0.798 . . . . 0.0 110.745 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -121.56 158.51 28.37 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -132.04 135.83 46.78 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 169.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.7 -40.99 75.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.145 0.978 . . . . 0.0 112.674 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -69.81 -32.14 70.43 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 p -85.02 -22.47 29.04 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.95 28.58 12.87 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.394 2.278 . . . . 0.0 113.423 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -153.14 174.38 14.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.315 1.446 . . . . 0.0 111.843 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -74.45 156.99 36.38 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.482 0.658 . . . . 0.0 112.266 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.97 -0.52 24.66 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.823 1.649 . . . . 0.0 115.385 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.64 10.47 81.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.301 0.953 . . . . 0.0 113.417 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.285 15.6 p90 -143.6 157.7 44.22 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -169.28 -161.73 20.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.684 1.135 . . . . 0.0 114.153 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -138.64 152.56 48.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.938 1.695 . . . . 0.0 113.883 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.91 129.41 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.293 1.437 . . . . 0.0 111.499 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -91.38 138.59 31.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.15 1.78 . . . . 0.0 114.541 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -120.22 152.44 37.72 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -70.04 -30.17 67.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.1 t -155.7 149.69 25.46 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.609 1.163 . . . . 0.0 112.728 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.46 -29.68 66.37 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.029 0.932 . . . . 0.0 112.096 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -56.91 -26.41 59.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 24.1 mm -80.87 -52.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.815 0.846 . . . . 0.0 110.129 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.4 t -53.87 -36.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.617 1.567 . . . . 0.0 112.271 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -53.4 -47.16 69.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.886 0.874 . . . . 0.0 112.937 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -68.08 -44.84 75.37 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.074 0.852 . . . . 0.0 111.392 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.2 t -54.46 -41.93 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 96.7 m -72.21 -37.44 69.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.278 1.431 . . . . 0.0 114.453 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -66.31 -33.66 76.24 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.4 mt -73.0 112.05 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 169.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -70.64 -61.12 1.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.179 -0.951 . . . . 0.0 111.648 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 52.8 m-85 -94.66 133.41 38.36 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -127.23 124.2 38.36 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.499 1.92 . . . . 0.0 110.382 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.23 107.7 19.38 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.339 -0.851 . . . . 0.0 112.718 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.3 mt -128.14 122.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.377 1.071 . . . . 0.0 110.832 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.37 45.02 23.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.472 1.109 . . . . 0.0 112.818 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 63.31 -9.75 0.12 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 128.502 2.721 . . . . 0.0 116.158 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -87.89 142.47 27.77 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 126.322 1.849 . . . . 0.0 109.83 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 58.5 mtt -86.09 129.96 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.416 -0.803 . . . . 0.0 112.512 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.9 163.14 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.046 2.138 . . . . 0.0 111.718 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -128.26 162.94 25.85 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.519 0.727 . . . . 0.0 110.899 169.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.5 158.19 43.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.374 1.07 . . . . 0.0 113.196 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -144.25 165.53 27.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.631 1.573 . . . . 0.0 111.242 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.48 152.13 18.69 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.16 155.22 45.3 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 169.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.91 144.93 99.0 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -168.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -67.65 168.53 18.11 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.279 3.32 . . . . 0.0 114.694 -171.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -136.59 163.02 31.52 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.415 2.286 . . . . 0.0 111.2 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -63.13 153.61 33.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.136 1.374 . . . . 0.0 113.155 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 p -82.65 152.71 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.221 1.408 . . . . 0.0 113.815 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.5 ptp -152.09 162.07 41.67 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.478 1.511 . . . . 0.0 111.709 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.6 t -155.69 131.56 5.63 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.997 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -83.39 -9.83 10.16 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.558 2.838 . . . . 0.0 114.014 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.285 1.1 p -70.11 159.32 34.12 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.05 175.39 40.95 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.058 1.313 . . . . 0.0 113.179 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.6 m -69.52 143.28 53.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.71 160.1 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.016 1.726 . . . . 0.0 111.366 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -151.29 154.25 36.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.176 1.39 . . . . 0.0 112.541 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -83.15 172.7 51.49 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.616 1.103 . . . . 0.0 113.456 170.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -73.39 168.41 19.27 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.397 1.079 . . . . 0.0 112.924 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 39.5 p . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 112.768 168.053 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.784 -0.527 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -95.68 153.37 17.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.127 1.371 . . . . 0.0 113.32 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -128.2 25.35 5.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.385 1.874 . . . . 0.0 110.851 169.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 46.3 tpp -138.48 137.1 36.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.212 1.805 . . . . 0.0 111.394 -172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -89.78 31.54 0.95 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.617 1.567 . . . . 0.0 112.979 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -148.57 149.32 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.15 1.78 . . . . 0.0 111.232 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.55 149.3 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.054 1.742 . . . . 0.0 111.316 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.88 134.58 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.781 1.233 . . . . 0.0 109.58 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.43 145.95 14.95 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 114.518 0.567 . . . . 0.0 114.518 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.6 7.16 32.34 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.689 1.614 . . . . 0.0 114.609 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.5 139.48 58.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.164 1.385 . . . . 0.0 112.183 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 t -62.66 155.02 27.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.235 1.014 . . . . 0.0 112.506 171.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.57 -20.1 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.479 0.712 . . . . 0.0 112.214 169.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -71.76 -26.9 62.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.065 0.946 . . . . 0.0 113.151 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.0 m -73.59 143.49 46.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.735 1.614 . . . . 0.0 113.812 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.8 t -123.94 163.71 20.78 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.265 1.426 . . . . 0.0 114.207 169.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.6 p -57.9 -30.61 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.78 -34.51 78.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.832 0.853 . . . . 0.0 112.458 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -68.27 -47.19 68.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.85 -45.25 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.662 0.785 . . . . 0.0 111.025 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -61.01 -46.29 91.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 118.952 -0.547 . . . . 0.0 112.151 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -59.7 -42.8 93.8 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -65.03 -38.8 92.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -75.97 -29.19 58.17 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 173.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -58.71 -18.9 35.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.334 1.454 . . . . 0.0 114.572 171.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -66.19 -23.88 66.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.388 -0.82 . . . . 0.0 112.777 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -89.28 -37.76 14.7 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.04 176.47 39.69 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.175 1.845 . . . . 0.0 111.45 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -59.44 127.82 34.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.6 t -100.39 118.27 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.184 1.794 . . . . 0.0 108.397 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -78.27 -37.33 45.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -152.15 153.26 33.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.958 2.103 . . . . 0.0 114.684 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.18 29.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.4 ptp -157.85 147.59 20.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.248 1.019 . . . . 0.0 112.3 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.6 mt -127.83 153.87 46.1 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.521 1.529 . . . . 0.0 111.673 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 mmt -78.39 70.68 4.78 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.358 1.063 . . . . 0.0 112.52 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -60.33 140.98 56.83 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.48 119.51 29.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.899 1.279 . . . . 0.0 112.461 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -21.91 66.91 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.72 60.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -119.89 -19.31 7.96 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.17 26.19 13.46 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.571 1.948 . . . . 0.0 113.57 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -144.68 173.46 11.82 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.069 1.747 . . . . 0.0 110.93 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -92.12 158.82 15.99 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -70.5 -0.21 8.0 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.57 63.44 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.769 1.176 . . . . 0.0 114.376 -172.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -144.8 159.82 42.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -176.17 -160.15 23.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.0 0.81 . . . . 0.0 114.909 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -132.8 149.29 52.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.608 1.963 . . . . 0.0 115.357 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 t -135.09 128.11 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.254 1.421 . . . . 0.0 111.749 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 61.6 m -96.55 127.34 42.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.668 1.587 . . . . 0.0 111.418 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.43 157.95 15.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -61.81 -37.96 86.33 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.745 0.818 . . . . 0.0 112.84 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -151.79 143.52 23.65 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -57.14 -26.78 61.1 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.573 1.549 . . . . 0.0 113.051 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.91 -26.92 68.46 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.7 mm -78.72 -50.28 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.628 0.771 . . . . 0.0 109.458 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.96 -33.11 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.664 1.186 . . . . 0.0 111.201 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -48.16 -43.1 31.17 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -76.41 -45.51 31.29 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.639 -0.663 . . . . 0.0 111.764 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.35 -36.95 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.1 t -84.07 -24.27 30.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.583 1.153 . . . . 0.0 112.567 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -72.7 -35.61 67.66 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.02 -1.05 . . . . 0.0 112.155 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.14 138.41 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.022 0.929 . . . . 0.0 110.465 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -127.37 156.14 42.49 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.863 1.265 . . . . 0.0 111.951 169.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.443 18.2 m-85 61.04 47.15 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 -171.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -56.96 129.47 41.77 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.83 1.652 . . . . 0.0 111.201 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.29 125.0 28.62 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.446 0.566 . . . . 0.0 111.803 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.68 117.06 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.245 1.818 . . . . 0.0 108.781 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 50.03 43.79 25.61 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.287 1.035 . . . . 0.0 112.95 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 63.74 -13.88 0.08 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 128.173 2.589 . . . . 0.0 116.4 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.48 157.16 36.06 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.81 1.644 . . . . 0.0 109.265 169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 26.7 mtt -109.6 141.06 42.65 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.73 151.24 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.122 1.769 . . . . 0.0 114.031 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.72 144.98 26.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.842 0.857 . . . . 0.0 112.14 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 4.9 t -108.77 143.67 37.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.627 1.571 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -140.8 157.7 45.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.728 1.611 . . . . 0.0 111.123 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -67.74 129.81 41.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.549 0.739 . . . . 0.0 111.894 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -84.43 70.9 10.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.906 0.882 . . . . 0.0 112.364 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 49.87 71.76 1.47 Allowed Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 126.994 2.118 . . . . 0.0 114.721 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.71 161.7 20.57 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.603 2.869 . . . . 0.0 114.505 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -130.8 150.69 51.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.101 1.76 . . . . 0.0 110.938 172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -78.88 46.05 0.65 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.294 1.438 . . . . 0.0 113.617 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.78 140.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.781 1.232 . . . . 0.0 114.116 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 66.2 mtt -84.3 160.24 20.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.553 1.141 . . . . 0.0 112.344 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -145.19 79.31 11.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 110.782 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.94 -13.57 17.44 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.664 2.91 . . . . 0.0 113.709 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 140.44 51.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 117.187 2.291 . . . . 0.0 117.187 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -176.33 -175.8 43.98 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.789 1.185 . . . . 0.0 113.123 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.7 t -152.09 158.69 43.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.174 1.389 . . . . 0.0 111.464 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.8 148.16 52.3 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.281 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -66.89 133.54 50.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 111.887 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.46 139.04 27.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.249 0.928 . . . . 0.0 112.883 173.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.44 137.78 24.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.833 1.653 . . . . 0.0 111.412 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.253 1.276 0 C-N-CA 125.836 1.654 . . . . 0.0 114.484 -173.185 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.9 t -152.4 152.28 31.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.009 1.324 . . . . 0.0 111.482 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -145.95 38.26 1.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.165 1.786 . . . . 0.0 111.623 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -134.71 139.31 45.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.058 2.143 . . . . 0.0 109.444 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -108.42 10.72 27.38 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.74 147.76 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.785 1.634 . . . . 0.0 111.672 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.29 152.85 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -92.27 148.25 22.28 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.375 2.27 . . . . 0.0 111.86 167.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.0 t -137.79 135.1 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.015 1.326 . . . . 0.0 109.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.23 155.84 26.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.977 0.798 . . . . 0.0 114.288 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.94 10.01 41.16 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.558 1.551 . . . . 0.0 114.725 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -67.13 137.67 56.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.866 1.266 . . . . 0.0 112.532 -176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 t -65.93 152.46 44.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.256 1.023 . . . . 0.0 111.76 169.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -70.53 -15.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.574 -0.704 . . . . 0.0 111.796 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -70.38 -29.85 66.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.303 1.041 . . . . 0.0 112.689 170.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.3 m -78.85 139.12 38.4 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.992 1.717 . . . . 0.0 113.605 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.1 t -118.82 165.14 14.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.44 1.496 . . . . 0.0 114.726 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.93 -33.98 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -72.63 -27.01 61.87 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.72 -46.88 64.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.977 0.808 . . . . 0.0 109.169 171.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.44 -46.61 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.686 0.794 . . . . 0.0 110.493 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -57.18 -50.77 71.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.005 0.922 . . . . 0.0 111.855 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -60.21 -44.29 95.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 112.973 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.07 -38.8 92.37 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.306 48.6 m-85 -73.07 -31.2 64.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -60.42 -18.07 48.49 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -65.45 -24.88 67.29 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.55 0.74 . . . . 0.0 112.718 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -85.55 -35.64 20.97 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.85 175.3 36.19 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.668 2.08 . . . . 0.0 111.139 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -58.81 125.03 21.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.761 -0.847 . . . . 0.0 112.98 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.1 t -94.01 124.01 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.835 1.654 . . . . 0.0 107.234 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.85 -31.5 20.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.987 0.515 . . . . 0.0 110.356 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -161.51 155.56 22.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.884 1.274 . . . . 0.0 109.767 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.83 149.51 34.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.048 1.339 . . . . 0.0 111.268 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.4 ptp -156.07 154.9 31.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.634 1.174 . . . . 0.0 112.166 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.41 152.3 46.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.302 1.441 . . . . 0.0 111.419 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 91.7 mmm -83.31 84.13 7.61 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.764 0.826 . . . . 0.0 111.788 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.262 28.0 m-85 -67.18 119.27 11.81 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.1 115.46 21.9 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.152 0.981 . . . . 0.0 111.811 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -66.44 -16.79 64.38 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.15 0.98 . . . . 0.0 112.821 -175.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -22.75 60.4 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 171.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 p -130.29 -11.61 4.09 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.36 27.16 16.72 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.159 1.783 . . . . 0.0 114.515 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -134.13 167.33 20.86 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.905 1.682 . . . . 0.0 111.24 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -72.28 154.51 40.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.602 0.715 . . . . 0.0 112.32 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -80.87 7.47 10.46 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.193 1.797 . . . . 0.0 115.096 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.46 11.84 63.74 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.992 1.282 . . . . 0.0 114.414 -172.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.256 18.5 p90 -145.98 160.78 41.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.66 -162.16 23.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.54 1.066 . . . . 0.0 114.77 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.07 148.12 44.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.653 1.981 . . . . 0.0 113.84 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.56 123.59 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.422 1.489 . . . . 0.0 111.606 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 90.4 m -93.25 128.47 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.026 1.33 . . . . 0.0 110.501 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -99.91 153.15 19.39 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.2 -33.29 75.47 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.8 t -152.94 143.65 22.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 112.815 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -55.83 -27.16 50.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.668 1.587 . . . . 0.0 113.185 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.38 -27.12 69.09 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.3 mm -77.54 -48.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.254 0.621 . . . . 0.0 109.686 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.08 -34.07 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.292 1.037 . . . . 0.0 111.244 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -50.23 -42.85 52.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.476 1.51 . . . . 0.0 113.54 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -77.35 -47.61 19.47 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.497 0.719 . . . . 0.0 111.595 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.3 -43.3 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.9 t -76.01 -24.47 55.29 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.848 1.259 . . . . 0.0 112.19 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -78.27 -33.27 49.7 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.041 -1.037 . . . . 0.0 112.539 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 30.2 mt -67.97 148.47 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.429 1.091 . . . . 0.0 110.748 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -134.84 152.03 51.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.368 26.6 m-85 58.42 50.6 9.17 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -171.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -60.13 133.55 56.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.334 . . . . 0.0 111.971 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -82.93 133.47 35.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.805 -0.56 . . . . 0.0 111.896 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.1 mt -145.24 125.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 126.695 1.998 . . . . 0.0 108.842 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 50.08 36.28 11.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.56 1.144 . . . . 0.0 113.495 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.07 -7.73 0.14 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 128.242 2.617 . . . . 0.0 116.058 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.17 173.62 11.65 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 109.33 167.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.3 mtt -120.85 145.78 47.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.42 161.75 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.366 2.266 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.27 152.25 50.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.403 1.081 . . . . 0.0 110.017 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.06 157.97 44.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -170.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -147.44 160.93 42.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.88 2.072 . . . . 0.0 111.14 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 146.95 42.59 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.988 0.813 . . . . 0.0 111.844 172.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.73 23.83 5.03 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -153.51 164.19 21.32 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.397 1.079 . . . . 0.0 111.561 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.0 167.13 9.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.226 2.617 . . . . 0.0 113.49 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -56.46 142.98 36.73 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 0.0 112.458 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -147.66 156.21 42.55 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.286 1.435 . . . . 0.0 110.824 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -61.35 153.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.381 -0.824 . . . . 0.0 113.123 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 85.0 mmm -64.8 146.92 54.17 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.312 0.645 . . . . 0.0 111.661 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -63.88 -52.56 56.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.844 1.257 . . . . 0.0 113.16 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.6 138.83 35.97 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.204 1.936 . . . . 0.0 111.684 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 p -73.78 -19.7 60.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 175.72 163.88 29.21 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.884 1.707 . . . . 0.0 112.34 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 27.1 t -74.63 136.2 41.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.605 0.762 . . . . 0.0 111.882 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.13 39.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.194 0.997 . . . . 0.0 112.74 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -68.75 141.91 55.1 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.128 0.971 . . . . 0.0 111.063 174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -71.27 174.13 41.8 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.843 0.735 . . . . 0.0 113.631 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -64.7 139.18 58.74 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.94 0.896 . . . . 0.0 110.729 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.485 1.514 . . . . 0.0 113.731 -179.607 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.7 t -152.02 137.6 17.79 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.815 1.246 . . . . 0.0 111.447 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.19 -5.41 58.42 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.703 1.201 . . . . 0.0 113.788 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 56.3 mtt -69.08 141.63 54.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.774 0.829 . . . . 0.0 112.597 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -150.16 50.87 0.9 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.527 1.531 . . . . 0.0 110.768 -172.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -147.27 142.17 26.91 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.745 2.018 . . . . 0.0 109.393 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 pt -139.52 151.87 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.948 0.899 . . . . 0.0 113.236 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -92.67 145.71 24.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.17 2.188 . . . . 0.0 112.404 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.27 134.97 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 109.952 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.98 148.22 19.77 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.784 0.72 . . . . 0.0 114.256 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.77 9.57 59.72 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.936 1.255 . . . . 0.0 114.261 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.45 144.01 54.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.976 1.31 . . . . 0.0 111.575 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -67.15 158.03 32.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.155 0.582 . . . . 0.0 110.993 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.21 -26.3 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -71.31 -25.92 62.63 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.56 1.144 . . . . 0.0 113.712 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -70.2 119.15 13.96 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.299 1.3 t -98.5 164.18 12.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.45 -33.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -174.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -68.19 -32.49 72.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.1 0.96 . . . . 0.0 113.052 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.59 -46.06 73.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.849 0.75 . . . . 0.0 110.364 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.43 -48.97 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.303 1.041 . . . . 0.0 110.567 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.87 -49.07 79.15 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.869 0.867 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -60.0 -39.55 86.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 112.773 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -68.87 -49.07 61.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.324 49.4 m-85 -63.23 -29.22 70.6 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.44 -21.48 60.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -70.36 -25.73 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.019 0.827 . . . . 0.0 112.846 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -76.32 -38.81 55.46 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.63 167.65 29.57 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 127.328 2.394 . . . . 0.0 110.276 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -58.02 131.86 51.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.135 0.968 . . . . 0.0 113.294 -169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -93.69 138.26 20.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 126.565 1.946 . . . . 0.0 108.335 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.99 -45.11 10.49 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.932 1.293 . . . . 0.0 112.946 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -158.9 161.53 36.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.295 1.438 . . . . 0.0 109.881 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.11 156.86 42.82 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.148 1.379 . . . . 0.0 111.767 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -157.09 159.34 37.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.54 1.136 . . . . 0.0 113.163 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 73.3 mt -124.05 146.64 48.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.889 2.076 . . . . 0.0 111.136 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.9 mmm -85.56 128.76 34.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.474 0.71 . . . . 0.0 111.884 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -127.65 148.28 50.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.879 2.472 . . . . 0.0 114.064 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -113.61 116.77 30.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.081 0.952 . . . . 0.0 112.88 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -68.18 -22.47 64.83 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 p -76.04 -29.57 58.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 p -98.1 -16.45 19.55 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.622 1.569 . . . . 0.0 114.905 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 58.16 36.31 25.73 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.148 2.579 . . . . 0.0 113.812 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -152.52 169.34 22.87 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -56.11 154.63 7.47 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.362 3.065 . . . . 0.0 112.428 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.53 -8.49 15.0 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.57 16.11 76.45 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.384 0.993 . . . . 0.0 114.767 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.292 15.3 p90 -142.48 161.2 38.67 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.25 -168.41 25.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.689 1.138 . . . . 0.0 113.761 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -141.27 153.66 45.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.125 1.37 . . . . 0.0 112.965 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.0 130.98 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.356 1.462 . . . . 0.0 112.094 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.3 m -93.48 138.04 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.77 1.628 . . . . 0.0 113.85 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -111.51 148.8 32.4 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -69.76 -28.95 66.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.107 0.963 . . . . 0.0 112.738 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.2 t -143.45 130.36 20.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.459 1.103 . . . . 0.0 112.937 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.6 pm0 -57.85 -28.55 64.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.741 2.016 . . . . 0.0 113.378 172.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -65.32 -28.25 69.18 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 36.8 mm -74.7 -45.01 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 110.094 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.8 t -58.63 -37.59 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.435 1.094 . . . . 0.0 110.516 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -56.14 -45.51 79.57 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.987 0.812 . . . . 0.0 113.128 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -69.33 -45.95 68.24 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.923 0.783 . . . . 0.0 111.836 173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.88 -44.11 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 118.851 0.75 . . . . 0.0 110.834 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.67 -36.61 76.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.331 1.452 . . . . 0.0 113.033 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -37.32 86.25 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.116 -0.99 . . . . 0.0 112.816 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.01 117.38 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.54 0.736 . . . . 0.0 109.232 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -70.28 -61.44 1.77 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.486 -0.759 . . . . 0.0 111.777 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.335 53.5 m-85 -95.71 139.55 31.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -137.28 153.08 50.39 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.716 2.406 . . . . 0.0 109.606 -174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -124.2 115.93 21.89 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.129 -0.982 . . . . 0.0 112.82 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.8 mt -134.4 126.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.108 0.963 . . . . 0.0 111.049 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 51.0 38.23 19.89 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 112.826 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.12 -7.1 0.12 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.914 2.486 . . . . 0.0 115.86 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -78.52 140.52 38.55 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.128 1.771 . . . . 0.0 109.178 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 96.5 mtp -88.64 143.26 27.06 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.546 -0.721 . . . . 0.0 111.879 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.0 164.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.566 2.346 . . . . 0.0 111.628 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -124.9 158.29 33.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.818 0.847 . . . . 0.0 110.867 168.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.1 p -141.41 158.27 44.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.637 0.732 . . . . 0.0 112.58 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -155.78 163.07 40.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.62 1.568 . . . . 0.0 111.702 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -57.69 147.14 28.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.494 1.118 . . . . 0.0 112.416 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.81 161.62 37.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.704 1.601 . . . . 0.0 110.965 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -98.89 115.84 65.58 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.64 0.776 . . . . 0.0 112.222 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.54 166.71 21.72 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.684 2.922 . . . . 0.0 112.287 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 151.58 30.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.006 0.923 . . . . 0.0 111.487 168.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.55 135.72 50.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.71 0.804 . . . . 0.0 112.229 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.7 p -155.13 157.17 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.899 1.68 . . . . 0.0 113.11 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 76.6 mtm -126.77 152.11 47.33 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.65 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.0 p -145.01 59.8 6.46 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.496 1.119 . . . . 0.0 113.852 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.69 -16.81 29.95 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.49 2.793 . . . . 0.0 114.129 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.4 0.1 OUTLIER 62.88 -48.69 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -177.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 64.56 18.33 63.43 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.695 1.14 . . . . 0.0 114.494 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 139.08 58.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.399 1.099 . . . . 0.0 113.151 -172.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.15 29.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.06 1.344 . . . . 0.0 113.692 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -148.08 150.81 34.57 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.031 1.732 . . . . 0.0 111.019 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 79.63 -162.84 47.61 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.413 1.006 . . . . 0.0 113.814 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.9 ttm-85 -144.07 145.07 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.825 1.65 . . . . 0.0 111.498 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.093 1.757 . . . . 0.0 113.666 -179.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.5 p -150.4 153.41 35.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.979 1.311 . . . . 0.0 112.738 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -78.35 154.89 30.4 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.144 1.378 . . . . 0.0 113.208 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.09 151.16 26.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.697 1.199 . . . . 0.0 110.437 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.29 2.17 50.41 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.867 1.267 . . . . 0.0 113.528 173.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -140.56 151.78 44.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.21 1.404 . . . . 0.0 111.921 -172.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -139.8 151.57 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.608 1.163 . . . . 0.0 113.648 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -90.12 146.95 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.252 2.221 . . . . 0.0 112.973 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.28 138.06 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.099 1.76 . . . . 0.0 110.348 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.52 142.41 9.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.887 0.767 . . . . 0.0 114.85 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.54 4.92 30.16 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.089 1.804 . . . . 0.0 114.649 -175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.22 140.05 58.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.368 1.467 . . . . 0.0 112.277 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -66.23 152.47 44.81 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.802 0.841 . . . . 0.0 111.741 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.15 -14.81 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.43 -0.793 . . . . 0.0 111.552 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -71.03 -28.81 64.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.133 0.973 . . . . 0.0 112.68 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.0 m -74.08 140.54 45.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.658 1.583 . . . . 0.0 112.78 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.53 164.48 15.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.404 1.482 . . . . 0.0 114.572 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -58.81 -32.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -67.24 -32.1 72.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.893 0.877 . . . . 0.0 112.739 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -67.25 -50.06 61.98 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.5 -45.06 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 111.207 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.16 -47.76 84.58 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 111.747 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.16 -43.79 98.04 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -64.13 -38.6 91.64 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 48.1 m-85 -73.51 -29.68 62.63 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -60.76 -17.09 46.76 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -65.52 -24.14 67.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.61 0.764 . . . . 0.0 112.794 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -83.49 -34.4 25.36 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.06 174.64 34.98 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.849 2.166 . . . . 0.0 110.798 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -59.23 126.5 27.93 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.951 0.876 . . . . 0.0 113.162 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.92 126.83 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.707 1.603 . . . . 0.0 108.628 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -76.69 -46.3 26.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.071 0.948 . . . . 0.0 112.631 175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -158.72 161.11 37.03 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.22 1.008 . . . . 0.0 110.894 -172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.83 156.27 41.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.508 1.523 . . . . 0.0 111.818 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -154.47 158.88 40.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.81 1.244 . . . . 0.0 112.629 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.1 mt -126.8 147.79 49.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.874 1.67 . . . . 0.0 111.445 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.64 85.45 6.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.997 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.283 42.3 m-85 -65.11 128.14 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 171.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.36 134.02 34.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.33 1.052 . . . . 0.0 111.293 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.13 -39.4 93.0 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.35 1.06 . . . . 0.0 113.641 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.33 -39.96 18.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.268 1.4 p -93.17 -12.75 29.57 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 58.1 27.91 15.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.785 2.034 . . . . 0.0 114.619 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -138.33 164.53 29.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.446 1.898 . . . . 0.0 110.521 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -73.92 148.87 41.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.577 0.703 . . . . 0.0 112.726 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -78.23 7.26 6.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.853 1.661 . . . . 0.0 115.314 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.24 14.89 67.9 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.554 1.073 . . . . 0.0 114.41 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.311 14.6 p90 -139.52 158.26 44.43 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.07 -171.75 30.71 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.224 0.916 . . . . 0.0 114.845 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -134.23 149.4 50.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.923 2.089 . . . . 0.0 114.246 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.81 129.37 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.246 1.418 . . . . 0.0 111.209 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 76.8 m -100.53 124.1 45.63 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.409 1.484 . . . . 0.0 111.434 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -97.16 155.9 16.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -68.91 -30.86 69.43 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.2 t -153.02 143.59 22.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.343 1.057 . . . . 0.0 113.309 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -57.82 -26.2 61.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.571 1.548 . . . . 0.0 113.673 170.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -59.02 -35.68 73.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.202 1.001 . . . . 0.0 111.809 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.75 -47.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.052 0.941 . . . . 0.0 110.418 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.7 t -58.4 -37.56 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.635 1.174 . . . . 0.0 111.146 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.69 -48.71 74.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.036 0.835 . . . . 0.0 113.218 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.63 -42.1 82.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.082 0.855 . . . . 0.0 111.676 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.79 -39.16 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.512 0.596 . . . . 0.0 111.241 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 88.9 m -73.62 -38.48 65.04 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -66.29 -35.61 80.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 25.7 mt -73.21 116.36 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -68.94 -56.2 8.58 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.278 -0.889 . . . . 0.0 111.77 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.315 50.9 m-85 -104.12 136.82 43.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -130.81 137.42 49.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.787 2.035 . . . . 0.0 110.629 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -84.31 131.19 34.74 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.76 -0.588 . . . . 0.0 111.731 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.98 122.29 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.546 1.939 . . . . 0.0 109.546 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 49.62 40.01 18.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.555 1.142 . . . . 0.0 112.855 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 62.43 -8.01 0.12 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 128.688 2.795 . . . . 0.0 116.259 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -77.17 154.62 32.98 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.276 -1.515 . . . . 0.0 108.532 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 22.6 ptm -100.29 139.74 35.53 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.238 -0.914 . . . . 0.0 111.769 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.45 162.0 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.709 2.004 . . . . 0.0 111.719 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.82 162.55 17.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.5 p -144.06 154.27 43.05 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.695 1.198 . . . . 0.0 113.675 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -144.06 165.43 27.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.681 1.993 . . . . 0.0 111.758 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.54 134.67 57.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.024 0.93 . . . . 0.0 111.655 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.36 63.97 5.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.17 0.988 . . . . 0.0 112.988 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 54.29 74.67 0.71 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.579 1.951 . . . . 0.0 111.264 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.32 156.02 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.781 2.987 . . . . 0.0 116.545 -166.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -144.12 128.81 18.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.253 2.621 . . . . 0.0 108.028 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.17 104.92 0.98 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.853 0.861 . . . . 0.0 112.89 -169.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 19.1 t -144.24 128.37 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 126.114 1.765 . . . . 0.0 110.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 54.1 ttm -136.69 144.36 43.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.285 1.434 . . . . 0.0 111.622 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.4 t -148.91 92.35 4.4 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.775 1.23 . . . . 0.0 110.395 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.45 147.41 41.21 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.294 2.663 . . . . 0.0 112.987 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.319 0.2 OUTLIER -73.19 41.1 0.1 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 117.573 2.434 . . . . 0.0 117.573 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.59 142.85 47.36 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.627 1.108 . . . . 0.0 113.915 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.4 t -156.95 159.77 38.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.664 1.585 . . . . 0.0 111.263 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.08 140.03 57.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.304 1.041 . . . . 0.0 112.877 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -80.54 156.56 26.44 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.071 1.349 . . . . 0.0 113.024 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.96 175.83 47.26 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.479 1.037 . . . . 0.0 113.825 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -145.87 169.33 18.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.653 1.581 . . . . 0.0 112.549 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 49.6 p . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.113 1.765 . . . . 0.0 115.429 -179.023 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.0 m -128.07 28.12 5.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.023 1.729 . . . . 0.0 112.189 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -86.3 62.3 7.35 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.32 1.848 . . . . 0.0 112.425 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -135.86 148.6 48.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.525 1.13 . . . . 0.0 112.751 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -98.03 32.58 2.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.897 1.679 . . . . 0.0 112.738 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -141.13 149.65 41.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.724 1.61 . . . . 0.0 111.431 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.84 151.3 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.344 1.058 . . . . 0.0 113.763 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -88.72 145.64 25.51 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.526 1.931 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.3 138.05 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.471 1.509 . . . . 0.0 110.627 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.77 153.52 25.16 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 123.861 0.743 . . . . 0.0 114.33 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.81 34.88 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.034 1.302 . . . . 0.0 114.602 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.0 mt -64.21 136.24 57.02 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.106 1.363 . . . . 0.0 112.18 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -62.62 152.66 34.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.348 1.059 . . . . 0.0 112.37 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.6 -23.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.81 0.844 . . . . 0.0 111.725 171.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -67.62 -26.68 66.36 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.65 1.18 . . . . 0.0 113.282 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.2 m -76.97 147.64 36.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.074 1.749 . . . . 0.0 115.495 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.4 t -129.3 162.66 27.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.07 1.748 . . . . 0.0 113.094 168.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -57.72 -30.86 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.14 -33.99 77.33 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.911 0.884 . . . . 0.0 112.42 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.07 -47.24 68.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -58.23 -45.35 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.58 0.752 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -60.91 -47.44 86.38 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.141 0.577 . . . . 0.0 111.65 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -58.9 -45.76 89.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.971 0.908 . . . . 0.0 113.415 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -65.62 -38.68 90.1 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 49.4 m-85 -73.75 -29.18 62.07 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 171.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -61.19 -17.39 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -64.93 -23.04 67.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.659 0.784 . . . . 0.0 112.8 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -86.1 -29.29 23.46 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.73 174.95 30.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.98 2.228 . . . . 0.0 110.729 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -59.3 126.88 29.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.249 1.025 . . . . 0.0 112.882 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.53 123.25 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.799 1.64 . . . . 0.0 107.502 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.16 -33.73 24.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.325 0.65 . . . . 0.0 110.398 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -160.54 158.08 28.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.683 1.193 . . . . 0.0 110.168 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.01 149.11 30.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.205 1.402 . . . . 0.0 111.165 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.14 159.09 42.67 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.792 1.237 . . . . 0.0 112.432 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.0 mt -125.98 155.8 40.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.913 1.685 . . . . 0.0 111.028 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 88.3 mmm -83.46 132.92 34.93 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -118.12 148.49 42.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.97 105.15 17.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.174 0.99 . . . . 0.0 108.977 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -59.96 -25.51 65.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.251 1.3 p -78.17 -17.46 56.79 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -126.58 -15.03 5.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.329 17.0 p30 54.77 17.42 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 127.897 2.479 . . . . 0.0 115.543 -170.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -81.79 145.82 30.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.974 1.31 . . . . 0.0 110.324 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -79.18 157.82 27.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.259 0.552 . . . . 0.0 112.041 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -84.48 1.55 45.08 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.52 66.8 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.267 1.413 . . . . 0.0 114.597 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -145.22 159.74 42.55 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.582 2.068 . . . . 0.0 116.582 -178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.94 -164.43 27.49 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.271 0.939 . . . . 0.0 115.129 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -136.59 147.67 47.1 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.75 2.02 . . . . 0.0 114.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.26 127.6 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.704 1.202 . . . . 0.0 111.3 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.9 m -96.81 122.67 40.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.343 1.457 . . . . 0.0 111.278 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.29 158.99 16.26 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -65.89 -35.62 81.15 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.617 -0.677 . . . . 0.0 112.597 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.7 t -149.73 147.23 27.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.562 1.145 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -62.17 -24.5 67.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.687 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.76 -30.31 71.35 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.22 -47.46 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.549 0.739 . . . . 0.0 109.874 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.65 -34.28 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.383 1.073 . . . . 0.0 110.526 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -52.24 -40.09 61.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.8 1.24 . . . . 0.0 113.163 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -80.54 -45.24 17.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.615 0.643 . . . . 0.0 112.09 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 42.0 t -55.8 -44.66 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.845 0.748 . . . . 0.0 112.006 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 22.3 t -73.21 -33.0 65.12 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.085 1.354 . . . . 0.0 112.145 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -67.42 -38.74 85.03 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.292 -0.88 . . . . 0.0 112.484 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.7 mt -71.66 114.81 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -68.75 -49.63 57.19 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.897 -1.127 . . . . 0.0 112.149 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 62.4 m-85 -108.43 138.85 44.04 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.97 129.45 34.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.919 1.687 . . . . 0.0 111.123 -174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -77.94 134.15 37.93 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.53 -0.731 . . . . 0.0 112.39 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.9 mt -145.83 118.71 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 127.493 2.317 . . . . 0.0 108.199 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 50.69 45.94 26.38 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.05 0.94 . . . . 0.0 113.359 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 65.86 -18.22 0.1 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 128.045 2.538 . . . . 0.0 116.259 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -75.26 155.33 36.84 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.403 1.881 . . . . 0.0 109.844 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 62.7 mtm -108.17 125.09 51.23 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.472 -0.768 . . . . 0.0 111.397 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.16 163.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.345 1.858 . . . . 0.0 111.868 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -122.44 155.71 35.56 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.349 0.66 . . . . 0.0 111.112 168.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 30.1 p -139.14 155.84 47.57 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -145.06 173.46 11.88 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.491 1.917 . . . . 0.0 111.775 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -60.34 135.39 57.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.113 0.965 . . . . 0.0 111.315 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.98 139.69 36.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.208 0.603 . . . . 0.0 110.793 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.01 141.47 71.29 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -78.63 -14.08 14.39 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.464 2.776 . . . . 0.0 114.24 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt 51.7 48.72 22.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.082 2.153 . . . . 0.0 114.132 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -145.07 157.1 44.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.644 1.578 . . . . 0.0 111.95 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.93 144.26 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.067 1.347 . . . . 0.0 113.379 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 60.0 tpp -74.01 -31.64 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.459 1.104 . . . . 0.0 113.633 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.8 t -125.95 72.86 70.4 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.086 1.355 . . . . 0.0 111.168 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.83 166.53 28.62 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.988 3.125 . . . . 0.0 112.514 175.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.444 0.6 OUTLIER 61.82 173.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.99 26.97 63.26 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.534 1.064 . . . . 0.0 114.183 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.3 p -69.45 173.74 5.6 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.387 1.475 . . . . 0.0 113.402 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.3 8.53 1.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? 64.2 -33.69 0.14 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 129.33 3.052 . . . . 0.0 116.412 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.32 -169.31 54.71 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.82 1.2 . . . . 0.0 114.111 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -68.78 164.92 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.966 1.307 . . . . 0.0 113.433 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.187 1.795 . . . . 0.0 115.361 -179.611 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -64.33 144.59 57.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.472 1.109 . . . . 0.0 113.213 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -62.25 133.2 54.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.331 . . . . 0.0 112.28 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -68.36 135.76 52.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -129.01 24.23 5.63 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.135 2.174 . . . . 0.0 110.418 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -151.92 154.2 35.64 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.033 1.333 . . . . 0.0 110.286 -169.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.66 154.81 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.076 . . . . 0.0 112.896 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -91.01 145.57 24.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.399 1.879 . . . . 0.0 112.054 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.03 131.4 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.55 1.54 . . . . 0.0 109.908 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.13 12.66 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.607 0.622 . . . . 0.0 114.5 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.58 10.79 26.42 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.759 1.647 . . . . 0.0 114.717 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 37.7 mt -61.61 136.38 57.99 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.219 1.408 . . . . 0.0 111.929 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 p -79.92 179.18 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.9 m -79.5 -20.17 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.306 1.043 . . . . 0.0 112.56 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.38 -37.75 56.72 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.897 0.879 . . . . 0.0 110.527 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 m -68.96 140.5 55.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.72 1.608 . . . . 0.0 115.295 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.6 t -144.44 173.71 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.678 1.991 . . . . 0.0 112.218 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.1 -32.28 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -68.44 -39.98 81.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.906 0.882 . . . . 0.0 112.433 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -65.06 -41.89 94.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.97 -53.02 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.374 1.07 . . . . 0.0 109.137 174.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -58.86 -48.17 82.32 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.67 0.668 . . . . 0.0 111.962 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -60.5 -42.01 95.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.737 0.815 . . . . 0.0 112.832 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.14 -46.02 68.65 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.329 54.6 m-85 -66.57 -28.0 68.17 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -59.57 -21.01 59.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -71.51 -25.89 62.44 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.417 -0.802 . . . . 0.0 112.767 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -75.49 -36.26 60.64 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.98 177.08 37.86 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.877 2.179 . . . . 0.0 110.963 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -60.01 131.27 50.34 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.12 0.96 . . . . 0.0 112.968 -172.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 36.9 t -108.06 133.46 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.757 2.023 . . . . 0.0 107.446 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -101.32 -23.12 14.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.01 150.9 17.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.892 2.077 . . . . 0.0 113.379 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.46 145.0 31.65 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.289 1.036 . . . . 0.0 110.997 171.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.7 ptm -157.43 158.77 36.47 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.742 1.217 . . . . 0.0 112.331 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.14 150.13 49.64 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.805 1.642 . . . . 0.0 111.808 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.4 mmt -82.57 143.89 30.72 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.667 0.787 . . . . 0.0 110.564 169.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.86 154.33 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -110.12 111.83 23.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.345 1.058 . . . . 0.0 112.548 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -59.14 -21.7 59.74 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.68 1.192 . . . . 0.0 114.049 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -18.37 63.29 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -136.36 -18.89 1.47 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 62.1 t30 59.59 22.48 11.14 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.975 2.11 . . . . 0.0 113.864 -171.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -106.9 160.73 15.3 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.409 1.484 . . . . 0.0 110.525 174.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -71.82 153.82 41.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.222 0.534 . . . . 0.0 111.552 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mtp85 -82.34 2.53 31.78 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -172.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.7 9.92 82.23 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.56 1.076 . . . . 0.0 113.771 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.27 19.6 p90 -143.47 156.65 44.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.08 -164.69 22.09 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.441 1.019 . . . . 0.0 114.174 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.09 151.72 46.93 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.994 1.718 . . . . 0.0 114.144 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 t -137.26 128.27 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.944 1.298 . . . . 0.0 112.101 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -90.36 139.62 30.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.866 1.666 . . . . 0.0 113.287 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -123.34 150.5 43.57 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 117.279 2.325 . . . . 0.0 117.279 -174.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -67.15 -33.02 74.53 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.4 t -147.4 148.59 31.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.74 1.216 . . . . 0.0 113.192 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -57.44 -29.38 64.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.543 1.137 . . . . 0.0 112.836 171.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -61.64 -30.8 70.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -78.94 -48.67 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 110.249 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.95 -43.06 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.04 1.336 . . . . 0.0 110.434 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -56.4 -47.98 77.87 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.975 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -64.99 -45.13 86.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.019 0.827 . . . . 0.0 111.688 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.48 -36.13 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.629 0.65 . . . . 0.0 111.705 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.6 m -73.24 -39.87 65.11 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -66.4 -35.3 79.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.037 0.935 . . . . 0.0 113.22 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.18 115.0 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -68.29 -58.74 3.93 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.716 -0.615 . . . . 0.0 111.279 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.327 53.4 m-85 -104.71 137.94 41.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -131.05 125.48 33.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.981 2.112 . . . . 0.0 109.865 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.51 121.57 32.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.416 -0.803 . . . . 0.0 112.535 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.4 mt -139.15 126.44 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.891 1.277 . . . . 0.0 109.91 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.41 40.0 21.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.622 1.169 . . . . 0.0 113.687 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 62.97 -7.91 0.14 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 128.1 2.56 . . . . 0.0 115.876 -171.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -81.58 170.13 16.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.807 2.043 . . . . 0.0 110.37 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.6 mtp -121.21 134.89 55.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.207 1.003 . . . . 0.0 112.105 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.02 159.04 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.849 2.06 . . . . 0.0 112.399 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -124.79 152.3 44.05 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.81 0.844 . . . . 0.0 112.506 172.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 77.7 m -124.5 144.95 49.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.547 1.139 . . . . 0.0 113.015 -169.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -141.79 169.89 16.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.276 1.43 . . . . 0.0 112.78 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -63.1 150.32 42.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.512 1.125 . . . . 0.0 112.789 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -150.4 152.62 34.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.291 1.436 . . . . 0.0 110.681 171.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -70.33 145.67 93.5 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.501 -0.75 . . . . 0.0 112.391 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.41 134.32 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.219 2.613 . . . . 0.0 112.385 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -72.13 -35.36 69.1 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -147.96 146.94 29.17 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.695 2.398 . . . . 0.0 110.657 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.8 p -75.61 148.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.134 0.974 . . . . 0.0 113.427 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.3 145.61 55.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.735 0.814 . . . . 0.0 111.668 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 t -149.04 118.5 3.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.405 1.082 . . . . 0.0 110.707 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.27 165.83 27.18 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.683 2.922 . . . . 0.0 113.206 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 t -146.1 157.25 43.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -81.1 -175.84 50.34 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.175 1.369 . . . . 0.0 114.829 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.9 t -151.24 147.51 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.31 1.444 . . . . 0.0 111.908 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.98 -14.07 59.65 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.464 1.105 . . . . 0.0 113.781 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -71.53 148.85 46.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.556 1.143 . . . . 0.0 112.632 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 174.6 177.36 43.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.072 1.32 . . . . 0.0 113.131 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -148.89 151.3 34.44 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.295 1.438 . . . . 0.0 111.33 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.878 2.071 . . . . 0.0 113.535 -177.073 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.33 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.5 m -133.2 129.45 37.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.848 1.259 . . . . 0.0 113.306 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -73.8 97.02 2.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.305 1.442 . . . . 0.0 109.422 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -152.33 140.26 20.1 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.5 1.12 . . . . 0.0 110.983 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -105.7 4.6 30.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.83 1.252 . . . . 0.0 113.485 -171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.85 149.5 37.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.345 1.458 . . . . 0.0 111.859 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -139.38 151.03 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.406 1.083 . . . . 0.0 113.919 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.13 148.39 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.97 2.108 . . . . 0.0 112.782 167.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.0 t -134.89 134.99 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 109.645 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.48 155.85 26.72 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.016 0.817 . . . . 0.0 114.327 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.79 7.56 66.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.798 1.19 . . . . 0.0 113.784 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.76 143.56 57.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 111.656 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -69.47 154.08 42.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.174 0.589 . . . . 0.0 110.041 167.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.59 -15.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.771 -0.581 . . . . 0.0 111.708 168.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -73.75 -28.85 61.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.074 1.35 . . . . 0.0 113.126 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 m -67.06 123.89 21.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.265 0.8 OUTLIER -80.86 160.58 24.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.52 -29.85 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -75.23 -36.78 61.3 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.397 0.679 . . . . 0.0 111.43 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.02 -43.37 98.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.78 -50.44 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.85 0.86 . . . . 0.0 109.681 173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.49 -46.8 88.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.686 0.675 . . . . 0.0 112.313 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -59.15 -40.15 84.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.534 1.134 . . . . 0.0 112.237 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.41 -54.56 34.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 171.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 48.6 m-85 -63.41 -23.7 67.52 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -60.93 -13.85 18.6 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.31 -29.13 69.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.886 1.221 . . . . 0.0 112.726 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -85.1 -34.43 22.2 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.214 1.005 . . . . 0.0 112.248 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.21 -179.8 41.63 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 127.077 2.275 . . . . 0.0 110.788 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.71 122.72 16.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.19 0.995 . . . . 0.0 112.315 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.7 t -95.65 123.81 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -82.08 -39.94 22.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.753 -0.592 . . . . 0.0 109.547 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -157.91 159.89 37.03 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.63 1.172 . . . . 0.0 110.152 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.62 34.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.383 1.473 . . . . 0.0 110.955 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 mmt -148.65 159.37 44.17 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.654 1.582 . . . . 0.0 113.003 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.0 mt -126.84 143.57 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.983 2.113 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 43.0 mtm -97.62 132.5 43.21 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -126.08 144.37 50.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.925 2.09 . . . . 0.0 116.206 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.0 111.57 19.4 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -61.42 -36.22 79.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.845 0.858 . . . . 0.0 112.991 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 p -75.31 -16.16 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.264 1.4 p -123.17 -5.41 8.38 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.292 1.0 OUTLIER 52.18 39.41 26.78 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.208 2.603 . . . . 0.0 115.367 177.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.82 158.53 43.62 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -59.55 145.83 42.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.318 2.247 . . . . 0.0 113.349 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.56 -11.31 49.1 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.22 14.35 66.7 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.175 0.893 . . . . 0.0 113.99 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.38 4.7 p90 -141.09 162.45 35.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.89 -169.88 28.02 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.089 1.328 . . . . 0.0 114.604 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.05 150.26 52.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.262 2.225 . . . . 0.0 114.394 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 t -136.32 125.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.209 1.404 . . . . 0.0 111.82 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 94.4 m -98.31 128.92 44.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.353 1.461 . . . . 0.0 110.767 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -104.85 150.69 24.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -67.0 -38.13 85.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.575 0.75 . . . . 0.0 112.673 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 t -143.11 134.69 26.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 122.201 1.0 . . . . 0.0 112.904 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -58.34 -27.25 63.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.53 1.932 . . . . 0.0 113.256 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.55 -26.26 68.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -76.75 -50.81 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.904 0.882 . . . . 0.0 109.489 169.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.08 -36.62 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 111.987 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.19 -30.88 60.82 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -84.0 -49.08 9.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.552 0.741 . . . . 0.0 111.668 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.66 -43.58 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.315 0.961 . . . . 0.0 113.433 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.9 t -77.59 -19.17 56.02 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.446 1.098 . . . . 0.0 112.514 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -81.54 -31.19 32.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.254 1.021 . . . . 0.0 112.215 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.15 142.06 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.19 0.996 . . . . 0.0 109.519 168.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -131.23 161.43 32.25 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.743 1.217 . . . . 0.0 111.728 171.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.581 2.1 p90 58.31 45.17 17.46 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -57.41 142.65 43.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.425 2.29 . . . . 0.0 110.688 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.53 106.92 16.38 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.596 1.089 . . . . 0.0 112.978 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.1 mt -123.53 122.93 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.765 1.226 . . . . 0.0 110.528 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 50.97 41.36 27.09 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.461 1.104 . . . . 0.0 112.634 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 62.97 -10.59 0.1 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 128.379 2.672 . . . . 0.0 116.191 -171.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.51 139.92 38.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.166 1.787 . . . . 0.0 109.723 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 20.4 ptm -91.96 140.54 29.57 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.59 -0.694 . . . . 0.0 111.716 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.19 149.5 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.249 1.82 . . . . 0.0 113.289 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -119.83 151.58 38.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.785 1.234 . . . . 0.0 111.093 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 p -129.34 156.11 44.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -143.59 170.37 15.96 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.449 1.899 . . . . 0.0 110.954 -175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.66 153.68 19.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.732 0.813 . . . . 0.0 112.174 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.2 18.89 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.555 1.142 . . . . 0.0 113.979 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -164.51 165.11 13.1 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.539 1.936 . . . . 0.0 110.759 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -64.25 156.47 59.42 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.902 2.401 . . . . 0.0 111.747 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -66.55 120.5 13.52 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.909 0.884 . . . . 0.0 110.561 172.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.93 161.83 19.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.8 m -82.83 -3.42 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.941 1.696 . . . . 0.0 114.486 172.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 98.4 mmm -61.86 140.29 58.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 114.146 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -153.32 86.76 3.98 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.449 1.5 . . . . 0.0 109.424 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.12 155.67 56.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.478 2.785 . . . . 0.0 113.199 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -70.26 159.63 33.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 174.18 -40.19 0.13 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.952 0.787 . . . . 0.0 113.694 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 73.8 p -73.74 152.55 40.34 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.444 1.097 . . . . 0.0 112.525 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.78 33.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.929 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -70.79 116.96 11.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.629 1.172 . . . . 0.0 110.633 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.96 -23.18 77.17 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 114.836 0.695 . . . . 0.0 114.836 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -77.31 -21.45 53.45 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.219 1.408 . . . . 0.0 113.949 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.308 1.443 . . . . 0.0 113.801 -179.35 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 p -81.45 -1.08 44.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -71.55 -6.05 37.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.085 1.754 . . . . 0.0 115.272 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 21.6 mmt -60.5 118.76 6.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.618 1.167 . . . . 0.0 111.86 -170.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -121.33 26.36 8.94 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.79 1.236 . . . . 0.0 111.286 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -153.36 138.71 17.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.125 1.37 . . . . 0.0 110.324 -168.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.1 pt -140.61 149.16 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -173.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -87.88 147.93 24.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.039 1.736 . . . . 0.0 112.658 167.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.29 132.3 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.603 1.561 . . . . 0.0 109.777 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.96 11.64 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 115.026 0.771 . . . . 0.0 115.026 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.92 11.12 35.46 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.549 1.547 . . . . 0.0 114.453 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.3 mt -63.44 140.82 58.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.031 1.333 . . . . 0.0 112.168 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 t -66.47 155.37 37.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.004 0.921 . . . . 0.0 111.625 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 m -72.26 -14.8 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.696 -0.628 . . . . 0.0 111.656 169.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.04 -39.88 93.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.05 0.94 . . . . 0.0 111.969 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.15 127.86 33.83 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.15 165.38 13.52 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 171.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -62.82 -30.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -75.34 -37.49 60.65 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.42 0.688 . . . . 0.0 111.509 174.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.73 -47.18 86.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 t -57.94 -49.22 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 109.039 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -61.52 -44.28 97.35 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.079 0.854 . . . . 0.0 112.355 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -60.71 -46.18 91.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.349 1.06 . . . . 0.0 112.507 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.13 -44.66 96.98 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 48.0 m-85 -66.48 -31.22 71.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -62.28 -12.98 23.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.78 -31.42 72.05 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.248 0.931 . . . . 0.0 113.216 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.81 -39.86 66.29 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.63 168.5 28.92 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.849 2.643 . . . . 0.0 109.539 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -60.81 135.59 57.82 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.483 1.141 . . . . 0.0 113.192 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.47 128.78 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.081 1.753 . . . . 0.0 109.025 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.85 -49.38 30.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.625 1.17 . . . . 0.0 113.891 172.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -154.7 157.29 37.86 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.003 2.121 . . . . 0.0 114.811 -173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.6 39.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.683 1.193 . . . . 0.0 110.959 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.4 ptm -155.43 148.15 24.22 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.774 1.229 . . . . 0.0 112.095 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.98 151.9 49.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.887 1.675 . . . . 0.0 111.297 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 mmt -78.38 69.02 4.51 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.226 1.01 . . . . 0.0 112.77 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.254 54.6 m-85 -58.05 140.04 53.36 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 170.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -133.51 113.84 12.92 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 113.425 -175.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -59.99 -24.57 64.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.006 1.322 . . . . 0.0 113.287 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -24.4 67.66 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 172.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p -131.06 -8.25 3.87 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.04 30.65 20.12 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.861 2.064 . . . . 0.0 114.199 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -150.79 176.72 10.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.473 1.909 . . . . 0.0 109.953 172.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -87.73 154.31 20.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.45 0.643 . . . . 0.0 112.599 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -76.23 8.14 3.6 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.22 14.85 58.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.842 1.21 . . . . 0.0 115.099 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -145.56 158.49 43.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.86 -160.94 24.26 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -134.16 148.3 50.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.542 1.937 . . . . 0.0 114.751 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -136.28 133.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.267 1.427 . . . . 0.0 111.162 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.8 m -107.23 134.21 50.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 0.0 112.709 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.19 149.51 28.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 118.433 2.753 . . . . 0.0 118.433 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -67.91 -27.48 66.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.662 0.785 . . . . 0.0 112.932 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.4 t -147.76 138.74 23.41 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.876 1.27 . . . . 0.0 112.766 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -60.84 -27.63 68.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.697 1.599 . . . . 0.0 113.461 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -62.45 -26.53 68.56 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 30.2 mm -75.03 -50.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.962 0.905 . . . . 0.0 110.272 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 31.3 t -57.49 -34.51 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.348 1.459 . . . . 0.0 111.235 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -52.64 -42.68 64.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 113.165 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.58 -41.83 62.37 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.2 0.909 . . . . 0.0 112.127 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.42 -31.43 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 98.8 m -79.74 -40.28 29.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.171 1.388 . . . . 0.0 113.811 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.19 -43.27 95.59 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.407 0.683 . . . . 0.0 111.873 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.5 114.26 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.54 -51.71 26.8 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.087 -1.008 . . . . 0.0 111.81 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -94.8 139.28 31.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -133.49 132.64 41.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.654 1.582 . . . . 0.0 111.044 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -81.05 127.63 32.82 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.744 -0.598 . . . . 0.0 111.365 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 25.1 mt -140.46 125.0 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 109.136 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 50.47 40.24 22.76 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.219 1.008 . . . . 0.0 112.585 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.7 t30 63.22 -10.7 0.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 128.39 2.676 . . . . 0.0 115.912 -172.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -77.0 143.11 39.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.856 1.662 . . . . 0.0 109.426 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 23.1 ptm -97.15 138.35 34.78 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.424 -0.797 . . . . 0.0 111.458 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.4 m -131.89 146.69 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.731 2.012 . . . . 0.0 112.378 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -89.11 142.88 27.26 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.519 0.728 . . . . 0.0 111.324 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.87 148.63 52.56 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.626 1.17 . . . . 0.0 112.572 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -158.38 164.66 36.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.406 1.482 . . . . 0.0 112.179 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -61.79 143.28 56.53 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.019 0.927 . . . . 0.0 112.305 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -101.66 14.85 30.75 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . 0.253 14.0 pt20 43.57 50.81 6.67 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 127.392 2.277 . . . . 0.0 116.42 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -61.64 165.51 13.47 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.357 2.704 . . . . 0.0 113.431 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -53.43 143.41 19.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.475 1.51 . . . . 0.0 112.766 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -59.31 130.68 48.11 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.856 1.662 . . . . 0.0 112.937 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.8 t -143.04 136.2 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.557 1.943 . . . . 0.0 108.98 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.4 tpp -153.26 146.7 24.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.356 1.063 . . . . 0.0 111.902 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.9 t -154.71 119.89 2.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.111 1.364 . . . . 0.0 109.704 170.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 147.68 58.52 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.054 2.502 . . . . 0.0 112.447 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.2 t -151.67 162.91 40.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -176.4 158.28 24.51 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.584 1.564 . . . . 0.0 112.643 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.9 t -156.76 153.8 28.95 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.802 1.241 . . . . 0.0 111.922 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -151.42 153.22 34.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.87 1.668 . . . . 0.0 111.331 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -149.94 147.52 27.99 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.528 1.531 . . . . 0.0 111.47 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -175.67 -175.52 43.15 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.857 1.217 . . . . 0.0 113.175 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -148.26 147.87 29.83 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.819 1.648 . . . . 0.0 111.152 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.588 1.555 . . . . 0.0 113.283 172.759 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.25 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 m -147.6 161.28 41.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.095 1.358 . . . . 0.0 112.727 -172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -75.92 -27.57 57.69 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.475 -0.766 . . . . 0.0 112.814 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -65.44 126.47 28.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.232 1.013 . . . . 0.0 113.154 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -122.69 7.87 9.45 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.761 2.025 . . . . 0.0 112.909 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.73 154.5 48.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.222 1.409 . . . . 0.0 112.063 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.98 154.54 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.996 1.318 . . . . 0.0 113.313 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -91.4 149.25 21.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.671 1.988 . . . . 0.0 112.979 167.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.85 131.91 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.858 1.663 . . . . 0.0 109.981 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.5 139.62 7.74 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.47 9.51 21.36 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.236 1.874 . . . . 0.0 114.771 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.3 mt -62.75 136.3 57.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.369 1.468 . . . . 0.0 112.518 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -64.64 153.83 38.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.458 1.103 . . . . 0.0 112.05 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.19 -17.07 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.281 0.632 . . . . 0.0 112.332 169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -67.81 -37.5 82.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.938 0.895 . . . . 0.0 111.724 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.1 m -70.12 147.39 49.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.311 1.844 . . . . 0.0 114.484 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 t -140.05 171.54 14.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.688 1.595 . . . . 0.0 112.846 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 p -57.21 -31.99 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -67.2 -40.92 86.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.169 0.988 . . . . 0.0 112.325 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -64.04 -42.46 97.06 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.1 -51.23 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.163 0.985 . . . . 0.0 109.653 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -61.86 -45.85 92.01 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.022 0.828 . . . . 0.0 112.105 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -59.03 -41.79 88.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.761 0.824 . . . . 0.0 112.851 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.46 -46.74 68.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS 0.355 49.9 m-85 -66.43 -26.31 67.16 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 178.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.2 -24.95 66.7 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -65.96 -22.95 66.51 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.486 1.039 . . . . 0.0 112.765 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -71.94 -24.88 61.69 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.58 -98.62 0.13 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.617 1.103 . . . . 0.0 112.573 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -154.23 137.23 15.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.272 1.429 . . . . 0.0 112.031 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.33 130.5 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.194 1.798 . . . . 0.0 108.834 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 -46.97 19.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 112.869 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -158.55 161.21 37.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.531 1.132 . . . . 0.0 110.452 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.05 155.17 41.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.433 1.493 . . . . 0.0 111.48 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.55 155.14 32.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.392 1.077 . . . . 0.0 112.741 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -128.23 152.58 47.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.398 1.879 . . . . 0.0 110.967 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.6 mtp -83.66 144.83 29.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.399 0.68 . . . . 0.0 111.261 171.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.66 156.45 43.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 -172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -111.77 108.48 17.91 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.719 1.208 . . . . 0.0 112.173 168.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.2 -16.0 50.31 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -17.41 64.46 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.2 t -144.29 -14.89 0.59 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 57.17 39.66 28.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.319 1.848 . . . . 0.0 113.297 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -117.35 139.83 50.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.734 2.013 . . . . 0.0 109.355 175.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -70.31 156.52 39.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.29 0.567 . . . . 0.0 111.985 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -80.7 1.63 29.33 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.25 84.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.689 1.138 . . . . 0.0 114.115 -171.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.277 9.1 p90 -143.86 155.23 44.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 117.133 2.272 . . . . 0.0 117.133 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.59 -160.93 23.55 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.978 0.799 . . . . 0.0 114.936 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -137.82 150.69 47.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.297 1.839 . . . . 0.0 114.14 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.41 129.57 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.081 1.352 . . . . 0.0 111.407 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.1 m -97.69 122.83 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.275 1.43 . . . . 0.0 112.055 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -95.05 154.83 16.99 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -70.08 -31.82 69.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.922 0.889 . . . . 0.0 113.387 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 30.2 t -152.07 140.26 20.33 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -53.21 -33.87 54.63 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.752 2.021 . . . . 0.0 113.615 170.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.73 -22.25 66.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.13 -54.31 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.099 0.96 . . . . 0.0 109.509 169.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.7 -39.06 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.766 1.626 . . . . 0.0 111.506 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.7 -40.81 66.34 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -75.48 -42.43 53.05 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.054 0.843 . . . . 0.0 112.361 173.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.58 -30.78 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.02 -40.53 24.12 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.018 1.727 . . . . 0.0 113.287 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.35 -39.77 94.2 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.028 -1.045 . . . . 0.0 111.712 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.6 mt -74.48 108.68 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 168.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.28 -45.86 44.92 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.999 -1.063 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.44 133.59 42.6 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -131.03 130.12 42.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.872 1.669 . . . . 0.0 110.624 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -91.39 130.56 37.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.829 0.852 . . . . 0.0 111.997 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.95 126.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.538 1.535 . . . . 0.0 109.253 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 49.91 42.18 23.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.39 1.076 . . . . 0.0 113.422 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.97 -13.62 0.15 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 127.313 2.245 . . . . 0.0 115.932 -172.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.74 168.3 20.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.168 1.787 . . . . 0.0 110.609 169.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 97.5 mtp -127.18 139.89 52.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.333 1.053 . . . . 0.0 112.151 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.67 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.614 1.966 . . . . 0.0 112.005 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -87.91 141.71 28.37 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.683 0.393 . . . . 0.0 110.876 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.404 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 85.6 m -133.85 146.69 50.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.966 1.306 . . . . 0.0 111.356 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -158.05 171.12 20.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.55 1.14 . . . . 0.0 111.847 174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -59.96 140.68 56.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.71 1.204 . . . . 0.0 111.992 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -108.12 8.06 27.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.718 1.207 . . . . 0.0 113.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -149.52 152.86 36.1 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.66 2.384 . . . . 0.0 111.304 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.55 179.74 6.23 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.244 3.296 . . . . 0.0 112.802 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -132.02 155.11 48.6 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.835 1.254 . . . . 0.0 111.878 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.61 163.84 26.92 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 110.901 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.0 p -65.98 -22.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 28.4 ptm -80.27 162.25 24.7 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.896 1.678 . . . . 0.0 113.757 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 t -161.97 129.83 2.77 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.758 2.023 . . . . 0.0 108.516 168.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.21 144.68 42.29 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.906 2.404 . . . . 0.0 113.153 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 p -82.91 152.91 25.34 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -80.97 143.63 24.32 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.216 0.912 . . . . 0.0 113.216 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.4 p -75.23 156.47 35.72 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.588 1.155 . . . . 0.0 113.168 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.26 161.04 42.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.496 1.518 . . . . 0.0 111.865 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -136.4 18.5 3.14 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.0 -172.03 53.57 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.522 1.058 . . . . 0.0 113.701 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -63.08 153.39 34.26 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.254 1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.829 173.646 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.5 t -153.16 159.31 42.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.438 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -71.06 107.71 4.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.433 1.093 . . . . 0.0 110.892 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 17.2 ptm -158.36 121.28 3.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.849 1.259 . . . . 0.0 111.358 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -117.81 20.84 13.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.852 1.661 . . . . 0.0 110.868 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -154.91 144.29 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.198 1.399 . . . . 0.0 111.374 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 pt -140.41 155.01 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.586 1.155 . . . . 0.0 113.301 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -94.5 145.77 24.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.198 2.199 . . . . 0.0 112.789 167.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.1 138.77 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.051 1.74 . . . . 0.0 109.726 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.51 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.93 13.65 54.23 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.375 1.464 . . . . 0.0 114.215 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.5 mt -62.79 138.6 58.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.256 1.422 . . . . 0.0 112.215 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.1 t -64.44 155.15 33.56 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.112 0.965 . . . . 0.0 111.734 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.4 p -67.97 -21.07 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.868 169.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -69.95 -30.89 68.37 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.478 1.111 . . . . 0.0 112.911 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.4 m -79.7 128.69 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.393 1.477 . . . . 0.0 114.236 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.51 166.21 12.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.02 -30.12 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 169.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -74.76 -35.94 62.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.486 0.715 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.7 -46.87 87.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.632 0.651 . . . . 0.0 112.364 170.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.5 t -61.73 -50.62 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.595 1.158 . . . . 0.0 109.422 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.7 -48.59 81.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.82 0.736 . . . . 0.0 112.177 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -60.73 -39.45 88.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.789 0.836 . . . . 0.0 112.553 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.61 -48.66 66.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 50.4 m-85 -62.92 -29.5 70.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -59.91 -20.84 59.62 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -70.29 -25.66 63.43 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.14 0.882 . . . . 0.0 112.674 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.42 -38.28 59.91 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.17 37.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.518 2.008 . . . . 0.0 111.326 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -58.55 119.41 6.99 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.109 0.964 . . . . 0.0 112.995 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -93.93 131.4 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.0 107.987 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -86.44 -35.1 19.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -163.87 158.6 20.09 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.249 1.419 . . . . 0.0 109.398 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.21 139.52 22.33 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.067 1.347 . . . . 0.0 110.608 172.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.1 mmt -148.8 151.12 34.23 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.421 1.488 . . . . 0.0 112.254 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.3 mt -122.62 151.73 41.17 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.487 1.515 . . . . 0.0 111.074 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtp -81.3 75.42 8.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.711 0.804 . . . . 0.0 112.35 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -61.07 143.13 55.99 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -129.18 122.42 29.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.42 -23.92 66.17 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -79.38 -13.67 59.46 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 174.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.0 p -123.67 -19.53 5.76 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 59.0 25.66 14.11 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.58 1.952 . . . . 0.0 114.828 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -145.9 171.07 15.36 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.632 1.573 . . . . 0.0 110.879 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -78.18 150.07 33.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 112.077 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -78.96 12.8 2.01 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 88.63 15.15 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.786 1.184 . . . . 0.0 114.674 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.266 8.5 p90 -146.91 159.09 43.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.28 -160.59 22.74 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.192 0.901 . . . . 0.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.35 150.65 44.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.029 1.731 . . . . 0.0 114.207 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.27 130.32 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.354 1.461 . . . . 0.0 111.938 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -93.75 144.73 25.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.401 1.88 . . . . 0.0 114.431 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -125.95 151.08 47.47 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 118.167 2.654 . . . . 0.0 118.167 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -61.57 -37.2 82.96 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.004 1.322 . . . . 0.0 113.636 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 t -153.94 148.19 25.9 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.321 1.049 . . . . 0.0 112.496 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -61.8 -24.73 67.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.184 0.994 . . . . 0.0 112.583 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -56.46 -35.92 68.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.545 1.138 . . . . 0.0 111.909 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.44 -51.42 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.954 0.902 . . . . 0.0 110.057 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.9 t -57.77 -38.41 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.351 1.06 . . . . 0.0 111.716 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -54.12 -45.75 72.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.021 0.928 . . . . 0.0 112.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -72.31 -43.36 64.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.828 0.74 . . . . 0.0 112.023 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.0 -43.33 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.057 0.844 . . . . 0.0 111.465 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 44.5 t -74.87 -33.64 62.12 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.083 1.353 . . . . 0.0 113.074 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -64.67 -42.05 95.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.3 mt -71.44 107.62 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 169.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.69 -43.63 65.64 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.39 -1.444 . . . . 0.0 112.544 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -99.82 138.61 36.66 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -138.88 136.51 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.993 1.717 . . . . 0.0 110.836 -173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -103.15 130.6 50.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.089 0.956 . . . . 0.0 112.738 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.4 130.61 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.567 1.547 . . . . 0.0 109.285 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 52.33 37.14 21.56 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.33 1.052 . . . . 0.0 113.413 -175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 61.68 -5.47 0.14 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 127.946 2.498 . . . . 0.0 115.768 -170.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.43 167.33 20.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.697 2.399 . . . . 0.0 109.216 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 98.1 mtp -123.21 143.61 49.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.968 0.907 . . . . 0.0 112.909 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.78 164.54 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.226 2.61 . . . . 0.0 111.653 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -109.31 155.43 21.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.807 0.843 . . . . 0.0 110.826 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.4 p -141.85 154.67 45.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.285 0.634 . . . . 0.0 110.747 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -159.96 -175.36 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.749 1.22 . . . . 0.0 111.729 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -53.39 149.61 7.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.559 1.544 . . . . 0.0 114.637 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.06 155.48 42.24 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.698 1.999 . . . . 0.0 109.458 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.43 139.6 92.04 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.491 -0.766 . . . . 0.0 112.796 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -58.63 155.49 36.76 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.856 3.037 . . . . 0.0 116.53 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -140.81 30.4 1.86 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.052 2.141 . . . . 0.0 113.064 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -71.56 169.96 14.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.196 1.398 . . . . 0.0 113.284 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.38 142.78 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.527 1.531 . . . . 0.0 112.707 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 96.9 mtp -75.32 154.78 37.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.333 1.053 . . . . 0.0 112.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 42.5 t -157.48 133.43 6.0 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.09 1.356 . . . . 0.0 110.864 172.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.81 -10.72 9.33 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.464 2.776 . . . . 0.0 113.883 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.287 1.1 p -72.19 159.94 33.27 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 -174.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.61 175.41 41.32 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.347 1.451 . . . . 0.0 112.88 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.5 p -70.03 153.31 43.36 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.467 1.107 . . . . 0.0 113.788 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.29 161.47 41.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.887 1.675 . . . . 0.0 111.554 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -69.82 144.17 52.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.154 0.982 . . . . 0.0 112.237 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.01 -10.63 85.37 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.419 1.009 . . . . 0.0 115.431 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -148.7 143.95 26.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.28 1.832 . . . . 0.0 111.267 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.379 1.471 . . . . 0.0 113.285 177.333 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.3 p -137.94 11.62 2.87 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.714 1.606 . . . . 0.0 113.878 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -73.68 -20.1 60.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.979 1.711 . . . . 0.0 114.465 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -72.25 159.95 33.21 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -126.29 23.06 7.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.696 1.998 . . . . 0.0 110.917 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -148.55 155.3 40.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.222 -0.924 . . . . 0.0 112.542 -167.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.31 153.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.908 1.283 . . . . 0.0 113.137 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -93.71 145.55 24.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.274 2.23 . . . . 0.0 112.237 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -133.43 139.93 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.759 1.624 . . . . 0.0 110.213 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.77 147.72 17.45 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 118.785 0.72 . . . . 0.0 114.652 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.55 12.04 34.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.667 1.603 . . . . 0.0 114.323 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.49 136.57 55.87 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.121 1.368 . . . . 0.0 112.117 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -65.89 154.98 37.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.169 0.988 . . . . 0.0 112.139 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.96 -17.0 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 121.655 -0.653 . . . . 0.0 111.327 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -69.73 -30.07 67.6 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.243 1.017 . . . . 0.0 112.54 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -74.96 131.39 40.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.814 1.645 . . . . 0.0 114.884 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -97.54 167.75 10.78 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 115.318 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.55 -28.75 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -75.01 -35.91 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.632 0.773 . . . . 0.0 111.795 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.49 -45.15 94.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 169.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -61.01 -51.25 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.206 1.002 . . . . 0.0 109.232 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -57.23 -49.49 75.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.436 0.694 . . . . 0.0 112.063 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -60.47 -41.72 94.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.065 0.946 . . . . 0.0 112.554 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -66.48 -48.21 70.58 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.316 54.5 m-85 -65.46 -29.47 70.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.37 -20.91 61.28 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -69.14 -26.47 64.9 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.184 0.902 . . . . 0.0 112.635 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -77.62 -38.52 47.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.65 179.9 41.16 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.406 1.955 . . . . 0.0 111.208 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -64.66 121.82 15.4 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.2 132.54 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.683 1.993 . . . . 0.0 107.827 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.85 -55.96 5.12 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 113.18 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.69 169.54 21.35 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.18 0.992 . . . . 0.0 109.872 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.4 152.95 47.51 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.557 1.543 . . . . 0.0 111.842 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 48.9 mmm -149.2 158.26 44.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.501 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.6 mt -124.19 152.33 43.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.58 1.552 . . . . 0.0 111.581 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.09 101.68 7.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.104 0.962 . . . . 0.0 110.317 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.279 62.8 m-85 -82.07 130.17 35.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -83.15 103.68 12.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.434 1.093 . . . . 0.0 108.167 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.27 -22.6 61.41 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -69.43 -25.59 64.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.356 0.2 OUTLIER -133.86 -4.35 2.84 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 176.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.2 t30 58.32 42.38 21.68 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.372 1.869 . . . . 0.0 113.229 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -118.83 148.71 42.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.555 1.942 . . . . 0.0 110.206 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -76.95 151.04 35.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.258 0.935 . . . . 0.0 112.539 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -81.96 7.32 13.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.19 10.54 71.21 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.773 1.177 . . . . 0.0 114.598 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.29 11.8 p90 -141.75 159.69 41.7 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.84 -162.43 23.17 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.99 0.805 . . . . 0.0 114.506 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.22 150.12 46.43 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.497 1.919 . . . . 0.0 113.891 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.4 t -133.72 128.14 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.921 1.288 . . . . 0.0 111.59 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.6 m -92.33 140.39 29.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.146 1.378 . . . . 0.0 113.067 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -122.53 152.65 40.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.056 2.142 . . . . 0.0 116.641 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -76.6 -29.13 56.42 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 t -135.83 129.95 33.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.187 0.995 . . . . 0.0 113.577 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 pm0 -62.88 -29.93 71.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.119 1.768 . . . . 0.0 112.791 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.57 -31.51 72.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.45 -46.41 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.766 0.826 . . . . 0.0 110.118 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.1 t -54.46 -43.5 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.265 1.026 . . . . 0.0 109.836 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.2 -53.13 61.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.0 0.92 . . . . 0.0 113.337 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -64.87 -43.0 94.39 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.22 0.918 . . . . 0.0 111.836 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.84 -42.12 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.777 0.717 . . . . 0.0 110.153 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 92.8 m -70.42 -31.38 68.56 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.87 -36.13 79.74 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.29 0.95 . . . . 0.0 112.892 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.6 mt -74.9 136.13 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.985 0.914 . . . . 0.0 110.235 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -131.09 160.18 35.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.984 1.314 . . . . 0.0 111.67 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.477 5.3 m-85 63.34 46.79 4.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -62.29 134.92 57.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.374 1.869 . . . . 0.0 110.885 171.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -93.34 112.83 24.86 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.463 -0.773 . . . . 0.0 112.57 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.0 mt -132.62 120.34 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.556 0.742 . . . . 0.0 111.311 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 49.62 44.16 24.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.769 1.227 . . . . 0.0 113.109 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.4 m120 62.64 -8.04 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 128.076 2.55 . . . . 0.0 115.852 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -84.56 154.02 22.89 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.593 1.957 . . . . 0.0 109.471 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 57.5 mmm -99.64 139.91 34.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.175 0.59 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.37 160.44 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.815 1.646 . . . . 0.0 114.004 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -123.12 159.2 29.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.706 1.202 . . . . 0.0 111.482 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -144.99 159.18 43.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.245 1.018 . . . . 0.0 112.954 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -145.22 162.14 37.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.422 1.889 . . . . 0.0 111.037 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -58.64 145.82 38.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.673 0.789 . . . . 0.0 112.939 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.37 46.92 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.683 1.593 . . . . 0.0 110.012 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -70.49 144.53 91.73 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.195 -0.94 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.74 135.41 32.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.187 2.591 . . . . 0.0 112.275 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -76.84 -25.43 53.17 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.11 161.93 41.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.51 2.324 . . . . 0.0 110.895 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.05 143.36 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.967 1.307 . . . . 0.0 112.436 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -153.98 151.06 28.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.997 1.319 . . . . 0.0 111.077 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.4 t -151.07 123.32 4.02 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.871 1.268 . . . . 0.0 109.252 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.68 147.91 46.02 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.042 2.495 . . . . 0.0 112.705 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.2 p -72.32 -18.48 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.204 1.928 . . . . 0.0 116.204 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 175.59 175.27 42.87 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.227 1.394 . . . . 0.0 113.193 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 46.5 t -159.0 -47.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.839 1.255 . . . . 0.0 112.155 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.3 153.26 41.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.212 1.005 . . . . 0.0 112.657 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 160.63 43.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 111.493 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.35 144.6 47.75 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.003 0.811 . . . . 0.0 113.622 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.47 142.24 48.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.904 1.282 . . . . 0.0 110.572 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.05 1.74 . . . . 0.0 113.696 176.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.9 m -69.35 140.31 54.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.031 0.932 . . . . 0.0 113.114 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -72.45 128.74 36.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.487 0.715 . . . . 0.0 112.5 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.3 mmt -136.19 58.7 1.73 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.441 1.896 . . . . 0.0 110.128 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -91.27 2.01 56.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.369 1.468 . . . . 0.0 112.151 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -133.73 167.51 20.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.457 1.903 . . . . 0.0 110.825 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 pt -140.88 148.74 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.709 1.204 . . . . 0.0 112.848 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -81.5 148.85 28.99 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.797 1.639 . . . . 0.0 111.189 164.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.35 135.2 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.533 1.533 . . . . 0.0 109.854 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.1 149.27 21.24 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.592 0.633 . . . . 0.0 114.674 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.86 9.03 55.06 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.535 1.54 . . . . 0.0 114.526 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.79 138.48 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.929 1.292 . . . . 0.0 112.018 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -65.23 152.09 44.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.508 0.723 . . . . 0.0 111.192 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 m -72.32 -14.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.579 -0.701 . . . . 0.0 111.696 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -70.43 -31.59 68.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.983 0.913 . . . . 0.0 112.199 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -73.83 141.0 46.18 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.794 1.638 . . . . 0.0 113.406 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -123.59 166.3 15.7 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.23 -31.21 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -65.84 -38.09 87.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.053 0.941 . . . . 0.0 112.334 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.8 -43.24 84.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.856 . . . . 0.0 109.547 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.47 -49.42 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.562 1.145 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -62.46 -46.4 88.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.575 0.625 . . . . 0.0 111.781 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -59.7 -42.25 92.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 112.368 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -66.03 -49.47 67.6 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.299 42.5 m-85 -62.93 -27.67 69.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.62 -16.44 48.4 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -65.41 -31.55 72.71 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.51 -35.71 58.18 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.9 175.51 36.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 127.117 2.294 . . . . 0.0 110.553 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -63.3 133.3 53.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.3 t -112.34 122.54 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.492 1.917 . . . . 0.0 109.492 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -77.31 -45.2 26.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.355 1.062 . . . . 0.0 112.235 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.83 159.46 41.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.608 1.963 . . . . 0.0 115.18 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.68 152.33 40.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.084 1.354 . . . . 0.0 110.762 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.3 ptp -157.78 147.57 20.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.505 1.122 . . . . 0.0 112.19 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.6 mt -126.93 153.27 46.03 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.593 1.557 . . . . 0.0 111.593 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 95.5 mmm -78.37 67.67 4.21 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 112.641 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -59.24 141.0 55.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -133.84 114.77 13.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.655 1.182 . . . . 0.0 113.985 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -62.5 -19.1 63.25 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -22.16 65.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 171.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -133.3 -9.05 2.94 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.17 26.04 15.62 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.747 2.019 . . . . 0.0 114.746 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -148.58 175.93 10.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.187 1.795 . . . . 0.0 110.282 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -86.24 156.55 20.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.471 0.653 . . . . 0.0 112.544 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -74.53 6.3 3.91 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.06 13.5 58.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.023 1.297 . . . . 0.0 114.862 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.26 16.0 p90 -145.69 161.1 40.67 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.32 -160.38 23.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.216 0.912 . . . . 0.0 114.72 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -136.9 151.97 49.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.245 1.818 . . . . 0.0 114.342 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.15 131.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.505 1.522 . . . . 0.0 111.042 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.8 m -99.06 126.42 44.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.037 1.735 . . . . 0.0 113.243 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -104.2 154.09 20.18 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -74.41 -18.46 60.65 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.5 t -153.04 141.14 20.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.327 1.051 . . . . 0.0 113.11 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -62.87 -27.4 69.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 112.817 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.34 -28.11 68.98 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.47 -48.7 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.765 0.826 . . . . 0.0 110.102 170.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.05 -40.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.065 1.346 . . . . 0.0 110.554 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -56.93 -43.7 81.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.041 0.837 . . . . 0.0 113.134 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -70.63 -43.18 69.76 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.109 0.868 . . . . 0.0 111.994 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -58.45 -37.54 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.717 0.69 . . . . 0.0 111.477 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 50.4 t -73.6 -41.56 62.69 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 113.092 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -62.43 -38.37 89.48 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.219 -0.925 . . . . 0.0 112.491 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.69 106.5 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -65.53 -55.63 16.74 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.158 -0.963 . . . . 0.0 111.671 -174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.361 63.9 m-85 -103.27 137.0 41.99 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -131.47 159.66 37.43 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.081 2.553 . . . . 0.0 109.655 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -126.66 125.24 41.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.629 1.104 . . . . 0.0 113.533 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.37 125.75 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.325 1.45 . . . . 0.0 109.757 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 50.17 40.19 21.37 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.237 1.015 . . . . 0.0 112.871 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.05 -8.61 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.308 2.643 . . . . 0.0 116.32 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -79.44 140.64 37.31 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.834 1.654 . . . . 0.0 109.232 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 39.5 mtm -92.33 147.78 22.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 m -138.24 153.49 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.769 2.428 . . . . 0.0 111.533 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.35 150.31 28.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.631 0.773 . . . . 0.0 111.293 170.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -143.26 142.91 31.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.827 0.851 . . . . 0.0 112.906 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -144.51 156.42 44.16 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.023 1.329 . . . . 0.0 111.626 -168.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -54.9 141.49 33.22 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.91 146.99 41.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.917 1.687 . . . . 0.0 111.59 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.09 133.49 28.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.052 0.941 . . . . 0.0 113.528 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -68.92 165.56 29.52 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.996 3.131 . . . . 0.0 114.233 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.27 -9.43 55.04 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -156.19 163.53 39.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.936 1.694 . . . . 0.0 112.578 -176.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.5 139.92 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.619 1.167 . . . . 0.0 112.465 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 73.2 mtp -137.44 129.73 29.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.495 1.518 . . . . 0.0 110.095 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.3 t -164.0 126.45 1.61 Allowed Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.988 0.915 . . . . 0.0 110.654 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.78 146.55 33.78 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.905 2.403 . . . . 0.0 112.115 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -152.37 166.3 32.31 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.03 -170.01 54.77 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.102 1.334 . . . . 0.0 114.716 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 t -155.28 173.69 16.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.825 1.65 . . . . 0.0 110.984 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.46 169.13 7.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.025 1.73 . . . . 0.0 114.113 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.82 160.71 38.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.586 1.555 . . . . 0.0 111.545 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 87.33 166.9 43.06 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.113 1.34 . . . . 0.0 114.32 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.83 129.5 39.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.376 1.471 . . . . 0.0 110.343 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.647 1.579 . . . . 0.0 112.769 178.732 . . . . . . . . 0 0 . 1 stop_ save_